,assignee_names,assignees,filing_status,granted_year,id,inventor_names,publication_date,times_cited,title,year
0,['SPHINGOTEC GMBH'],,Application,,WO-2016170023-A1,"['BERGMANN, ANDREAS', 'MELANDER, OLLE']",2016-10-27,,A METHOD FOR PREDICTING THE RISK OF INCIDENCE OF CHRONIC KIDNEY DISEASE,2016
1,"['Purdue Pharma LP', 'PURDUE PHARMACEUTICAL PRODUCTS L P']","[{'id': 'grid.418726.e', 'name': 'Purdue Pharma (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9993482-B2,['Thomas Jorg Mehrling'],2018-06-12,,Pharmaceutical combination comprising a class III receptor tyrosine kinase inhibitor and the alkylating histone-deacetylase inhibitor fusion molecule EDO-S101 together with its use in the treatment of cancer,2015
2,"['Sunshire Lake Pharma Co Ltd', 'Sunshine Lake Pharma Co Ltd', 'Calitor Sciences LLC', 'SUNSHINE LAKE PHARMA CO LTD', 'CALITOR SCIENCES LLC', 'SUNSHIRE LAKE PHARMA CO LTD']",,Grant,2018.0,US-9957233-B1,['Ning Xi'],2018-05-01,,Process for preparing substituted quinolin-4-ol compounds,2017
3,['LAZZARINO GIUSEPPE'],,Application,,WO-2018078665-A1,"['LAZZARINO, GIUSEPPE', 'TAVAZZI, BARBARA', 'LAZZARINO, Giacomo', 'AMORINI, ANGELA MARIA', 'DI STASIO, Enrico', 'GASPERINI, Claudio']",2018-05-03,,BIOMARKERS AND METHODS FOR IN VITRO DIAGNOSIS OF MULTIPLE SCLEROSIS,2017
4,"['DIASORIN S P A', 'UNIV LOUVAIN']","[{'id': 'grid.7942.8', 'acronym': 'UCL', 'name': 'Catholic University of Louvain', 'country_name': 'Belgium'}]",Application,,WO-2016113719-A1,"['GRUSON, Damien', 'ROUSSEAU, MICHEL', 'ZIEROLD, CLAUDIA', 'BONELLI, FABRIZIO', 'BLOCKI, Frank']",2016-07-21,,"USE OF 1,25-DIHYDROXYVITAMIN D VALUES IN RATIO WITH PTH AS A PROGNOSTIC BIOMARKER",2016
5,['LABORATOIRES M&L'],,Application,,WO-2018002475-A1,"['Cenizo, Valérie', 'LEMAIRE, Géraldine', 'PORTES, PASCAL']",2018-01-04,,USE OF AN ESSENTIAL OIL OF EVERLASTING FLOWER IN ORDER TO INCREASE OR RESTORE TACTILE PERCEPTION,2017
6,['UNIV LONDON QUEEN MARY'],"[{'id': 'grid.4868.2', 'acronym': 'QMUL', 'name': 'Queen Mary University of London', 'country_name': 'United Kingdom'}]",Application,,WO-2016146979-A1,"['NISSIM, AHUVA', 'POZZILLI, PAOLO', 'STROLLO, Rocky']",2016-09-22,,ANTIBODIES AGAINST MODIFIED INSULIN FOR USE IN TREATMENT OF AND ASSAYS FOR DIABETES,2016
7,['NOVINTETHICAL PHARMA SA'],"[{'id': 'grid.487293.3', 'name': 'Novintethical Pharma (Switzerland)', 'country_name': 'Switzerland'}]",Application,,WO-2017207223-A1,"['Alonso Cohen, Miguel Angel', 'Di Fulvio, Marco']",2017-12-07,1.0,COMPOSITIONS FOR THE TREATMENT OF INTESTINAL DISORDERS,2017
8,"['INST NAT SANTE RECH MED', 'UNIV RENNES']","[{'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}, {'id': 'grid.410368.8', 'name': 'University of Rennes 1', 'country_name': 'France'}]",Application,,WO-2013064555-A1,"['PINEAU, CHARLES', 'ROLLAND, Antoine', 'CALVEL, Pierre', 'LAVIGNE, Régis']",2013-05-10,1.0,METHOD FOR PREDICTING THE PRESENCE OF REPRODUCTIVE CELLS IN TESTIS,2012
9,"['Institute for Res in Biomedicine', 'INSTITUTE FOR RES IN BIOMEDICINE']","[{'id': 'grid.29078.34', 'acronym': 'USI', 'name': 'University of Italian Switzerland', 'country_name': 'Switzerland'}]",Application,,EP-3308778-A1,"['GEIGER, Roger', 'LANZAVECCHIA, ANTONIO', 'SALLUSTO, Federica']",2018-04-18,,ARGININE AND ITS USE AS A T CELL MODULATOR,2016
10,['INSTITUTE FOR RES IN BIOMEDICINE'],"[{'id': 'grid.29078.34', 'acronym': 'USI', 'name': 'University of Italian Switzerland', 'country_name': 'Switzerland'}]",Application,,WO-2018069471-A1,"['GEIGER, Roger', 'LANZAVECCHIA, ANTONIO', 'SALLUSTO, Federica']",2018-04-19,,ARGININE AND ITS USE AS A T CELL MODULATOR,2017
11,"['GLAXOSMITHKLINE BIOLOGICALS SA', 'UNIV PIERRE ET MARIE CURIE (PARIS 6)', 'INST NAT SANTE RECH MED']","[{'id': 'grid.425090.a', 'acronym': 'GSK', 'name': 'GlaxoSmithKline (Belgium)', 'country_name': 'Belgium'}, {'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}, {'id': 'grid.462844.8', 'name': 'Sorbonne University', 'country_name': 'France'}]",Application,,WO-2017102939-A1,"['MOREL, SANDRA', 'POUCHY, Charlotte, Véronique', 'SALOMON, Benoit, Laurent', 'VANERHEYDE, Nathalie, Raoul, Liliane']",2017-06-22,,USE OF ADJUVANTS FOR THE PREVENTION AND/OR TREATMENT OF AUTOIMMUNE DISEASES,2016
12,['ECOLE POLYTECHNIQUE FED LAUSANNE EPFL'],,Application,,WO-2018041995-A3,"['TSAO, HOI NOK', 'GRAETZEL, MICHAEL']",2018-04-12,,OPTOELECTRONIC AND/OR ELECTROCHEMICAL LEARNING DEVICE,2017
13,"['DELTA ELECTRONICS (THAILAND) PUBLIC COMPANY LIMITE', 'DET INTERNATIONAL HOLDING LTD']",,Application,,EP-3258582-A1,"['Beinlich, Dominik Reinhard']",2017-12-20,,RIPPLE COMPENSATION CIRCUIT OF POWER SUPPLY AND COMPENSATING METHOD THEREOF,2016
14,"['SAP Portals Israel Ltd', 'SAP PORTALS ISRAEL LTD']",,Grant,2017.0,US-9854396-B2,"['Evgeny Himmelreich', 'Nirit Cohen-Zur', 'Rachel Ebner']",2017-12-26,3.0,Monitoring movement transitions via cellular network data,2015
15,"['Commissariat a l Energie Atomique et aux Energies Alternatives', 'COMMISSARIAT ENERGIE ATOMIQUE']","[{'id': 'grid.5583.b', 'acronym': 'CEA', 'name': 'Atomic Energy and Alternative Energies Commission', 'country_name': 'France'}]",Application,,FR-3043480-A1,"['CALVANESE STRINATI EMILIO', 'OUEIS JESSICA']",2017-05-12,,METHOD AND SYSTEM FOR COMPILING CLUSTERS OF COMPUTER CLOUD EQUIPMENT WITH DISTRIBUTED RESOURCE ALLOCATION AND CORRECTION OF CENTRALIZED FEASIBILITY,2015
16,['NESTEC SA'],"[{'id': 'grid.419905.0', 'name': 'Nestlé (Switzerland)', 'country_name': 'Switzerland'}]",Application,,WO-2017085138-A1,"['BREUILLE, DENIS', 'OFFORD CAVIN, ELIZABETH', 'ROESSLE, CLAUDIA', 'FIELDING, Roger']",2017-05-26,,METHODS USING WHEY PROTEIN TO IMPROVE OR MAINTAIN MUSCLE QUALITY,2016
17,"['Biovie Inc', 'Nanoantibiotics Inc', 'Universita Degli Studi di Padova', 'NANOANTIBIOTICS INC', 'UNIV DEGLI STUDI DI PADOVA', 'BIOVIE INC']","[{'id': 'grid.5608.b', 'acronym': 'UNIPD', 'name': 'University of Padua', 'country_name': 'Italy'}]",Grant,2017.0,US-9655945-B2,"['Paolo Angeli', 'Penelope Markham', 'Jonathan Adams']",2017-05-23,1.0,Treatment of ascites,2016
18,"['ASSIST PUBLIQUE HOPITAUX DE PARIS AP HP', 'INST NAT SANTE RECH MED', 'UNIV PARIS DESCARTES']","[{'id': 'grid.10992.33', 'name': 'Paris Descartes University', 'country_name': 'France'}, {'id': 'grid.50550.35', 'acronym': 'AP-HP', 'name': 'Assistance Publique -Hopitaux De Paris', 'country_name': 'France'}, {'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}]",Application,,WO-2018046870-A1,"['MENASCHE, PHILIPPE', 'RENAULT, Nisa', 'BELLAMY, Valérie', 'PIDIAL, Laetitia']",2018-03-15,,BIOMATERIAL FOR THERAPEUTIC USE,2017
19,['DEBRECENI EGYETEM'],"[{'id': 'grid.7122.6', 'name': 'University of Debrecen', 'country_name': 'Hungary'}]",Application,,WO-2016120647-A2,"['NAGY, László', 'VARGA, Tamás']",2016-08-04,,MUSCLE REGENERATION,2015
20,"[""UNIVERSITA' DEGLI STUDI DI ROMA LA SAPIENZA""]","[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Application,,WO-2017149474-A1,"['SARTO, MARIA SABRINA', 'POLIMENI, Antonella', 'UCCELLETTI, DANIELA', ""BOSSU', Maurizio"", 'BREGNOCCHI, Agnese', 'CHANDRAIAHGARI, Chandrakanth Reddy', 'ZANNI, Elena', 'DE ANGELIS, Francesca']",2017-09-08,,PROCESS FOR THE PRODUCTION OF ANTIMICROBIAL DENTAL ADHESIVES INCLUDING GRAPHENE AND RELATIVE PRODUCT THEREOF,2017
21,['UNIV KING ABDULLAH SCI & TECH'],"[{'id': 'grid.45672.32', 'acronym': 'KAUST', 'name': 'King Abdullah University of Science and Technology', 'country_name': 'Saudi Arabia'}]",Application,,WO-2017103783-A1,"['LI, LAIN-JONG', 'MING, Jun']",2017-06-22,,"LITHIUM-SULFUR BATTERY, A DUAL BLOCKING LAYER, METHODS OF MAKING, AND METHODS OF USE THEREOF",2016
22,['ALU-ÖNTÖ KFT'],,Application,,WO-2016181177-A2,"['HAJAS, Gergely']",2016-11-17,,CASTING PROCESS AND SAND MOULD PROVIDED WITH AN INLET SYSTEM FOR PRODUCING AT LEAST PARTLY THIN WALLED ALUMINIUM CASTS WITH SAND MOULDING TECHNOLOGY BY MEANS OF GRAVITY CASTING,2016
23,['AMGEN INC'],"[{'id': 'grid.417886.4', 'acronym': 'Amgen, Inc.', 'name': 'Amgen (United States)', 'country_name': 'United States'}]",Application,,WO-2016176427-A1,"['BACH, BRUCE ALLEN', 'VOGL, Florian']",2016-11-03,,TREATMENT OF OVARIAN CANCER IN PATIENTS WITH ASCITES USING A SPECIFIC BINDING AGENT OF HUMAN ANGIOPOIETIN-2 IN COMBINATION WITH A TAXANE,2016
24,"['Fujitsu Ltd', 'FUJITSU LTD']","[{'id': 'grid.418251.b', 'name': 'Fujitsu (Japan)', 'country_name': 'Japan'}]",Application,,DE-102016214332-A1,"['Kiyoshi Nakayama', 'Wei-Peng Chen']",2017-07-20,,Aggregated and optimized virtual - power station - control,2016
25,"['Fresenius Medical Care Deutschland GmbH', 'FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH']","[{'id': 'grid.415062.4', 'name': 'Fresenius Medical Care (Germany)', 'country_name': 'Germany'}]",Application,,DE-102015015597-A1,"['Janine Büchel', 'Robert Pohlmeier', 'Sonja Steppan']",2017-06-08,,Treatment of stroke by means of haemofiltration,2015
26,"['Commissariat a l Energie Atomique et aux Energies Alternatives', 'COMMISSARIAT ENERGIE ATOMIQUE']","[{'id': 'grid.5583.b', 'acronym': 'CEA', 'name': 'Atomic Energy and Alternative Energies Commission', 'country_name': 'France'}]",Application,,FR-3043480-A1,"['CALVANESE STRINATI EMILIO', 'OUEIS JESSICA']",2017-05-12,,METHOD AND SYSTEM FOR COMPILING CLUSTERS OF COMPUTER CLOUD EQUIPMENT WITH DISTRIBUTED RESOURCE ALLOCATION AND CORRECTION OF CENTRALIZED FEASIBILITY,2015
27,['LIVERPOOL SCHOOL OF TROPICAL MEDICINE'],"[{'id': 'grid.48004.38', 'acronym': 'LSTM', 'name': 'Liverpool School of Tropical Medicine', 'country_name': 'United Kingdom'}]",Application,,WO-2017103615-A1,"['BIAGINI, Giancarlo A.', 'WARD, STEPHEN A.', 'NIXON, Gemma L.', ""O'NEILL, Paul M.""]",2017-06-22,1.0,COMBINATION PRODUCT,2016
28,['UNIV KING ABDULLAH SCI & TECH'],"[{'id': 'grid.45672.32', 'acronym': 'KAUST', 'name': 'King Abdullah University of Science and Technology', 'country_name': 'Saudi Arabia'}]",Application,,WO-2017103783-A1,"['LI, LAIN-JONG', 'MING, Jun']",2017-06-22,,"LITHIUM-SULFUR BATTERY, A DUAL BLOCKING LAYER, METHODS OF MAKING, AND METHODS OF USE THEREOF",2016
29,['CERENIS THERAPEUTICS HOLDING SA'],"[{'id': 'grid.476203.4', 'name': 'Cerenis Therapeutics (France)', 'country_name': 'France'}]",Application,,WO-2018029505-A1,"['HECKLAU PEYROTTES, Constance']",2018-02-15,,CER-001 THERAPY FOR TREATING FAMILIAL PRIMARY HYPOALPHALIPOPROTEINEMIA,2016
30,['FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH'],"[{'id': 'grid.415062.4', 'name': 'Fresenius Medical Care (Germany)', 'country_name': 'Germany'}]",Application,,WO-2017093553-A1,"['BÜCHEL, JANINE', 'POHLMEIER, ROBERT', 'STEPPAN, SONJA']",2017-06-08,,HEMOFILTRATION SOLUTIONS FOR THE TREATMENT OF STROKES,2016
31,"['Commissariat a l Energie Atomique et aux Energies Alternatives', 'COMMISSARIAT ENERGIE ATOMIQUE']","[{'id': 'grid.5583.b', 'acronym': 'CEA', 'name': 'Atomic Energy and Alternative Energies Commission', 'country_name': 'France'}]",Application,,FR-3045859-A1,"['CALVANESE STRINATI EMILIO', 'OUEIS JESSICA']",2017-06-23,,METHOD AND APPARATUS FOR FORMING A COMPUTER CLOUD STORING THE RESULT OF EXECUTION FROM A COMPUTER TASK,2015
32,['FRIEDRICH MIESCHER INST FOR BIOMEDICAL RES'],"[{'id': 'grid.482245.d', 'acronym': 'FMI', 'name': 'Friedrich Miescher Institute', 'country_name': 'Switzerland'}]",Application,,WO-2017093931-A1,"['Hartl, Dominik', 'SCHUEBELER, DIRK', 'ROSKA, BOTOND', 'KREBS, Arnaud', 'JUETTNER, Josephine']",2017-06-08,,"SYNP159, A PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN ROD PHOTORECEPTORS",2016
33,['BIO-P S R L'],,Application,,WO-2017130106-A1,"['PAGNANELLI, FRANCESCA', 'TORO, LUIGI', 'DI CAPRIO, Fabrizio', 'ALTIMARI, Pietro']",2017-08-03,1.0,PROCESS FOR PRODUCING STARCH FROM MICROALGAE,2017
34,"['INSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE)', 'UNIVERSITÉ DE MONTPELLIER', 'CENTRE HOSPITALIER UNIV DE MONTPELLIER']","[{'id': 'grid.121334.6', 'acronym': 'UM', 'name': 'University of Montpellier', 'country_name': 'France'}, {'id': 'grid.157868.5', 'acronym': 'CHRU MTP', 'name': 'University Hospital of Montpellier', 'country_name': 'France'}, {'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}]",Application,,WO-2017144471-A1,"['CARTRON, GUILLAUME', 'APPARAILLY, FLORENCE', 'DUROUX-RICHARD, Isabelle', 'GAGEZ, Anne-Laure']",2017-08-31,1.0,METHOD FOR PREDICTING WHETHER A SUBJECT WILL ACHIEVE A LYMPHODEPLETION WITH AN ANTIBODY SPECIFIC FOR CD20,2017
35,"['Beth Israel Deaconess Medical Center Inc', 'LU KUN PING', 'TUN-KYI ADRIAN', 'FINN GREG', 'BETH ISRAEL DEACONESS MEDICAL CT INC']","[{'id': 'grid.239395.7', 'acronym': 'BIDMC', 'name': 'Beth Israel Deaconess Medical Center', 'country_name': 'United States'}]",Grant,2016.0,US-9439884-B2,"['Kun Ping Lu', 'Adrian Tun-Kyi', 'Greg Finn']",2016-09-13,,Methods for the treatment of immune disorders,2012
36,['UNIVERSITÀ DEGLI STUDI DI ROMA LA SAPIENZA'],"[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Application,,WO-2016102586-A1,"['CERVONE, FELICE', 'DE LORENZO, GIULIA', 'FERRARI, SIMONE', 'BENEDETTI, Manuel', 'PONTIGGIA, DANIELA']",2016-06-30,,FUSION PROTEIN AND TRANSGENIC PLANT EXPRESSING SAID PROTEIN,2015
37,"['Mirati Therapeutics Inc', 'MIRATI THERAPEUTICS INC']","[{'id': 'grid.421297.b', 'name': 'Mirati Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9809541-B2,"['Matthew Arnold Marx', 'Arkadii Vaisburg', 'James Gail Christensen', 'Robert Anthony Galemmo, Jr.']",2017-11-07,1.0,LSD1 inhibitors,2016
38,"['Mirati Therapeutics Inc', 'MIRATI THERAPEUTICS INC']","[{'id': 'grid.421297.b', 'name': 'Mirati Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10059668-B2,"['Arkadii Vaisburg', 'Matthew Arnold Marx']",2018-08-28,,LSD1 inhibitors,2016
39,['THE UNIV OF BIRMINGHAM'],"[{'id': 'grid.6572.6', 'name': 'University of Birmingham', 'country_name': 'United Kingdom'}]",Application,,WO-2017199042-A1,"['KYSELA, Boris', 'AHMED, ZUBAIR', 'TUXWORTH, Richard']",2017-11-23,1.0,TREATMENT OF NEUROLOGICAL PATHOLOGIES WITH INHIBITORS OF DNA DAMAGE REPAIR,2017
40,"['Resverlogix Corp', 'HANSEN HENRIK C', 'WAGNER GREGORY S', 'ATTWELL SARAH C', 'MCLURE KEVIN G', 'KULIKOWSKI EWELINA B', 'RESVERLOGIX CORP']","[{'id': 'grid.476666.3', 'name': 'Resverlogix (Canada)', 'country_name': 'Canada'}]",Grant,2017.0,US-9757368-B2,"['Henrik C. Hansen', 'Gregory S. Wagner', 'Sarah C. Attwell', 'Kevin G. McLure', 'Ewelina B. Kulikowski']",2017-09-12,3.0,Anti-inflammatory agents,2010
41,"['Coulombic Inc', 'COULOMBIC INC']",,Grant,2017.0,US-9831503-B2,['David Andrew Sopchak'],2017-11-28,1.0,Electrodes and electrochemical devices and methods of making electrodes and electrochemical devices,2015
42,"['AlderBio Holdings LLC', 'ALDERBIO HOLDINGS LLC']",,Grant,2018.0,US-10066009-B2,"['Brian Robert Kovacevich', 'Leon F. Garcia-Martinez', 'Katie Olson ANDERSON', 'Benjamin H. Dutzar', 'Jens J. Billgren', 'John A. Latham', 'Danielle M. Mitchell', 'Patricia Dianne McNeill', 'Nicole M. Janson', 'Maria-Cristina Loomis']",2018-09-04,,Anti-CGRP compositions and use thereof,2016
43,"['ASSIST PUBLIQUE HOPITAUX DE PARIS AP HP', 'INST NAT SANTE RECH MED', 'UNIV PARIS DESCARTES']","[{'id': 'grid.10992.33', 'name': 'Paris Descartes University', 'country_name': 'France'}, {'id': 'grid.50550.35', 'acronym': 'AP-HP', 'name': 'Assistance Publique -Hopitaux De Paris', 'country_name': 'France'}, {'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}]",Application,,WO-2018046870-A1,"['MENASCHE, PHILIPPE', 'RENAULT, Nisa', 'BELLAMY, Valérie', 'PIDIAL, Laetitia']",2018-03-15,,BIOMATERIAL FOR THERAPEUTIC USE,2017
44,"['Samsung Life Public Welfare Foundation', 'SAMSUNG LIFE PUBLIC WELFARE FOUNDATION']","[{'id': 'grid.490620.9', 'name': 'Samsung Life Public Welfare Foundation', 'country_name': 'South Korea'}]",Grant,2018.0,US-9919011-B2,"['Yun Sil Chang', 'Won Soon Park', 'Dong Kyung SUNG', 'So Yoon AHN']",2018-03-20,,Method for treating an inflammatory brain disease comprising administering a stem cell-derived exosome,2015
45,"['Neuroenergy Ventures Inc', 'NEUROENERGY VENTURES INC']",,Grant,2018.0,US-9925164-B1,['Sami Hashim'],2018-03-27,,Glyceryl 3-hydroxybutyrates for traumatic brain injury,2017
46,"['AlderBio Holdings LLC', 'KOVACEVICH BRIAN ROBERT', 'GARCIA-MARTINEZ LEON F', 'OLSON KATIE', 'DUTZAR BENJAMIN H', 'BILLGREN JENS J', 'LATHAM JOHN A', 'MITCHELL DANIELLE M', 'MCNEILL PATRICIA DIANNE', 'JANSON NICOLE M', 'LOOMIS MARIA-CRISTINA', 'ALDERBIO HOLDINGS LLC']",,Grant,2017.0,US-9745373-B2,"['Brian Robert Kovacevich', 'Leon F. Garcia-Martinez', 'Katie Olson', 'Benjamin H. Dutzar', 'Jens J. Billgren', 'John A. Latham', 'Danielle M. Mitchell', 'Patricia Dianne McNeill', 'Nicole M. Janson', 'Maria-Cristina Loomis']",2017-08-29,5.0,Anti-CGRP compositions and use thereof,2012
47,"['University of Iowa Research Foundation (UIRF)', 'AlderBio Holdings LLC', 'RUSSO ANDREW F', 'KAISER ERIC A', 'RECOBER ANA', 'KUBURAS ADISA', 'RADDANT ANN C', 'KOVACEVICH BRIAN ROBERT', 'LATHAM JOHN A', 'SMITH JEFFREY T L', 'GARCIA-MARTINEZ LEON F', 'ALDERBIO HOLDINGS LLC']","[{'id': 'grid.214572.7', 'acronym': 'UI', 'name': 'University of Iowa', 'country_name': 'United States'}]",Grant,2017.0,US-9708393-B2,"['Andrew F. Russo', 'Eric A. Kaiser', 'Ana Recober', 'Adisa Kuburas', 'Ann C. Raddant', 'Brian Robert Kovacevich', 'John A. Latham', 'Jeffrey T. L. Smith', 'Leon F. Garcia-Martinez']",2017-07-18,5.0,"Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers",2012
48,"['University of Iowa Research Foundation (UIRF)', 'AlderBio Holdings LLC', 'RUSSO ANDREW F', 'KAISER ERIC A', 'RECOBER ANA', 'KUBURAS ADISA', 'RADDANT ANN C', 'KOVACEVICH BRIAN ROBERT', 'LATHAM JOHN A', 'SMITH JEFFREY T L', 'GARCIA-MARTINEZ LEON F', 'ALDERBIO HOLDINGS LLC']","[{'id': 'grid.214572.7', 'acronym': 'UI', 'name': 'University of Iowa', 'country_name': 'United States'}]",Grant,2018.0,US-9855332-B2,"['Andrew F. Russo', 'Eric A. Kaiser', 'Ana Recober', 'Adisa Kuburas', 'Ann C. Raddant', 'Brian Robert Kovacevich', 'John A. Latham', 'Jeffrey T. L. Smith', 'Leon F. Garcia-Martinez']",2018-01-02,5.0,Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels,2012
49,['MTM PLASTICS GMBH'],,Application,,WO-2017207610-A1,"['PETERS, TOBIAS', 'Böttner, Ralf', 'MEYER, TORSTEN', 'SCRIBA, MICHAEL']",2017-12-07,,METHOD AND APPARATUS FOR ANALYZING INHOMOGENEOUS BULK CARGO,2017
50,"['Teva Pharmaceuticals International GmbH', 'TEVA PHARMACEUTICALS INT GMBH']",,Grant,2018.0,US-9896502-B2,"['Marcelo Bigal', 'Sarah Walter', 'Henry Stern', 'Michael Chang']",2018-02-20,1.0,Antagonist antibodies directed against calcitonin gene-related peptide and methods using same,2015
51,"[""UNIVERSITA' DEGLI STUDI DI SIENA"", ""UNIVERSITA' DEGLI STUDI DI ROMA TOR VERGATA""]","[{'id': 'grid.6530.0', 'name': 'University of Rome Tor Vergata', 'country_name': 'Italy'}, {'id': 'grid.9024.f', 'acronym': 'UNISI', 'name': 'University of Siena', 'country_name': 'Italy'}]",Application,,WO-2017081709-A1,"['THALLER, MARIA, CRISTINA', ""D'ANDREA, Marco, Maria"", 'ROSSOLINI, GIAN, MARIA']",2017-05-18,,BACTERIOPHAGE ABLE TO LYSE KLEBSIELLA PNEUMONIAE EXPRESSING A CPSKKBO-4 CAPSULAR POLYSACCHARIDE AND RELATED MEDICAL USES THEREOF,2016
52,"['RUPRECHT KARLS UNIV HEIDELBERG', 'THORAXKLINIK HEIDELBERG GGMBH']","[{'id': 'grid.7700.0', 'name': 'Heidelberg University', 'country_name': 'Germany'}, {'id': 'grid.5253.1', 'name': 'University Hospital Heidelberg', 'country_name': 'Germany'}]",Application,,WO-2018041959-A1,"['GRÜNIG, Ekkehard', 'HINDERHOFER, Katrin', 'EICHSTAEDT, Christina A.']",2018-03-08,,GENE PANEL SPECIFIC FOR PULMONARY HYPERTENSION AND ITS USES,2017
53,['BOSTON SCIENT SCIMED INC'],"[{'id': 'grid.418905.1', 'acronym': 'BSC', 'name': 'Boston Scientific (United States)', 'country_name': 'United States'}]",Application,,WO-2017172588-A1,"['RAYBIN, Samuel', 'HOLLYER, Matthew, B.']",2017-10-05,,INJECTABLE COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF,2017
54,"['INSTYTUT FARMAKOLOGII POLSKIEJ AKADEMII NAUK', 'INST FARMAKOLOGII POLSKIEJ AKADEMII NAUK']","[{'id': 'grid.418903.7', 'name': 'Institute of Pharmacology', 'country_name': 'Poland'}]",Application,,EP-3272745-A1,"['Hogendorf, Adam', 'Hogendorf, Agata', 'SATALA, GRZEGORZ', 'Kurczab, Rafal', 'Bugno, Ryszard', 'Staron, Jakub', 'Lenda, Tomasz', 'BOJARSKI, Andrzej J.']",2018-01-24,,IMIDAZOLYL-SUBSTITUTED INDOLE DERIVATIVES BINDING 5-HT7 SEROTONIN RECEPTOR AND PHARMACEUTICAL COMPOSITIONS THEREOF,2016
55,['AMGEN RES (MUNICH) GMBH'],"[{'id': 'grid.420023.7', 'name': 'Amgen (Germany)', 'country_name': 'Germany'}]",Application,,WO-2016184931-A1,"['KLINGER, MATTHIAS', 'ZUGMAIER, GERHARD']",2016-11-24,,B-CELL DEPLETION AS A DIAGNOSTIC MARKER,2016
56,['CYNORA GMBH'],,Application,,WO-2016079097-A1,"['Volz, Daniel', 'Ambrosek, David']",2016-05-26,,COPPER(I) COMPLEXES FOR OPTOELECTRONIC APPLICATIONS,2015
57,"['Regulus Therapeutics Inc', 'REGULUS THERAPEUTICS INC']","[{'id': 'grid.488377.7', 'name': 'Regulus Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9994842-B2,"['Christine Esau', 'Sanjay Bhanot']",2018-06-12,,Methods for use in modulating miR-122A,2015
58,"['Commissariat a l Energie Atomique et aux Energies Alternatives', ""Commissariat à l'Energie Atomique et aux Energies Alternatives""]","[{'id': 'grid.5583.b', 'acronym': 'CEA', 'name': 'Atomic Energy and Alternative Energies Commission', 'country_name': 'France'}]",Application,,EP-3211826-A1,"['SAVRY, OLIVIER']",2017-08-30,,METHOD FOR HANDLING IMPLICIT CERTIFICATES USING A DISTRIBUTED PUBLIC KEY INFRASTRUCTURE,2017
59,['INST FARMAKOLOGII POLSKIEJ AKADEMII NAUK'],"[{'id': 'grid.418903.7', 'name': 'Institute of Pharmacology', 'country_name': 'Poland'}]",Application,,WO-2018015558-A1,"['Hogendorf, Adam', 'Hogendorf, Agata', 'SATALA, GRZEGORZ', 'Kurczab, Rafal', 'Bugno, Ryszard', 'Staron, Jakub', 'Lenda, Tomasz', 'BOJARSKI, Andrzej J.']",2018-01-25,,IMIDAZOLYL-SUBSTITUTED INDOLE DERIVATIVES BINDING 5-HT7 SEROTONIN RECEPTOR AND PHARMACEUTICAL COMPOSITIONS THEREOF,2017
60,['UNIVERSITÄT ROSTOCK'],"[{'id': 'grid.10493.3f', 'name': 'University of Rostock', 'country_name': 'Germany'}]",Application,,WO-2017108895-A1,"['DAVID, ROBERT', 'Rimmbach, Christian', 'Wolfien, Markus']",2017-06-29,,"METHOD FOR PRODUCING SINOATRIAL NODE CELLS (CARDIAC PACEMAKER CELLS) FROM STEM CELLS, AND METHOD FOR PURIFYING SINOATRIAL NODE CELLS PRODUCED FROM STEM CELLS",2016
61,"['Commissariat a l Energie Atomique et aux Energies Alternatives', 'COMMISSARIAT ENERGIE ATOMIQUE']","[{'id': 'grid.5583.b', 'acronym': 'CEA', 'name': 'Atomic Energy and Alternative Energies Commission', 'country_name': 'France'}]",Application,,FR-3048319-A1,['SAVRY OLIVIER'],2017-09-01,,Method of managing certificates are implicit by means of an infrastructure has loops distributed public,2016
62,"['AARHUS UNIV', 'UNIVERSITÀ DI ROMA “LA SAPIENZA”']","[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}, {'id': 'grid.7048.b', 'acronym': 'AU', 'name': 'Aarhus University', 'country_name': 'Denmark'}]",Application,,WO-2017008816-A1,"['FERAPONTOVA, Elena', 'BOFFI, Alberto']",2017-01-19,,ENZYMATIC ELECTRODE FOR REGENERATION OF OXIDISED AND/OR REDUCED FORMS OF PYRIDINE NUCLEOTIDES,2016
63,"['Ojai Energetics Pbc', 'OJAI ENERGETICS PBC']",,Grant,2018.0,US-10080736-B2,"['William Kleidon', 'Justin Kirkland']",2018-09-25,1.0,Microencapsulated cannabinoid compositions,2017
64,"['Burlington Hc Research Group Inc', 'THE BURLINGTON HC RES GROUP INC']","[{'id': 'grid.421455.3', 'name': 'Renewable Energy Systems (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9849143-B2,"['Dale M. Walker', 'Adriana Elisa Kajon', 'Vernon E. Walker']",2017-12-26,,Broad spectrum antiviral and methods of use,2017
65,"['WALKER VERNON E DR', 'Burlington Hc Research Group Inc', 'WALKER DALE M', 'KAJON ADRIANA ELISA', 'WALKER VERNON E', 'THE BURLINGTON HC RES GROUP INC']","[{'id': 'grid.421455.3', 'name': 'Renewable Energy Systems (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9585849-B2,"['Dale M. Walker', 'Adriana Elisa Kajon', 'Vernon E. Walker']",2017-03-07,1.0,Broad spectrum antiviral and methods of use,2007
66,"['Modernatx Inc', 'MODERNATX INC']",,Grant,2018.0,US-10064935-B2,"['Giuseppe Ciaramella', 'Shinu John', 'Kambiz Mousavi']",2018-09-04,4.0,Human cytomegalovirus RNA vaccines,2017
67,"['CONSUMED CVBA', 'POWER OF PLATELETS PTE LTD']",,Application,,WO-2018091713-A1,"['FAHMY, Hossam Mostafa', 'GOORIS, Theo']",2018-05-24,,A METHOD FOR PREPARING A GROWTH FACTORS CONTAINING PLATELET RELEASATE,2017
68,"['Ludwig Maximilians Universitaet Muenchen (LMU UNiversitaet)', 'LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN']","[{'id': 'grid.5252.0', 'acronym': 'LMU', 'name': 'Ludwig Maximilian University of Munich', 'country_name': 'Germany'}]",Grant,2016.0,US-9415087-B2,"['Nikolai Naoumov', 'Albrecht von Brunn']",2016-08-16,,Compositions and methods for treating coronavirus infection,2015
69,['UNIV MONASH'],"[{'id': 'grid.1002.3', 'name': 'Monash University', 'country_name': 'Australia'}]",Application,,WO-2017008101-A1,"['MCGOWAN, SHEENA', 'SCAMMELLS, PETER', 'VINH, Natalie', 'DRINKWATER, Nyssa', 'Lee, Jisook']",2017-01-19,,NOVEL AMINOPEPTIDASE INHIBITORS AND METHODS OF USE,2016
70,"['Qualcomm Inc', 'QUALCOMM INC']","[{'id': 'grid.430388.4', 'name': 'Qualcomm (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9781246-B2,"['Soumya Das', 'Edwin Chongwoo PARK']",2017-10-03,,Augmenting reality using a small cell,2015
71,['ACTELION PHARMACEUTICALS LTD'],"[{'id': 'grid.417650.1', 'name': 'Actelion (Switzerland)', 'country_name': 'Switzerland'}]",Application,,WO-2016091996-A1,"['DINGEMANSE, JASPER', 'HOCH, MATTHIAS', 'KRAUSE, ANDREAS']",2016-06-16,2.0,DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST,2015
72,['OTT DAVID MICHAEL'],,Grant,2018.0,US-9968580-B2,['David Michael Ott'],2018-05-15,,"Method of treating Rett syndrome by oral administration of acetate which is provided as composition comprising magnesium acetate, calcium acetate or ethylacetate",2016
73,"['Mitsubishi Electric Corp', 'Mitsubishi Electric R&D Centre Europe BV Netherlands', 'MITSUBISHI ELECTRIC R&D CT EUROPE BV', 'MITSUBISHI ELECTRIC CORP']","[{'id': 'grid.425847.8', 'name': 'Mitsubishi Electric (Netherlands)', 'country_name': 'Netherlands'}, {'id': 'grid.462605.3', 'name': 'Mitsubishi Electric (Japan)', 'country_name': 'Japan'}]",Application,,EP-3188373-A1,"['KHANFOUCI, MOURAD', 'Brunel, Loïc']",2017-07-05,,FAST DISTRIBUTED CLUSTERING FOR COOPERATION IN TELECOMMUNICATIONS NETWORKS,2015
74,"['TC1 LLC', 'TC1 LLC']",,Application,,US-20170104369-A1,['Ethan Falk Petersen'],2017-04-13,,RESONANT POWER TRANSFER SYSTEMS HAVING EFFICIENCY OPTIMIZATION BASED ON RECEIVER IMPEDANCE,2016
75,['QUALCOMM INC'],"[{'id': 'grid.430388.4', 'name': 'Qualcomm (United States)', 'country_name': 'United States'}]",Application,,WO-2017039806-A1,"['DAS, SOUMYA', 'PARK, Edwin, Chongwoo']",2017-03-09,,SMALL CELL EDGE COMPUTING PLATFORM,2016
76,"['Qualcomm Inc', 'QUALCOMM INC']","[{'id': 'grid.430388.4', 'name': 'Qualcomm (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9936042-B2,"['Soumya Das', 'Edwin Chongwoo PARK']",2018-04-03,,Local retrieving and caching of content to small cells,2015
77,['QUALCOMM INC'],"[{'id': 'grid.430388.4', 'name': 'Qualcomm (United States)', 'country_name': 'United States'}]",Application,,WO-2017039812-A1,"['PARK, Edwin, Chongwoo', 'DAS, SOUMYA']",2017-03-09,,SMALL CELL APPLICATION PLATFORM,2016
78,"['Mitsubishi Electric Corp', 'Mitsubishi Electric R&D Centre Europe BV Netherlands', 'MITSUBISHI ELECTRIC R&D CT EUROPE BV', 'MITSUBISHI ELECTRIC CORP']","[{'id': 'grid.425847.8', 'name': 'Mitsubishi Electric (Netherlands)', 'country_name': 'Netherlands'}, {'id': 'grid.462605.3', 'name': 'Mitsubishi Electric (Japan)', 'country_name': 'Japan'}]",Application,,EP-3188372-A1,"['KHANFOUCI, MOURAD', 'Brunel, Loïc']",2017-07-05,,GRAPH CLUSTERING FOR COOPERATION IN TELECOMMUNICATIONS NETWORKS,2015
79,"['IGENOMIX SL', 'SIMON VALLES CARLOS', 'HORCAJADAS ALMANSA JOSE ANTONIO', 'DIAZ GIMENO PATRICIA', 'PELLICER MARTINEZ ANTONIO', 'IGENOMIX S L']",,Grant,2018.0,US-10081840-B2,"['Carlos Simón Vallés', 'José Antonio Horcajadas Almansa', 'Patricia Díaz Gimeno', 'Antonio Pellicer Martínez']",2018-09-25,,Gene expression profile as an endometrial receptivity marker,2009
80,"['Rubius Therapeutics Inc', 'RUBIUS THERAPEUTICS INC']",,Grant,2017.0,US-9644180-B2,"['Avak Kahvejian', 'Jordi Mata-Fink', 'John Round', 'David Arthur Berry', 'Noubar B. Afeyan']",2017-05-09,7.0,Synthetic membrane-receiver complexes,2015
81,"['United States Government As Represented By Dpartment Of Veterans Affairs', 'Yale University', 'US Department of Veterans Affairs', 'UNIV YALE', 'THE US DEPARTMENT OF VETERANS AFFAIRS', 'THE US DEPARTMENT OF VETERANS AFFAIRS']","[{'id': 'grid.47100.32', 'name': 'Yale University', 'country_name': 'United States'}, {'id': 'grid.418356.d', 'acronym': 'VA ', 'name': 'United States Department of Veterans Affairs', 'country_name': 'United States'}]",Grant,2018.0,US-10040867-B2,"['James E. Hansen', 'Richard H. Weisbart', 'Melissa Young', 'Philip W. Noble']",2018-08-07,,Cell penetrating anti-guanosine antibody based therapy for cancers with Ras mutations,2015
82,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9695167-B2,"['Liangxing Wu', 'Xiaozhao Wang', 'Wenqing Yao', 'Colin Zhang']",2017-07-04,10.0,"Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors",2015
83,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9994546-B2,"['Liangxing Wu', 'Wenqing Yao']",2018-06-12,5.0,Cyclopropylamines as LSD1 inhibitors,2016
84,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10047086-B2,"['Liangxing Wu', 'Leah C. Konkol', 'Neil Lajkiewicz', 'Liang Lu', 'Meizhong Xu', 'Wenqing Yao', 'Zhiyong Yu', 'Colin Zhang', 'Chunhong He']",2018-08-14,,Imidazopyridines and imidazopyrazines as LSD1 inhibitors,2017
85,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9758523-B2,"['Liangxing Wu', 'Xiaozhao Wang', 'Wenqing Yao', 'Colin Zhang']",2017-09-12,7.0,Triazolopyridines and triazolopyrazines as LSD1 inhibitors,2015
86,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9944647-B2,"['Chunhong He', 'Zhenwu Li', 'Liangxing Wu', 'Wenqing Yao', 'Fenglei Zhang']",2018-04-17,7.0,Heterocyclic compounds as LSD1 inhibitors,2016
87,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9493450-B2,"['Liangxing Wu', 'Chunhong He', 'Leah C. Konkol', 'Ding-Quan Qian', 'Wenqing Yao']",2016-11-15,11.0,Cyclopropylamines as LSD1 inhibitors,2015
88,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9527835-B2,"['Liangxing Wu', 'Chunhong He', 'Ding-Quan Qian', 'Bo Shen', 'Wenqing Yao']",2016-12-27,11.0,Cyclopropylamines as LSD1 inhibitors,2015
89,['MASSACHUSETTS INST TECHNOLOGY'],"[{'id': 'grid.116068.8', 'acronym': 'MIT', 'name': 'Massachusetts Institute of Technology', 'country_name': 'United States'}]",Application,,WO-2016033422-A1,"['LI, XIN', 'CEDER, GERBRAND']",2016-03-03,,SODIUM TRANSITION METAL OXIDE ELECTROACTIVE COMPOUNDS,2015
90,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9695180-B2,"['Liangxing Wu', 'Joel R. Courter', 'Chunhong He', 'Jingwei Li', 'Liang Lu', 'Yaping Sun', 'Xiaozhao Wang', 'Wenqing Yao', 'Colin Zhang', 'Jincong Zhuo']",2017-07-04,10.0,"Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors",2015
91,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9670210-B2,"['Liangxing Wu', 'Chunhong He', 'Wenqing Yao', 'Fenglei Zhang']",2017-06-06,9.0,Cyclopropylamines as LSD1 inhibitors,2015
92,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9695168-B2,"['Liangxing Wu', 'Leah C. Konkol', 'Neil Lajkiewicz', 'Liang Lu', 'Meizhong Xu', 'Wenqing Yao', 'Zhiyong Yu', 'Colin Zhang', 'Chunhong He']",2017-07-04,10.0,"Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors",2015
93,"['Lockheed Martin Corp', 'LOCKHEED CORP']","[{'id': 'grid.419474.b', 'name': 'Lockheed Martin (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9600765-B1,"['Richard N. Pedersen', 'Mark A. Friesel', 'Paul D. Mountcastle']",2017-03-21,,Classification systems and methods using convex hulls,2016
94,['IMP INNOVATIONS LTD'],"[{'id': 'grid.420918.6', 'name': 'Imperial Innovations (United Kingdom)', 'country_name': 'United Kingdom'}]",Application,,WO-2016024131-A1,"['FRANZOSO, GUIDO', 'TORNATORE, LAURA', 'BEGALLI, Federica', ""D'ANDREA, Daniel""]",2016-02-18,,GADD45BETA/MKK7 INHIBITOR FOR THE TREATMENT OF A RESISTANT HAEMATOLOGICAL MALIGNANCY,2015
95,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9493442-B2,"['Liangxing Wu', 'Joel R. Courter', 'Chunhong He', 'Bo Shen', 'Xiaozhao Wang', 'Wenqing Yao', 'Fenglei Zhang']",2016-11-15,11.0,Cyclopropylamines as LSD1 inhibitors,2015
96,"['Biogen Chesapeake LLC', 'BIOGEN CHESAPEAKE LLC']",,Grant,2018.0,US-10004703-B2,"['Sven Martin Jacobson', 'Robert Ang']",2018-06-26,,Treatment of alzheimer's disease using compounds that reduce the activity of non-selective CA++ activated ATP-sensitive cation channels regulated by SUR1 channels,2013
97,"['Universite de Bourgogne', 'Université de Bourgogne']","[{'id': 'grid.5613.1', 'acronym': 'uB', 'name': 'University of Burgundy', 'country_name': 'France'}]",Grant,2018.0,US-9863048-B2,"['Jacques ANDRIEU', 'Charles DEVILLERS', 'Guillaume de ROBILLARD']",2018-01-09,,Synthesis and use of biobased imidazolium carboxylates,2014
98,"['Universite de Bourgogne', 'Université de Bourgogne']","[{'id': 'grid.5613.1', 'acronym': 'uB', 'name': 'University of Burgundy', 'country_name': 'France'}]",Application,,EP-2963155-A1,"['Andrieu, Jacques', 'Devillers, Charles', 'De Robillard, Guillaume']",2016-01-06,,Synthesis and use of biobased imidazolium carboxylates,2014
99,['Université de Bourgogne'],"[{'id': 'grid.5613.1', 'acronym': 'uB', 'name': 'University of Burgundy', 'country_name': 'France'}]",Application,,WO-2016001436-A1,"['Andrieu, Jacques', 'Devillers, Charles', 'De Robillard, Guillaume']",2016-01-07,,SYNTHESIS AND USE OF BIO-BASED IMIDAZOLIUM CARBOXYLATES,2015
100,"['COMMISSARIAT ENERGIE ATOMIQUE', 'INSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE']","[{'id': 'grid.5583.b', 'acronym': 'CEA', 'name': 'Atomic Energy and Alternative Energies Commission', 'country_name': 'France'}]",Application,,WO-2018100325-A1,"['WERNER, Thilo', 'BICHLER, OLIVIER', 'VIANELLO, ELISA', 'YVERT, BLAISE']",2018-06-07,,"MODULATION DEVICE AND METHOD, ARTIFICIAL SYNAPSE COMPRISING SAID MODULATION DEVICE, SHORT-TERM PLASTICITY METHOD IN AN ARTIFICIAL NEURAL NETWORK COMPRISING SAID ARTIFICIAL SYNAPSE",2017
101,['CONSIGLIO NAZIONALE RICERCHE'],"[{'id': 'grid.5326.2', 'acronym': 'CNR', 'name': 'National Research Council', 'country_name': 'Italy'}]",Application,,WO-2016016119-A1,"['PASSANANTI, CLAUDIO', 'CORBI, NICOLETTA', 'DI CERTO, MARIA GRAZIA', 'MATTEI, ELISABETTA', 'PISANI, Cinzia', 'STRIMPAKOS, Georgios', 'LUVISETTO, SIRO']",2016-02-04,10.0,COMPOSITIONS AND METHODS FOR TREATMENT OF MUSCULAR DYSTROPHY,2015
102,"['De Lille 1, University of', 'Centre National de la Recherche Scientifique CNRS', 'Universite Lille 1 Sciences et Technologies', 'UNIV DE LILLE 1', 'CENTRE NAT RECH SCIENT']","[{'id': 'grid.4461.7', 'name': 'Lille 1 University', 'country_name': 'France'}, {'id': 'grid.4444.0', 'acronym': 'CNRS', 'name': 'French National Centre for Scientific Research', 'country_name': 'France'}]",Application,,FR-3050050-A1,"['CAPPY ALAIN', 'DANNEVILLE FRANCOIS', 'HOEL VIRGINIE', 'LOYEZ CHRISTOPHE']",2017-10-13,1.0,ARTIFICIAL NEURONE,2016
103,['ENEA ENTE NUOVE TEC'],,Application,,WO-2016012968-A1,"['GIULIANO, GIOVANNI', 'FERRANTE, PAOLA', 'FRUSCIANTE, Sarah', 'DIRETTO, Gianfranco', 'PIETRELLA, Marco', 'Al-Babili, Salim']",2016-01-28,1.0,A CAROTENOID DIOXYGENASE AND METHODS FOR THE BIOTECHNOLOGICAL PRODUCTION IN MICROORGANISMS AND PLANTS OF COMPOUNDS DERIVED FROM SAFFRON,2015
104,"[""Agenzia Nazionale Per Le Nuove Tecnologie L'ener- Gia E Lo Sviluppo Economico Sostenibile (enea)"", 'Agenzia Nazionale per le Nuove Tecnologie l Energia e lo Sviluppo Economico Sostenibile (ENEA)', 'AGENZIA NAZ PER LE NUOVE TECNOLOGIE LENERGIA E LO SVILUPPO ECONOMICO SOSTENIBILE ENEA', 'AGENZIA NAZ PER LE NUOVE TECNOLOGIE LENER GIA E LO SVILUPPO ECONOMICO SOSTENIBILE ENEA']","[{'id': 'grid.5196.b', 'acronym': 'ENEA', 'name': 'Italian National Agency for New Technologies, Energy and Sustainable Economic Development', 'country_name': 'Italy'}]",Grant,2018.0,US-9969989-B2,"['Giovanni Giuliano', 'Paola Ferrante', 'Sarah Frusciante', 'Gianfranco Diretto', 'Marco Pietrella', 'Salim Al-Babili']",2018-05-15,,Carotenoid dioxygenase and methods for the biotechnological production in microorganisms and plants of compounds derived from saffron,2015
105,"['Universita degli Studi di Roma La Sapienza', 'Università degli Studi di Roma “La Sapienza”', 'UNIV DEGLI STUDI DI ROMA “LA SAPIENZA”']","[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Grant,2017.0,US-9827292-B2,"['Cinzia Marchese', 'Simona Ceccarelli', 'Antonio Angeloni']",2017-11-28,,Use of KGF in the treatment of menopausal disorders,2013
106,"['University of Zurich', 'Universität Zürich']","[{'id': 'grid.7400.3', 'acronym': 'UZH', 'name': 'University of Zurich', 'country_name': 'Switzerland'}]",Application,,EP-3208750-A1,"['Binas, Jonathan', 'NEIL, DANIEL']",2017-08-23,,AN ANALOGUE ELECTRONIC DEEP NEURAL NETWORK,2016
107,"['Universita degli Studi di Roma La Sapienza', 'UNIVERSIT DEGLI STUDI DI ROMA LA SAPIENZA']","[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Application,,US-20150224172-A1,"['Cinzia Marchese', 'Simona Ceccarelli', 'Antonio Angeloni']",2015-08-13,1.0,USE OF KGF IN THE TREATMENT OF MENOPAUSAL DISORDERS,2013
108,"['UNIV DE LILLE 1', 'CENTRE NAT RECH SCIENT']","[{'id': 'grid.4461.7', 'name': 'Lille 1 University', 'country_name': 'France'}, {'id': 'grid.4444.0', 'acronym': 'CNRS', 'name': 'French National Centre for Scientific Research', 'country_name': 'France'}]",Application,,WO-2017178352-A1,"['CAPPY, Alain', 'DANNEVILLE, François', 'HOEL, Virginie', 'LOYEZ, CHRISTOPHE']",2017-10-19,,ARTIFICIAL NEURON,2017
109,['Universität Zürich'],"[{'id': 'grid.7400.3', 'acronym': 'UZH', 'name': 'University of Zurich', 'country_name': 'Switzerland'}]",Application,,WO-2017144372-A1,"['BINAS, Jonathan Jakob Moses', 'NEIL, Daniel Lawrence']",2017-08-31,,AN ANALOGUE ELECTRONIC NEURAL NETWORK,2017
110,"['CROCE CARLO M', 'GUTTRIDGE DENIS C']",,Grant,2018.0,US-10036018-B2,"['Carlo M. Croce', 'Denis C. Guttridge']",2018-07-31,,Compositions and methods for treating cachexia,2015
111,"['Commissariat a l Energie Atomique et aux Energies Alternatives', 'COMMISSARIAT ENERGIE ATOMIQUE']","[{'id': 'grid.5583.b', 'acronym': 'CEA', 'name': 'Atomic Energy and Alternative Energies Commission', 'country_name': 'France'}]",Application,,FR-3059805-A1,"['WERNER THILO', 'BICHLER OLIVIER', 'VIANELLO ELISA', 'YVERT BLAISE']",2018-06-08,,"The device and method of modulation, comprising said artificial synapse modulation device, a short term plasticity in an artificial neural network comprising the said artificial synapse",2016
112,"['Columbia University of New York', 'UNIV COLUMBIA']","[{'id': 'grid.21729.3f', 'acronym': 'CU', 'name': 'Columbia University', 'country_name': 'United States'}]",Grant,2017.0,US-9654478-B2,"['Salvatore J. Stolfo', 'Gabriela F. Ciocarlie', 'Vanessa Frias-Martinez', 'Janak Parekh', 'Angelos D. Keromytis', 'Joseph Sherrick']",2017-05-16,1.0,"Methods, media, and systems for securing communications between a first node and a second node",2016
113,"['Cedars-Sinai Medical Center', 'CEDARS-SINAI MEDICAL CENTER']","[{'id': 'grid.50956.3f', 'name': 'Cedars-Sinai Medical Center', 'country_name': 'United States'}]",Application,,EP-3154544-A4,"['EDDERKAOUI, MOUAD', 'MURALI, RAMACHANDRAN', 'PANDOL, STEPHEN']",2017-12-20,,COMPOSITIONS AND METHODS FOR TREATING CANCERS,2015
114,['UNIV COLLEGE DUBLIN NAT UNIV OF IRELAND DUBLIN'],"[{'id': 'grid.7886.1', 'acronym': 'UCD', 'name': 'University College Dublin', 'country_name': 'Ireland'}]",Application,,WO-2017129618-A1,"['ENGLISH, Niall J.']",2017-08-03,,A METHOD OF GENERATING HYDROGEN FROM WATER SPLITTING AND A PHOTOELECTROCHEMICAL CELL FOR PERFORMING WATER SPLITTING,2017
115,"['ETH ZURICH (EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH)', 'Eidgenoessische Technische Hochschule Zurich (ETHZ)', 'Disney Enterprises Inc', 'DISNEY ENTPR INC', 'ETH ZURICH EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH']","[{'id': 'grid.452365.3', 'name': 'Walt Disney (United States)', 'country_name': 'United States'}, {'id': 'grid.5801.c', 'name': 'Swiss Federal Institute of Technology in Zurich', 'country_name': 'Switzerland'}]",Grant,2018.0,US-10091435-B2,"['Henning Zimmer', 'Alexander Sorkine Hornung', 'Mario Botsch', 'Federico PERAZZI']",2018-10-02,,Video segmentation from an uncalibrated camera array,2016
116,['IKEDA FOOD RES CO LTD'],,Application,,WO-2017141879-A1,"['宮島 彩', '青木\u3000秀之', '佐藤\u3000ふみ', '亀田 剛旨']",2017-08-24,,PANCREATIC LIPASE INHIBITOR COMPOSITION AND PRODUCTION METHOD FOR PANCREATIC LIPASE INHIBITOR COMPOSITION,2017
117,"['InterDigital CE Patent Holdings', 'THOMSON LICENSING']","[{'id': 'grid.426216.5', 'name': 'Technicolor (France)', 'country_name': 'France'}]",Grant,2018.0,US-9948909-B2,"['Vincent Demoulin', 'Neus SABATER']",2018-04-17,,Apparatus and a method for modifying colors of a focal stack of a scene according to a color palette,2016
118,"['Thomson Licensing SA', 'THOMSON LICENSING']","[{'id': 'grid.426216.5', 'name': 'Technicolor (France)', 'country_name': 'France'}]",Application,,EP-3113475-A1,"['DEMOULIN, VINCENT', 'SABATER, Neus']",2017-01-04,,AN APPARATUS AND A METHOD FOR MODIFYING COLOURS OF A FOCAL STACK OF A SCENE ACCORDING TO A COLOUR PALETTE,2015
119,['UNIV NEWCASTLE'],"[{'id': 'grid.1006.7', 'name': 'Newcastle University', 'country_name': 'United Kingdom'}]",Application,,WO-2015052511-A1,"['YAN, JEFF']",2015-04-16,,TEST FOR DISTINGUISHIING BETWEEN A HUMAN AND A COMPUTER PROGRAM,2014
120,"['NOVARTIS AG', 'GLASS DAVID', 'MANNICK JOAN', 'MURPHY LEON']","[{'id': 'grid.419481.1', 'name': 'Novartis (Switzerland)', 'country_name': 'Switzerland'}]",Application,,WO-2016185443-A1,"['GLASS, DAVID', 'MANNICK, JOAN', 'MURPHY, LEON']",2016-11-24,1.0,PHARMACEUTICAL COMBINATION OF EVEROLIMUS WITH DACTOLISIB,2016
121,['UNIV COURT UNIV OF EDINBURGH'],"[{'id': 'grid.4305.2', 'name': 'University of Edinburgh', 'country_name': 'United Kingdom'}]",Application,,WO-2016185160-A1,"['UNCITI-BROCETA, ASIER', 'FRASER, CRAIG', 'O. CARRAGHER, Neil']",2016-11-24,,COMPOUNDS,2016
122,"['Cedars-Sinai Medical Center', 'CEDARS SINAI MEDICAL CENTER']","[{'id': 'grid.50956.3f', 'name': 'Cedars-Sinai Medical Center', 'country_name': 'United States'}]",Grant,2018.0,US-10029997-B2,"['Mouad Edderkaoui', 'Ramachandran Murali', 'Stephen PANDOL']",2018-07-24,1.0,Compositions and methods for treating cancers,2015
123,"['Fondazione Telethon', 'Ospedale San raffaele Srl', 'FOND TELETHON', 'OSPEDALE SAN RAFFAELE SRL']","[{'id': 'grid.11492.3f', 'acronym': 'Telethon', 'name': 'Telethon Foundation', 'country_name': 'Italy'}, {'id': 'grid.18887.3e', 'name': 'San Raffaele Hospital', 'country_name': 'Italy'}]",Grant,2018.0,US-9951328-B2,"['Alessandra Biffi', 'Bernhard Rudolf Gentner', 'Luigi Naldini']",2018-04-24,,Gene vector,2017
124,['CIPOLLI MARCO'],,Application,,WO-2018050706-A1,"['CIPOLLI, MARCO', 'BEZZERRI, Valentino', 'ASSAEL, Baroukh Maurice']",2018-03-22,,METHOD OF TREATMENT OF SHWACHMAN-DIAMOND SYNDROME,2017
125,"['PROBIOTICAL NORTH AMERICA Inc', 'MOGNA GIOVANNI', 'PROBIOTICAL NORTH AMERICA INC']","[{'id': 'grid.478269.6', 'acronym': 'AONA', 'name': 'AO North America', 'country_name': 'United States'}]",Grant,2018.0,US-10028982-B2,['Giovanni Mogna'],2018-07-24,,Composition comprising N-acetylcysteine and/or microencapsulated gastroprotected lysozyme in association with probiotic bacteria capable of restoring the stomach's own barrier effect which is lost during the pharmacological treatment of gastric hyperacidity,2012
126,"['Purdue Pharma LP', 'PURDUE PHARMACEUTICAL PRODUCTS L P']","[{'id': 'grid.418726.e', 'name': 'Purdue Pharma (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9993482-B2,['Thomas Jorg Mehrling'],2018-06-12,,Pharmaceutical combination comprising a class III receptor tyrosine kinase inhibitor and the alkylating histone-deacetylase inhibitor fusion molecule EDO-S101 together with its use in the treatment of cancer,2015
127,"['Autotelic LLC', 'AUTOTELIC LLC', 'AUTOTELIC LLC']",,Grant,2018.0,US-9989543-B2,['Vuong Trieu'],2018-06-05,,"Composition, device, and method for detecting olmesartan and improving compliance in treating hypertension",2017
128,['ERYDEL S P A'],,Application,,WO-2016116850-A1,"['MAGNANI, MAURO', 'BIAGIOTTI, SARA', 'MENOTTA, Michele']",2016-07-28,1.0,METHOD OF EVALUATING THE RESPONSE OF ATAXIA TELANGIECTASIA PATIENTS TO GLUCOCORTICOIDS TREATMENT,2016
129,"['PROBIOTICAL SpA', 'MOGNA GIOVANNI', 'STROZZI GIAN PAOLO', 'MOGNA LUCA', 'PROBIOTICAL SPA']",,Grant,2018.0,US-9925224-B2,"['Giovanni Mogna', 'Gian Paolo Strozzi', 'Luca Mogna']",2018-03-27,1.0,Bacterial strains belonging to the genus bifidobacterium for use in the treatment of hypercholesterolaemia,2012
130,"['University of Arizona', 'UNIV ARIZONA']","[{'id': 'grid.134563.6', 'acronym': 'UA', 'name': 'University of Arizona', 'country_name': 'United States'}]",Grant,2018.0,US-10069592-B1,"['Marwan M. Krunz', 'Berk Akgun', 'Peyman Siyari', 'Hanif Rahbari', 'Rashad Mohamed Eletreby', 'Onur Ozan Koyluoglu']",2018-09-04,,Systems and methods for securing wireless communications,2016
131,['UNIV MINNESOTA'],"[{'id': 'grid.437349.e', 'name': 'University of Minnesota System', 'country_name': 'United States'}]",Application,,WO-2016141220-A1,"['WANG, ZHENGQIANG']",2016-09-09,1.0,"3-HYDROXYPYRIMIDINE-2,4-DIONE-5-CARBOXAMIDES AS POTENT INHIBITORS OF HIV",2016
132,"['Servicio Andaluz de Salud', 'SERVICIO ANDALUZ DE SALUD']","[{'id': 'grid.418355.e', 'acronym': 'SAS', 'name': 'Andalusian Health Service', 'country_name': 'Spain'}]",Grant,2018.0,US-10045994-B2,"['José Antonio PÉREZ SIMÓN', 'María Victoria Barbado González']",2018-08-14,,Agents for treating multiple myeloma,2014
133,['GW RES LIMITED'],,Application,,WO-2018037203-A1,"['STOTT, COLIN', 'NABISSI, MASSIMO']",2018-03-01,,USE OF CANNABINOIDS IN THE TREATMENT OF MULTIPLE MYELOMA,2017
134,['SERVICIO ANDALUZ DE SALUD'],"[{'id': 'grid.418355.e', 'acronym': 'SAS', 'name': 'Andalusian Health Service', 'country_name': 'Spain'}]",Application,,WO-2014198993-A1,"['PÉREZ SIMÓN, José Antonio', 'BARBADO GONZÁLEZ, María Victoria']",2014-12-18,3.0,AGENTS FOR TREATING MULTIPLE MYELOMA,2014
135,['MICROSOFT TECHNOLOGY LICENSING LLC'],"[{'id': 'grid.419815.0', 'name': 'Microsoft (United States)', 'country_name': 'United States'}]",Application,,WO-2017205105-A1,"['MUDIGONDA, UMA MAHESH']",2017-11-30,,SUBNET STRETCHING VIA LAYER THREE COMMUNICATIONS,2017
136,"['Medical Diagnostic Laboratories LLC', 'GALLAGHER GRANT', 'GALLAGHER GRANT E', 'ESKDALE JOYCE', 'SIEGEL RACHAEL', 'MEDICAL DIAGNOSTIC LABORATORIES LLC']",,Grant,2016.0,US-9464321-B2,"['Grant Gallagher', 'Grant E. Gallagher', 'Joyce Eskdale', 'Rachael Siegel']",2016-10-11,,"Methods and reagents that specifically detect, distinguish and quantify IFN-λ2 mRNA from IFN-λ3 mRNA in humans",2014
137,"['University of Kentucky Research Foundation', 'ILLINOIS TOOL WORKS', 'UNIV OF KENTUCKY RESEARCH FOUNDATION']","[{'id': 'grid.266539.d', 'name': 'University of Kentucky', 'country_name': 'United States'}, {'id': 'grid.455620.0', 'acronym': 'ITW ', 'name': 'Illinois Tool Works (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9975196-B2,"['Yuming Zhang', 'Weijie Zhang']",2018-05-22,,Measurement of three-dimensional welding torch orientation for manual arc welding process,2015
138,"['Teva Pharmaceutical Industries Ltd', 'TEVA PHARMA']","[{'id': 'grid.452797.a', 'name': 'Teva Pharmaceuticals (Israel)', 'country_name': 'Israel'}]",Application,,EP-3082814-A4,"['HAGAI, Esther, Lukasiewicz', 'MELAMED-GAL, Sigal', 'EYAL, ELI', 'WICKENBERG, Anna']",2017-06-21,,USE OF LAQUINIMOD TO DELAY HUNTINGTON'S DISEASE PROGRESSION,2014
139,"['Brown University', 'UNIV BROWN']","[{'id': 'grid.40263.33', 'name': 'Brown University', 'country_name': 'United States'}]",Grant,2018.0,US-10058506-B2,"['Anita Shukla', 'Shashank Shukla']",2018-08-28,,Tunable anti-microbial loaded hydrogels,2015
140,['A1M PHARMA AB'],,Application,,WO-2017144674-A1,"['AUSTIN, MARTIN', 'GRAM, Magnus Göran', 'Åkerström, Bo']",2017-08-31,,ALPHA-1-MICROGLOBULIN FOR USE IN THE PROTECTION OF KIDNEYS IN CONNECTION WITH USE OF CONTRAST MEDIA,2017
141,['ILLINOIS TOOL WORKS'],"[{'id': 'grid.455620.0', 'acronym': 'ITW ', 'name': 'Illinois Tool Works (United States)', 'country_name': 'United States'}]",Application,,WO-2016111887-A3,"['ZHANG, YU MING', 'ZHANG, WEIJIE']",2016-09-01,,MEASUREMENT OF THREE-DIMENSIONAL WELDING TORCH ORIENTATION FOR MANUAL ARC WELDING PROCESS,2015
142,"['Harvard College', 'Children s Medical Center Corp', 'HARVARD COLLEGE', 'CHILDRENS MEDICAL CENTER']","[{'id': 'grid.414197.e', 'name': ""Dayton Children's Hospital"", 'country_name': 'United States'}, {'id': 'grid.38142.3c', 'name': 'Harvard University', 'country_name': 'United States'}, {'id': 'grid.2515.3', 'name': ""Boston Children's Hospital"", 'country_name': 'United States'}, {'id': 'grid.414196.f', 'name': ""Children's Medical Center"", 'country_name': 'United States'}]",Grant,2018.0,US-9914958-B2,"['Wesley Philip Wong', 'Kenneth Anders Halvorsen']",2018-03-13,,Nucleic acid-based linkers for detecting and measuring interactions,2012
143,['Fehér János'],,Application,,WO-2017009676-A1,"['FEHÉR, János']",2017-01-19,,COMPOSITIONS FOR MAINTAINING AND RESTORING MICROBIOTA-HOST SYMBIOSIS,2016
144,"['Google LLC', 'GOOGLE INC']","[{'id': 'grid.420451.6', 'name': 'Google', 'country_name': 'United States'}]",Grant,2015.0,US-9129228-B1,['Christian Szegedy'],2015-09-08,,Robust and fast model fitting by adaptive sampling,2014
145,"['University of Georgia Research Foundation Inc (UGARF)', 'UNIV GEORGIA']","[{'id': 'grid.213876.9', 'acronym': 'UGA', 'name': 'University of Georgia', 'country_name': 'United States'}]",Grant,2017.0,US-9566338-B2,"['Donald A. Harn', 'RAFAELLA QUEIROZ', 'LISA MCEWEN']",2017-02-14,,Vaccine delivery method,2013
146,"['dSPACE Digital Signal Processing and Control Engineering GmbH', 'DSPACE GMBH']",,Application,,EP-3104278-A1,"['Lünstroth, Frank', 'Hillebrand, Sebastian', 'FISCHER, KARSTEN']",2016-12-14,,METHOD FOR THE REALISTIC ESTIMATION OF FUNCTION RUNTIMES IN PIL SIMULATION,2015
147,"[""Brigham and Women's Hospital"", ""THE BRIGHAM AND WOMEN'S HOSPITAL INC""]","[{'id': 'grid.62560.37', 'acronym': 'BWH', 'name': ""Brigham and Women's Hospital"", 'country_name': 'United States'}]",Grant,2017.0,US-9561264-B2,"['Markus H. Frank', 'Mohamed H. Sayegh']",2017-02-07,4.0,Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof,2013
148,['CLINUVEL AG'],,Application,,WO-2015063099-A1,"['WOLGEN, PHILIPPE']",2015-05-07,,ALPHA-MSH ANALOGUES FOR USE IN THE TREATMENT OF HAILEY-HAILEY DISEASE,2014
149,['DSPACE GMBH'],,Application,,WO-2016198503-A1,"['Lünstroth, Frank', 'Hillebrand, Sebastian', 'FISCHER, KARSTEN']",2016-12-15,,METHOD FOR THE REALISTIC ASSESSMENT OF FUNCTION RUN TIMES IN PIL SIMULATION,2016
150,['BIOGEN MA INC'],,Application,,WO-2016090154-A1,"['RANA, Jitesh']",2016-06-09,1.0,MULTIPLE SCLEROSIS TREATMENT REGIMEN USING DIMETHYL FUMARATE,2015
151,['SIEMENS AG'],"[{'id': 'grid.5406.7', 'name': 'Siemens (Germany)', 'country_name': 'Germany'}]",Application,,WO-2017167373-A1,"['CASPERSEN, Michael', 'EGELUND, Sune Daaskov', 'THERKILDSEN, Kasper Tipsmark']",2017-10-05,,A TECHNIQUE FOR IN-SITU ANODE ACTIVATION BY A CATHODE IN AN ALKALINE WATER ELECTROLYTIC CELL,2016
152,"['CECCATELLI SANDRA', 'SPULBER DAN STEFAN']",,Application,,WO-2016038107-A1,"['CECCATELLI, Sandra', 'SPULBER, Dan Stefan']",2016-03-17,2.0,METHODS AND COMPOSITIONS FOR BIOMARKERS OF DEPRESSION AND PHARMACORESPONSE,2015
153,['VIIV HEALTHCARE UK (NO 5) LTD'],"[{'id': 'grid.476798.3', 'name': 'ViiV Healthcare (United Kingdom)', 'country_name': 'United Kingdom'}]",Application,,WO-2017025917-A1,"['EASTMAN, KYLE J.', 'KADOW, JOHN F.', 'PARCELLA, KYLE E.', 'NAIDU, B. NARASIMHULU', 'WANG, TAO', 'YIN, ZHIWEI', 'ZHANG, ZHONGXING']",2017-02-16,4.0,5-(N-BENZYL TETRAHYDROISOQUINOLIN-6-YL) PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION,2016
154,['OPTERION HEALTH AG'],,Application,,WO-2017013121-A1,"['GRENTZMANN, GUIDO']",2017-01-26,,AQUEOUS SOLUTION COMPRISING A STILBENOID,2016
155,['VIIV HEALTHCARE UK (NO 5) LTD'],"[{'id': 'grid.476798.3', 'name': 'ViiV Healthcare (United Kingdom)', 'country_name': 'United Kingdom'}]",Application,,WO-2017025864-A1,"['KADOW, JOHN F.', 'NAIDU, B. NARASIMHULU', 'ROMINE, JEFFREY LEE', 'SIVAPRAKASAM, Prasanna', 'ST. LAURENT, DENIS R.']",2017-02-16,1.0,PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION,2016
156,"['UNIV ROMA', 'UNI DEGLI STUDI CAMERINO']",,Application,,WO-2014057432-A3,"['CARACCIOLO, Giulio', 'POZZI, Daniela', 'MARCHINI, Simona', 'AMICI, AUGUSTO']",2014-07-24,,MULTICOMPONENT LIPID NANOPARTICLES AND PROCESSES FOR THE PREPARATION THEREOF,2013
157,"['Opterion Health AG', 'OPTERION HEALTH AG']",,Application,,EP-3120838-A1,"['GRENTZMANN, GUIDO']",2017-01-25,,AQUEOUS SOLUTION COMPRISING A POLYPHENOL,2015
158,"['KONTOES CHARALAMPOS', 'CHAIREKAKIS THEMISTOKLIS']",,Application,,WO-2016132161-A1,"['KONTOES, Charalampos', 'CHAIREKAKIS, Themistoklis']",2016-08-25,,"METHOD THAT DETECTS AREAS OF ACTIVE FIRE HOTSPOTS IN REAL-TIME, CALCULATES THE MOST PROBABLE IGNITION POINT AND ASSESSES FIRE PROBABILITY INDICATORS, USING SATELLITE IMAGES AND FUEL DATA.",2016
159,['G-TREEBNT CO LTD'],,Application,,WO-2017030251-A1,"['강신욱', '김경순', '이시영', '성지혜']",2017-02-23,,NEUROTROPHIC KERATITIS TREATMENT COMPOSITION COMPRISING THYMOSIN BETA 4 AS ACTIVE INGREDIENT,2015
160,"['Neurostim Solutions LLC', 'CREASEY GRAHAM H', 'TOONG HOO MIN', 'Neurostim Solutions LLC']",,Grant,2018.0,US-10016600-B2,"['Graham H. Creasey', 'Hoo-min Toong']",2018-07-10,1.0,Topical neurological stimulation,2014
161,"['Genentech Inc', 'Constellation Pharmaceuticals Inc', 'CONSTELLATION PHARMACEUTICALS INC', 'GENENTECH INC', 'CONSTELLATION PHARMACEUTICALS INC']","[{'id': 'grid.418158.1', 'acronym': 'Roche', 'name': 'Roche (United States)', 'country_name': 'United States'}, {'id': 'grid.459493.6', 'name': 'Constellation Pharmaceuticals (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10035801-B2,"['Brian K. Albrecht', 'Steven F. Bellon', 'Victor S. Gehling', 'Jean-Christophe Harmange', 'Kwong Wah Lai', 'Jun Liang', 'Peter Dragovich', 'Daniel F. Ortwine', 'Sharada Labadie', 'Birong Zhang', 'James Richard Kiefer']",2018-07-31,,Pyrazolo compounds and uses thereof,2014
162,"['Genentech Inc', 'Constellation Pharmaceuticals Inc', 'GENENTECH INC', 'CONSTELLATION PHARMACEUTICALS INC']","[{'id': 'grid.459493.6', 'name': 'Constellation Pharmaceuticals (United States)', 'country_name': 'United States'}, {'id': 'grid.418158.1', 'acronym': 'Roche', 'name': 'Roche (United States)', 'country_name': 'United States'}]",Application,,US-20150065522-A1,"['Brian K. Albrecht', 'Steven F. Bellon', 'Victor S. Gehling', 'Jean-Christophe Harmange', 'Yves LeBlanc', 'Jun Liang', 'Steven Magnuson', 'Vicki Tsui', 'Birong Zhang']",2015-03-05,6.0,THERAPEUTIC COMPOUNDS AND USES THEREOF,2014
163,"['ST EUROPEO DI ONCOLOGIA', 'UNIVERSITÀ DEGLI STUDI DI MILANO']","[{'id': 'grid.4708.b', 'acronym': 'UNIMI', 'name': 'University of Milan', 'country_name': 'Italy'}]",Application,,WO-2017097865-A1,"['MAZZARELLA, Luca', 'MINUCCI, SAVERIO', 'PELICCI, PIER GIUSEPPE', 'PALLAVI, RANI', 'DURFORT, Tiphanie']",2017-06-15,,COMBINATION OF CALORIC RESTRICTION (CR) OR IGF1/INSULIN RECEPTOR INHIBITOR WITH LSD1 INHIBITOR,2016
164,"['Genentech Inc', 'Constellation Pharmaceuticals Inc', 'GENENTECH INC', 'CONSTELLATION PHARMACEUTICALS INC']","[{'id': 'grid.418158.1', 'acronym': 'Roche', 'name': 'Roche (United States)', 'country_name': 'United States'}, {'id': 'grid.459493.6', 'name': 'Constellation Pharmaceuticals (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9505767-B2,"['Brian K. Albrecht', 'Steven F. Bellon', 'Victor S. Gehling', 'Jean-Christophe Harmange', 'Yves LeBlanc', 'Jun Liang', 'Steven R. Magnuson', 'Vickie Hsiao-Wei Tsui', 'Birong Zhang']",2016-11-29,,"Pyrazolo[1,5-A]pyrimidin-7(4H)-onehistone demethylase inhibitors",2014
165,"['BASF SE', 'MAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V']","[{'id': 'grid.3319.8', 'name': 'BASF (Germany)', 'country_name': 'Germany'}, {'id': 'grid.4372.2', 'acronym': 'MPG', 'name': 'Max Planck Society', 'country_name': 'Germany'}]",Application,,WO-2016091957-A1,"['MUELLER, ANDREAS', 'SCHWAB, Matthias Georg', 'ZHONG, Mingjie', 'VENKATARAMAN, SHYAM SUNDAR', 'MÜLLEN, Klaus', 'Sachdev, Hermann', 'BINDER, AXEL']",2016-06-16,,PROCESS FOR PRODUCING AN ELECTRODE CONTAINING SILICON PARTICLES COATED WITH CARBON,2015
166,"['VEOLIA WATER SOLUTIONS & TECH', 'UNIV ROME', 'WERKER ALAN GIDEON', 'BENGTSSON SIMON OLOF HARALD', 'HJORT JOHN MARKUS', 'MORGAN-SAGASTUME FERNANDO', 'MAJONE MAURO', 'VALENTINO FRANCESCO']","[{'id': 'grid.426629.d', 'name': 'Veolia (France)', 'country_name': 'France'}]",Application,,WO-2016020884-A1,"['WERKER, ALAN GIDEON', 'BENGTSSON, SIMON OLOF HARALD', 'HJORT, John Markus', 'MORGAN-SAGASTUME, FERNANDO', 'MAJONE, MAURO', 'VALENTINO, FRANCESCO']",2016-02-11,,PROCESS FOR ENHANCING POLYHYDROXYALKANOATE ACCUMULATION IN ACTIVATED SLUDGE BIOMASS,2015
167,"['Nano and Advanced Materials Institute Ltd', 'NANO & ADVANCED MATERIALS INST LTD']","[{'id': 'grid.482544.b', 'acronym': 'NAMI', 'name': 'Nano and Advanced Materials Institute', 'country_name': 'China'}]",Application,,EP-2887431-A1,"['LIU, CHENMIN', 'CAI, LIFENG', 'Choi, Shing Yan', 'WONG, KA KAN']",2015-06-24,,Silicon core/shell nanomaterials for high performance anode of lithium ion batteries,2014
168,"['Nokia Solutions and Networks Oy', 'MARIN JAMES S', 'NOKIA SIEMENS NETWORKS OY']","[{'id': 'grid.6533.3', 'name': 'Nokia (Finland)', 'country_name': 'Finland'}]",Grant,2014.0,US-8660547-B2,['James S. Marin'],2014-02-25,4.0,Optimized energy consumption management in wireless base stations,2011
169,"['Universita degli Studi di Roma La Sapienza', 'UNIVERSITÀ DEGLI STUDI DI ROMA LA SAPIENZA']","[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Grant,2017.0,EP-2710378-B1,"['BARNABA, VINCENZO']",2017-03-15,,METHOD TO PROGNOSE VIRAL INFECTION BY MEASURING T CELL RESPONSE OR AUTO-ANTIBODIES TO APOPTOTIC EPITOPES,2012
170,['NESTEC SA'],"[{'id': 'grid.419905.0', 'name': 'Nestlé (Switzerland)', 'country_name': 'Switzerland'}]",Application,,WO-2017108419-A1,"['PANNEREC, Alice', 'FEIGE, Jerome']",2017-06-29,1.0,METHODS FOR TREATING SARCOPENIA AND FRAILTY,2016
171,"['UNIV ROMA', 'UNI DEGLI STUDI CAMERINO']",,Application,,WO-2014057432-A3,"['CARACCIOLO, Giulio', 'POZZI, Daniela', 'MARCHINI, Simona', 'AMICI, AUGUSTO']",2014-07-24,,MULTICOMPONENT LIPID NANOPARTICLES AND PROCESSES FOR THE PREPARATION THEREOF,2013
172,['UNIV ROMA'],,Application,,WO-2016042436-A1,"['BARNABA, VINCENZO']",2016-03-24,,METHOD AND KIT FOR THE PREDICTIVE PROGNOSIS OF RESPONSIVENESS TO TREATMENTS OF AUTOIMMUNE DISEASES,2015
173,['IKEDA FOOD RES CO LTD'],,Application,,WO-2017141879-A1,"['宮島 彩', '青木\u3000秀之', '佐藤\u3000ふみ', '亀田 剛旨']",2017-08-24,,PANCREATIC LIPASE INHIBITOR COMPOSITION AND PRODUCTION METHOD FOR PANCREATIC LIPASE INHIBITOR COMPOSITION,2017
174,"['ChemoCentryx Inc', 'CHEMOCENTRYX INC']","[{'id': 'grid.452218.8', 'name': 'ChemoCentryx (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9795599-B2,"['Daniel Dairaghi', 'Dean R. DRAGOLI', 'Jaroslaw Kalisiak', 'Christopher W. Lange', 'Manmohan Reddy Leleti', 'Yandong Li', 'Rebecca M. LUI', 'Venkat Reddy Mali', 'Viengkham Malathong', 'Jay P. Powers', 'Hiroko Tanaka', 'Joanne Tan', 'Matthew J. Walters', 'Ju Yang', 'Penglie Zhang']",2017-10-24,1.0,CCR6 compounds,2016
175,['CONSIGLIO NAZIONALE RICERCHE'],"[{'id': 'grid.5326.2', 'acronym': 'CNR', 'name': 'National Research Council', 'country_name': 'Italy'}]",Application,,WO-2015018503-A1,"['PASSANANTI, CLAUDIO', 'CORBI, NICOLETTA', 'DI CERTO, MARIA GRAZIA', 'MATTEI, ELISABETTA', 'PISANI, Cinzia', 'STRIMPAKOS, Georgios']",2015-02-12,21.0,COMPOSITIONS AND METHODS FOR TREATMENT OF MUSCULAR DYSTROPHY,2014
176,"['University of Illinois', 'US Department of Veterans Affairs', 'DUDLEY JR SAMUEL C', 'US DEPT VETERANS AFFAIRS', 'TRUSTEES OF THE UNIV OF ILLINOIS BOARD OF']","[{'id': 'grid.411030.7', 'name': 'University of Illinois System', 'country_name': 'United States'}, {'id': 'grid.418356.d', 'acronym': 'VA ', 'name': 'United States Department of Veterans Affairs', 'country_name': 'United States'}]",Grant,2015.0,US-9211301-B2,"['Samuel C. Dudley, Jr.']",2015-12-15,,Method for ameliorating or preventing arrhythmic risk associated with cardiomyopathy by improving conduction velocity,2012
177,"['University of Illinois', 'US Department of Veterans Affairs', 'DUDLEY JR SAMUEL C', 'US DEPT VETERANS AFFAIRS', 'TRUSTEES OF THE UNIV OF ILLINOIS BOARD OF']","[{'id': 'grid.411030.7', 'name': 'University of Illinois System', 'country_name': 'United States'}, {'id': 'grid.418356.d', 'acronym': 'VA ', 'name': 'United States Department of Veterans Affairs', 'country_name': 'United States'}]",Grant,2015.0,US-9220720-B2,"['Samuel C. Dudley, Jr.']",2015-12-29,,Method for ameliorating or preventing arrhythmic risk associated with cardiomyopathy,2012
178,"['Ionis Pharmaceuticals Inc', 'IONIS PHARMACEUTICALS INC']","[{'id': 'grid.282569.2', 'name': 'Ionis Pharmaceuticals (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9957504-B2,"['Thazha P. Prakash', 'Punit P. Seth', 'Eric E. Swayze', 'Mark J. Graham']",2018-05-01,,Compositions and methods for modulating apolipoprotein (a) expression,2015
179,['CONSIGLIO NAZIONALE RICERCHE'],"[{'id': 'grid.5326.2', 'acronym': 'CNR', 'name': 'National Research Council', 'country_name': 'Italy'}]",Application,,WO-2016016119-A1,"['PASSANANTI, CLAUDIO', 'CORBI, NICOLETTA', 'DI CERTO, MARIA GRAZIA', 'MATTEI, ELISABETTA', 'PISANI, Cinzia', 'STRIMPAKOS, Georgios', 'LUVISETTO, SIRO']",2016-02-04,10.0,COMPOSITIONS AND METHODS FOR TREATMENT OF MUSCULAR DYSTROPHY,2015
180,"['VETERANS AFFAIRS U S DEPARTMENT OF', 'University of Illinois', 'US Department of Veterans Affairs', 'DUDLEY JR SAMUEL C', 'US DEPT VETERANS AFFAIRS', 'TRUSTEES OF THE UNIV OF ILLINOIS BOARD OF']","[{'id': 'grid.418356.d', 'acronym': 'VA ', 'name': 'United States Department of Veterans Affairs', 'country_name': 'United States'}, {'id': 'grid.411030.7', 'name': 'University of Illinois System', 'country_name': 'United States'}]",Grant,2015.0,US-9050350-B2,"['Samuel C. Dudley, Jr.']",2015-06-09,,Method for modulating or controlling connexin 43(Cx43) level of a cell and reducing arrhythmic risk,2012
181,"['Huawei Technologies Canada Co Ltd', 'HUAWEI TECH CANADA CO LTD']","[{'id': 'grid.450842.f', 'name': 'Huawei Technologies (Canada)', 'country_name': 'Canada'}]",Grant,2018.0,US-9980218-B2,"['Ibrahim Aydin', 'Ngoc Dung Dao', 'Nimal Gamini Senarath', 'Halim Yanikomeroglu']",2018-05-22,,System and method for user terminal-aware cell switch-off,2016
182,"[""Ann & Robert H Lurie Children's Hospital"", ""Ann and Robert H Lurie Children's Hospital of Chicago"", ""ANN AND ROBERT H LURIE CHILDREN'S HOSPITAL OF CHICAGO"", ""ANN & ROBERT H LURIE CHILDREN'S HOSPITAL""]","[{'id': 'grid.413808.6', 'name': ""Lurie Children's Hospital"", 'country_name': 'United States'}]",Grant,2018.0,US-9856481-B2,"['Ann Harris', 'Lindsay R. Stolzenburg']",2018-01-02,,MicroRNA treatment of fibrosis,2016
183,"['Ionis Pharmaceuticals Inc', 'IONIS PHARMACEUTICALS INC']","[{'id': 'grid.282569.2', 'name': 'Ionis Pharmaceuticals (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9932581-B2,"['Thazha P. Prakash', 'Punit P. Seth', 'Eric E. Swayze', 'Mark J. Graham']",2018-04-03,,Compositions and methods for modulating apolipoprotein C-III expression,2015
184,"['University of Illinois', 'US Department of Veterans Affairs', 'DUDLEY JR SAMUEL C', 'US OF AMERICA DEPT OF VETERANS AFFAIRS', 'TRUSTEES OF THE UNIV OF ILLINOIS BOARD OF']","[{'id': 'grid.418356.d', 'acronym': 'VA ', 'name': 'United States Department of Veterans Affairs', 'country_name': 'United States'}, {'id': 'grid.411030.7', 'name': 'University of Illinois System', 'country_name': 'United States'}]",Grant,2015.0,US-9114151-B2,"['Samuel C. Dudley, Jr.']",2015-08-25,,Method for modulating or controlling sodium channel current by reactive oxygen species (ROS) originating from mitochondria,2011
185,"['Ionis Pharmaceuticals Inc', 'ISIS PHARMACEUTICALS INC', 'ISIS PHARMACEUTICALS INC']","[{'id': 'grid.282569.2', 'name': 'Ionis Pharmaceuticals (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9382540-B2,"['Thazha P. Prakash', 'Punit P. Seth', 'Eric E. Swayze', 'Susan M. Freier', 'Mark J. Graham', 'Rosanne M. Crooke']",2016-07-05,5.0,Compositions and methods for modulating angiopoietin-like 3 expression,2015
186,"['Modernatx Inc', 'MODERNATX INC']",,Grant,2018.0,US-10022425-B2,"['Stephane Bancel', 'Jason P. Schrum', 'Alexander Aristarkhov']",2018-07-17,,Engineered nucleic acids and methods of use thereof,2016
187,['QUALCOMM INC'],"[{'id': 'grid.430388.4', 'name': 'Qualcomm (United States)', 'country_name': 'United States'}]",Application,,WO-2016064604-A1,"['YII, Winston', 'REITMAYR, GERHARD', 'RAUBER, PETER H.', 'PAN, QI', 'SZALAVARI, ZSOLT', 'GERVAUTZ, Michael']",2016-04-28,,SELECTION STRATEGY FOR EXCHANGING MAP INFORMATION IN COLLABORATIVE MULTI-USER SLAM SYSTEMS,2015
188,['WALDBUSSER STEVEN'],,Grant,2017.0,US-9544182-B2,['Steven Waldbusser'],2017-01-10,,Monitoring gateway systems and methods for openflow type networks,2015
189,"['Modernatx Inc', 'MODERNATX INC']",,Grant,2018.0,US-10064959-B2,"['Jason P. Schrum', 'Suhaib Siddiqi', 'Kenechi Ejebe']",2018-09-04,,"Modified nucleosides, nucleotides, and nucleic acids, and uses thereof",2017
190,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9192651-B2,"['Tirtha Chakraborty', 'Antonin de Fougerolles']",2015-11-24,25.0,Modified polynucleotides for the production of secreted proteins,2013
191,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9301993-B2,"['Tirtha Chakraborty', 'Antonin de Fougerolles']",2016-04-05,23.0,Modified polynucleotides encoding apoptosis inducing factor 1,2013
192,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9181319-B2,"['Jason P. Schrum', 'Stephane Bancel', 'Noubar B. Afeyan']",2015-11-10,25.0,Engineered nucleic acids and methods of use thereof,2014
193,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9334328-B2,"['Jason P. Schrum', 'Suhaib Siddiqi', 'Kenechi Ejebe']",2016-05-10,27.0,"Modified nucleosides, nucleotides, and nucleic acids, and uses thereof",2013
194,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9216205-B2,"['Tirtha Chakraborty', 'Antonin de Fougerolles']",2015-12-22,4.0,Modified polynucleotides encoding granulysin,2013
195,"['Icahn School of Medicine at Mount Sinai', 'ICAHN SCHOOL MED MOUNT SINAI']","[{'id': 'grid.59734.3c', 'acronym': 'MSSM', 'name': 'Icahn School of Medicine at Mount Sinai', 'country_name': 'United States'}]",Grant,2017.0,US-9849172-B2,"['Adolfo Garcia-Sastre', 'Anice C. Lowen', 'Peter Palese', 'John Steel']",2017-12-26,2.0,Influenza virus vaccines and uses thereof,2015
196,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9089604-B2,"['Tirtha Chakraborty', 'Antonin de Fougerolles', 'Ron Weiss']",2015-07-28,28.0,Modified polynucleotides for treating galactosylceramidase protein deficiency,2014
197,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9447164-B2,"['Jason P. Schrum', 'Stephane Bancel', 'Noubar B. Afeyan', 'Kenechi Ejebe']",2016-09-20,3.0,Engineered nucleic acids and methods of use thereof,2015
198,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9220755-B2,"['Tirtha Chakraborty', 'Antonin de Fougerolles']",2015-12-29,23.0,Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders,2013
199,"['Modernatx Inc', 'MODERNATX INC']",,Grant,2018.0,US-9950068-B2,"['Antonin de Fougerolles', 'Sayda M. Elbashir']",2018-04-24,,Delivery and formulation of engineered nucleic acids,2016
200,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9233141-B2,"['Tirtha Chakraborty', 'Antonin de Fougerolles']",2016-01-12,24.0,Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders,2013
201,"['modeRNA Therapeutics Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9221891-B2,"['Stephane Bancel', 'Tirtha Chakraborty', 'Antonin de Fougerolles', 'Sayda M. Elbashir', 'Matthias John', 'Atanu Roy', 'Susan Whoriskey', 'Kristy M. Wood', 'Paul Hatala', 'Jason P. Schrum', 'Kenechi Ejebe', 'Jeff Lynn Ellsworth', 'Justin Guild']",2015-12-29,4.0,In vivo production of proteins,2013
202,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC', 'MODERNATX INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9657295-B2,"['Jason P. Schrum', 'Suhaib Siddiqi', 'Kenechi Ejebe']",2017-05-23,3.0,"Modified nucleosides, nucleotides, and nucleic acids, and uses thereof",2016
203,['INTERDIGITAL TECH CORP'],"[{'id': 'grid.420292.f', 'name': 'InterDigital (United States)', 'country_name': 'United States'}]",Application,,WO-2017070545-A1,"['DE FOY, XAVIER', 'REZNIK, ALEXANDER']",2017-04-27,1.0,SOFTWARE-DEFINED NETWORK ENHANCEMENTS ENABLING PROGRAMMABLE INFORMATION CENTRIC NETWORKING IN EDGE NETWORKS,2016
204,"['ITERATIVE THERAPEUTICS Inc', 'ARNASON BARRY G W', 'JENSEN MARK A', 'WHITE DAVID M', 'ITERATIVE THERAPEUTICS INC']",,Grant,2015.0,US-8986698-B2,"['Barry G. W. Arnason', 'Mark A. Jensen', 'David M. White']",2015-03-24,7.0,Method of using fusion proteins,2011
205,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9220792-B2,"['Tirtha Chakraborty', 'Antonin de Fougerolles']",2015-12-29,24.0,Modified polynucleotides encoding aquaporin-5,2013
206,"['modeRNA Therapeutics Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9303079-B2,"['Tirtha Chakraborty', 'Antonin de Fougerolles']",2016-04-05,26.0,Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins,2013
207,"['Akzo NV', 'Hollandsche Beton Groep NV', 'AKZO NV', 'HOLLANDSCHE BETONGROEP NV']","[{'id': 'grid.423893.7', 'name': 'AkzoNobel (Netherlands)', 'country_name': 'Netherlands'}]",Application,,EP-0223291-A2,"['Schürhoff, Hans-Jürgen', 'GERRITSE, ARIE', 'METS, LAMBERTUS CORNELIS']",1987-05-27,13.0,"Reinforcing element of synthetic material for use in reinforced concrete, more particularly prestressed concrete, reinforced concrete provided with such reinforcing elements, and processes of manufacturing reinforcing elements, and reinforced and prestressed concrete",1986
208,"['Modernatx Inc', 'MODERNATX INC']",,Grant,2017.0,US-9597380-B2,"['Tirtha Chakraborty', 'Stephane Bancel', 'Stephen G. Hoge', 'Atanu Roy', 'Antonin de Fougerolles', 'Noubar B. Afeyan']",2017-03-21,6.0,Terminally modified RNA,2013
209,"['Modernatx Inc', 'modeRNA Therapeutics', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-8999380-B2,"['Stephane Bancel', 'Tirtha Chakraborty', 'Antonin de Fougerolles', 'Sayda M. Elbashir', 'Matthias John', 'Atanu Roy', 'Susan Whoriskey', 'Kristy M. Wood', 'Paul Hatala', 'Jason P. Schrum', 'Kenechi Ejebe', 'Jeff Lynn Ellsworth', 'Justin Guild']",2015-04-07,60.0,Modified polynucleotides for the production of biologics and proteins associated with human disease,2013
210,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC', 'MODERNATX INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9572897-B2,"['Stephane Bancel', 'Tirtha Chakraborty', 'Antonin de Fougerolles', 'Sayda M. Elbashir', 'Matthias John', 'Atanu Roy', 'Susan Whoriskey', 'Kristy M. Wood', 'Paul Hatala', 'Jason P. Schrum', 'Kenechi Ejebe', 'Jeff Lynn Ellsworth', 'Justin Guild']",2017-02-21,8.0,Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins,2016
211,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9107886-B2,"['Tirtha Chakraborty', 'Antonin de Fougerolles']",2015-08-18,27.0,Modified polynucleotides encoding basic helix-loop-helix family member E41,2013
212,"['Modernatx Inc', 'modeRNA Therapeutics', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9186372-B2,"['Antonin de Fougerolles', 'Sayda M. Elbashir']",2015-11-17,24.0,Split dose administration,2013
213,"['Modernatx Inc', 'MODERNATX INC']",,Grant,2017.0,US-9533047-B2,"['Antonin de Fougerolles', 'Sayda M. Elbashir']",2017-01-03,7.0,Delivery and formulation of engineered nucleic acids,2014
214,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9061059-B2,"['Tirtha Chakraborty', 'Antonin de Fougerolles', 'Ron Weiss']",2015-06-23,30.0,Modified polynucleotides for treating protein deficiency,2014
215,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9114113-B2,"['Tirtha Chakraborty', 'Antonin de Fougerolles']",2015-08-25,27.0,Modified polynucleotides encoding citeD4,2013
216,"['modeRNA Therapeutics Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9464124-B2,"['Stephane Bancel', 'Jason P. Schrum', 'Alexander Aristarkhov']",2016-10-11,20.0,Engineered nucleic acids and methods of use thereof,2014
217,"['Modernatx Inc', 'MODERNATX INC']",,Grant,2018.0,US-9937233-B2,"['Jason P. Schrum', 'Stephane Bancel', 'Noubar B. Afeyan', 'Kenechi Ejebe']",2018-04-10,,Engineered nucleic acids and methods of use thereof,2016
218,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC', 'MODERNATX INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9827332-B2,"['Stephane Bancel', 'Tirtha Chakraborty', 'Antonin de Fougerolles', 'Sayda M. Elbashir', 'Jeff Lynn Ellsworth', 'Kenechi Ejebe', 'Justin Guild', 'Matthias John', 'Paul Hatala', 'Atanu Roy', 'Jason P. Schrum', 'Susan Whoriskey', 'Kristy M. Wood']",2017-11-28,,Modified polynucleotides for the production of proteins,2015
219,"['Modernatx Inc', 'MODERNATX INC']",,Grant,2017.0,US-9814760-B2,"['Stephane Bancel', 'Tirtha Chakraborty', 'Antonin de Fougerolles', 'Sayda M. Elbashir', 'Matthias John', 'Atanu Roy', 'Susan Whoriskey', 'Kristy M. Wood', 'Paul Hatala', 'Jason P. Schrum', 'Kenechi Ejebe', 'Jeff Lynn Ellsworth', 'Justin Guild']",2017-11-14,,Modified polynucleotides for the production of biologics and proteins associated with human disease,2015
220,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9295689-B2,"['Antonin de Fougerolles', 'Kristy M. Wood', 'Pedro Valencia']",2016-03-29,23.0,Formulation and delivery of PLGA microspheres,2013
221,"['Modernatx Inc', 'modeRNA Therapeutics', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9428535-B2,"['Antonin de Fougerolles', 'Atanu Roy', 'Jason P. Schrum', 'Suhaib Siddiqi', 'Paul Hatala', 'Stephane Bancel']",2016-08-30,16.0,"Modified nucleosides, nucleotides, and nucleic acids, and uses thereof",2012
222,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC', 'MODERNATX INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9587003-B2,"['Stephane Bancel', 'Tirtha Chakraborty', 'Antonin de Fougerolles', 'Sayda M. Elbashir', 'Matthias John', 'Atanu Roy', 'Susan Whoriskey', 'Kristy M. Wood', 'Paul Hatala', 'Jason P. Schrum', 'Kenechi Ejebe', 'Jeff Lynn Ellsworth', 'Justin Guild']",2017-03-07,10.0,Modified polynucleotides for the production of oncology-related proteins and peptides,2016
223,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9271996-B2,"['Antonin de Fougerolles', 'Kristy M. Wood', 'Pedro Valencia']",2016-03-01,,Formulation and delivery of PLGA microspheres,2013
224,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC', 'MODERNATX INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9782462-B2,"['Stephane Bancel', 'Tirtha Chakraborty', 'Antonin de Fougerolles', 'Sayda M. Elbashir', 'Matthias John', 'Atanu Roy', 'Susan Whoriskey', 'Kristy M. Wood', 'Paul Hatala', 'Jason P. Schrum', 'Kenechi Ejebe', 'Jeff Lynn Ellsworth', 'Justin Guild']",2017-10-10,,Modified polynucleotides for the production of proteins associated with human disease,2016
225,"['Modernatx Inc', 'MODERNATX INC']",,Grant,2017.0,US-9828416-B2,"['Stephane Bancel', 'Tirtha Chakraborty', 'Antonin de Fougerolles', 'Sayda M. Elbashir', 'Matthias John', 'Atanu Roy', 'Susan Whoriskey', 'Kristy M. Wood', 'Paul Hatala', 'Jason P. Schrum', 'Kenechi Ejebe', 'Jeff Lynn Ellsworth', 'Justin Guild']",2017-11-28,,Modified polynucleotides for the production of secreted proteins,2015
226,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9095552-B2,"['Tirtha Chakraborty', 'Antonin de Fougerolles']",2015-08-04,27.0,Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1,2013
227,['ROUSSY INST GUSTAVE'],"[{'id': 'grid.14925.3b', 'name': 'Institut Gustave Roussy', 'country_name': 'France'}]",Application,,WO-2016170022-A1,"['PIROZHKOVA, Iryna', 'OGRYZKO, VASILY']",2016-10-27,,"THERAPEUTIC METHODS, PRODUCTS AND COMPOSITIONS INHIBITING ZNF555",2016
228,"['Modernatx Inc', 'MODERNATX INC']",,Grant,2017.0,US-9701965-B2,"['Jason P. Schrum', 'Gregory J. Sieczkiewicz', 'Kenechi Ejebe', 'Sayda M. Elbashir']",2017-07-11,,Engineered nucleic acids and methods of use thereof,2014
229,"['Icahn School of Medicine at Mount Sinai', 'ICAHN SCHOOL MED MOUNT SINAI']","[{'id': 'grid.59734.3c', 'acronym': 'MSSM', 'name': 'Icahn School of Medicine at Mount Sinai', 'country_name': 'United States'}]",Grant,2018.0,US-9968670-B2,"['Adolfo Garcia-Sastre', 'Peter Palese', 'Florian Krammer']",2018-05-15,,Influenza virus vaccines and uses thereof,2013
230,"['Modernatx Inc', 'MODERNATX INC']",,Grant,2018.0,US-9878056-B2,"['Stephane Bancel', 'Eric Yi-Chun Huang']",2018-01-30,,Modified polynucleotides for the production of cosmetic proteins and peptides,2013
231,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9050297-B2,"['Tirtha Chakraborty', 'Antonin de Fougerolles', 'Ron Weiss']",2015-06-09,5.0,Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator,2013
232,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9255129-B2,"['Tirtha Chakraborty', 'Antonin de Fougerolles']",2016-02-09,2.0,Modified polynucleotides encoding SIAH E3 ubiquitin protein ligase 1,2013
233,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9149506-B2,"['Tirtha Chakraborty', 'Antonin de Fougerolles']",2015-10-06,4.0,Modified polynucleotides encoding septin-4,2013
234,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9675668-B2,"['Stephane Bancel', 'Tirtha Chakraborty', 'Antonin de Fougerolles', 'Susan Whoriskey', 'Ron Weiss']",2017-06-13,13.0,Modified polynucleotides encoding hepatitis A virus cellular receptor 2,2013
235,"['modeRNA Therapeutics Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9254311-B2,"['Stephane Bancel', 'Tirtha Chakraborty', 'Antonin de Fougerolles', 'Sayda M. Elbashir', 'Matthias John', 'Atanu Roy', 'Susan Whoriskey', 'Kristy M. Wood', 'Paul Hatala', 'Jason P. Schrum', 'Kenechi Ejebe', 'Jeff Lynn Ellsworth', 'Justin Guild']",2016-02-09,26.0,Modified polynucleotides for the production of proteins,2013
236,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-8980864-B2,"['Stephen G. Hoge', 'Antonin de Fougerolles', 'Jeff Lynn Ellsworth']",2015-03-17,30.0,Compositions and methods of altering cholesterol levels,2013
237,"['ITERATIVE THERAPEUTICS Inc', 'ITERATIVE THERAPEUTICS INC']",,Grant,2015.0,US-9127063-B2,"['Barry G. W. Arnason', 'Mark A. Jensen', 'David M. White']",2015-09-08,,Nucleic acids related to fusion proteins,2013
238,"['Modernatx Inc', 'MODERNA THERAPEUTICS INC']","[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9283287-B2,"['Tirtha Chakraborty', 'Antonin de Fougerolles', 'Ron Weiss']",2016-03-15,,Modified polynucleotides for the production of nuclear proteins,2015
239,"['Icahn School of Medicine at Mount Sinai', 'ICAHN SCHOOL MED MOUNT SINAI']","[{'id': 'grid.59734.3c', 'acronym': 'MSSM', 'name': 'Icahn School of Medicine at Mount Sinai', 'country_name': 'United States'}]",Grant,2018.0,US-9908930-B2,"['Peter Palese', 'Adolfo Garcia-Sastre', 'Gene Tan']",2018-03-06,,Antibodies against influenza virus hemagglutinin and uses thereof,2014
240,"['Firmenich SA', 'FIRMENICH & CIE']","[{'id': 'grid.480130.e', 'name': 'Firmenich (Switzerland)', 'country_name': 'Switzerland'}]",Application,,US-20170088793-A1,"['Christian Starkenmann', 'Myriam Troccaz', 'Fabienne MAYENZET']",2017-03-30,,COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES,2016
241,['ALCATEL LUCENT'],"[{'id': 'grid.1441.0', 'name': 'Alcatel-Lucent (France)', 'country_name': 'France'}]",Application,,WO-2015136362-A1,"['Vanderhulst, Geert', 'VAN DEN BROECK, MARC', 'Feki, Mohamed Ali', 'Kawsar, Fahim']",2015-09-17,,ACCESS CONTROL OF GEO-FENCED SERVICES USING CO-LOCATED WITNESSES,2015
242,"['MASSACHUSETTS INST TECHNOLOGY', 'VIRGINIA TECH INTELLECTUAL PROPERTIES INC']","[{'id': 'grid.438526.e', 'name': 'Virginia Tech', 'country_name': 'United States'}, {'id': 'grid.116068.8', 'acronym': 'MIT', 'name': 'Massachusetts Institute of Technology', 'country_name': 'United States'}]",Application,,WO-2016201264-A1,"['WEAVER, James, C', 'SON, Reuben, S.', 'GOWRISHANKAR, THIRUVALLUR, R.', 'SWEENEY, DANIEL, C.', 'DAVALOS, RAFAEL, V.']",2016-12-15,,METHODS FOR INDUCING ELECTROPORATION AND TISSUE ABLATION,2016
243,"['George Washington University', 'CHAWLA LAKHMIR', 'THE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORP']","[{'id': 'grid.253615.6', 'acronym': 'GWU', 'name': 'George Washington University', 'country_name': 'United States'}]",Grant,2017.0,US-9572856-B2,['Lakhmir Chawla'],2017-02-21,3.0,Method of treating low blood pressure,2009
244,"['La Jolla Pharma LLC', 'LA JOLLA PHARMACEUTICAL COMPANY']","[{'id': 'grid.419053.a', 'acronym': 'LJPC', 'name': 'La Jolla Pharmaceutical (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9457059-B2,['George Tidmarsh'],2016-10-04,3.0,Compositions and methods for treating renal failure,2014
245,"['George Washington University', 'THE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION']","[{'id': 'grid.253615.6', 'acronym': 'GWU', 'name': 'George Washington University', 'country_name': 'United States'}]",Grant,2018.0,US-10028995-B2,['Lakhmir Chawla'],2018-07-24,2.0,Angiotensin II alone or in combination for the treatment of hypotension,2015
246,"['George Washington University', 'THE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION']","[{'id': 'grid.253615.6', 'acronym': 'GWU', 'name': 'George Washington University', 'country_name': 'United States'}]",Grant,2018.0,US-9867863-B2,['Lakhmir Chawla'],2018-01-16,2.0,Method of treating low blood pressure,2016
247,"['Universite de Nantes', 'Institut National de la Sante et de la Recherche Medicale INSERM', 'INSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE', 'Université de Nantes']","[{'id': 'grid.4817.a', 'name': 'University of Nantes', 'country_name': 'France'}, {'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}]",Application,,EP-3059307-A1,"['NGUYEN, Tuan Huy', 'Fourrier, Angélique']",2016-08-24,1.0,Use of a laminin for differentiating pluripotent cells into hepatocyte lineage cells,2015
248,"['George Washington University', 'GEORGE WASHINGTON UNIVERSITY A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORP', 'GEORGE WASHINGTON UNIVERSITY A CONGRESSIONALLY NOT FOR PROFIT CORP']","[{'id': 'grid.253615.6', 'acronym': 'GWU', 'name': 'George Washington University', 'country_name': 'United States'}]",Grant,2015.0,US-9220745-B2,['Lakhmir Chawla'],2015-12-29,6.0,Angiotensin II alone or in combination for the treatment of hypotension,2014
249,['UNIV COLLEGE DUBLIN NAT UNIV OF IRELAND DUBLIN'],"[{'id': 'grid.7886.1', 'acronym': 'UCD', 'name': 'University College Dublin', 'country_name': 'Ireland'}]",Application,,WO-2017129618-A1,"['ENGLISH, Niall J.']",2017-08-03,,A METHOD OF GENERATING HYDROGEN FROM WATER SPLITTING AND A PHOTOELECTROCHEMICAL CELL FOR PERFORMING WATER SPLITTING,2017
250,"['Mirexus Biotechnologies Inc', 'MIREXUS BIOTECHNOLOGIES INC']",,Grant,2017.0,US-9737608-B2,"['Anton KORENEVSKI', 'Erzsebet PAPP-SZABO', 'John Robert Dutcher', 'Oleg STUKALOV']",2017-08-22,,Phytoglycogen nanoparticles and methods of manufacture thereof,2014
251,"[""Societa'italiana Acetilene & Derivati Siad SpA In Breve Siad SpA"", ""Societa'italiana Acetilene & Derivati S I A D SpA In Breve S I A D SpA"", ""SOCIETA'ITALIANA ACETILENE & DERIVATI S I A D S P A IN BREVE S I A D S P A""]",,Application,,EP-3281632-A1,"['BISSOLOTTI, GIORGIO', 'RISTAGNO, GIUSEPPE', 'LATINI, ROBERTO', 'WIK, LARS']",2018-02-14,,ARGON FOR USE IN THE PREVENTION OF BOTH CARDIAC AND CEREBRAL INJURY INDUCED BY ISCHEMIA/REPERFUSION FOLLOWING CARDIAC ARREST,2016
252,"['Commissariat a l Energie Atomique et aux Energies Alternatives', 'COMMISSARIAT ENERGIE ATOMIQUE']","[{'id': 'grid.5583.b', 'acronym': 'CEA', 'name': 'Atomic Energy and Alternative Energies Commission', 'country_name': 'France'}]",Application,,FR-3044450-A1,['CHAOUCH MOHAMED'],2017-06-02,,Method of characterization of a 3d scene by calculation of orientation,2015
253,['COMMISSARIAT ENERGIE ATOMIQUE'],"[{'id': 'grid.5583.b', 'acronym': 'CEA', 'name': 'Atomic Energy and Alternative Energies Commission', 'country_name': 'France'}]",Application,,WO-2017093057-A1,"['CHAOUCH, Mohamed']",2017-06-08,,METHOD FOR CHARACTERISING A SCENE BY CALCULATING THE 3D ORIENTATION,2016
254,"['Universita degli Studi di Roma La Sapienza', 'Miami-Diabetes Research Institute, University of', 'University of North Carolina at Chapel Hill', 'UNIV NORTH CAROLINA CHAPEL HILL', 'UNIV OF MIAMI-DIABETES RES INST', 'SAPIENZA UNIVERSITÀ DI ROMA']","[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}, {'id': 'grid.10698.36', 'acronym': 'UNC', 'name': 'University of North Carolina at Chapel Hill', 'country_name': 'United States'}, {'id': 'grid.26790.3a', 'acronym': 'UM', 'name': 'University of Miami', 'country_name': 'United States'}]",Grant,2017.0,US-9750770-B2,"['Lola M. Reid', 'Yunfang Wang', 'David A. GERBER', 'Giacomo LANZONI', 'Luca Inverardi', 'Juan Dominguez-Bendala', 'Domenico Alvaro', 'Vincenzo Cardinale', 'Eugenio Gaudio', 'Guido Carpino']",2017-09-05,,Method of treating pancreatic and liver conditions by endoscopic-mediated (or laparoscopic-mediated) transplantation of stem cells into/onto bile duct walls of particular regions of the biliary tree,2015
255,"['Duke University', 'UNIV DUKE']","[{'id': 'grid.26009.3d', 'name': 'Duke University', 'country_name': 'United States'}]",Grant,2017.0,US-9738879-B2,"['Charles Gersbach', 'David Ousterout']",2017-08-22,,Genetic correction of mutated genes,2013
256,"['MATRICARDI PIETRO', 'DI MEO CHIARA']",,Application,,WO-2015071873-A1,"['Matricardi, Pietro', 'DI MEO, CHIARA', 'VILLANI, CLAUDIO']",2015-05-21,1.0,NOVEL POLYMER PLATFORM TO PREPARE NANOHYDROGEL,2014
257,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9695167-B2,"['Liangxing Wu', 'Xiaozhao Wang', 'Wenqing Yao', 'Colin Zhang']",2017-07-04,10.0,"Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors",2015
258,"['DIABETES RESEARCH INSTITUTE', 'Universita degli Studi di Roma La Sapienza', 'Miami Diabetes Research Institute, University of', 'University of North Carolina at Chapel Hill', 'University of Miami', 'UNIV NORTH CAROLINA CHAPEL HILL', 'DIABETES RES INST', 'SAPIENZA UNIVERSITÀ DI ROMA', 'UNIV OF MIAMI—DIABETES RES INST']","[{'id': 'grid.418456.a', 'name': 'University of Miami Health System', 'country_name': 'United States'}, {'id': 'grid.10698.36', 'acronym': 'UNC', 'name': 'University of North Carolina at Chapel Hill', 'country_name': 'United States'}, {'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}, {'id': 'grid.4567.0', 'name': 'Helmholtz Zentrum München', 'country_name': 'Germany'}, {'id': 'grid.26790.3a', 'acronym': 'UM', 'name': 'University of Miami', 'country_name': 'United States'}, {'id': 'grid.280838.9', 'acronym': 'PNDRI', 'name': 'Pacific Northwest Diabetes Research Institute', 'country_name': 'United States'}]",Grant,2017.0,US-9533013-B2,"['Lola M. Reid', 'Yunfang Wang', 'David A. GERBER', 'Giacomo LANZONI', 'Luca Inverardi', 'Juan Dominguez-Bendala', 'Domenico Alvaro', 'Vincenzo Cardinale', 'Eugenio Gaudio', 'Guido Carpino']",2017-01-03,,Method of treating pancreatic and liver conditions by endoscopic-mediated (or laparoscopic-mediated) transplantation of stem cells into/onto bile duct walls of particular regions of the biliary tree,2014
259,"['Sangamo Therapeutics Inc', 'SANGAMO BIOSCIENCES INC', 'SANGAMO THERAPEUTICS INC']","[{'id': 'grid.421831.d', 'name': 'Sangamo BioSciences (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9957526-B2,"['Michael C. Holmes', 'Jianbin Wang']",2018-05-01,,Delivery methods and compositions for nuclease-mediated genome engineering,2014
260,['UNIV JOHANNESBURG WITWATERSRAND'],"[{'id': 'grid.412988.e', 'acronym': 'UJ', 'name': 'University of Johannesburg', 'country_name': 'South Africa'}]",Application,,WO-2017037685-A1,"['PILLAY, VINESS', 'DU TOIT, LISA CLAIRE', 'CHOONARA, YAHYA ESSOP', 'RAMBURRUN, Poornima', 'KUMAR, PRADEEP']",2017-03-09,,BIODEGRADABLE IMPLANT,2016
261,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9994546-B2,"['Liangxing Wu', 'Wenqing Yao']",2018-06-12,5.0,Cyclopropylamines as LSD1 inhibitors,2016
262,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10047086-B2,"['Liangxing Wu', 'Leah C. Konkol', 'Neil Lajkiewicz', 'Liang Lu', 'Meizhong Xu', 'Wenqing Yao', 'Zhiyong Yu', 'Colin Zhang', 'Chunhong He']",2018-08-14,,Imidazopyridines and imidazopyrazines as LSD1 inhibitors,2017
263,"['Pietro Matricardi', 'Chiara Di Meo', 'MATRICARDI PIETRO', 'DI MEO CHIARA']",,Grant,2018.0,US-10059811-B2,"['Pietro Matricardi', 'Chiara Di Meo', 'Claudio Villani']",2018-08-28,,Polymer platform to prepare nanohydrogel,2014
264,"['Duke University', 'UNIV DUKE']","[{'id': 'grid.26009.3d', 'name': 'Duke University', 'country_name': 'United States'}]",Grant,2017.0,US-9828582-B2,"['Pablo Perez-Pinera', 'Charles Gersbach']",2017-11-28,,Compositions and methods for the induction and tuning of gene expression,2014
265,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9758523-B2,"['Liangxing Wu', 'Xiaozhao Wang', 'Wenqing Yao', 'Colin Zhang']",2017-09-12,7.0,Triazolopyridines and triazolopyrazines as LSD1 inhibitors,2015
266,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9944647-B2,"['Chunhong He', 'Zhenwu Li', 'Liangxing Wu', 'Wenqing Yao', 'Fenglei Zhang']",2018-04-17,7.0,Heterocyclic compounds as LSD1 inhibitors,2016
267,"['Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eV', 'FRICKE STEPHAN', 'EMMRICH FRANK', 'HILGER NADJA', 'FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E V']","[{'id': 'grid.4561.6', 'acronym': 'FHG', 'name': 'Fraunhofer Society', 'country_name': 'Germany'}]",Grant,2017.0,US-9745552-B2,"['Stephan Fricke', 'Frank Emmrich', 'Nadja Hilger']",2017-08-29,,Anti CD4 antibodies to prevent in particular graft-versus-host-disease (GvHD),2011
268,"['Ludwig Maximilians Universitaet Muenchen (LMU UNiversitaet)', 'LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN']","[{'id': 'grid.5252.0', 'acronym': 'LMU', 'name': 'Ludwig Maximilian University of Munich', 'country_name': 'Germany'}]",Application,,EP-3112375-A1,"['PRINZ, Jörg Christoph', 'DORNMAIR, KLAUS']",2017-01-04,,"ANTIGENIC PEPTIDES FOR THE DIAGNOSIS, THERAPY MONITORING AND/OR TREATMENT OF PSORIASIS VULGARIS",2015
269,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9527835-B2,"['Liangxing Wu', 'Chunhong He', 'Ding-Quan Qian', 'Bo Shen', 'Wenqing Yao']",2016-12-27,11.0,Cyclopropylamines as LSD1 inhibitors,2015
270,"['Sangamo Therapeutics Inc', 'SANGAMO THERAPEUTICS INC']",,Grant,2017.0,US-9833479-B2,"['Anthony Conway', 'Gregory J. Cost', 'Michael C. Holmes', 'Fyodor Urnov']",2017-12-05,,Gene correction of SCID-related genes in hematopoietic stem and progenitor cells,2017
271,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9695180-B2,"['Liangxing Wu', 'Joel R. Courter', 'Chunhong He', 'Jingwei Li', 'Liang Lu', 'Yaping Sun', 'Xiaozhao Wang', 'Wenqing Yao', 'Colin Zhang', 'Jincong Zhuo']",2017-07-04,10.0,"Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors",2015
272,['LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN'],"[{'id': 'grid.5252.0', 'acronym': 'LMU', 'name': 'Ludwig Maximilian University of Munich', 'country_name': 'Germany'}]",Application,,WO-2017005615-A3,"['PRINZ, Jörg Christoph', 'DORNMAIR, KLAUS']",2017-07-13,,"ANTIGENIC PEPTIDES FOR THE DIAGNOSIS, THERAPY MONITORING AND/OR TREATMENT OF PSORIASIS VULGARIS",2016
273,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9695168-B2,"['Liangxing Wu', 'Leah C. Konkol', 'Neil Lajkiewicz', 'Liang Lu', 'Meizhong Xu', 'Wenqing Yao', 'Zhiyong Yu', 'Colin Zhang', 'Chunhong He']",2017-07-04,10.0,"Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors",2015
274,"['Sangamo Therapeutics Inc', 'SANGAMO BIOSCIENCES INC']","[{'id': 'grid.421831.d', 'name': 'Sangamo BioSciences (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9616090-B2,"['Anthony Conway', 'Gregory J. Cost', 'Michael C. Holmes', 'Fyodor Urnov']",2017-04-11,6.0,Gene correction of SCID-related genes in hematopoietic stem and progenitor cells,2015
275,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}, {'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9179997-B2,"['Eunhee Cho', 'Valentine Kozov', 'Sukanya Varadharajan', 'Steven N. Willard']",2015-11-10,,Thermochromic polyvinyl alcohol based hydrogel artery,2013
276,['URIOL RIVERA MIGUEL GIOVANNI'],,Application,,WO-2015121022-A1,"['URIOL RIVERA, MIGUEL GIOVANNI']",2015-08-20,,USE OF PARICALCITOL IN THE TREATMENT OF INFLAMMATORY ANAEMIA,2015
277,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}, {'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9131982-B2,"['John VanScoy', 'Ryan Sefkow', 'Stuart Rosenberg', 'Allen Keel', 'Riddhi Shah', 'Wenbo Hou']",2015-09-15,3.0,Mediguide-enabled renal denervation system for ensuring wall contact and mapping lesion locations,2013
278,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}, {'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9713494-B2,"['Yelena Nabutovsky', 'Edward Karst', 'Fujian Qu']",2017-07-25,2.0,Feedback systems and methods for renal denervation utilizing balloon catheter,2016
279,"['St Jude Medical LLC', 'NGUYEN THO HOANG', 'HATA CARY', 'DE LA RAMA ALAN', 'TRAN VIVIAN', 'CHEN PETER C', 'ST JUDE MEDICAL']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-8974446-B2,"['Tho Hoang Nguyen', 'Cary Hata', 'Alan de la Rama', 'Vivian Tran', 'Peter C. Chen']",2015-03-10,13.0,Ultrasound ablation apparatus with discrete staggered ablation zones,2011
280,"['St Jude Medical AB', 'Pacesetter Inc', 'PERSSON TORBJORN', 'EMANUELSSON CECILIA', 'ABRAHAMSON HANS', 'ST JUDE MEDICAL']","[{'id': 'grid.480384.3', 'name': 'St. Jude Medical (Sweden)', 'country_name': 'Sweden'}, {'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-8934988-B2,"['Torbjorn Persson', 'Cecilia Emanuelsson', 'Hans Abrahamson']",2015-01-13,8.0,Ablation stent with meander structure,2012
281,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}, {'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9510902-B2,['Edward E. Parsonage'],2016-12-06,4.0,Ablation catheters and systems including rotational monitoring means,2013
282,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}, {'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9974477-B2,"['Martin Cholette', 'Sergio Shkurovich']",2018-05-22,,Quantification of renal denervation via alterations in renal blood flow pre/post ablation,2013
283,"['St Jude Medical LLC', 'ST JUDE MEDICAL']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8876813-B2,"['Xiaoyi Min', 'Stuart Rosenberg', 'Gabriel Mouchawar']",2014-11-04,8.0,"Methods, systems, and apparatus for neural signal detection",2013
284,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}, {'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9775663-B2,"['John B. Blix', 'James C. Baker', 'Kevin K. Ennett', 'John Eric Hein', 'Joseph Allen Brotz', 'Joseph William Barnier', 'Raymond Vincent Froehlich', 'Michael Olsen', 'Sukanya Varadharajan', 'Catherine A. Pipenhagen']",2017-10-03,2.0,"Ablation system, methods, and controllers",2014
285,"['Massachusetts Institute of Technology', 'MASSACHUSETTS INST TECHNOLOGY']","[{'id': 'grid.116068.8', 'acronym': 'MIT', 'name': 'Massachusetts Institute of Technology', 'country_name': 'United States'}]",Grant,2017.0,US-9791258-B2,"['Jacob C. Mower', 'Nicholas C. Harris', 'Dirk R. Englund', 'Greg Steinbrecher']",2017-10-17,3.0,"Methods, systems, and apparatus for programmable quantum photonic processing",2016
286,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV']","[{'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}, {'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-D747491-S1,"['Sara A. Thompson', 'Mark A. Catron', 'Eric Collins', 'Matija Klemenc', 'Karen M. Kensok', 'John B. Blix']",2016-01-12,,Ablation generator,2013
287,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}, {'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9861433-B2,['Troy Tegg'],2018-01-09,,Helical-shaped ablation catheter and methods of use,2014
288,"['Bristol Myers Squibb Co', 'SQUIBB BRISTOL MYERS CO']","[{'id': 'grid.419971.3', 'acronym': 'BMS', 'name': 'Bristol-Myers Squibb (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10052360-B2,"['Robert Cohen', 'SUZETTE BELDER-CARR', 'David Hagerty', 'ROBERT JAMES PEACH', 'Jean-Claude Becker']",2018-08-21,,Methods for treating dermatomyositis or polymyositis by administering a soluble CTLA4 molecule,2016
289,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}, {'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10080601-B2,"['Joseph Allen Brotz', 'John Eric Hein', 'Raymond Vincent Froehlich', 'Joseph William Barnier']",2018-09-25,,"Ablation system, methods, and controllers",2016
290,"['RA PHARMACEUTICALS Inc', 'RA PHARMACEUTICALS INC']",,Grant,2018.0,US-9937222-B2,"['Michelle Denise Hoarty', 'Ketki Ashok Dhamnaskar', 'Daniel Elbaum', 'Kristopher Josephson', 'Kelley Cronin Larson', 'Zhong Ma', 'Nathan Ezekiel Nims', 'Alonso Ricardo', 'Kathleen Seyb', 'Guo-Qing Tang', 'Douglas A. Treco', 'Zhaolin Wang', 'Ping Ye', 'HONG ZHENG', 'Sarah Jacqueline Perlmutter']",2018-04-10,,Modulators of complement activity,2016
291,"['Pacesetter Inc', 'FAIN ERIC S', 'CHOLETTE MARTIN', 'DULAK GARY R', 'BORNZIN GENE A', 'POORE JOHN W', 'PACESETTER INC']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9427579-B2,"['Eric S. Fain', 'Martin Cholette', 'Gary R. Dulak', 'Gene A. Bornzin', 'John W. Poore']",2016-08-30,12.0,System and method for performing renal denervation verification,2011
292,"['Forma Therapeutics Inc', 'FORMA THERAPEUTICS INC']",,Grant,2018.0,US-10005734-B2,"['Jian Lin', 'Anna Ericsson', 'Ann-Marie Campbell', 'Gary Gustafson', 'Zhongguo Wang', 'R. Bruce Diebold', 'Susan Ashwell', 'DAVID R. LANCIA, JR.', 'Justin Andrew Caravella', 'Wei Lu']",2018-06-26,4.0,Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors,2015
293,"['St Jude Medical LLC', 'St Jude Medical Cardiology Division Inc', 'NG KOK-HWEE', 'ST JUDE MEDICAL CARDIOLOGY DIV']","[{'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}, {'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8909316-B2,['Kok-Hwee Ng'],2014-12-09,39.0,Apparatus and method of assessing transvascular denervation,2011
294,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV', 'ST JUDE MEDICAL CARDIOLOGY DIV']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}, {'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9314300-B2,"['Yelena Nabutovsky', 'Edward Karst', 'Fujian Qu']",2016-04-19,14.0,Feedback systems and methods for renal denervation utilizing balloon catheter,2015
295,"['Forma Therapeutics Inc', 'FORMA THERAPEUTICS INC']",,Grant,2017.0,US-9771349-B2,"['Jian Lin', 'Anna Ericsson', 'Ann-Marie Campbell', 'Gary Gustafson', 'Zhongguo Wang', 'R. Bruce Diebold', 'Susan Ashwell', 'DAVID R. LANCIA, JR.', 'Justin Andrew Caravella', 'Wei Lu']",2017-09-26,5.0,Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors,2015
296,"['Chugai Pharmaceutical Co Ltd', 'Genentech Inc', 'Hoffmann-La Roche Inc', 'GENENTECH INC', 'Hoffmann-La Roche Inc', 'CHUGAI PHARMACEUTICAL CO LTD', 'Hoffmann-La Roche Inc']","[{'id': 'grid.418158.1', 'acronym': 'Roche', 'name': 'Roche (United States)', 'country_name': 'United States'}, {'id': 'grid.418587.7', 'name': 'Roche (Japan)', 'country_name': 'Japan'}]",Grant,2017.0,US-9539263-B2,"['Xiaoping Zhang', 'Kimio Terao', 'Angelika M. Jahreis']",2017-01-10,5.0,Subcutaneously administered anti-IL-6 receptor antibody for treatment of systemic sclerosis,2013
297,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}, {'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9872728-B2,"['Paul A. Belk', 'Jennifer M. Heisel']",2018-01-23,,Apparatuses and methods for affixing electrodes to an intravascular balloon,2014
298,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}, {'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9179973-B2,"['Yelena Nabutovsky', 'Edward Karst', 'Fujian Qu']",2015-11-10,14.0,Feedback systems and methods for renal denervation utilizing balloon catheter,2013
299,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}, {'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9713490-B2,"['Joseph Allen Brotz', 'John Eric Hein', 'Raymond Vincent Froehlich', 'Joseph William Barnier']",2017-07-25,1.0,"Ablation system, methods, and controllers",2014
300,"['Pacesetter Inc', 'PACESETTER INC']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9801684-B2,"['Eric S. Fain', 'Martin Cholette', 'Gary R. Dulak', 'Gene A. Bornzin', 'John W. Poore']",2017-10-31,2.0,System and method for performing renal denervation verification,2016
301,"['Dynavax Technologies Corp', 'DYNAVAX TECH CORPORATION']","[{'id': 'grid.418630.8', 'name': 'Dynavax Technologies (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9993495-B2,"['Cristiana Guiducci', 'Robert L. Coffman']",2018-06-12,3.0,Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer of the lung,2016
302,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}, {'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9913961-B2,"['Tobias Cajamarca', 'Gregory James Dakin', 'Jeffrey John Strong']",2018-03-13,,Flexible catheter shaft and method of manufacture,2014
303,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}, {'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-D793559-S1,"['Sara A. Thompson', 'Mark A. Catron', 'Eric Collins', 'Matija Klemenc', 'Karen M. Kensok', 'John B. Blix']",2017-08-01,,Ablation generator,2015
304,"['St Jude Medical LLC', 'DE LA RAMA ALAN', 'HATA CARY', 'ST JUDE MEDICAL']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-8979839-B2,"['Alan de la Rama', 'Cary Hata']",2015-03-17,11.0,Assembly of staggered ablation elements,2010
305,"['Forma Therapeutics Inc', 'FORMA THERAPEUTICS INC']",,Grant,2017.0,US-9815817-B2,"['Jian Lin', 'Anna Ericsson', 'Ann-Marie Campbell', 'Gary Gustafson', 'Zhongguo Wang', 'R Bruce Diebold', 'Susan Ashwell', 'DAVID R. LANCIA, JR.', 'Justin Andrew Caravella', 'Wei Lu']",2017-11-14,3.0,Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors,2015
306,"['Massachusetts Institute of Technology', 'MOWER JACOB C', 'HARRIS NICHOLAS C', 'ENGLUND DIRK R', 'STEINBRECHER GREG', 'MASSACHUSETTS INST TECHNOLOGY']","[{'id': 'grid.116068.8', 'acronym': 'MIT', 'name': 'Massachusetts Institute of Technology', 'country_name': 'United States'}]",Grant,2016.0,US-9354039-B2,"['Jacob C. Mower', 'Nicholas C. Harris', 'Dirk R. Englund', 'Greg Steinbrecher']",2016-05-31,4.0,"Methods, systems, and apparatus for programmable quantum photonic processing",2015
307,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}, {'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9427283-B2,"['Yelena Nabutovsky', 'Edward Karst', 'Fujian Qu']",2016-08-30,15.0,Feedback systems and methods for renal denervation utilizing balloon catheter,2016
308,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}, {'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9775966-B2,"['James Paul Goodman', 'Kevin Gin Park', 'Bradley C. Knippel']",2017-10-03,,Catheter system,2014
309,['GE HEALTHCARE LTD'],"[{'id': 'grid.420685.d', 'acronym': 'GEC', 'name': 'General Electric (United Kingdom)', 'country_name': 'United Kingdom'}]",Application,,WO-2016097351-A1,"['JACKSON, ALEXANDER', 'MORISSON-IVESON, VERONIQUE', 'WYNN, DUNCAN, GEORGE', 'JOSE, Jinto', 'RANGASWAMY, CHITRALEKHA']",2016-06-23,,18F LABELLED THIAZOLYLHYDRAZONE DERIVATIVES,2015
310,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}, {'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9861436-B2,['Edward E. Parsonage'],2018-01-09,,Ablation catheters and systems including rotational monitoring means,2016
311,"['Canon Inc', 'CANON KK']","[{'id': 'grid.471046.0', 'name': 'Canon (Japan)', 'country_name': 'Japan'}]",Grant,2018.0,US-10075621-B2,['Hiromitsu Nishikawa'],2018-09-11,,Print data generating apparatus and print data generating method,2015
312,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}, {'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9186212-B2,"['Yelena Nabutovsky', 'Edward Karst', 'Xiaoyi Min', 'Stuart Rosenberg', 'Kritika Gupta']",2015-11-17,13.0,Feedback systems and methods utilizing two or more sites along denervation catheter,2013
313,"['Allergan Inc', 'ALLERGAN INC']","[{'id': 'grid.417882.0', 'name': 'Allergan (United States)', 'country_name': 'United States'}]",Application,,US-20150140062-A1,"['Jane-Guo Shiah', 'Rahul Bhagat', 'Wendy M. Blanda', 'Thierry Nivaggioli', 'Lin Peng', 'David Chou', 'David A. Weber']",2015-05-21,1.0,METHODS OF TREATMENT OF OCULAR CONDITIONS WITH A SUSTAINED DRUG DELIVERY IMPLANT,2014
314,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}, {'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9561070-B2,"['Joseph Allen Brotz', 'John Eric Hein', 'Raymond Vincent Froehlich', 'Joseph William Barnier']",2017-02-07,3.0,"Ablation system, methods, and controllers",2014
315,"['Forma Therapeutics Inc', 'FORMA THERAPEUTICS INC']",,Grant,2017.0,US-9834539-B2,"['Jian Lin', 'Anna Ericsson', 'Ann-Marie Campbell', 'Gary Gustafson', 'Zhongguo Wang', 'R. Bruce Diebold', 'Susan Ashwell', 'DAVID R. LANCIA, JR.', 'Justin Andrew Caravella', 'Wei Lu']",2017-12-05,3.0,Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors,2015
316,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}, {'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-D774043-S1,"['Sara A. Thompson', 'Mark A. Catron', 'Eric Collins', 'Matija Klemenc', 'John B. Blix']",2016-12-13,2.0,Display screen with graphical user interface for ablation generator,2013
317,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}, {'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-D829238-S1,"['Sara A. Thompson', 'Mark A. Catron', 'Eric Collins', 'Matija Klemenc', 'John B. Blix']",2018-09-25,,Display screen with graphical user interface for ablation generator,2018
318,['ALLERGAN INC'],"[{'id': 'grid.417882.0', 'name': 'Allergan (United States)', 'country_name': 'United States'}]",Application,,WO-2015073895-A1,"['SHIAH, JANE-GUO', 'BHAGAT, RAHUL', 'BLANDA, WENDY M.', 'NIVAGGIOLI, THIERRY', 'PENG, LIN', 'CHOU, DAVID', 'WEBER, DAVID A.']",2015-05-21,,METHODS OF TREATMENT OF OCULAR CONDITIONS WITH A SUSTAINED DRUG DELIVERY IMPLANT,2014
319,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}, {'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9999748-B2,"['Tobias Cajamarca', 'Jeffrey John Strong', 'Russell D. Terwey', 'Bruce Robert Weir', 'Janson Lee Ayer', 'Ryan Kenneth Buesseler']",2018-06-19,,Flexible catheter shaft and method of manufacture,2014
320,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}, {'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9987070-B2,"['John B. Blix', 'James C. Baker', 'Kevin K. Ennett', 'John Eric Hein', 'Joseph Allen Brotz', 'Joseph William Barnier', 'Raymond Victor Froehlich', 'Michael Olsen', 'Sukanya Varadharajan']",2018-06-05,,"Ablation system, methods, and controllers",2014
321,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}, {'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10034705-B2,"['John Jason Buysman', 'Ryan Kenneth Buesseler', 'Qingshan Ye', 'Victor Yevgenyevich Kotov', 'Gregory James Dakin', 'Russ Terwey', 'Janson Lee Ayer']",2018-07-31,,High strength electrode assembly for catheter system including novel electrode,2014
322,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV INC']","[{'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}, {'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-D815131-S1,"['Sara A. Thompson', 'Mark A. Catron', 'Eric Collins', 'Matija Klemenc', 'John B. Blix']",2018-04-10,1.0,Display screen with graphical user interface for ablation generator,2016
323,"['St Jude Medical Cardiology Division Inc', 'ST JUDE MEDICAL CARDIOLOGY DIV']","[{'id': 'grid.453884.6', 'name': 'St. Jude Medical (United States)', 'country_name': 'United States'}, {'id': 'grid.417574.4', 'name': 'Abbott (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9113929-B2,['Edward E. Parsonage'],2015-08-25,,Non-electric field renal denervation electrode,2013
324,"['Syngenta Participations AG', 'SYNGENTA PARTICIPATIONS AG']","[{'id': 'grid.420222.4', 'name': 'Syngenta (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2017.0,US-9815803-B2,"['Tomas Smejkal', 'Helmars Smits', 'Christian LOTHSCHUETZ', 'Miroslav Terinek']",2017-11-14,,Process for the preparation of substituted cycloserines,2017
325,"['BIOASTRA TECHNOLOGIES Inc', 'BIOASTRA TECH INC']",,Grant,2018.0,US-9963627-B2,"['Sumitra Rajagopalan', 'Giovanni Alexander Fabra Prieto']",2018-05-08,,Nanostructured phase change materials for solid state thermal management,2013
326,['SYNGENTA PARTICIPATIONS AG'],"[{'id': 'grid.420222.4', 'name': 'Syngenta (Switzerland)', 'country_name': 'Switzerland'}]",Application,,WO-2015166094-A1,"['SMEJKAL, TOMAS', 'SMITS, HELMARS', 'LOTHSCHUETZ, CHRISTIAN', 'TERINEK, MIROSLAV']",2015-11-05,,PROCESS FOR THE PREPARATION OF SUBSTITUTED CYCLOSERINES,2015
327,"['Caterpillar Inc', 'CATERPILLAR INC']","[{'id': 'grid.418702.8', 'name': 'Caterpillar (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9985315-B1,['Kenneth Stonecipher'],2018-05-29,,"Hydrothermal carbon anode, polymer stabilized, sodium-ion cell",2015
328,"['Syngenta Participations AG', 'SYNGENTA PARTICIPATIONS AG']","[{'id': 'grid.420222.4', 'name': 'Syngenta (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2017.0,US-9643938-B2,"['Tomas Smejkal', 'Helmars Smits', 'Christian LOTHSCHUETZ', 'Miroslav Terinek']",2017-05-09,,Process for the preparation of substituted cycloserines,2015
329,"['Bayer Pharma AG', 'Bayer Pharma AG']","[{'id': 'grid.420044.6', 'name': 'Bayer (Germany)', 'country_name': 'Germany'}]",Grant,2017.0,US-9556181-B2,"['Ulrich Klar', 'Lars Wortmann', 'Georg Kettschau', 'Florian Pühler', 'Philip Lienau', 'Detlev Sülzle']",2017-01-31,,Substituted pyrazolopyrimidinylamino-indazoles,2014
330,"['Bayer Pharma AG', 'Bayer Pharma AG']","[{'id': 'grid.420044.6', 'name': 'Bayer (Germany)', 'country_name': 'Germany'}]",Grant,2017.0,US-9540392-B2,"['Georg Kettschau', 'Florian Puehler', 'Knut Eis', 'Ulrich Klar', 'Dirk Kosemund', 'Detlev Sülzle', 'Philip Lienau', 'Andrea Hägebarth', 'Ulf Bömer', 'Lars Wortmann', 'Keith Graham', 'Antje Margret Wengner']",2017-01-10,1.0,Thienopyrimidines,2013
331,"['University of South Florida', 'ZESIEWICZ THERESA A', 'SULLIVAN KELLY L', 'UNIV SOUTH FLORIDA']","[{'id': 'grid.170693.a', 'acronym': 'USF', 'name': 'University of South Florida', 'country_name': 'United States'}]",Grant,2016.0,US-9463190-B2,"['Theresa A. Zesiewicz', 'Kelly L. Sullivan']",2016-10-11,,Methods of treating disease-induced ataxia and non-ataxic imbalance,2009
332,"['Bayer Pharma AG', 'Bayer Pharma AG']","[{'id': 'grid.420044.6', 'name': 'Bayer (Germany)', 'country_name': 'Germany'}]",Grant,2016.0,US-9296757-B2,"['Ulrich Klar', 'Georg Kettschau', 'Dirk Kosemund', 'Florian Pühler', 'Knut Eis', 'Philip Lienau', 'Ulf Bömer', 'Detlev Sülzle', 'Lars Wortmann']",2016-03-29,,Substituted benzothienopyrimidines,2013
333,"['Bayer Pharma AG', 'Bayer Pharma AG']","[{'id': 'grid.420044.6', 'name': 'Bayer (Germany)', 'country_name': 'Germany'}]",Grant,2016.0,US-9382255-B2,"['Ulrich Klar', 'Lars Wortmann', 'Georg Kettschau', 'Florian Püehler', 'Philip Lienau', 'Kirstin Petersen', 'Andrea Hägebarth', 'Detlev Sülzle', 'Anja Richter']",2016-07-05,1.0,Substituted pyrrolopyrimidinylamino-benzothiazolones as MKNK kinase inhibitors,2013
334,['UNIV TEXAS'],"[{'id': 'grid.55460.32', 'acronym': 'UT System', 'name': 'The University of Texas System', 'country_name': 'United States'}]",Application,,WO-2014210509-A1,"['ROMANAK, Katherine', 'BENNETT, Philip, C.']",2014-12-31,2.0,PROCESS-BASED APPROACH FOR THE DETECTION OF CO2 INJECTATE LEAKAGE,2014
335,"['Bayer Pharma AG', 'Bayer Pharma AG']","[{'id': 'grid.420044.6', 'name': 'Bayer (Germany)', 'country_name': 'Germany'}]",Grant,2017.0,US-9675612-B2,"['Ulrich Klar', 'Lars Wortmann', 'Keith Graham', 'Florian Puehler', 'Detlev Sülzle', 'Georg Kettschau', 'Philip Lienau']",2017-06-13,,Substituted thiazolopyrimidines,2014
336,"['University of South Florida', 'ZESIEWICZ THERESA A', 'SULLIVAN KELLY L', 'UNIV SOUTH FLORIDA']","[{'id': 'grid.170693.a', 'acronym': 'USF', 'name': 'University of South Florida', 'country_name': 'United States'}]",Grant,2017.0,US-9782404-B2,"['Theresa A. Zesiewicz', 'Kelly L. Sullivan']",2017-10-10,,Methods of treating disease-induced ataxia and non-ataxic imbalance,2014
337,['CONATUS PHARMACEUTICALS INC'],"[{'id': 'grid.476199.4', 'name': 'Conatus Pharmaceuticals (United States)', 'country_name': 'United States'}]",Application,,WO-2017079566-A1,"['SPADA, ALFRED, P.']",2017-05-11,,CASPASE INHIBITORS FOR USE IN THE TREATMENT OF LIVER CANCER,2016
338,['US HEALTH'],,Application,,WO-2016168615-A1,"['FIELDS, Richard Douglas', 'DUTTA, Dipankar Jyoti', 'WOO, DONG HO']",2016-10-20,,METHODS OF TREATING OR PREVENTING DEMYELINATION USING THROMBIN INHIBITORS AND METHODS OF DETECTING DEMYELINATION USING NEUROFASCIN 155,2016
339,"['Iucf-Hyu (industry-University Cooperation Found Hanyang University)', 'Hanyang University Industry-University Cooperation Foundation (IUCF)', 'IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUND HANYANG UNIVERSITY)']","[{'id': 'grid.49606.3d', 'name': 'Hanyang University', 'country_name': 'South Korea'}]",Application,,EP-3171436-A4,"['JEONG,, Yosub', 'LEE, Yunjung', 'PARK, Jinbeom', 'SUN, Yangkook']",2017-12-27,,LITHIUM AIR BATTERY AND METHOD FOR MANUFACTURING SAME,2015
340,"['Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eV', 'FRAUNHOFER GES FORSCHUNG']","[{'id': 'grid.4561.6', 'acronym': 'FHG', 'name': 'Fraunhofer Society', 'country_name': 'Germany'}]",Application,,DE-102017205049-A1,"['Jürgen Gluch', 'Malgorzata Kopycinska-Müller', 'Bernd Köhler', 'Ute Rabe']",2018-09-27,,A method for calibrating a tip of a scanning atomic force microscope,2017
341,['THE UNIV OF BIRMINGHAM'],"[{'id': 'grid.6572.6', 'name': 'University of Birmingham', 'country_name': 'United Kingdom'}]",Application,,WO-2018042207-A1,"['ZHUANG, XIAODONG', 'MCKEATING, Jane Alison']",2018-03-08,,TREATMENT AND PREVENTION OF VIRAL INFECTION,2017
342,"['ALBUFERA ENERGY STORAGE S L', 'Albufera Energy Storage SL', 'ALBUFERA ENERGY STORAGE S L']",,Application,,EP-3229309-A1,"['PINO MARTÍNEZ, Mikel', 'RODRÍGUEZ SOLER, Paloma', 'CHACÓN GUADALIX, Joaquín José']",2017-10-11,,RECHARGEABLE ALUMINUM-AIR ELECTROCHEMICAL CELL,2017
343,"['University of Michigan', 'New York University', 'Ohio State University Research Foundation', 'UNIV NEW YORK', 'UNIV MICHIGAN', 'UNIV OHIO STATE RES FOUND']","[{'id': 'grid.137628.9', 'acronym': 'NYU', 'name': 'New York University', 'country_name': 'United States'}, {'id': 'grid.214458.e', 'acronym': 'UM', 'name': 'University of Michigan', 'country_name': 'United States'}, {'id': 'grid.261331.4', 'acronym': 'OSU', 'name': 'The Ohio State University', 'country_name': 'United States'}]",Application,,US-20140220159-A1,"['Paramjit S. ARORA', 'Quintin PAN', 'Anna MAPP']",2014-08-07,1.0,HYDROGEN-BOND SURROGATE PEPTIDES AND PEPTIDOMIMETICS FOR p53 REACTIVATION,2014
344,"['CYTORI THERAPEUTICS INC', 'FRASER JOHN', 'MAGALON GUY']","[{'id': 'grid.488266.6', 'name': 'Cytori Therapeutics (United States)', 'country_name': 'United States'}]",Application,,WO-2015042182-A1,"['FRASER, JOHN', 'MAGALON, Guy']",2015-03-26,,METHODS OF USING ADIPOSE TISSUE-DERIVED CELLS IN THE MODULATION OF PAIN AND/OR FIBROSIS,2014
345,"['Northwestern University', 'UNIV NORTHWESTERN']","[{'id': 'grid.16753.36', 'acronym': 'NU', 'name': 'Northwestern University', 'country_name': 'United States'}]",Grant,2018.0,US-9938397-B2,"['John M. Torkelson', 'Krishnan A. Iyer']",2018-04-10,,Direct use of natural antioxidant-rich agro-wastes as thermal stabilizers for polymers,2016
346,['OPTIBIOTIX LTD'],,Application,,WO-2015067936-A1,"[""O'HARA, Stephen, Patrick""]",2015-05-14,8.0,COMPOSITION,2014
347,"['University of Michigan', 'New York University', 'Ohio State University Research Foundation', 'UNIV NEW YORK', 'UNIV OHIO STATE RES FOUND', 'UNIV MICHIGAN REGENTS']","[{'id': 'grid.214458.e', 'acronym': 'UM', 'name': 'University of Michigan', 'country_name': 'United States'}, {'id': 'grid.261331.4', 'acronym': 'OSU', 'name': 'The Ohio State University', 'country_name': 'United States'}, {'id': 'grid.137628.9', 'acronym': 'NYU', 'name': 'New York University', 'country_name': 'United States'}]",Grant,2017.0,US-9605026-B2,"['Paramjit S. ARORA', 'Quintin PAN', 'Anna MAPP']",2017-03-28,,Hydrogen-bond surrogate peptides and peptidomimetics for p53 reactivation,2014
348,"['University of Michigan', 'New York University', 'Ohio State University Research Foundation', 'UNIV NEW YORK', 'UNIV MICHIGAN', 'UNIV OHIO STATE RES FOUND']","[{'id': 'grid.261331.4', 'acronym': 'OSU', 'name': 'The Ohio State University', 'country_name': 'United States'}, {'id': 'grid.214458.e', 'acronym': 'UM', 'name': 'University of Michigan', 'country_name': 'United States'}, {'id': 'grid.137628.9', 'acronym': 'NYU', 'name': 'New York University', 'country_name': 'United States'}]",Application,,US-20140205681-A1,"['Paramjit S. ARORA', 'Quintin PAN', 'Anna MAPP']",2014-07-24,4.0,HYDROGEN-BOND SURROGATE PEPTIDES AND PEPTIDOMIMETICS FOR p53 REACTIVATION,2014
349,['IUCF HYU'],"[{'id': 'grid.49606.3d', 'name': 'Hanyang University', 'country_name': 'South Korea'}]",Application,,WO-2016010403-A1,"['정요섭', '이윤정', '박진범', '선양국']",2016-01-21,,LITHIUM AIR BATTERY AND METHOD FOR MANUFACTURING SAME,2015
350,"['QuantumScape Corp', 'QUANTUMSCAPE CORP']",,Grant,2017.0,US-9819024-B2,"['Cheng-Chieh Chao', 'Zhebo Chen', 'Tim Holme', 'Marie A. Mayer', 'Gilbert N. Riley, Jr.']",2017-11-14,,Solid state catholytes and electrolytes for energy storage devices,2017
351,"['QuantumScape Corp', 'QUANTUMSCAPE CORP']",,Grant,2018.0,US-9859560-B2,"['Tim Holme', 'Ken Desmond', 'Weston Arthur Hermann', 'Joseph Han', 'Zhebo Chen']",2018-01-02,,Electrode materials with mixed particle sizes,2015
352,"['Wisconsin Alumni Research Foundation', 'WISCONSIN ALUMNI RES FOUND']","[{'id': 'grid.453773.1', 'acronym': 'WARF', 'name': 'Wisconsin Alumni Research Foundation', 'country_name': 'United States'}]",Grant,2018.0,US-10074819-B2,"['Michael Scott Arnold', 'Padma Gopalan', 'Gerald Joseph Brady', 'Yongho Joo', 'Harold T. Evensen']",2018-09-11,,Floating evaporative assembly of aligned carbon nanotubes,2017
353,['OPTIBIOTIX LTD'],,Application,,WO-2016071693-A1,"[""O'HARA, Stephen Patrick""]",2016-05-12,1.0,COMPOSITION,2015
354,"['AARHUS UNIV', 'UNIVERSITÀ DI ROMA “LA SAPIENZA”']","[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}, {'id': 'grid.7048.b', 'acronym': 'AU', 'name': 'Aarhus University', 'country_name': 'Denmark'}]",Application,,WO-2017008816-A1,"['FERAPONTOVA, Elena', 'BOFFI, Alberto']",2017-01-19,,ENZYMATIC ELECTRODE FOR REGENERATION OF OXIDISED AND/OR REDUCED FORMS OF PYRIDINE NUCLEOTIDES,2016
355,"['Tenax Therapeutics Inc', 'TENAX THERAPEUTICS INC']",,Application,,US-20150374689-A1,"['John Kelley', 'Doug Randall', 'Douglas Hay']",2015-12-31,,Use of Levosimendan to Treat Left Ventricular Systolic Dysfunction in Patients Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass,2015
356,"['Charite Universitaetsmedizin Berlin', 'CERMAKOVA IVA', 'CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN']","[{'id': 'grid.6363.0', 'name': 'Charité – University Medicine Berlin', 'country_name': 'Germany'}]",Application,,DE-102014207513-A1,"['Jürgen Braun', 'Ingolf Sack', 'Sebastian Hirsch', 'Ivo CERMAK']",2015-10-22,,Elastography device and method for the operation thereof,2014
357,['DEUTSCHES KREBSFORSCH'],"[{'id': 'grid.7497.d', 'acronym': 'DKFZ', 'name': 'German Cancer Research Center', 'country_name': 'Germany'}]",Application,,WO-2015049063-A1,"['KUMAR, RAJIVE', 'SCHADENDORF, DIRK']",2015-04-09,1.0,"HUMAN TERT PROMOTER VARIANTS, AS WELL AS KITS, METHODS AND USES THEREOF",2014
358,"['DISCOVERYBIOMED Inc', 'DISCOVERYBIOMED INC']","[{'id': 'grid.420651.4', 'acronym': 'DBM', 'name': 'DiscoveryBioMed (United States)', 'country_name': 'United States'}]",Grant,2017.0,AU-2014240003-B2,"['DIXON, JOHN', 'GAO, HONGWU', 'MAI, DEBORAH', 'RITCHIE, Joseph P.', 'SCHWIEBERT, ERIK', 'SEALES, Eric C.', 'STREIFF, John']",2017-12-14,,Coumarin derivatives and methods of use in treating hyperproliferative diseases,2014
359,"['BROAD INST INC', 'DANA FARBER CANCER INST INC', 'GEN HOSPITAL CORP', 'HARVARD COLLEGE']","[{'id': 'grid.32224.35', 'acronym': 'MGH', 'name': 'Massachusetts General Hospital', 'country_name': 'United States'}, {'id': 'grid.38142.3c', 'name': 'Harvard University', 'country_name': 'United States'}, {'id': 'grid.65499.37', 'name': 'Dana-Farber Cancer Institute', 'country_name': 'United States'}, {'id': 'grid.66859.34', 'name': 'Broad Institute', 'country_name': 'United States'}]",Application,,WO-2015077717-A1,"['CLEMENT, Kendell', 'GETZ, GAD', 'LANDAU, Dan-avi', 'MEISSNER, ALEXANDER', 'WU, Catherine, Ju-ying']",2015-05-28,2.0,"COMPOSITIONS AND METHODS FOR DIAGNOSING, EVALUATING AND TREATING CANCER BY MEANS OF THE DNA METHYLATION STATUS",2014
360,['UMC UTRECHT HOLDING BV'],"[{'id': 'grid.7692.a', 'acronym': 'UMC', 'name': 'University Medical Center Utrecht', 'country_name': 'Netherlands'}]",Application,,WO-2015107184-A1,"['VOS, Marc A.']",2015-07-23,,PREDICTION OF CARDIAC RESYNCHRONIZATION THERAPY RESPONSE BASED ON VARIABILITY OF REPOLARIZATION,2015
361,"['CECCATELLI SANDRA', 'SPULBER DAN STEFAN']",,Application,,WO-2016038107-A1,"['CECCATELLI, Sandra', 'SPULBER, Dan Stefan']",2016-03-17,2.0,METHODS AND COMPOSITIONS FOR BIOMARKERS OF DEPRESSION AND PHARMACORESPONSE,2015
362,"['Janssen Pharmaceuticals Inc', 'CID-NÚÑEZ JOSÉ MARIA', 'TRABANCO-SUÁREZ ANDRÉS AVELINO', 'VEGA RAMIRO JUAN ANTONIO', 'OEHLRICH DANIEL', 'TRESADERN GARY JOHN', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC']",,Grant,2015.0,US-8993591-B2,"['José Maria Cid-Núñez', 'Andrés Avelino Trabanco-Suárez', 'Juan Antonio Vega Ramiro', 'Daniel Oehlrich', 'Gary John Tresadern', 'Gregor James MacDonald']",2015-03-31,1.0,"1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors",2011
363,"['Janssen Pharmaceuticals Inc', 'CID-NÚÑEZ JOSÉ MARIA', 'TRABANCO-SUÁREZ ANDRÉS AVELINO', 'VEGA RAMIRO JUAN ANTONIO', 'OEHLRICH DANIEL', 'TRESADERN GARY JOHN', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC']",,Grant,2016.0,US-9271967-B2,"['José Maria Cid-Núñez', 'Andrés Avelino Trabanco-Suárez', 'Juan Antonio Vega Ramiro', 'Daniel Oehlrich', 'Gary John Tresadern', 'Gregor James MacDonald']",2016-03-01,1.0,"1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2011
364,"['Janssen Pharmaceutica NV', 'Addex Therapeutics Ltd', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA']","[{'id': 'grid.419619.2', 'name': 'Janssen (Belgium)', 'country_name': 'Belgium'}, {'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8906939-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey']",2014-12-09,,3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives,2008
365,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'LUTJENS ROBERT JOHANNES', 'FINN PATRICK TERRY', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8722894-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lutjens', 'Patrick Terry Finn']",2014-05-13,,"1,3-disubstituted-4-phenyl-1H-pyridin-2-ones",2008
366,"['Eisai R&D Management Co Ltd', 'EISAI R&D MAN CO LTD']","[{'id': 'grid.418765.9', 'name': 'Eisai (Japan)', 'country_name': 'Japan'}]",Grant,2016.0,US-9458176-B2,"['Mamoru Takaishi', 'Nobuhiro Sato', 'Tomoyuki Shibuguchi', 'Takafumi Motoki', 'Yoshinori Takahashi', 'Takeo Sasaki', 'Alan Braunton']",2016-10-04,10.0,"Tetrahydroimidazo(1,5-D)[1,4]oxazepine derivative",2014
367,"['Janssen Pharmaceutica NV', 'JANSSEN PHARMACEUTICA NV']","[{'id': 'grid.419619.2', 'name': 'Janssen (Belgium)', 'country_name': 'Belgium'}]",Grant,2017.0,US-9708315-B2,"['José Maria Cid-Núñez', 'Andrés Avelino Trabanco-Suárez', 'Marc André Ceusters', 'Hilde Lavreysen']",2017-07-18,1.0,"1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of MGLUR2 receptors",2014
368,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'OEHLRICH DANIEL', 'TRABANCO-SUAREZ ANDRES AVELINO', 'TRESADERN GARY JOHN', 'VEGA RAMIRO JUAN ANTONIO', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-8937060-B2,"['Jose Maria Cid-Nunez', 'Daniel Oehlrich', 'Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Gregor James MacDonald']",2015-01-20,9.0,"1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders",2010
369,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-9132122-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lütjens', 'Terry Patrick Finn']",2015-09-15,,"1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones",2013
370,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'LUTJENS ROBERT JOHANNES', 'FINN PATRICK TERRY', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8748621-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lutjens', 'Patrick Terry Finn']",2014-06-10,,"1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones",2012
371,['DISCOVERYBIOMED INC'],"[{'id': 'grid.420651.4', 'acronym': 'DBM', 'name': 'DiscoveryBioMed (United States)', 'country_name': 'United States'}]",Application,,WO-2014152278-A2,"['SCHWIEBERT, ERIK', 'STREIFF, John', 'DIXON, JOHN', 'GAO, HONGWU', 'RITCHIE, Joseph P.', 'SEALES, Eric C.', 'MAI, DEBORAH']",2014-09-25,4.0,COUMARIN DERIVATIVES AND METHODS OF USE IN TREATING HYPERPROLIFERATIVE DISEASES,2014
372,"['Merck Patent GmbH', 'MERCK PATENT GMBH']","[{'id': 'grid.39009.33', 'name': 'Merck (Germany)', 'country_name': 'Germany'}]",Grant,2017.0,US-9708321-B2,"['Nadia Brugger', 'Brian L. Hodous', 'Amanda E. Sutton', 'Justin Potnick', 'Theresa L. Johnson', 'Thomas E. Richardson', 'Thomas Francis Nelson HAXELL', 'James M. Dorsey', 'Robert James Foglesong']",2017-07-18,,Spiro-quinazolinone derivatives and their use as positive allosteric modulators of mGluR4,2014
373,"['STMicroelectronics SRL', 'ST MICROELECTRONICS SRL']","[{'id': 'grid.5403.2', 'acronym': 'ST', 'name': 'STMicroelectronics (Italy)', 'country_name': 'Italy'}]",Grant,2016.0,US-9384315-B2,"['Mattia Monetti', 'Alberto Balzarotti']",2016-07-05,,"Method, system and computer program product for electrical and thermal analysis at a substrate level",2014
374,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-9085577-B2,"['Jose Maria Cid-Nunez', 'Ana Isabel De Lucas Olivares', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald']",2015-07-21,,"7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2014
375,"['Electronics and Telecommunications Research Institute', 'KOREA ELECTRONICS TELECOMM']","[{'id': 'grid.36303.35', 'acronym': 'ETRI', 'name': 'Electronics and Telecommunications Research Institute', 'country_name': 'South Korea'}]",Application,,US-20150139505-A1,"['Blagovest Iordanov VLADIMIROV', 'So-Yeon Lee', 'Sang-Joon Park', 'Jong-hyun Park', 'Kyo-Il Chung']",2015-05-21,2.0,METHOD AND APPARATUS FOR PREDICTING HUMAN MOTION IN VIRTUAL ENVIRONMENT,2014
376,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'DE LUCAS OLIVARES ANA ISABEL', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-8946205-B2,"['Jose Maria Cid-Nunez', 'Ana Isabel De Lucas Olivares', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald']",2015-02-03,1.0,"1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2010
377,"['DISCOVERYBIOMED Inc', 'DISCOVERYBIOMED INC']","[{'id': 'grid.420651.4', 'acronym': 'DBM', 'name': 'DiscoveryBioMed (United States)', 'country_name': 'United States'}]",Application,,EP-2970249-A4,"['SCHWIEBERT, ERIK', 'STREIFF, John', 'DIXON, JOHN', 'GAO, HONGWU', 'RITCHIE, Joseph P.', 'SEALES, Eric C.', 'MAI, DEBORAH']",2017-03-15,,COUMARIN DERIVATIVES AND METHODS OF USE IN TREATING HYPERPROLIFERATIVE DISEASES,2014
378,"['Regenacy Pharmaceuticals LLC', 'ACETYLON PHARMACEUTICALS INC']","[{'id': 'grid.427616.0', 'name': 'Acetylon Pharmaceuticals (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9562013-B2,"['John H. Van Duzer', 'Ralph Mazitschek']",2017-02-07,3.0,Selective HDAC3 inhibitors,2015
379,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2016.0,US-9266834-B2,"['Hassan Julien Imogai', 'Jose Maria Cid-Nunez', 'Jose Ignacio Andres-Gil', 'Andres Avelino Trabanco-Suarez', 'JULEN OYARZABAL SANTAMARINA', 'Frank Matthias Dautzenberg', 'Gregor James MacDonald', 'SHRILEY ELIZABETH PULLAN', 'Robert Johannes Lutjens', 'Guillaume Albert Jacques Duvey', 'Vanthea Nhem', 'Terry Patrick Finn', 'Gagik Melikyan']",2016-02-23,,"1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors",2014
380,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'LUTJENS ROBERT JOHANNES', 'FINN TERRY PATRICK', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-9114138-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lutjens', 'Terry Patrick Finn']",2015-08-25,,"1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones",2008
381,"['Merck Patent GmbH', 'MERCK PATENT GMBH']","[{'id': 'grid.39009.33', 'name': 'Merck (Germany)', 'country_name': 'Germany'}]",Application,,US-20150361079-A1,"['Nadia Brugger', 'Brian L. Hodous', 'Amanda E. Sutton', 'Justin Potnick', 'Theresa L. Johnson', 'Thomas E. Richardson', 'Thomas Francis Nelson HAXELL', 'James M. Dorsey', 'Robert James Foglesong']",2015-12-17,,Spiro-Quinazolinone Derivatives and their Use as Positive Allosteric Modulators of mGluR4,2014
382,"['DISCOVERYBIOMED Inc', 'DISCOVERYBIOMED INC']","[{'id': 'grid.420651.4', 'acronym': 'DBM', 'name': 'DiscoveryBioMed (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9676779-B2,"['Erik Schwiebert', 'John Streiff', 'John Dixon', 'Hongwu Gao']",2017-06-13,,Small molecule CFTR correctors,2013
383,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'DE LUCAS OLIVARES ANA ISABEL', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8716480-B2,"['Jose Maria Cid-Nunez', 'Ana Isabel De Lucas Olivares', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald']",2014-05-06,1.0,"7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2010
384,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8697689-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez']",2014-04-15,1.0,Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors,2009
385,"['Janssen Cilag SA', 'Janssen Pharmaceuticals Inc', 'CID-NÚÑEZ JOSÉ MARIA', 'TRABANCO-SUÁREZ ANDRÉS AVELINO', 'VEGA RAMIRO JUAN ANTONIO', 'OEHLRICH DANIEL', 'TRESADERN GARY JOHN', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC']",,Grant,2015.0,US-9012448-B2,"['José Maria Cid-Núñez', 'Andrés Avelino Trabanco-Suárez', 'Juan Antonio Vega Ramiro', 'Daniel Oehlrich', 'Gary John Tresadern', 'Gregor James MacDonald']",2015-04-21,8.0,"1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors",2011
386,"['DISCOVERYBIOMED Inc', 'DISCOVERYBIOMED INC']","[{'id': 'grid.420651.4', 'acronym': 'DBM', 'name': 'DiscoveryBioMed (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9815825-B2,"['Erik Schwiebert', 'John Streiff', 'John Dixon', 'Hongwu Gao']",2017-11-14,,"Coumarin derivatives and methods of use in treating cystic fibrosis, chronic obstructive pulmonary disease, and misfolded protein disorders",2014
387,"['Janssen Pharmaceutica NV', 'Addex Therapeutics Ltd', 'TRABANCO-SUAREZ ANDRES AVELINO', 'TRESADERN GARY JOHN', 'VEGA RAMIRO JUAN ANTONIO', 'CID-NUNEZ JOSE MARIA', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}, {'id': 'grid.419619.2', 'name': 'Janssen (Belgium)', 'country_name': 'Belgium'}]",Grant,2014.0,US-8785486-B2,"['Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Jose Maria Cid-Nunez']",2014-07-22,,"Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2008
388,"['DISCOVERYBIOMED Inc', 'DISCOVERYBIOMED INC']","[{'id': 'grid.420651.4', 'acronym': 'DBM', 'name': 'DiscoveryBioMed (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9546176-B2,"['Erik Schwiebert', 'John Streiff', 'John Dixon', 'Hongwu Gao']",2017-01-17,,Small molecule bicyclic and tricyclic CFTR correctors,2013
389,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'LUTJENS ROBERT JOHANNES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-9067891-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lutjens']",2015-06-30,,"1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mGluR2-receptors",2012
390,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2016.0,US-9226930-B2,"['Jose Maria Cid-Nunez', 'Daniel Oehlrich', 'Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Gregor James MacDonald']",2016-01-05,1.0,"1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders",2014
391,['REINEKE FRANK'],,Application,,WO-2016202425-A1,"['REINECKE, Julia', 'REINECKE, TOBIAS']",2016-12-22,,"INPUT DEVICE FOR CONTROLLING AN AVATAR IN A COMPUTER-GENERATED ENVIRONMENT, AND A METHOD FOR CONTROLLING SAME",2016
392,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8691849-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez']",2014-04-08,,3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors,2009
393,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA', 'ADDEX PHARMA, S.A.']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2018.0,US-10071095-B2,"['Jose Maria Cid-Nunez', 'Daniel Oehlrich', 'Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Gregor James MACDONOLD']",2018-09-11,,"1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders",2017
394,"['DISCOVERYBIOMED Inc', 'University of Alabama at Birmingham Research Foundation', 'SCHWIEBERT ERIK M', 'DISCOVERYBIOMED INC']","[{'id': 'grid.265892.2', 'acronym': 'UAB', 'name': 'University of Alabama at Birmingham', 'country_name': 'United States'}, {'id': 'grid.420651.4', 'acronym': 'DBM', 'name': 'DiscoveryBioMed (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9221840-B2,['Erik M. Schwiebert'],2015-12-29,2.0,Treating protein folding disorders with small molecule CFTR correctors,2012
395,"['STATE UNIVERSITY OF YEREVAN', 'Addex Therapeutics Ltd', 'Janssen Cilag SA', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'ANDRES-GIL JOSE IGNACIO', 'TRABANCO-SUAREZ ANDRES AVELINO', 'OYARZABAL SANTAMARINA JULEN', 'DAUTZENBERG FRANK MATTHIAS', 'MACDONALD GREGOR JAMES', 'PULLAN SHIRLEY ELIZABETH', 'LUTJENS ROBERT JOHANNES', 'DUVEY GUILLAUME ALBERT JACQUES', 'NHEM VANTHEA', 'FINN TERRY PATRICK', 'MELIKYAN GAGIK', 'MUTEL VINCENT', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}, {'id': 'grid.21072.36', 'acronym': 'YSU', 'name': 'Yerevan State University', 'country_name': 'Armenia'}]",Grant,2014.0,US-8841323-B2,"['Hassan Julien Imogai', 'Jose Maria Cid-Nunez', 'Jose Ignacio Andres-Gil', 'Andres Avelino Trabanco-Suarez', 'Julen Oyarzabal Santamarina', 'Frank Matthias Dautzenberg', 'Gregor James MacDonald', 'Shirley Elizabeth Pullan', 'Robert Johannes Lutjens', 'Guillaume Albert Jacques Duvey', 'Vanthea Nhem', 'Terry Patrick Finn', 'Gagik Melikyan']",2014-09-23,,"1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors",2007
396,"['Vanderbilt University', 'UNIV VANDERBILT']","[{'id': 'grid.152326.1', 'name': 'Vanderbilt University', 'country_name': 'United States'}]",Grant,2016.0,US-9382208-B1,"['P. Jeffrey Conn', 'Craig W. Lindsley', 'Kyle A. Emmitte', 'Andrew S. Felts', 'Katrina A. Bollinger']",2016-07-05,1.0,Negative allosteric modulators of metabotropic glutamate receptor 2,2016
397,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2017.0,US-9737533-B2,"['Jose Maria Cid-Nunez', 'Daniel Oehlrich', 'Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Gregor James MacDonald']",2017-08-22,1.0,"1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders",2015
398,"['Union Therapeutics', 'ANTIBIOTX AS']","[{'id': 'grid.476020.7', 'name': 'AntibioTx (Denmark)', 'country_name': 'Denmark'}]",Grant,2018.0,US-9949988-B2,"['Emilie Flora Aurore DELAVENNE', 'Daniel Jean Jacques SIMON', 'Morten Otto Alexander SOMMER', 'Rasmus Vendler TOFT-KEHLER']",2018-04-24,,Antibacterial use of halogenated salicylanilides,2017
399,"['GENENTECH INC', 'TOWNSEND MICHAEL J', 'SU ZHENG', 'WOHLGEMUTH JAY G', 'BEHRENS TIMOTHY W', 'LAL PREETI G']","[{'id': 'grid.418158.1', 'acronym': 'Roche', 'name': 'Roche (United States)', 'country_name': 'United States'}]",Application,,WO-2010075249-A2,"['TOWNSEND, MICHAEL J.', 'SU, Zheng', 'WOHLGEMUTH, JAY G.', 'BEHRENS, TIMOTHY W.', 'LAL, PREETI G.']",2010-07-01,6.0,A METHOD FOR TREATING RHEUMATOID ARTHRITIS WITH B-CELL ANTAGONISTS,2009
400,"['Scripps Research Institute', 'SCRIPPS RESEARCH INST']","[{'id': 'grid.214007.0', 'acronym': 'TSRI', 'name': 'Scripps Research Institute', 'country_name': 'United States'}]",Application,,EP-2925760-A4,['BOGER DALE L'],2015-10-21,,C20'-UREA DERIVATIVES OF VINCA ALKALOIDS,2013
401,"['Boehringer Ingelheim International GmbH', 'BOEHRINGER INGELHEIM INT']","[{'id': 'grid.420061.1', 'name': 'Boehringer Ingelheim (Germany)', 'country_name': 'Germany'}]",Grant,2018.0,US-9932399-B2,"['Karl-Heinz Heider', 'Eric Borges', 'Elinborg Ostermann']",2018-04-03,,Anti CD37 antibodies,2015
402,"['BOEHRINGER INGELHEIM VETMEDICA INC', 'Université de Montréal', 'UNIVERSITÉ DU QUÉBEC À MONTRÉAL']","[{'id': 'grid.14848.31', 'name': 'University of Montreal', 'country_name': 'Canada'}, {'id': 'grid.38678.32', 'acronym': 'UQÀM', 'name': 'University of Quebec at Montreal', 'country_name': 'Canada'}, {'id': 'grid.418412.a', 'acronym': 'Boehringer Ingelheim Pharmaceuticals', 'name': 'Boehringer Ingelheim (United States)', 'country_name': 'United States'}]",Application,,WO-2017062558-A1,"['GOTTSCHALK, MARCELO', 'GOYETTE-DESJARDINS, Guillaume', 'KEMPKER, Jennifer Anne', 'NEUBAUER, AXEL', 'ROY, René', 'SEGURA, Mariela', 'SHIAO, Tze Chieh']",2017-04-13,,STREPTOCOCCUS SUIS POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION,2016
403,['BEST STEVEN RICHARD DEVORE'],,Grant,2015.0,US-8974365-B2,['Steven Richard Devore Best'],2015-03-10,,Treatment of thalamocortical dysrhythmia,2013
404,"['Harvard College', 'HUEBSCH NATHANIEL D', 'MOONEY DAVID J', 'HARVARD COLLEGE']","[{'id': 'grid.38142.3c', 'name': 'Harvard University', 'country_name': 'United States'}]",Grant,2016.0,US-9297005-B2,"['Nathaniel D. Huebsch', 'David J. Mooney']",2016-03-29,,Harnessing cell dynamics to engineer materials,2010
405,"['Qualcomm Inc', 'QUALCOMM INC']","[{'id': 'grid.430388.4', 'name': 'Qualcomm (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9385672-B2,['Rahul Karmaker'],2016-07-05,,Compensated common-mode feedback for an amplifier,2014
406,"['Harvard College', 'MOONEY DAVID J', 'ALI OMAR ABDEL-RAHMAN', 'HARVARD COLLEGE']","[{'id': 'grid.38142.3c', 'name': 'Harvard University', 'country_name': 'United States'}]",Grant,2017.0,US-9770535-B2,"['David J. Mooney', 'Omar abdel-Rahman Ali']",2017-09-26,,Scaffolds for cell collection or elimination,2008
407,"['Harvard College', 'HARVARD COLLEGE']","[{'id': 'grid.38142.3c', 'name': 'Harvard University', 'country_name': 'United States'}]",Grant,2018.0,US-9937249-B2,"['JaeYun Kim', 'Weiwei Aileen Li', 'David J. Mooney']",2018-04-10,,Mesoporous silica compositions for modulating immune responses,2013
408,['X-CHEM INC'],,Application,,WO-2017190048-A1,"['CLARK, MATTHEW', 'KEEFE, ANTHONY, D.', 'GUILINGER, JOHN', 'ZHANG, YING', 'TIAN, Xia']",2017-11-02,,COVALENT BTK INHIBITORS AND USES THEREOF,2017
409,"['Harvard College', 'BENCHERIF SIDI A', 'MOONEY DAVID J', 'EDWARDS DAVID', 'SANDS ROGER WARREN', 'HARVARD COLLEGE']","[{'id': 'grid.38142.3c', 'name': 'Harvard University', 'country_name': 'United States'}]",Grant,2018.0,US-10045947-B2,"['Sidi A. Bencherif', 'David J. Mooney', 'David Edwards', 'Roger Warren Sands']",2018-08-14,,Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration,2012
410,['SAN RAFFAELE ROMA S R L'],,Application,,WO-2018029717-A2,"['VOLTERRANI, Mauruzio', 'IELLAMO, Ferdinando', 'VERRELLI, Cristiano, Maria', 'TIBERTI, MARCO', 'TOMEI, Patrizio']",2018-02-15,,INDIVIDUALLY TAILORED EXERCISE TRAINING AND REHABILITATION TECHNIQUE: MEDICAL PERSONAL TRAINER,2017
411,"['Harvard College', 'Dana-Farber Cancer Institute Inc', 'HARVARD COLLEGE', 'DANA FARBER CANCER INST INC']","[{'id': 'grid.65499.37', 'name': 'Dana-Farber Cancer Institute', 'country_name': 'United States'}, {'id': 'grid.38142.3c', 'name': 'Harvard University', 'country_name': 'United States'}]",Grant,2016.0,US-9370558-B2,"['Omar abdel-Rahman Ali', 'Glenn Dranoff', 'David J. Mooney']",2016-06-21,9.0,Controlled delivery of TLR agonists in structural polymeric devices,2013
412,"['Harvard College', 'HARVARD COLLEGE']","[{'id': 'grid.38142.3c', 'name': 'Harvard University', 'country_name': 'United States'}]",Grant,2017.0,US-9675561-B2,"['Sidi A. Bencherif', 'Roger Warren Sands', 'Sandeep T. Koshy', 'David J. Mooney']",2017-06-13,2.0,Injectable cryogel vaccine devices and methods of use thereof,2014
413,"['Harvard College', 'Forsyth Dental Infirmary for Children', 'HARVARD COLLEGE', 'FORSYTH DENTAL IN RY FOR CHILDREN F']","[{'id': 'grid.38142.3c', 'name': 'Harvard University', 'country_name': 'United States'}]",Grant,2016.0,US-9381235-B2,"['Roger Warren Sands', 'Eduardo Alexandre Barros e Silva', 'Toshihisa Kawai', 'David J. Mooney']",2016-07-05,3.0,Programming of cells for tolerogenic therapies,2014
414,"['Harvard College', 'Dana-Farber Cancer Institute Inc', 'HARVARD COLLEGE', 'DANA-FARBER CANCER INST INC', 'DANA-FARBER CANCER INST']","[{'id': 'grid.38142.3c', 'name': 'Harvard University', 'country_name': 'United States'}, {'id': 'grid.65499.37', 'name': 'Dana-Farber Cancer Institute', 'country_name': 'United States'}]",Grant,2017.0,US-9821045-B2,"['Omar abdel-Rahman Ali', 'Glenn Dranoff', 'David J. Mooney']",2017-11-21,1.0,Controlled delivery of TLR3 agonists in structural polymeric devices,2016
415,"['University of Rochester', 'UNIV ROCHESTER']","[{'id': 'grid.16416.34', 'acronym': 'UR', 'name': 'University of Rochester', 'country_name': 'United States'}]",Grant,2017.0,US-9833467-B2,['ROMAN A. ELISEEV'],2017-12-05,,Use of cyclophilin D inhibitors to treat or prevent bone disorders,2013
416,"['Harvard College', 'Forsyth Dental Infirmary for Children', 'HARVARD COLLEGE', 'FORSYTH DENTAL INFIRMARY FOR CHILDREN']","[{'id': 'grid.38142.3c', 'name': 'Harvard University', 'country_name': 'United States'}]",Grant,2018.0,US-10080789-B2,"['Roger Warren Sands', 'Eduardo Alexandre Barros e Silva', 'Toshihisa Kawai', 'David J. Mooney']",2018-09-25,,Programming of cells for tolerogenic therapies,2016
417,"[""ST SUPERIORE DI SANITA'""]",,Application,,WO-2017195224-A1,"['DIANA, GIOVANNI']",2017-11-16,,RHO GTPASE ACTIVATING BACTERIAL TOXINS FOR USE IN THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM BY MUCOSAL ADMINISTRATION,2016
418,"['UNIV SIENA', 'UNIV CALABRIA']","[{'id': 'grid.7778.f', 'acronym': 'UNICAL', 'name': 'University of Calabria', 'country_name': 'Italy'}, {'id': 'grid.9024.f', 'acronym': 'UNISI', 'name': 'University of Siena', 'country_name': 'Italy'}]",Application,,WO-2015162216-A1,"['BRIZZI, ANTONELLA', 'AIELLO, Francesca', 'CORELLI, FEDERICO']",2015-10-29,,BIARYL AMIDE OR UREA DERIVATIVES AS TRPV1 LIGANDS,2015
419,"['Harvard College', 'Brown University', 'MOONEY DAVID J', 'BORSELLI CRISTINA', 'VANDENBURGH HERMAN', 'SHVARTSMAN DIMITRY', 'STORRIE HANNAH', 'LICHTMAN JEFF', 'HARVARD COLLEGE']","[{'id': 'grid.40263.33', 'name': 'Brown University', 'country_name': 'United States'}, {'id': 'grid.38142.3c', 'name': 'Harvard University', 'country_name': 'United States'}]",Grant,2017.0,US-9610328-B2,"['David J. Mooney', 'Cristina Borselli', 'Herman Vandenburgh', 'Dimitry Shvartsman', 'Hannah Storrie', 'Jeff Lichtman']",2017-04-04,,Enhancement of skeletal muscle stem cell engraftment by dual delivery of VEGF and IGF-1,2011
420,"['Harvard College', 'University of Michigan', 'HARVARD COLLEGE', 'UNIV MICHIGAN']","[{'id': 'grid.214458.e', 'acronym': 'UM', 'name': 'University of Michigan', 'country_name': 'United States'}, {'id': 'grid.38142.3c', 'name': 'Harvard University', 'country_name': 'United States'}]",Grant,2016.0,US-9446107-B2,"['David J. Mooney', 'Omar abdel-Rahman Ali', 'Eduardo Alexandre Barros e Silva', 'Hyun Joon Kong', 'ELLIOT EARL HILL, JR.', 'Tanyarut Boontheekul']",2016-09-20,6.0,Scaffolds for cell transplantation,2015
421,"['Johns Hopkins University', 'UNIV JOHNS HOPKINS']","[{'id': 'grid.21107.35', 'acronym': 'JHU', 'name': 'Johns Hopkins University', 'country_name': 'United States'}]",Grant,2016.0,US-9505727-B2,"['Frank Bosmans', 'Dimpy Kalia']",2016-11-29,1.0,Rufinamide and derivatives and their use in modulating the gating process of human voltage-gated sodium channels,2015
422,['BEST STEVEN RICHARD DEVORE'],,Grant,2017.0,US-9649501-B2,['Steven Richard Devore Best'],2017-05-16,,Treatment of thalamocortical dysrhythmia,2015
423,"['Oracle International Corp', 'KACHER DONALD', 'SRIRAMBHATLA KISHORE', 'VENUGOPAL NANDA', 'RAIZADA ABHISHEK', 'KULKARNI ABHAY', 'ORACLE INT CORP']","[{'id': 'grid.419799.b', 'name': 'Oracle (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8799235-B2,"['Donald KACHER', 'Kishore Srirambhatla', 'Nanda VENUGOPAL', 'Abhishek RAIZADA', 'Abhay Kulkarni']",2014-08-05,1.0,Data de-duplication system,2012
424,"['Harvard College', 'CAO LAN', 'BOUHADIR KAMAL H', 'MOONEY DAVID J', 'HARVARD COLLEGE']","[{'id': 'grid.38142.3c', 'name': 'Harvard University', 'country_name': 'United States'}]",Grant,2017.0,US-9603894-B2,"['Lan Cao', 'Kamal H. Bouhadir', 'David J. Mooney']",2017-03-28,,Materials presenting notch signaling molecules to control cell behavior,2011
425,"['Harvard College', 'MOONEY DAVID J', 'YUEN WILLIAM W', 'ARANY PRAVEEN', 'HARVARD COLLEGE']","[{'id': 'grid.38142.3c', 'name': 'Harvard University', 'country_name': 'United States'}]",Grant,2017.0,US-9693954-B2,"['David J. Mooney', 'William W. Yuen', 'Praveen Arany']",2017-07-04,,Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones,2011
426,['QUALCOMM INC'],"[{'id': 'grid.430388.4', 'name': 'Qualcomm (United States)', 'country_name': 'United States'}]",Application,,WO-2016085668-A1,"['KARMAKER, RAHUL']",2016-06-02,,COMPENSATED COMMON-MODE FEEDBACK FOR AN AMPLIFIER,2015
427,"['Harvard College', 'KIM JAEYUN', 'MOONEY DAVID J', 'LI WEIWEI AILEEN', 'ARANY PRAVEEN', 'GADISH OR', 'HARVARD COLLEGE']","[{'id': 'grid.38142.3c', 'name': 'Harvard University', 'country_name': 'United States'}]",Grant,2016.0,US-9486512-B2,"['JaeYun Kim', 'David J. Mooney', 'Weiwei Aileen Li', 'Praveen Arany', 'Or Gadish']",2016-11-08,6.0,In situ antigen-generating cancer vaccine,2012
428,['ARENA GOFFREDO ORAZIO'],,Application,,EP-3280813-A4,"['ARENA, Goffredo Orazio']",2018-02-14,,METHOD OF DIAGNOSIS OF CANCER AND USES THEREOF,2015
429,"['Harvard College', 'University of Michigan', 'HARVARD COLLEGE', 'UNIV MICHIGAN']","[{'id': 'grid.38142.3c', 'name': 'Harvard University', 'country_name': 'United States'}, {'id': 'grid.214458.e', 'acronym': 'UM', 'name': 'University of Michigan', 'country_name': 'United States'}]",Grant,2015.0,US-9132210-B2,"['David J. Mooney', 'Omar abdel-Rahman Ali', 'Eduardo Alexandre Barros e Silva', 'Hyun Joon Kong', 'ELLIOT EARL HILL, JR.', 'Tanyarut Boontheekul']",2015-09-15,14.0,Scaffolds for cell transplantation,2014
430,"['Arthrosurface Inc', 'ARTHROSURFACE INC']",,Grant,2017.0,US-9668757-B2,"['Steven Ek', 'Anthony Miniaci']",2017-06-06,1.0,"Devices, apparatuses, kits, and methods for repair of articular surface and/or articular rim",2013
431,['UNIVERSITÀ DEGLI STUDI DI ROMA LA SAPIENZA'],"[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Application,,WO-2016102586-A1,"['CERVONE, FELICE', 'DE LORENZO, GIULIA', 'FERRARI, SIMONE', 'BENEDETTI, Manuel', 'PONTIGGIA, DANIELA']",2016-06-30,,FUSION PROTEIN AND TRANSGENIC PLANT EXPRESSING SAID PROTEIN,2015
432,"['Inist St Co Ltd', 'UNIV INDUSTRY COOPERATION GROUP KYUNG HEE UNIV', 'INIST ST CO LTD']","[{'id': 'grid.289247.2', 'name': 'Kyung Hee University', 'country_name': 'South Korea'}]",Grant,2018.0,US-9956270-B2,"['Hyun Su Bae', 'Hyo Jung Lee', 'Gi Hyun Lee', 'Hyun Seong Kim', 'Soo Jin Park', 'Eun Sook Chung', 'Tae Won Choi']",2018-05-01,,Pharmaceutical composition comprising bee venom-phospholipase A2 (BV-PLA2) for treating or preventing diseases related to degradation of abnormal regulatory T cell activity,2016
433,['CONSIGLIO NAZIONALE RICERCHE'],"[{'id': 'grid.5326.2', 'acronym': 'CNR', 'name': 'National Research Council', 'country_name': 'Italy'}]",Application,,WO-2016051340-A1,"['CECI, Pierpaolo', 'FALVO, Elisabetta']",2016-04-07,1.0,"A FUSION PROTEIN, A NANOPARTICLE COMPOSED BY A PLURALITY OF MONOMERS OF SAID FUSION PROTEIN, AND USES THEREOF",2015
434,['MASSACHUSETTS GEN HOSPITAL'],"[{'id': 'grid.32224.35', 'acronym': 'MGH', 'name': 'Massachusetts General Hospital', 'country_name': 'United States'}]",Application,,WO-2016161129-A1,"['ELMALEH, DAVID, R.', 'TAKAHASHI, KAZUE']",2016-10-06,1.0,SELF ASSEMBLING MOLECULES FOR TARGETED DRUG DELIVERY,2016
435,"['Sharesun Co Ltd', 'SHARESUN CO LTD']",,Application,,EP-3206236-A4,"['JI, JINGJIA', 'QIN, YUSEN', 'ZHU, Fan']",2017-11-22,,METHOD FOR HORIZONTALLY ELECTROCHEMICALLY DEPOSITING METAL,2015
436,['INCYTE CORP'],"[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Application,,WO-2015123408-A1,"['WU, LIANGXING', 'HE, CHUNHONG', 'QIAN, DING-QUAN', 'SHEN, BO', 'WANG, XIAOZHAO', 'YAO, WENQING', 'COURTER, JOEL, R.', 'ZHANG, FENGLEI']",2015-08-20,15.0,CYCLOPROPYLAMINES AS LSD1 INHIBITORS,2015
437,['ORANGE'],"[{'id': 'grid.89485.38', 'name': 'Orange (France)', 'country_name': 'France'}]",Application,,WO-2014096687-A1,"['YOU, Wei', 'MATHIEU, BERTRAND']",2014-06-26,,TECHNIQUE FOR COMMUNICATION IN A COMMUNICATION NETWORK CENTERED ON INFORMATION,2013
438,"['France Telecom SA', 'FRANCE TELECOM']","[{'id': 'grid.89485.38', 'name': 'Orange (France)', 'country_name': 'France'}]",Application,,FR-2999846-A1,"['YOU WEI', 'MATHIEU BERTRAND']",2014-06-20,,Method of communication in a network of the communication center on the information,2012
439,['PF MEDICAMENT'],"[{'id': 'grid.417944.b', 'name': 'Pierre Fabre (France)', 'country_name': 'France'}]",Application,,WO-2018055037-A1,"['BERTHOUMIEU, DIDIER', 'CORDOLIANI, Jean-François']",2018-03-29,,USE OF SOLID POLYETHYLENE GLYCOL FORMULATIONS IN THE TREATMENT OF CONSTIPATION,2017
440,['INCYTE CORP'],"[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Application,,WO-2016161282-A1,"['HE, CHUNHONG', 'LI, ZHENWU', 'WU, LIANGXING', 'YAO, WENQING', 'ZHANG, FENGLEI']",2016-10-06,10.0,HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS,2016
441,['CISCO TECH INC'],"[{'id': 'grid.421222.5', 'name': 'Cisco Systems (United States)', 'country_name': 'United States'}]",Application,,WO-2018022310-A1,"['WOOD, Christopher, A.', 'SCOTT, GLENN, C.']",2018-02-01,,SYSTEM AND METHOD FOR EPHEMERAL ENTRIES IN A FORWARDING INFORMATION BASE IN A CONTENT CENTRIC NETWORK,2017
442,"['HedgePath Pharmaceuticals Inc', 'HEDGEPATH PHARMACEUTICALS INC']","[{'id': 'grid.421385.9', 'name': 'HedgePath Pharmaceuticals (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9962381-B2,"['Nicholas J. Virca', ""Francis E. O'Donnell, Jr.""]",2018-05-08,,Treatment and prognostic monitoring of cancerous proliferation disorders using Hedgehog pathway inhibitors,2017
443,"['NEC Corp', 'NEC EUROPE LTD', 'NEC CORP']","[{'id': 'grid.474373.0', 'name': 'NEC (Germany)', 'country_name': 'Germany'}, {'id': 'grid.420377.5', 'name': 'NEC Corporation (Japan)', 'country_name': 'Japan'}]",Grant,2017.0,US-9781061-B2,"['Dirk Kutscher', 'Fabian Schneider']",2017-10-03,,Method and system for providing an information centric network with a software defined network,2013
444,"['Ustav Organicke Chemie A Biochemie AV CR VVI', 'Vysoka Skola Chemicko Technologicka V Praze', 'USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I', 'VS CHEMICKO TECHNOLOGICKA V PRAZE']","[{'id': 'grid.448072.d', 'acronym': 'VŠCHT ', 'name': 'University of Chemistry and Technology', 'country_name': 'Czechia'}, {'id': 'grid.418892.e', 'acronym': 'IOCB', 'name': 'Institute of Organic Chemistry and Biochemistry', 'country_name': 'Czechia'}]",Grant,2018.0,US-9932339-B2,"['Filip TEPLY', 'Miroslav Hajek', 'Erika KUZMOVA', 'Jaroslav KOZAK', 'Veronika KOMARKOVA', 'Pavla HUBALKOVA', 'Paul Eduardo REYES-GUTIERREZ', 'Michael JIRASEK', 'Manoj R. SONAWANE', 'Vishwas D. JOSHI', 'Lukas SEVERA', 'Jana NOVOTNA']",2018-04-03,,"Helquats with heteroaromatic substituents, preparation thereof, and use thereof as G-quadruplex stabilizers",2015
445,"['Teva Pharmaceutical Industries Ltd', 'KNAPPERTZ VOLKER', 'TEVA PHARMA']","[{'id': 'grid.452797.a', 'name': 'Teva Pharmaceuticals (Israel)', 'country_name': 'Israel'}]",Grant,2017.0,US-9662322-B2,['Volker Knappertz'],2017-05-30,1.0,Laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS) patients with a high disability status,2015
446,['BABRAHAM INST'],"[{'id': 'grid.418195.0', 'name': 'Babraham Institute', 'country_name': 'United Kingdom'}]",Application,,WO-2017208001-A1,"['FRASER, PETER', 'SCHOENFELDER, Stefan', 'SPIVAKOV, Mikhail']",2017-12-07,,BIOMARKERS FOR PLATELET DISORDERS,2017
447,"['MCCORD DARLENE E', 'KARAGIANNIS THOMAS']",,Application,,EP-2925307-A1,"['MCCORD, Darlene E.', 'KARAGIANNIS, THOMAS']",2015-10-07,,"HYDROXYTYROSOL AND OLEUROPEIN COMPOSITIONS FOR INDUCTION OF DNA DAMAGE, CELL DEATH AND LSD1 INHIBITION",2013
448,"['MCCORD DARLENE E', 'KARAGIANNIS THOMAS']",,Application,,EP-2925307-A4,"['MCCORD DARLENE E', 'KARAGIANNIS THOMAS']",2016-06-08,,"HYDROXYTYROSOL AND OLEUROPEIN COMPOSITIONS FOR INDUCTION OF DNA DAMAGE, CELL DEATH AND LSD1 INHIBITION",2013
449,['INCYTE CORP'],"[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Application,,WO-2015123465-A1,"['WU, LIANGXING', 'HE, CHUNHONG', 'QIAN, DING-QUAN', 'SHEN, BO', 'WANG, XIAOZHAO', 'YAO, WENQING', 'ZHANG, FENGLEI', 'COURTER, JOEL R.']",2015-08-20,21.0,CYCLOPROPYLAMINES AS LSD1 INHIBITORS,2015
450,"['UNIVERSIT DEGLI STUDI DI ROMA LA SAPIENZA', 'IST FISIOTERAP OSPITALROMA', 'FRANCESCHIN MARCO', 'CASAGRANDE VALENTINA']","[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Application,,WO-2014057511-A1,"['FRANCESCHIN, MARCO', 'CASAGRANDE, Valentina', 'ORTAGGI, GIANCARLO', 'BIANCO, Armando, Doriano', 'BIROCCIO, Annamaria']",2014-04-17,,USE OF EMICORONS AS SELECTIVE INDUCERS OF DAMAGE TO THE TELOMERE DNA,2013
451,['SCHAEFFLER TECHNOLOGIES GMBH'],"[{'id': 'grid.471296.f', 'name': 'Schaeffler (Germany)', 'country_name': 'Germany'}]",Application,,WO-2015014362-A1,"['SCHMAUS, Stefan', 'DIETRICH, MARKUS', 'ZIMMERMANN, MARTIN', 'Moebs, Francis']",2015-02-05,,METHOD FOR DETERMINING A FAULT IN AN ELECTRONICALLY COMMUTATED ELECTRIC MOTOR,2014
452,['GE HEALTHCARE LTD'],"[{'id': 'grid.420685.d', 'acronym': 'GEC', 'name': 'General Electric (United Kingdom)', 'country_name': 'United Kingdom'}]",Application,,WO-2016097351-A1,"['JACKSON, ALEXANDER', 'MORISSON-IVESON, VERONIQUE', 'WYNN, DUNCAN, GEORGE', 'JOSE, Jinto', 'RANGASWAMY, CHITRALEKHA']",2016-06-23,,18F LABELLED THIAZOLYLHYDRAZONE DERIVATIVES,2015
453,"['HedgePath Pharmaceuticals Inc', 'HEDGEPATH PHARMACEUTICALS INC']","[{'id': 'grid.421385.9', 'name': 'HedgePath Pharmaceuticals (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9968600-B2,"['Nicholas J. Virca', ""Francis E. O'Donnell, Jr.""]",2018-05-15,,Treatment and prognostic monitoring of non-cancerous proliferation disorders using hedgehog pathway inhibitors,2017
454,"['Universidade de Aveiro', 'UNIV AVEIRO']","[{'id': 'grid.7311.4', 'name': 'University of Aveiro', 'country_name': 'Portugal'}]",Grant,2017.0,DE-212016000066-U1,,2017-10-19,,System for positron emission tomography with two axes of rotation,2016
455,"['HEDGEPATH LLC', 'HedgePath Pharmaceuticals Inc', 'HEDGEPATH LLC', 'HEDGEPATH PHARMACEUTICALS INC']","[{'id': 'grid.421385.9', 'name': 'HedgePath Pharmaceuticals (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9192609-B2,"['Nicholas J. Virca', ""Francis E. O'Donnell, Jr.""]",2015-11-24,1.0,Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitors,2014
456,['UNIV AVEIRO'],"[{'id': 'grid.7311.4', 'name': 'University of Aveiro', 'country_name': 'Portugal'}]",Application,,WO-2016147130-A1,"['CALAPEZ DE ALBUQUERQUE VELOSO, João Filipe', 'CORREIA DE CASTRO, Ismael Filipe', 'DA CONCEIÇÃO MOUTINHO, Luís Miguel', 'DAS NEVES DIAS CARRAMATE, Lara Filipa', 'MENDES CORREIA, Pedro Manuel', 'MONTEIRO DA SILVA, Ana Luísa']",2016-09-22,,POSITRON EMISSION TOMOGRAPHY SYSTEM AND METHOD WITH TWO ROTATION SHAFTS,2016
457,"['USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I', 'VS CHEMICKO TECHNOLOGICKA V PRAZE']","[{'id': 'grid.418892.e', 'acronym': 'IOCB', 'name': 'Institute of Organic Chemistry and Biochemistry', 'country_name': 'Czechia'}]",Application,,WO-2015180701-A1,"['TEPLY, FILIP', 'HAJEK, MIROSLAV', 'KUZMOVA, Erika', 'KOZAK, JAROSLAV', 'KOMARKOVA, Veronika', 'HUBALKOVA, Pavla', 'REYES-GUTIERREZ, Paul Eduardo', 'JIRASEK, Michael', 'SONAWANE, Monoj R.', 'JOSHI, VISHWAS D.', 'SEVERA, LUKAS', 'NOVOTNA, Jana']",2015-12-03,,"HELQUATS WITH HETEROAROMATIC SUBSTITUENTS, PREPARATION THEREOF, AND USE THEREOF AS G-QUADRUPLEX STABILIZERS",2015
458,['INCYTE CORP'],"[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Application,,WO-2017184934-A1,"['ROCCO, WILLIAM L.', 'LIU, YING', 'LI, MEI', 'SHAH, TANVI', 'WU, Huifang']",2017-10-26,,FORMULATIONS OF AN LSD1 INHIBITOR,2017
459,['NEC EUROPE LTD'],"[{'id': 'grid.474373.0', 'name': 'NEC (Germany)', 'country_name': 'Germany'}]",Application,,WO-2014166551-A1,"['KUTSCHER, DIRK', 'SCHNEIDER, Fabian']",2014-10-16,6.0,METHOD AND SYSTEM FOR PROVIDING AN INFORMATION CENTRIC NETWORK,2013
460,"['ELEANORE BENNETT CHARITABLE TRUST #2', 'ELEANORE BENNETT CHARITABLE TRUST #2']",,Grant,2017.0,US-9618511-B2,['Henry W. Querfurth'],2017-04-11,,Methods and compositions for treating alzheimer's disease,2015
461,"['University of Pennsylvania', 'CARSTENS RUSS P', 'WARZECHA CLAUDE', 'HOGENESCH JOHN', 'SATO TREY', 'UNIV PENNSYLVANIA']","[{'id': 'grid.29857.31', 'acronym': 'PSU', 'name': 'Pennsylvania State University', 'country_name': 'United States'}, {'id': 'grid.25879.31', 'name': 'University of Pennsylvania', 'country_name': 'United States'}]",Grant,2015.0,US-9127078-B2,"['Russ P. Carstens', 'Claude Warzecha', 'John Hogenesch', 'Trey Sato']",2015-09-08,,Methods and compositions using splicing regulatory proteins involved in tumor suppression,2009
462,"['US Secretary of Army', 'U S ARMY RES LABORATORY ATTN: RDRL-LOC-I', 'US ARMY']","[{'id': 'grid.420282.e', 'acronym': 'ARL', 'name': 'United States Army Research Laboratory', 'country_name': 'United States'}, {'id': 'grid.427904.c', 'acronym': 'DA', 'name': 'United States Department of the Army', 'country_name': 'United States'}, {'id': 'grid.420176.6', 'acronym': 'USA', 'name': 'United States Army', 'country_name': 'United States'}]",Grant,2017.0,US-9817253-B2,"['Robert C. Hoffman', 'Shizhuo Yin']",2017-11-14,,High-speed wide field-of-view electro-optic system and method,2015
463,"['STRIDES ARCOLAB LTD', 'JAIN RAJEEV', 'NARANG TARUN', 'CHETLAPALLI SATYA SRINIVAS', 'METHAKU SUNDARRAJA VIJAY KANTH']",,Application,,WO-2012131734-A1,"['JAIN, RAJEEV', 'NARANG, Tarun', 'CHETLAPALLI, Satya Srinivas', 'METHAKU, Sundarraja Vijay Kanth']",2012-10-04,10.0,TOPICAL COMPOSITION FOR THE TREATMENT OF VITILIGO,2012
464,"['TricornTech Taiwan', 'CHOU TSUNG-KUAN A', 'WANG LI-PENG']",,Application,,WO-2015084815-A1,"['CHOU, TSUNG-KUAN A.', 'WANG, LI-PENG']",2015-06-11,,REAL-TIME AIR MONITORING WITH MULTIPLE SENSING MODES,2014
465,['NOGRA PHARMA LTD'],,Application,,WO-2017089555-A1,"['MCNULTY, Marie', 'VITI, FRANCESCA', 'BELLINVIA, SALVATORE']",2017-06-01,,IL-34 ANTISENSE OLIGONUCLEOTIDES AND METHODS OF USING SAME,2016
466,"['Glialogix Inc', 'GLIALOGIX INC']","[{'id': 'grid.428654.9', 'name': 'Glialogix (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9974798-B2,"['Thaddeus Cromwell Reeder', 'Mark Wade Moore', 'Douglas Alan Lorenz', 'David Keith Lyon']",2018-05-22,,Compositions and methods for the treatment of neurodegenerative and other diseases,2016
467,"['Glialogix Inc', 'REEDER THADDEUS CROMWELL', 'MOORE MARK WADE', 'LORENZ DOUGLAS ALAN', 'LYON DAVID KEITH', 'GLIALOGIX INC']","[{'id': 'grid.428654.9', 'name': 'Glialogix (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9918997-B2,"['Thaddeus Cromwell Reeder', 'Mark Wade Moore', 'Douglas Alan Lorenz', 'David Keith Lyon']",2018-03-20,,Compositions and methods for the treatment of neurodegenerative and other diseases,2017
468,"['ASS INST DE MYOLOGIE', 'CENTRE NAT RECH SCIENT', 'INST NAT SANTE RECH MED', 'UNIV PIERRE ET MARIE CURIE PARIS 6']","[{'id': 'grid.4444.0', 'acronym': 'CNRS', 'name': 'French National Centre for Scientific Research', 'country_name': 'France'}, {'id': 'grid.418250.a', 'name': 'Institute of Myology', 'country_name': 'France'}, {'id': 'grid.462844.8', 'name': 'Sorbonne University', 'country_name': 'France'}, {'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}]",Application,,WO-2016016449-A1,"['BARKATS, MARTINE', 'BIFERI, Maria-Grazia', 'VOIT, THOMAS']",2016-02-04,1.0,TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS,2015
469,"['Epizyme Inc', 'EPIZYME INC']","[{'id': 'grid.459523.c', 'name': 'Epizyme (United States)', 'country_name': 'United States'}]",Application,,EP-3194398-A4,"['OLHAVA, EDWARD JAMES', 'MORADEI, OSCAR MIGUEL', 'SHAPIRO, GIDEON', 'CHESWORTH, RICHARD', 'JIN, LEI', 'BABINE, ROBERT E.']",2018-02-21,,"SALTS, CO-CRYSTALS, AMORPHOUS FORMS, AND CRYSTALLINE FORMS OF A CO-ACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1 (CARM1) INHIBITOR",2015
470,"['Tricorntech Taiwan', 'TricornTech Taiwan']",,Application,,EP-3077828-A4,"['CHOU, TSUNG-KUAN A.', 'WANG, LI-PENG']",2017-07-26,,REAL-TIME AIR MONITORING WITH MULTIPLE SENSING MODES,2014
471,['MINUTILLO CLAUDIA'],,Application,,WO-2015107554-A1,"['LOTTI, Jacopo', 'MISURACA, Emiliano', 'BARYGINA, Victoria']",2015-07-23,,"A COMPOSITION FOR USE IN TREATMENT OF DERMATOLOGICAL DISEASES, AND RELATIVE PHARMACEUTICAL PREPARATIONS",2014
472,"['Glialogix Inc', 'GLIALOGIX INC']","[{'id': 'grid.428654.9', 'name': 'Glialogix (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9980978-B2,"['Thaddeus Cromwell Reeder', 'Mark Wade Moore', 'Douglas Alan Lorenz', 'David Keith Lyon']",2018-05-29,,Compositions and methods for the treatment of neurodegenerative and other diseases,2016
473,['ERYDEL S P A'],,Application,,WO-2016116850-A1,"['MAGNANI, MAURO', 'BIAGIOTTI, SARA', 'MENOTTA, Michele']",2016-07-28,1.0,METHOD OF EVALUATING THE RESPONSE OF ATAXIA TELANGIECTASIA PATIENTS TO GLUCOCORTICOIDS TREATMENT,2016
474,['SCHUHMACHER FRANK'],,Grant,2017.0,DE-102016008756-B3,['gleich Patentinhaber'],2017-08-31,,Dpa - resistant dual - rail - - - flip flop precharged with error recognition,2016
475,"['Glialogix Inc', 'GLIALOGIX INC']","[{'id': 'grid.428654.9', 'name': 'Glialogix (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9597339-B2,"['Thaddeus Cromwell Reeder', 'Mark Wade Moore', 'Douglas Alan Lorenz', 'David Keith Lyon']",2017-03-21,,Compositions and methods for the treatment of neurodegenerative and other diseases,2014
476,['ASS INST DE MYOLOGIE'],"[{'id': 'grid.418250.a', 'name': 'Institute of Myology', 'country_name': 'France'}]",Application,,WO-2017050836-A1,"['DUMONCEAUX, JULIE', 'VOIT, THOMAS', 'DICKSON, JOHN GEORGE', 'Popplewell, Linda Jane']",2017-03-30,,ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF,2016
477,"['LU WUYUAN', 'WITZ ISAAC', 'MAMAN SHELLY', 'UNIV MARYLAND', 'UNIV RAMOT']","[{'id': 'grid.12136.37', 'acronym': 'TAU', 'name': 'Tel Aviv University', 'country_name': 'Israel'}, {'id': 'grid.164295.d', 'acronym': 'UMCP', 'name': 'University of Maryland, College Park', 'country_name': 'United States'}]",Application,,WO-2015179657-A1,"['LU, WUYUAN', 'WITZ, ISAAC', 'MAMAN, Shelly']",2015-11-26,,TREATMENT OF CANCER AND INHIBITION OF METASTASIS USING HEMOGLOBIN BETA SUBUNIT,2015
478,['GLIALOGIX INC'],"[{'id': 'grid.428654.9', 'name': 'Glialogix (United States)', 'country_name': 'United States'}]",Application,,WO-2014121137-A2,"['REEDER, Thaddeus, Cromwell', 'MOORE, Mark, Wade', 'LORENZ, DOUGLAS, ALAN', 'LYON, DAVID, KEITH']",2014-08-07,2.0,COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE AND OTHER DISEASES,2014
479,"['PILARIS LABS LLC', 'PILARIS LABS LLC']",,Grant,2017.0,US-9532941-B2,"['Steven D. Shapiro', 'Michael T. Borenstein']",2017-01-03,,Method for treatment of hair loss with a combination of natural ingredients,2015
480,"['Genesis Robotics And Motion Technologies Canada Ulc', 'GENESIS ROBOTICS LLP']",,Grant,2017.0,US-9755463-B2,"['James Brent Klassen', 'Stephen Smith CHAMBERLAIN']",2017-09-05,3.0,Electric machine,2016
481,"['Thales SA', 'THALES SA']","[{'id': 'grid.410363.3', 'name': 'Thales Group (France)', 'country_name': 'France'}]",Application,,EP-3333745-A1,"[""GUYOMARC'H, Jean"", 'LACROIX, JEAN-MARC', 'THIERRY, PHILIPPE', 'GUILLOU, Erwan']",2018-06-13,,DEVICE FOR MANAGING USERS ACCESS RIGHTS BASED ON ROLES AND ASSOCIATED MANAGING METHOD,2017
482,"['CHARLESTON LABORATORIES Inc', 'CHARLESTON LABORATORIES INC']",,Grant,2017.0,US-9775837-B2,"['Paul Bosse', 'John Ameling', 'Bernard Schachtel', 'Ray Takigiku']",2017-10-03,1.0,Pharmaceutical compositions,2015
483,['UCL BUSINESS PLC'],"[{'id': 'grid.83440.3b', 'acronym': 'UCL', 'name': 'University College London', 'country_name': 'United Kingdom'}]",Application,,WO-2016181122-A1,"['NATHWANI, AMIT', 'RAJ, Deepak']",2016-11-17,,FABRY DISEASE GENE THERAPY,2016
484,"['LOCL PHARMA Inc', 'LOCL PHARMA INC']",,Grant,2018.0,US-9855264-B2,"['Paul Bosse', 'John Ameling', 'Bernard Schachtel', 'Ray Takigiku']",2018-01-02,,Pharmaceutical compositions,2016
485,"['OXFORD INSTR IND PRODUCTS LTD', 'INST OF FOOD RES']","[{'id': 'grid.423320.4', 'name': 'Oxford Instruments (United Kingdom)', 'country_name': 'United Kingdom'}, {'id': 'grid.40368.39', 'acronym': 'IFR', 'name': 'Quadram Institute', 'country_name': 'United Kingdom'}]",Application,,WO-2015033154-A1,"['WILLIAMSON, DAVID', 'KEMSLEY, Kate']",2015-03-12,,NMR SAMPLE ANALYSIS,2014
486,"['Genesis Robotics And Motion Technologies Canada Ulc', 'GENESIS ROBOTICS LLP']",,Grant,2017.0,US-9742227-B2,['James Brent Klassen'],2017-08-22,,Electric machine,2016
487,"['University of Texas System', 'UNIV TEXAS']","[{'id': 'grid.55460.32', 'acronym': 'UT System', 'name': 'The University of Texas System', 'country_name': 'United States'}]",Application,,EP-2919817-A4,"['RAO MANJEET K', 'IMAM JAAFER S', 'ZOGHI BEHYAR', 'CHANG YAO-FU', 'SUBBARAYALU PANNEERDOSS']",2016-10-19,,MIRNAS AS NOVEL THERAPEUTIC ADJUVANTS AND BIOMARKERS FOR THE PROGNOSIS AND TREATMENT OF DRUG RESISTANT BREAST CANCERS,2013
488,"['Genesis Robotics And Motion Technologies Canada Ulc', 'GENESIS ROBOTICS LLP', 'Genesis Robotics LLC']",,Grant,2017.0,US-9748803-B2,['James Brent Klassen'],2017-08-29,,Electric machine,2016
489,"['OXFORD INSTR IND PRODUCTS Ltd', 'Institute of Food Research', 'Oxford Instruments Industrial Products Ltd', 'OXFORD INSTR IND PRODUCTS LTD', 'INST OF FOOD RES']","[{'id': 'grid.40368.39', 'acronym': 'IFR', 'name': 'Quadram Institute', 'country_name': 'United Kingdom'}, {'id': 'grid.423320.4', 'name': 'Oxford Instruments (United Kingdom)', 'country_name': 'United Kingdom'}]",Application,,GB-2533244-A,"['DAVID WILLIAMSON', 'Kate Kemsley']",2016-06-15,,NMR Sample analysis,2014
490,"['X Development LLC', 'GOOGLE INC']","[{'id': 'grid.420451.6', 'name': 'Google', 'country_name': 'United States'}]",Grant,2016.0,US-9323966-B2,['Travis Deyle'],2016-04-26,,Device for backscatter communication,2014
491,"['STC.UNM', 'STC UNM']","[{'id': 'grid.266832.b', 'acronym': 'UNM', 'name': 'University of New Mexico', 'country_name': 'United States'}]",Grant,2016.0,US-9476090-B2,"['Carl Brown, III', 'Steven Wayde GRAVES', 'Darko Stefanovic', 'Matthew Richard Lakin']",2016-10-25,,"Signal propagation biomolecules, devices and methods",2014
492,"['Genesis Robotics And Motion Technologies Canada Ulc', 'GENESIS ROBOTICS LLP']",,Grant,2017.0,US-9748804-B2,['James Brent Klassen'],2017-08-29,2.0,Electric machine,2016
493,"['Thales SA', 'THALES SA']","[{'id': 'grid.410363.3', 'name': 'Thales Group (France)', 'country_name': 'France'}]",Application,,FR-3060153-A1,"[""GUYOMARC'H JEAN"", 'LACROIX JEAN MARC', 'THIERRY PHILIPPE', 'GUILLOU ERWAN']",2018-06-15,,Management device of the rights of access by users of actual and method of managing associated,2016
494,"['Zosano Pharma Corp', 'ZP OPCO INC', 'ZOSANO PHARMA CORP']",,Grant,2018.0,US-9918932-B2,"['Mahmoud Ameri', 'Donald Kellerman', 'Peter E. Daddona', 'Yi Ao']",2018-03-20,,Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines,2017
495,"['Outotec Oyj', 'KAIPIO JARI', 'VAUHKONEN MARKO', 'REUNANEN JUHA', 'LEHIKOINEN ANSSI', 'OUTOTEC OY']","[{'id': 'grid.436982.2', 'name': 'Outotec (Finland)', 'country_name': 'Finland'}]",Grant,2015.0,US-9182264-B2,"['Jari Kaipio', 'Marko Vauhkonen', 'Juha Reunanen', 'Anssi Lehikoinen']",2015-11-10,,Probe indicating intermaterial boundaries,2011
496,"['PILARIS LABS LLC', 'SHAPIRO STEVEN D', 'BORENSTEIN MICHAEL T', 'PILARIS LABS LLC']",,Grant,2015.0,US-8985124-B2,"['Steven D. Shapiro', 'Michael T. Borenstein']",2015-03-24,1.0,Method for treatment of hair loss with a combination of natural ingredients,2012
497,"['X Development LLC', 'GOOGLE INC']","[{'id': 'grid.420451.6', 'name': 'Google', 'country_name': 'United States'}]",Grant,2016.0,US-9357341-B2,['Travis Deyle'],2016-05-31,4.0,Receiver for backscatter communication,2014
498,"['Genesis Robotics And Motion Technologies Canada Ulc', 'GENESIS ROBOTICS LLP']",,Grant,2017.0,US-9742225-B2,"['James Brent Klassen', 'Stephen Smith CHAMBERLAIN']",2017-08-22,1.0,Electric machine,2016
499,"['Genesis Robotics And Motion Technologies Canada Ulc', 'GENESIS ROBOTICS AND MOTION TECH CANADA ULC', 'GENESIS ROBOTICS & MOTION TECH CANADA ULC']",,Grant,2018.0,US-10075030-B2,['James Brent Klassen'],2018-09-11,,Electric machine,2016
500,"['Rockwell Automation Technologies Inc', 'ROCKWELL AUTOMATION TECH INC']","[{'id': 'grid.455982.7', 'name': 'Rockwell Automation (United States)', 'country_name': 'United States'}]",Application,,EP-3145099-A3,"['DAY, SCOTT DUANE', 'BAYER, MICHAEL ROBERT', 'MAZUR, DAVID CHRISTOPHER', 'NOLAN, JEFFREY GERARD', 'GAMA, SERGIO LUIZ', 'KAY, JOHN ALBERT', 'VENNE, BRUCE K.']",2017-06-14,,INDUSTRIAL AUTOMATION PACKAGED POWER SOLUTION FOR INTELLIGENT MOTOR CONTROL AND INTELLIGENT SWITCHGEAR WITH ENERGY MANAGEMENT,2016
501,"['Genesis Robotics And Motion Technologies Canada Ulc', 'GENESIS ROBOTICS LLP']",,Grant,2017.0,US-9742226-B2,['James Brent Klassen'],2017-08-22,,Electric machine,2016
502,['CHARLESTON LAB INC'],,Application,,WO-2015157738-A1,"['BOSSE, PAUL', 'AMELING, JOHN', 'SCHACHTEL, BERNARD', 'KOZAREK, William']",2015-10-15,9.0,PHARMACEUTICAL COMPOSITIONS,2015
503,"['Outotec Oyj', 'KAIPIO JARI', 'VAUHKONEN MARKO', 'REUNANEN JUHA', 'LEHIKOINEN ANSSI', 'OUTOTEC OYJ']","[{'id': 'grid.436982.2', 'name': 'Outotec (Finland)', 'country_name': 'Finland'}]",Application,,US-20130054191-A1,"['Jari Kaipio', 'Marko Vauhkonen', 'Juha Reunanen', 'Anssi Lehikoinen']",2013-02-28,1.0,PROBE INDICATING INTERMATERIAL BOUNDARIES,2011
504,"[""Brigham and Women's Hospital"", 'BRIGHAM & WOMENS HOSPITAL INC']","[{'id': 'grid.62560.37', 'acronym': 'BWH', 'name': ""Brigham and Women's Hospital"", 'country_name': 'United States'}]",Grant,2018.0,US-9951331-B2,['Anna M. Krichevsky'],2018-04-24,,Targeting microRNA-26a/b for the treatment of neurodegenerative disease,2014
505,"['Children s Medical Center Corp', 'CHILDRENS MEDICAL CENTER']","[{'id': 'grid.414197.e', 'name': ""Dayton Children's Hospital"", 'country_name': 'United States'}, {'id': 'grid.2515.3', 'name': ""Boston Children's Hospital"", 'country_name': 'United States'}, {'id': 'grid.414196.f', 'name': ""Children's Medical Center"", 'country_name': 'United States'}]",Grant,2018.0,US-9994813-B2,['Richard I. Gregory'],2018-06-12,,Role for the perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway,2014
506,"['LOCL PHARMA Inc', 'LOCL PHARMA INC']",,Grant,2017.0,US-9789105-B2,"['Paul Bosse', 'John Ameling', 'Bernard Schachtel', 'Ray Takigiku']",2017-10-17,,Pharmaceutical compositions,2015
507,"['LOCL PHARMA Inc', 'LOCL PHARMA INC']",,Grant,2017.0,US-9789104-B2,"['Paul Bosse', 'John Ameling', 'Bernard Schachtel', 'Ray Takigiku']",2017-10-17,,Pharmaceutical compositions,2015
508,"['LOCL PHARMA Inc', 'LOCL PHARMA INC', 'LOCAL PHARMA INC']",,Grant,2018.0,US-10064856-B2,"['Paul Bosse', 'John Ameling', 'Bernard Schachtel', 'Ray Takigiku']",2018-09-04,,Pharmaceutical compositions,2017
509,"['Regeneron Pharmaceuticals Inc', 'REGENERON PHARMA']","[{'id': 'grid.418961.3', 'name': 'Regeneron (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8791244-B2,"['Christopher Daly', 'Douglas MacDonald', 'Xunbao Duan']",2014-07-29,5.0,Anti-ErbB3 antibodies and uses thereof,2012
510,"['Regeneron Pharmaceuticals Inc', 'REGENERON PHARMA']","[{'id': 'grid.418961.3', 'name': 'Regeneron (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9273143-B2,"['Christopher Daly', 'Douglas MacDonald', 'Xunbao Duan']",2016-03-01,1.0,Methods and compositions comprising a combination of an anti-ErbB3 antibody and an anti-EGFR antibody,2013
511,"['TAKIS S R L', 'AURISICCHIO LUIGI', 'CILIBERTO GENNARO', 'MANCINI RITA', 'MARRA EMANUELE', 'ROSCILLI GUISEPPE']",,Application,,WO-2012059224-A1,"['AURISICCHIO LUIGI', 'CILIBERTO GENNARO', 'MANCINI RITA', 'MARRA EMANUELE', 'ROSCILLI GUISEPPE']",2012-05-10,9.0,IMMUNOTHERAPY AGAINST ERBB-3 RECEPTOR,2011
512,"['Regeneron Pharmaceuticals Inc', 'REGENERON PHARMA']","[{'id': 'grid.418961.3', 'name': 'Regeneron (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9827310-B2,"['Christopher Daly', 'Douglas MacDonald', 'Xunbao Duan']",2017-11-28,,Anti-ErbB3 antibodies and uses thereof,2016
513,"['MedImmune LLC', 'MEDIMMUNE LLC']","[{'id': 'grid.418152.b', 'acronym': 'AstraZeneca', 'name': 'AstraZeneca (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10040857-B2,"['Partha S. Chowdhury', 'David Tice', 'Zhan Xiao', 'Philipp Steiner', 'Krista Kinneer', 'Marlon Rebelatto']",2018-08-07,,Binding molecules specific for HER3 and uses thereof,2015
514,"['Kinki University', 'SofSera Corp', 'SOFSERA CORP', 'UNIV KINKI']","[{'id': 'grid.258622.9', 'name': 'Kindai University', 'country_name': 'Japan'}]",Application,,EP-2982465-A4,"['FURUZONO TSUTOMU', 'KOGAI YASUMICHI', 'KAWABE KARL KAZUSHIGE']",2016-09-07,,"METHOD FOR CONTROLLING PARTICLE SIZE OF SILVER PARTICLES, SILVER PARTICLES, ANTIMICROBIAL AGENT CONTAINING SILVER PARTICLES, AND USE THEREOF",2014
515,['REGENERON PHARMA'],"[{'id': 'grid.418961.3', 'name': 'Regeneron (United States)', 'country_name': 'United States'}]",Application,,WO-2013048883-A3,"['DALY, CHRISTOPHER', 'MACDONALD, DOUGLAS', 'DUAN, XUNBAO']",2013-06-27,,ANTI-ERBB3 ANTIBODIES AND USES THEREOF,2012
516,"['Pelogenix LLC', 'WARDELL MARK R', 'SABACINSKI KENNETH A', 'PELOGENIX LLC']",,Grant,2018.0,US-10024817-B2,"['Mark R. Wardell', 'Kenneth A. Sabacinski']",2018-07-17,,Method for detecting proteases and active infection in biological fluids and tissues,2015
517,['GRACE THERAPEUTICS LLC'],,Application,,WO-2017123744-A1,"['KOTTAYIL, S., GEORGE', 'KUMAR, AMRESH', 'SUNTHANKAR, Prasanna', 'KAVURU, Vimal']",2017-07-20,,BETAMETHASONE ORAL SPRAY FORMULATION AND METHOD OF USE TO TREAT ATAXIA,2017
518,"['MedImmune LLC', 'MEDIMMUNE LLC', 'MEDIMMUNE LLC']","[{'id': 'grid.418152.b', 'acronym': 'AstraZeneca', 'name': 'AstraZeneca (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9220775-B2,"['Partha S. Chowdhury', 'David Tice', 'Zhan Xiao', 'Philipp Steiner', 'Krista Kinneer', 'Marlon Rebelatto']",2015-12-29,3.0,Binding molecules specific for HER3 and uses thereof,2012
519,"['Regeneron Pharmaceuticals Inc', 'REGENERON PHARMA']","[{'id': 'grid.418961.3', 'name': 'Regeneron (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9284380-B2,"['Christopher Daly', 'Douglas MacDonald', 'Xunbao Duan']",2016-03-15,1.0,Anti-ErbB3 antibodies and uses thereof,2014
520,['IRSN'],"[{'id': 'grid.418735.c', 'acronym': 'IRSN', 'name': 'Radioprotection and Nuclear Safety Institute', 'country_name': 'France'}]",Application,,WO-2015091767-A1,"['TROMPIER, François']",2015-06-25,,"RADICAL SPECIES, AND METHOD FOR MEASURING RECEIVED DOSES",2014
521,['UNIV STUTTGART'],"[{'id': 'grid.5719.a', 'name': 'University of Stuttgart', 'country_name': 'Germany'}]",Application,,WO-2018050848-A1,"['KONTERMANN, ROLAND', 'SCHMITT, LISA', 'HUTT, Meiko', 'SEIFERT, OLIVER', 'OLAYIOYE, MONILOLA', 'HUST, MICHAEL', 'Dübel, Stefan', 'ZANTOW, Jonas']",2018-03-22,,ANTIGEN BINDING PROTEIN AGAINST HER3,2017
522,"['General Electric Co', 'GEN ELECTRIC']","[{'id': 'grid.418143.b', 'acronym': 'GE', 'name': 'General Electric (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9718735-B2,"['John McConnell Delvaux', 'Andres Jose Garcia-Crespo', 'Victor John Morgan', 'Jacob John Kittleson']",2017-08-01,,CMC turbine components and methods of forming CMC turbine components,2015
523,"['Institut de Radioprotection et de Surete Nucleaire (IRSN)', 'INST DE RADIOPROTECTION ET DE SURETE NUCLEAIRE']","[{'id': 'grid.418735.c', 'acronym': 'IRSN', 'name': 'Radioprotection and Nuclear Safety Institute', 'country_name': 'France'}]",Grant,2018.0,US-10031093-B2,['François Trompier'],2018-07-24,,"Radical species, and method for measuring received doses",2014
524,['CANCER THERAPEUTICS CRC PTY LTD'],,Application,,WO-2014128465-A1,"['STUPPLE, PAUL ANTHONY', 'WALKER, Scott Raymond', 'PINSON, Jo-Anne', 'LAGIAKOS, Helen Rachel', 'LUNNISS, Gillian Elizabeth', 'HOLMES, IAN PETER', 'STUPPLE, Alexandra Elizabeth', 'BERGMAN, YLVA ELISABET', 'FOITZIK, Richard Charles', 'KERSTEN, Wilhelmus Johannes Antonius', 'CAMERINO, Michelle Ang']",2014-08-28,2.0,2-(HETERO)ARYL-BENZIMIDAZOLE AND IMIDAZOPYRIDINE DERIVATIVES AS INHIBITORS OF ASPARAGIME EMETHYL TRANSFERASE,2014
525,"['International Business Machines Corp', 'IBM']","[{'id': 'grid.410484.d', 'name': 'IBM (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9946972-B2,['Jakub Marecek'],2018-04-17,,Optimization of mixed-criticality systems,2014
526,['LM WP PATENT HOLDING AS'],"[{'id': 'grid.35434.35', 'name': 'LM Wind Power (Denmark)', 'country_name': 'Denmark'}]",Application,,WO-2017081230-A1,"['ZHANG, Shuai', 'FRØLUND PEDERSEN, Gert', 'HANSEN, LARS BO']",2017-05-18,,A DEFLECTION MONITORING SYSTEM FOR A WIND TURBINE BLADE,2016
527,"['Janssen Pharmaceuticals Inc', 'CID-NÚÑEZ JOSÉ MARIA', 'TRABANCO-SUÁREZ ANDRÉS AVELINO', 'VEGA RAMIRO JUAN ANTONIO', 'OEHLRICH DANIEL', 'TRESADERN GARY JOHN', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC']",,Grant,2015.0,US-8993591-B2,"['José Maria Cid-Núñez', 'Andrés Avelino Trabanco-Suárez', 'Juan Antonio Vega Ramiro', 'Daniel Oehlrich', 'Gary John Tresadern', 'Gregor James MacDonald']",2015-03-31,1.0,"1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors",2011
528,"['Janssen Pharmaceuticals Inc', 'CID-NÚÑEZ JOSÉ MARIA', 'TRABANCO-SUÁREZ ANDRÉS AVELINO', 'VEGA RAMIRO JUAN ANTONIO', 'OEHLRICH DANIEL', 'TRESADERN GARY JOHN', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC']",,Grant,2016.0,US-9271967-B2,"['José Maria Cid-Núñez', 'Andrés Avelino Trabanco-Suárez', 'Juan Antonio Vega Ramiro', 'Daniel Oehlrich', 'Gary John Tresadern', 'Gregor James MacDonald']",2016-03-01,1.0,"1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2011
529,"['Aeromics Inc', 'AEROMICS INC']","[{'id': 'grid.432560.6', 'name': 'Aeromics (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9827253-B2,"['Marc F. Pelletier', 'Paul Robert Mcguirk', 'George William Farr', 'Robert Zamboni', 'John Colucci', 'Helmi Zaghdane']",2017-11-28,1.0,Prodrug salts,2014
530,"['Janssen Pharmaceutica NV', 'Addex Therapeutics Ltd', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA']","[{'id': 'grid.419619.2', 'name': 'Janssen (Belgium)', 'country_name': 'Belgium'}, {'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8906939-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey']",2014-12-09,,3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives,2008
531,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'LUTJENS ROBERT JOHANNES', 'FINN PATRICK TERRY', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8722894-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lutjens', 'Patrick Terry Finn']",2014-05-13,,"1,3-disubstituted-4-phenyl-1H-pyridin-2-ones",2008
532,"['Janssen Pharmaceutica NV', 'JANSSEN PHARMACEUTICA NV']","[{'id': 'grid.419619.2', 'name': 'Janssen (Belgium)', 'country_name': 'Belgium'}]",Grant,2017.0,US-9708315-B2,"['José Maria Cid-Núñez', 'Andrés Avelino Trabanco-Suárez', 'Marc André Ceusters', 'Hilde Lavreysen']",2017-07-18,1.0,"1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of MGLUR2 receptors",2014
533,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'OEHLRICH DANIEL', 'TRABANCO-SUAREZ ANDRES AVELINO', 'TRESADERN GARY JOHN', 'VEGA RAMIRO JUAN ANTONIO', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-8937060-B2,"['Jose Maria Cid-Nunez', 'Daniel Oehlrich', 'Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Gregor James MacDonald']",2015-01-20,9.0,"1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders",2010
534,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-9132122-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lütjens', 'Terry Patrick Finn']",2015-09-15,,"1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones",2013
535,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'LUTJENS ROBERT JOHANNES', 'FINN PATRICK TERRY', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8748621-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lutjens', 'Patrick Terry Finn']",2014-06-10,,"1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones",2012
536,"['AEROMICS LLC', 'Aeromics Inc', 'AEROMICS INC']","[{'id': 'grid.432560.6', 'name': 'Aeromics (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9994514-B2,"['Marc F. Pelletier', 'George William Farr', 'Paul Robert Mcguirk', 'Christopher H. Hall', 'Walter F. Boron']",2018-06-12,1.0,Methods of treating cerebral edema and spinal cord edema,2013
537,"['INSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE', 'UNIVERSITÉ PARIS DESCARTES', 'UNIVERSITÉ PIERRE ET MARIE CURIE PARIS 6', 'UNIVERSITÉ PARIS DIDEROT PARIS 7', 'ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS APHP']","[{'id': 'grid.50550.35', 'acronym': 'AP-HP', 'name': 'Assistance Publique -Hopitaux De Paris', 'country_name': 'France'}, {'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}, {'id': 'grid.10992.33', 'name': 'Paris Descartes University', 'country_name': 'France'}, {'id': 'grid.7452.4', 'name': 'Paris Diderot University', 'country_name': 'France'}, {'id': 'grid.462844.8', 'name': 'Sorbonne University', 'country_name': 'France'}]",Application,,WO-2015086727-A2,"['SUSIN, SANTOS', 'KAROYAN, Philippe', 'LAUNAY, PIERRE', 'MERLE-BERAL, Hélène']",2015-06-18,3.0,NEW PROGNOSTIC METHOD FOR PATIENTS SUFFERING OF A CANCER,2014
538,['MERIAL INC'],"[{'id': 'grid.417555.7', 'acronym': 'Sanofi', 'name': 'Sanofi (United States)', 'country_name': 'United States'}]",Application,,WO-2017176948-A1,"['YANG, CHUNHUA', 'LE HIR DE FALLOIS, LOIC, PATRICK', 'MENG, CHARLES, Q.', 'LONG, ALAN', 'GORTER DE VRIES, Roelof, Johannes', 'BAILLON, BRUNO', 'LAFONT, SYLVAINE', 'GAY DE SAINT MICHEL, Myriam', 'KOZLOVIC, STEPHANE']",2017-10-12,1.0,PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY ENRICHED ISOXAZOLINE COMPOUNDS - CRYSTALLINE TOLUENE SOLVATE OF (S)-AFOXOLANER,2017
539,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-9085577-B2,"['Jose Maria Cid-Nunez', 'Ana Isabel De Lucas Olivares', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald']",2015-07-21,,"7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2014
540,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'DE LUCAS OLIVARES ANA ISABEL', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-8946205-B2,"['Jose Maria Cid-Nunez', 'Ana Isabel De Lucas Olivares', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald']",2015-02-03,1.0,"1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2010
541,"['MITRACORE TECHNOLOGIES INC', 'COHEN GIDEON', 'LAGACE ETIENNE', 'BERRADA MARWANE', 'PERKINS CHARLES', 'CHU BOBY']",,Application,,WO-2013049734-A1,"['COHEN, GIDEON', 'LAGACE, Etienne', 'BERRADA, MARWANE', 'PERKINS, CHARLES', 'CHU, Boby']",2013-04-04,3.0,APPARATUSES AND METHODS FOR CUTTING A TISSUE BRIDGE AND/OR REMOVING A HEART VALVE CLIP OR SUTURE,2012
542,"['AEROMICS LLC', 'Aeromics Inc', 'AEROMICS INC']","[{'id': 'grid.432560.6', 'name': 'Aeromics (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9949991-B2,"['Marc F. Pelletier', 'Paul Robert Mcguirk', 'George William Farr', 'Steven Williams']",2018-04-24,1.0,Methods of treating aquaporin-mediated conditions,2014
543,"['General Electric Co', 'GEN ELECTRIC']","[{'id': 'grid.418143.b', 'acronym': 'GE', 'name': 'General Electric (United States)', 'country_name': 'United States'}]",Application,,US-20160221881-A1,"['John McConnell Delvaux', 'Andres Jose Garcia-Crespo', 'Victor John Morgan', 'Jacob John Kittleson']",2016-08-04,1.0,CMC TURBINE COMPONENTS AND METHODS OF FORMING CMC TURBINE COMPONENTS,2015
544,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2016.0,US-9266834-B2,"['Hassan Julien Imogai', 'Jose Maria Cid-Nunez', 'Jose Ignacio Andres-Gil', 'Andres Avelino Trabanco-Suarez', 'JULEN OYARZABAL SANTAMARINA', 'Frank Matthias Dautzenberg', 'Gregor James MacDonald', 'SHRILEY ELIZABETH PULLAN', 'Robert Johannes Lutjens', 'Guillaume Albert Jacques Duvey', 'Vanthea Nhem', 'Terry Patrick Finn', 'Gagik Melikyan']",2016-02-23,,"1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors",2014
545,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'LUTJENS ROBERT JOHANNES', 'FINN TERRY PATRICK', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-9114138-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lutjens', 'Terry Patrick Finn']",2015-08-25,,"1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones",2008
546,['ROSS JOHN R'],,Application,,US-20110046928-A1,['John R. Ross'],2011-02-24,3.0,"Process for making models of photons, electrons, magnitism, gravity and other things",2010
547,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'DE LUCAS OLIVARES ANA ISABEL', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8716480-B2,"['Jose Maria Cid-Nunez', 'Ana Isabel De Lucas Olivares', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald']",2014-05-06,1.0,"7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2010
548,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8697689-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez']",2014-04-15,1.0,Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors,2009
549,"['Janssen Cilag SA', 'Janssen Pharmaceuticals Inc', 'CID-NÚÑEZ JOSÉ MARIA', 'TRABANCO-SUÁREZ ANDRÉS AVELINO', 'VEGA RAMIRO JUAN ANTONIO', 'OEHLRICH DANIEL', 'TRESADERN GARY JOHN', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC']",,Grant,2015.0,US-9012448-B2,"['José Maria Cid-Núñez', 'Andrés Avelino Trabanco-Suárez', 'Juan Antonio Vega Ramiro', 'Daniel Oehlrich', 'Gary John Tresadern', 'Gregor James MacDonald']",2015-04-21,8.0,"1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors",2011
550,"['Civitas Therapeutics Inc', 'CIVITAS THERAPEUTICS INC']","[{'id': 'grid.417402.4', 'name': 'Acorda Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9387169-B2,"['Michael M. Lipp', 'Abhijit Kamerkar']",2016-07-12,,Rapamycin powders for pulmonary delivery,2015
551,"['Janssen Pharmaceutica NV', 'Addex Therapeutics Ltd', 'TRABANCO-SUAREZ ANDRES AVELINO', 'TRESADERN GARY JOHN', 'VEGA RAMIRO JUAN ANTONIO', 'CID-NUNEZ JOSE MARIA', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}, {'id': 'grid.419619.2', 'name': 'Janssen (Belgium)', 'country_name': 'Belgium'}]",Grant,2014.0,US-8785486-B2,"['Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Jose Maria Cid-Nunez']",2014-07-22,,"Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2008
552,"['Institut de Radioprotection et de Surete Nucleaire (IRSN)', 'IRSN']","[{'id': 'grid.418735.c', 'acronym': 'IRSN', 'name': 'Radioprotection and Nuclear Safety Institute', 'country_name': 'France'}]",Application,,FR-3015050-A1,['TROMPIER FRANCOIS'],2015-06-19,,Radical species and to the measurement of doses received,2013
553,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'LUTJENS ROBERT JOHANNES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-9067891-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lutjens']",2015-06-30,,"1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mGluR2-receptors",2012
554,['LAM THERAPEUTICS INC'],,Application,,WO-2015123219-A1,"['ARMER, Thomas', 'MELVIN, LAWRENCE, S.', 'ROTHBERG, JONATHAN, M.', 'LICHENSTEIN, HENRI']",2015-08-20,5.0,RAPAMYCIN FOR THE TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS,2015
555,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2016.0,US-9226930-B2,"['Jose Maria Cid-Nunez', 'Daniel Oehlrich', 'Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Gregor James MacDonald']",2016-01-05,1.0,"1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders",2014
556,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8691849-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez']",2014-04-08,,3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors,2009
557,['TORAY FINECHEMICALS CO LTD'],,Application,,WO-2014162947-A1,['中谷 仁郎'],2014-10-09,2.0,METHOD FOR PRODUCING DIGLYCIDYLAMINE-TYPE EPOXY COMPOUND,2014
558,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA', 'ADDEX PHARMA, S.A.']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2018.0,US-10071095-B2,"['Jose Maria Cid-Nunez', 'Daniel Oehlrich', 'Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Gregor James MACDONOLD']",2018-09-11,,"1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders",2017
559,['LAM THERAPEUTICS INC'],,Application,,WO-2016130645-A1,"['ARMER, Thomas', 'MELVIN, LAWRENCE, S., JR.', 'ROTHBERG, JONATHAN, M.', 'LICHENSTEIN, HENRI']",2016-08-18,,RAPAMYCIN FOR THE TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS,2016
560,"['STATE UNIVERSITY OF YEREVAN', 'Addex Therapeutics Ltd', 'Janssen Cilag SA', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'ANDRES-GIL JOSE IGNACIO', 'TRABANCO-SUAREZ ANDRES AVELINO', 'OYARZABAL SANTAMARINA JULEN', 'DAUTZENBERG FRANK MATTHIAS', 'MACDONALD GREGOR JAMES', 'PULLAN SHIRLEY ELIZABETH', 'LUTJENS ROBERT JOHANNES', 'DUVEY GUILLAUME ALBERT JACQUES', 'NHEM VANTHEA', 'FINN TERRY PATRICK', 'MELIKYAN GAGIK', 'MUTEL VINCENT', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}, {'id': 'grid.21072.36', 'acronym': 'YSU', 'name': 'Yerevan State University', 'country_name': 'Armenia'}]",Grant,2014.0,US-8841323-B2,"['Hassan Julien Imogai', 'Jose Maria Cid-Nunez', 'Jose Ignacio Andres-Gil', 'Andres Avelino Trabanco-Suarez', 'Julen Oyarzabal Santamarina', 'Frank Matthias Dautzenberg', 'Gregor James MacDonald', 'Shirley Elizabeth Pullan', 'Robert Johannes Lutjens', 'Guillaume Albert Jacques Duvey', 'Vanthea Nhem', 'Terry Patrick Finn', 'Gagik Melikyan']",2014-09-23,,"1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors",2007
561,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2017.0,US-9737533-B2,"['Jose Maria Cid-Nunez', 'Daniel Oehlrich', 'Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Gregor James MacDonald']",2017-08-22,1.0,"1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders",2015
562,"['Universita degli Studi di Bari Aldo Moro', 'UNIVERSIT DEGLI STUDI DI BARI ALDO MORO']","[{'id': 'grid.7644.1', 'name': 'University of Bari Aldo Moro', 'country_name': 'Italy'}]",Application,,EP-2816037-A3,"['LEOPOLDO, MARCELLO', 'LACIVITA, ENZA', 'COLABUFO, NICOLA ANTONIO', 'DE GIORGIO, Paola', 'BERARDI, FRANCESCO', 'PERRONE, ROBERTO']",2015-04-01,,New 1-arylpiperazinic ligands of 5-HT7 receptor and use thereof,2011
563,['WINTERFIELD ROLAND W'],,Application,,WO-2015148982-A1,"['WINTERFIELD, Roland, W.']",2015-10-01,2.0,BETA-HYDROXY BETA-METHYLBUTYRATE FOR ALLEVIATING STATIN MYOPATHY,2015
564,"['Medtronic Ablation Frontiers LLC', 'STRUNK AARON R', 'NOVICHENOK ALEX', 'MEDTRONIC ABLATION FRONTIERS']","[{'id': 'grid.419673.e', 'acronym': 'Medtronic', 'name': 'Medtronic (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-8984969-B2,"['Aaron R. Strunk', 'Alex NOVICHENOK']",2015-03-24,2.0,Thermochromic polyacrylamide tissue phantom and its use for evaluation of ablation therapies,2012
565,"['University of California', 'Otonomy Inc', 'LICHTER JAY', 'TRAMMEL ANDREW M', 'PIU FABRICE', 'DELLAMARY LUIS A', 'YE QIANG', 'LEBEL CARL', 'SCAIFE MICHAEL CHRISTOPHER', 'HARRIS JEFFREY P', 'OTONOMY INC', 'UNIV CALIFORNIA']","[{'id': 'grid.30389.31', 'name': 'University of California System', 'country_name': 'United States'}, {'id': 'grid.488355.7', 'name': 'Otonomy (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9132087-B2,"['Jay Lichter', 'Andrew M. Trammel', 'Fabrice Piu', 'Luis A. Dellamary', 'Qiang Ye', 'Carl LEBEL', 'Michael Christopher SCAIFE', 'Jeffrey P. Harris']",2015-09-15,6.0,Auris formulations for treating otic diseases and conditions,2009
566,"['Ionis Pharmaceuticals Inc', 'IONIS PHARMACEUTICALS INC']","[{'id': 'grid.282569.2', 'name': 'Ionis Pharmaceuticals (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9957504-B2,"['Thazha P. Prakash', 'Punit P. Seth', 'Eric E. Swayze', 'Mark J. Graham']",2018-05-01,,Compositions and methods for modulating apolipoprotein (a) expression,2015
567,"['F Hoffmann-La Roche AG', 'SIEBEL CHRISTIAN W']","[{'id': 'grid.417570.0', 'name': 'Roche (Switzerland)', 'country_name': 'Switzerland'}]",Application,,US-20120328608-A1,['Christian W. Siebel'],2012-12-27,10.0,METHODS OF TREATING CANCER USING NOTCH ANTAGONISTS,2010
568,"['F Hoffmann-La Roche AG', 'SIEBEL CHRISTIAN W', 'GENENTECH INC']","[{'id': 'grid.417570.0', 'name': 'Roche (Switzerland)', 'country_name': 'Switzerland'}, {'id': 'grid.418158.1', 'acronym': 'Roche', 'name': 'Roche (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9200071-B2,['Christian W. Siebel'],2015-12-01,2.0,Methods of treating cancer using Notch1 and Notch3 antagonists,2010
569,['WINTERFIELD ROLAND W'],,Grant,2016.0,US-9399026-B2,['Roland W. Winterfield'],2016-07-26,,Methods for alleviating statin myopathy,2015
570,['FRATAGENE THERAPEUTICS LTD'],,Application,,WO-2016103223-A1,"['TESTI, ROBERTO', 'MALISAN, Florence']",2016-06-30,1.0,METHODS OF TREATING FRIEDREICH'S ATAXIA USING SRC INHIBITORS,2015
571,['LILLY CO ELI'],"[{'id': 'grid.417540.3', 'acronym': 'Eli Lilly & Company', 'name': 'Eli Lilly (United States)', 'country_name': 'United States'}]",Application,,WO-2015167890-A1,"['LEDGARD, ANDREW JAMES']",2015-11-05,,"(THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS SELECTIVE 5-HT2A INVERSE AGONISTS",2015
572,"['Zosano Pharma Corp', 'ZP OPCO INC', 'ZOSANO PHARMA CORP']",,Grant,2018.0,US-9918932-B2,"['Mahmoud Ameri', 'Donald Kellerman', 'Peter E. Daddona', 'Yi Ao']",2018-03-20,,Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines,2017
573,"['University of California', 'Otonomy Inc', 'OTONOMY INC', 'UNIV CALIFORNIA']","[{'id': 'grid.488355.7', 'name': 'Otonomy (United States)', 'country_name': 'United States'}, {'id': 'grid.30389.31', 'name': 'University of California System', 'country_name': 'United States'}]",Application,,US-20090297533-A1,"['Luis A. Dellamary', 'Sergio G. Duron', 'Jeffrey P. Harris', 'Carl LEBEL', 'Jay Lichter', 'Fabrice Piu', 'Michael Christopher SCAIFE', 'Andrew M. Trammel', 'Benedikt VOLLRATH', 'Qiang Ye']",2009-12-03,38.0,CONTROLLED RELEASE IMMUNOMODULATOR COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS,2009
574,['FRATAGENE THERAPEUTICS LTD'],,Application,,WO-2016046759-A2,"['TESTI, ROBERTO', 'INCANI, OTTAVIANO', 'RUFINI, Alessandra', 'DEMARTINO, Gabriella']",2016-03-31,,COMPOSITIONS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA,2015
575,"['Ionis Pharmaceuticals Inc', 'IONIS PHARMACEUTICALS INC']","[{'id': 'grid.282569.2', 'name': 'Ionis Pharmaceuticals (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9932581-B2,"['Thazha P. Prakash', 'Punit P. Seth', 'Eric E. Swayze', 'Mark J. Graham']",2018-04-03,,Compositions and methods for modulating apolipoprotein C-III expression,2015
576,"['Ionis Pharmaceuticals Inc', 'ISIS PHARMACEUTICALS INC', 'ISIS PHARMACEUTICALS INC']","[{'id': 'grid.282569.2', 'name': 'Ionis Pharmaceuticals (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9382540-B2,"['Thazha P. Prakash', 'Punit P. Seth', 'Eric E. Swayze', 'Susan M. Freier', 'Mark J. Graham', 'Rosanne M. Crooke']",2016-07-05,5.0,Compositions and methods for modulating angiopoietin-like 3 expression,2015
577,"['Medtronic Ablation Frontiers LLC', 'MEDTRONIC ABLATION FRONTIERS']","[{'id': 'grid.419673.e', 'acronym': 'Medtronic', 'name': 'Medtronic (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10024730-B2,"['Aaron R. Strunk', 'Alex NOVICHENOK']",2018-07-17,,Thermochromic polyacrylamide tissue phantom and its use for evaluation of ablation therapies,2015
578,"['Medtronic Ablation Frontiers LLC', 'STRUNK AARON R', 'NOVICHENOK ALEX', 'MEDTRONIC ABLATION FRONTIERS']","[{'id': 'grid.419673.e', 'acronym': 'Medtronic', 'name': 'Medtronic (United States)', 'country_name': 'United States'}]",Application,,US-20130192392-A1,"['Aaron R. Strunk', 'Alex NOVICHENOK']",2013-08-01,6.0,THERMOCHROMIC POLYACRYLAMIDE TISSUE PHANTOM AND ITS USE FOR EVALUATION OF  ABLATION THERAPIES,2012
579,"['California Institute of Technology', 'ROUMI FARSHID', 'ROUMI JAMSHID', 'CALIFORNIA INST OF TECHN']","[{'id': 'grid.20861.3d', 'acronym': 'CIT', 'name': 'California Institute of Technology', 'country_name': 'United States'}]",Grant,2017.0,US-9831043-B2,"['Farshid ROUMI', 'Jamshid Roumi']",2017-11-28,3.0,Electrochemical energy storage systems and methods,2011
580,"['California Institute of Technology', 'CALIFORNIA INST OF TECHN']","[{'id': 'grid.20861.3d', 'acronym': 'CIT', 'name': 'California Institute of Technology', 'country_name': 'United States'}]",Grant,2018.0,US-9954213-B2,['Farshid ROUMI'],2018-04-24,,Electrochemical systems with at least one electronically and ionically conductive layer,2016
581,['UNIV ROMA'],,Application,,WO-2016042436-A1,"['BARNABA, VINCENZO']",2016-03-24,,METHOD AND KIT FOR THE PREDICTIVE PROGNOSIS OF RESPONSIVENESS TO TREATMENTS OF AUTOIMMUNE DISEASES,2015
582,"['Bayerische Motoren Werke AG', 'BAYERISCHE MOTOREN WERKE AG', 'WESTFÄLISCHE WILHELM UNIVERSITÄT MÜNSTER']","[{'id': 'grid.5949.1', 'acronym': 'WWU', 'name': 'University of Münster', 'country_name': 'Germany'}, {'id': 'grid.14039.3f', 'name': 'BMW (Germany)', 'country_name': 'Germany'}]",Application,,DE-102014209209-A1,"['Dominic Bresser', 'Giuseppe Antonio Elia', 'Jusef Hassoun', 'Yang-Kook Sun', 'Franziska Müller', 'Stefano Passerini', 'Bruno Scrosati']",2015-11-19,1.0,Lithium - air - battery,2014
583,"['California Institute of Technology', 'CALIFORNIA INST OF TECHN']","[{'id': 'grid.20861.3d', 'acronym': 'CIT', 'name': 'California Institute of Technology', 'country_name': 'United States'}]",Grant,2016.0,US-9379368-B2,['Farshid ROUMI'],2016-06-28,14.0,Electrochemical systems with electronically conductive layers,2013
584,['MAEDA MATERIAL CO LTD'],,Application,,WO-2015132860-A1,['前田\u3000悦弘'],2015-09-11,,"WATER TREATMENT ADSORBING AGENT, MANUFACTURING METHOD THEREFOR, WATER TREATMENT APPARATUS, CARTRIDGE FOR WATER TREATMENT APPARATUS, AND WATER TREATMENT METHOD",2014
585,"['UNIVERSITÀ DEGLI STUDI DI GENOVA', 'L-NUTRA INC']","[{'id': 'grid.5606.5', 'acronym': 'UniGe', 'name': 'University of Genoa', 'country_name': 'Italy'}]",Application,,WO-2017140641-A1,"['NENCIONI, Alessio', 'BALLESTRERO, Alberto', 'ODETTI, Patrizio', 'MONACELLI, Fiammetta', 'CAFFA, Irene', 'LONGO, VALTER']",2017-08-24,,USE OF A FASTING MIMICKING DIET TO ENHANCE THE EFFICACY OF ANTIESTROGENS IN CANCER THERAPY,2017
586,['UNIV KING ABDULLAH SCI & TECH'],"[{'id': 'grid.45672.32', 'acronym': 'KAUST', 'name': 'King Abdullah University of Science and Technology', 'country_name': 'Saudi Arabia'}]",Application,,WO-2017103783-A1,"['LI, LAIN-JONG', 'MING, Jun']",2017-06-22,,"LITHIUM-SULFUR BATTERY, A DUAL BLOCKING LAYER, METHODS OF MAKING, AND METHODS OF USE THEREOF",2016
587,"['Fujitsu Ltd', 'FUJITSU LTD']","[{'id': 'grid.418251.b', 'name': 'Fujitsu (Japan)', 'country_name': 'Japan'}]",Application,,EP-3276512-A1,"['OGASAWARA, Keita', 'SUWA, TAMON']",2018-01-31,,"COMPUTER-READABLE RECORDING MEDIUM, PARTICLE SIMULATION METHOD, AND INFORMATION PROCESSING APPARATUS",2017
588,"['UNIV ROMA', 'IEG TECHNOLOGIE GMBH', 'FENICE S P A']",,Application,,WO-2015162527-A1,"['PETRANGELI PAPINI, MARCO', 'MAJONE, MAURO', 'BARIC, Massimiliano', 'PIERRO, Lucia']",2015-10-29,,"PROCESS, ARRANGEMENT AND PLANT FOR THE CLEAN-UP OF WATERS CONTAMINATED BY CHLORINATED SOLVENTS, NITRATES AND SULFATES",2015
589,"['California Institute of Technology', 'CALIFORNIA INST OF TECHN']","[{'id': 'grid.20861.3d', 'acronym': 'CIT', 'name': 'California Institute of Technology', 'country_name': 'United States'}]",Grant,2018.0,US-9991492-B2,['Farshid ROUMI'],2018-06-05,1.0,Separator enclosures for electrodes and electrochemical cells,2014
590,"['Boeing Co', 'BOEING CO']","[{'id': 'grid.423121.7', 'name': 'Boeing (United States)', 'country_name': 'United States'}]",Application,,US-20150191604-A1,"['Lawrence M. Lawless', 'Bruce M. Griffin']",2015-07-09,1.0,Composition and Method for Inhibiting Corrosion of an Anodized Material,2014
591,"['Boeing Co', 'BOEING CO']","[{'id': 'grid.423121.7', 'name': 'Boeing (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9771481-B2,"['Lawrence M. Lawless', 'Bruce M. Griffin']",2017-09-26,,Composition and method for inhibiting corrosion of an anodized material,2014
592,"['Samsung Electronics Co Ltd', 'SAMSUNG ELECTRONICS CO LTD']","[{'id': 'grid.419666.a', 'name': 'Samsung (South Korea)', 'country_name': 'South Korea'}]",Grant,2016.0,US-9431658-B2,"['Won-sung Choi', 'Dong-Min Im', 'Victor Roev', 'Young-gyoon Ryu', 'Dong-Joon Lee', 'Seung-Sik Hwang']",2016-08-30,,"Positive electrode for lithium batteries, lithium battery including the positive electrode, and methods of manufacture thereof",2014
593,"['Cyberonics Inc', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9737716-B2,"['Imad Libbus', 'Bruce H. Kenknight', 'Badri Amurthur']",2017-08-22,,Vagus nerve and carotid baroreceptor stimulation system,2014
594,"['Heptares Therapeutics Ltd', 'HEPTARES THERAPEUTICS LTD']","[{'id': 'grid.451116.6', 'name': 'Sosei Group Corporation (United Kingdom)', 'country_name': 'United Kingdom'}]",Grant,2017.0,US-9802935-B2,"['John Andrew Christopher', 'Miles Stuart Congreve', 'Sarah Joanne Bucknell', 'Francesca Deflorian', 'Mark Pickworth', 'Jonathan Stephen Mason']",2017-10-31,2.0,CGRP receptor antagonists,2016
595,"['East Tennessee State University', 'Cyberonics Inc', 'CYBERONICS INC', 'EAST TENNESSEE STATE UNIV']","[{'id': 'grid.255381.8', 'acronym': 'ETSU', 'name': 'East Tennessee State University', 'country_name': 'United States'}, {'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9789316-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight', 'Jeffrey L. Ardell']",2017-10-17,,Neurostimulation and recording of physiological response for the treatment of chronic cardiac dysfunction,2016
596,"['AlderBio Holdings LLC', 'ALDERBIO HOLDINGS LLC']",,Grant,2018.0,US-10066009-B2,"['Brian Robert Kovacevich', 'Leon F. Garcia-Martinez', 'Katie Olson ANDERSON', 'Benjamin H. Dutzar', 'Jens J. Billgren', 'John A. Latham', 'Danielle M. Mitchell', 'Patricia Dianne McNeill', 'Nicole M. Janson', 'Maria-Cristina Loomis']",2018-09-04,,Anti-CGRP compositions and use thereof,2016
597,['MICROSOFT TECHNOLOGY LICENSING LLC'],"[{'id': 'grid.419815.0', 'name': 'Microsoft (United States)', 'country_name': 'United States'}]",Application,,WO-2015119838-A3,"['KIKKERI, HARSHAVARDHANA', 'THIBODEAU, BRYAN J.']",2016-06-16,,CONTROLLING A ROBOT IN THE PRESENCE OF A MOVING OBJECT,2015
598,"['East Tennessee State University', 'Cyberonics Inc', 'CYBERONICS INC', 'EAST TENNESSEE STATE UNIV']","[{'id': 'grid.255381.8', 'acronym': 'ETSU', 'name': 'East Tennessee State University', 'country_name': 'United States'}, {'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9999773-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight', 'Jeffrey L. Ardell', 'Gregory A. Ordway']",2018-06-19,,Implantable neurostimulator-implemented method utilizing multi-modal stimulation parameters,2014
599,"['East Tennessee State University', 'Cyberonics Inc', 'CYBERONICS INC']","[{'id': 'grid.255381.8', 'acronym': 'ETSU', 'name': 'East Tennessee State University', 'country_name': 'United States'}, {'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9409024-B2,"['Bruce H. Kenknight', 'Jeffrey L. Ardell', 'Imad Libbus', 'Badri Amurthur']",2016-08-09,12.0,Neurostimulation in a neural fulcrum zone for the treatment of chronic cardiac dysfunction,2014
600,"['California Institute of Technology', 'NEWMAN DIANNE K', 'HUNTER RYAN C', 'CALIFORNIA INST OF TECHN']","[{'id': 'grid.20861.3d', 'acronym': 'CIT', 'name': 'California Institute of Technology', 'country_name': 'United States'}]",Grant,2018.0,US-9926526-B2,"['Dianne K. Newman', 'Ryan C. HUNTER']",2018-03-27,1.0,Methods and system for interfering with viability of bacteria and related compounds and compositions,2012
601,"['Cyberonics Inc', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9504832-B2,"['Imad Libbus', 'Bruce H. Kenknight', 'Badri Amurthur', 'Scott R. Stubbs']",2016-11-29,3.0,Neurostimulation titration process via adaptive parametric modification,2014
602,"['Cyberonics Inc', 'LIBBUS IMAD', 'AMURTHUR BADRI', 'KENKNIGHT BRUCE H', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2013.0,US-8577458-B1,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight']",2013-11-05,63.0,Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with leadless heart rate monitoring,2011
603,"['Heptares Therapeutics Ltd', 'HEPTARES THERAPEUTICS LTD']","[{'id': 'grid.451116.6', 'name': 'Sosei Group Corporation (United Kingdom)', 'country_name': 'United Kingdom'}]",Grant,2018.0,US-9925178-B2,"['John Andrew Christopher', 'Miles Stuart Congreve', 'Sarah Joanne Bucknell', 'Francesca Deflorian', 'Mark Pickworth', 'Jonathan Stephen Mason']",2018-03-27,2.0,CGRP receptor antagonists,2017
604,"['Cyberonics Inc', 'LIBBUS IMAD', 'AMURTHUR BADRI', 'KENKNIGHT BRUCE H', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2013.0,US-8571654-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight']",2013-10-29,58.0,Vagus nerve neurostimulator with multiple patient-selectable modes for treating chronic cardiac dysfunction,2012
605,"['East Tennessee State University', 'Cyberonics Inc', 'CYBERONICS INC', 'UNIV TENNESSEE EAST']","[{'id': 'grid.255381.8', 'acronym': 'ETSU', 'name': 'East Tennessee State University', 'country_name': 'United States'}, {'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9272143-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight', 'Jeffrey L. Ardell']",2016-03-01,12.0,Responsive neurostimulation for the treatment of chronic cardiac dysfunction,2014
606,"['Ierfc European Institute For Cystic Fibrosis Research', 'I E R F C EUROP INST FOR CYSTIC FIBROSIS RES']","[{'id': 'grid.18887.3e', 'name': 'San Raffaele Hospital', 'country_name': 'Italy'}]",Application,,EP-2664326-A1,"['MAIURI, LUIGI', 'Raia, Valeria', 'BORELLA, FABIO', 'KROEMER, GUIDO']",2013-11-20,1.0,Combined therapy for cystic fibrosis,2012
607,"['Cyberonics Inc', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9643008-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight']",2017-05-09,,Implantable neurostimulator-implemented method for enhancing post-exercise recovery through vagus nerve stimulation,2012
608,"['MUSC Foundation for Research Development', 'MUSC FOUNDATION FOR RES DEVELOPMENT', 'MEDICAL UNIV OF SOUTH CAROLINA']","[{'id': 'grid.259828.c', 'acronym': 'MUSC', 'name': 'Medical University of South Carolina', 'country_name': 'United States'}]",Grant,2018.0,US-9879251-B2,"['Harold D. May', 'Christopher W. Marshall', 'Edward V. Labelle']",2018-01-30,,Microbial electrosynthetic cells,2013
609,"['East Tennessee State University', 'Cyberonics Inc', 'CYBERONICS INC', 'EAST TENNESSEE STATE UNIV']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}, {'id': 'grid.255381.8', 'acronym': 'ETSU', 'name': 'East Tennessee State University', 'country_name': 'United States'}]",Grant,2016.0,US-9446237-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight', 'Jeffrey L. Ardell']",2016-09-20,1.0,Responsive neurostimulation for the treatment of chronic cardiac dysfunction,2015
610,"['Cyberonics Inc', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9533153-B2,"['Imad Libbus', 'Bruce H. Kenknight', 'Badri Amurthur']",2017-01-03,5.0,Neurostimulation titration process,2014
611,"['Cyberonics Inc', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-8965522-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight']",2015-02-24,5.0,Implantable neurostimulator for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with bounded titration,2014
612,"['Cyberonics Inc', 'LIBBUS IMAD', 'AMURTHUR BADRI', 'KENKNIGHT BRUCE H', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8918191-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight']",2014-12-23,10.0,Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with bounded titration,2011
613,"['Livanova Usa Inc', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8923964-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight']",2014-12-30,13.0,Implantable neurostimulator-implemented method for enhancing heart failure patient awakening through vagus nerve stimulation,2012
614,"['AlderBio Holdings LLC', 'KOVACEVICH BRIAN ROBERT', 'GARCIA-MARTINEZ LEON F', 'OLSON KATIE', 'DUTZAR BENJAMIN H', 'BILLGREN JENS J', 'LATHAM JOHN A', 'MITCHELL DANIELLE M', 'MCNEILL PATRICIA DIANNE', 'JANSON NICOLE M', 'LOOMIS MARIA-CRISTINA', 'ALDERBIO HOLDINGS LLC']",,Grant,2017.0,US-9745373-B2,"['Brian Robert Kovacevich', 'Leon F. Garcia-Martinez', 'Katie Olson', 'Benjamin H. Dutzar', 'Jens J. Billgren', 'John A. Latham', 'Danielle M. Mitchell', 'Patricia Dianne McNeill', 'Nicole M. Janson', 'Maria-Cristina Loomis']",2017-08-29,5.0,Anti-CGRP compositions and use thereof,2012
615,"['Livanova Usa Inc', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10004903-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight']",2018-06-26,,Implantable neurostimulator-implemented method for enhancing heart failure patient awakening through vagus nerve stimulation,2017
616,"['East Tennessee State University', 'Cyberonics Inc', 'CYBERONICS INC', 'EAST TENNESSEE STATE UNIV']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}, {'id': 'grid.255381.8', 'acronym': 'ETSU', 'name': 'East Tennessee State University', 'country_name': 'United States'}]",Grant,2017.0,US-9669220-B2,"['Bruce H. Kenknight', 'Jeffrey L. Ardell', 'Imad Libbus', 'Badri Amurthur']",2017-06-06,3.0,Neurostimulation in a neural fulcrum zone for the treatment of chronic cardiac dysfunction,2016
617,"['University of Iowa Research Foundation (UIRF)', 'AlderBio Holdings LLC', 'RUSSO ANDREW F', 'KAISER ERIC A', 'RECOBER ANA', 'KUBURAS ADISA', 'RADDANT ANN C', 'KOVACEVICH BRIAN ROBERT', 'LATHAM JOHN A', 'SMITH JEFFREY T L', 'GARCIA-MARTINEZ LEON F', 'ALDERBIO HOLDINGS LLC']","[{'id': 'grid.214572.7', 'acronym': 'UI', 'name': 'University of Iowa', 'country_name': 'United States'}]",Grant,2017.0,US-9708393-B2,"['Andrew F. Russo', 'Eric A. Kaiser', 'Ana Recober', 'Adisa Kuburas', 'Ann C. Raddant', 'Brian Robert Kovacevich', 'John A. Latham', 'Jeffrey T. L. Smith', 'Leon F. Garcia-Martinez']",2017-07-18,5.0,"Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers",2012
618,"['Cyberonics Inc', 'LIBBUS IMAD', 'AMURTHUR BADRI', 'KENKNIGHT BRUCE H', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8918190-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight']",2014-12-23,42.0,Implantable device for evaluating autonomic cardiovascular drive in a patient suffering from chronic cardiac dysfunction,2011
619,"['University of Iowa Research Foundation (UIRF)', 'AlderBio Holdings LLC', 'RUSSO ANDREW F', 'KAISER ERIC A', 'RECOBER ANA', 'KUBURAS ADISA', 'RADDANT ANN C', 'KOVACEVICH BRIAN ROBERT', 'LATHAM JOHN A', 'SMITH JEFFREY T L', 'GARCIA-MARTINEZ LEON F', 'ALDERBIO HOLDINGS LLC']","[{'id': 'grid.214572.7', 'acronym': 'UI', 'name': 'University of Iowa', 'country_name': 'United States'}]",Grant,2018.0,US-9855332-B2,"['Andrew F. Russo', 'Eric A. Kaiser', 'Ana Recober', 'Adisa Kuburas', 'Ann C. Raddant', 'Brian Robert Kovacevich', 'John A. Latham', 'Jeffrey T. L. Smith', 'Leon F. Garcia-Martinez']",2018-01-02,5.0,Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels,2012
620,"['East Tennessee State University', 'Cyberonics Inc', 'CYBERONICS INC', 'EAST TENNESSEE STATE UNIV']","[{'id': 'grid.255381.8', 'acronym': 'ETSU', 'name': 'East Tennessee State University', 'country_name': 'United States'}, {'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9713719-B2,"['Bruce H. Kenknight', 'Imad Libbus', 'Badri Amurthur', 'Jeffrey L. Ardell']",2017-07-25,3.0,Fine resolution identification of a neural fulcrum for the treatment of chronic cardiac dysfunction,2014
621,"['Cyberonics Inc', 'LIBBUS IMAD', 'AMURTHUR BADRI', 'KENKNIGHT BRUCE H', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2013.0,US-8600505-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight']",2013-12-03,77.0,Implantable device for facilitating control of electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction,2011
622,"['Livanova Usa Inc', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9393419-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight']",2016-07-19,,Implantable neurostimulator-implemented method for enhancing heart failure patient awakening through vagus nerve stimulation,2014
623,"['Cyberonics Inc', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9643011-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight']",2017-05-09,,Implantable neurostimulator-implemented method for managing tachyarrhythmic risk during sleep through vagus nerve stimulation,2013
624,"['Heptares Therapeutics Ltd', 'HEPTARES THERAPEUTICS LTD']","[{'id': 'grid.451116.6', 'name': 'Sosei Group Corporation (United Kingdom)', 'country_name': 'United Kingdom'}]",Grant,2017.0,US-9808457-B2,"['John Andrew Christopher', 'Miles Stuart Congreve', 'Sarah Joanne Bucknell', 'Francesca Deflorian', 'Mark Pickworth', 'Jonathan Stephen Mason']",2017-11-07,2.0,CGRP receptor antagonists,2016
625,"['East Tennessee State University', 'Cyberonics Inc', 'CYBERONICS INC', 'EAST TENNESSEE STATE UNIV']","[{'id': 'grid.255381.8', 'acronym': 'ETSU', 'name': 'East Tennessee State University', 'country_name': 'United States'}, {'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9415224-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight', 'Jeffrey L. Ardell']",2016-08-16,4.0,Neurostimulation and recording of physiological response for the treatment of chronic cardiac dysfunction,2014
626,"['Cyberonics Inc', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9919157-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight']",2018-03-20,,Implantable neurostimulator-implemented method for managing bradycardia through vagus nerve stimulation,2014
627,"['Cyberonics Inc', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8923990-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight']",2014-12-30,5.0,Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with leadless heart rate monitoring,2013
628,"['Cyberonics Inc', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9526898-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight']",2016-12-27,1.0,Implantable neurostimulator for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with bounded titration,2015
629,"['Livanova Usa Inc', 'East Tennessee State University', 'CYBERONICS INC', 'EAST TENNESSEE STATE UNIV']","[{'id': 'grid.255381.8', 'acronym': 'ETSU', 'name': 'East Tennessee State University', 'country_name': 'United States'}, {'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9950169-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight', 'Jeffrey L. Ardell']",2018-04-24,3.0,Dynamic stimulation adjustment for identification of a neural fulcrum,2014
630,"['Cyberonics Inc', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9770599-B2,"['Imad Libbus', 'Bruce H. Kenknight', 'Badri Amurthur', 'Scott R. Stubbs']",2017-09-26,,Vagus nerve stimulation and subcutaneous defibrillation system,2014
631,"['East Tennessee State University', 'Cyberonics Inc', 'CYBERONICS INC', 'EAST TENNESSEE STATE UNIV']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}, {'id': 'grid.255381.8', 'acronym': 'ETSU', 'name': 'East Tennessee State University', 'country_name': 'United States'}]",Grant,2017.0,US-9808626-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight', 'Jeffrey L. Ardell']",2017-11-07,,Responsive neurostimulation for the treatment of chronic cardiac dysfunction,2016
632,"['Cyberonics Inc', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9764138-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight']",2017-09-19,,Implantable neurostimulator-implemented method for managing tachyarrhythmia through vagus nerve stimulation,2016
633,"['Heptares Therapeutics Ltd', 'HEPTARES THERAPEUTICS LTD']","[{'id': 'grid.451116.6', 'name': 'Sosei Group Corporation (United Kingdom)', 'country_name': 'United Kingdom'}]",Grant,2017.0,US-9688660-B2,"['John Andrew Christopher', 'Miles Stuart Congreve', 'Sarah Joanne Bucknell', 'Francesca Deflorian', 'Mark Pickworth', 'Jonathan Stephen Mason']",2017-06-27,3.0,CGRP receptor antagonists,2016
634,"['Cyberonics Inc', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8700150-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight']",2014-04-15,8.0,Implantable neurostimulator for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with bounded titration,2013
635,"['Cyberonics Inc', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9452290-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight']",2016-09-27,8.0,Implantable neurostimulator-implemented method for managing tachyarrhythmia through vagus nerve stimulation,2012
636,"['TRIFECTA BRACE PTY LTD', 'NICHOLAS MICHAEL', 'NICHOLSON-PERRY KATHRYN', 'NEWTON-JOHN TOBY', 'KETSIMUR CATHERINE']",,Application,,WO-2017147652-A1,"['NICHOLAS, MICHAEL', 'NICHOLSON-PERRY, Kathryn', 'NEWTON-JOHN, Toby', 'KETSIMUR, Catherine', 'COOLICAN, Myles Raphael James', 'MOLLOY, Allan Richard', 'ROGER, GREGORY JAMES']",2017-09-08,1.0,"PSYCHO-SOCIAL METHODS AND APPARATUS FOR: REHABILITATION, PRE-OPERATIVELY AND POST-OPERATIVELY TO ORTHOPAEDIC SURGERY",2017
637,"['Cyberonics Inc', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9511228-B2,"['Badri Amurthur', 'Imad Libbus', 'Bruce H. Kenknight']",2016-12-06,5.0,Implantable neurostimulator-implemented method for managing hypertension through renal denervation and vagus nerve stimulation,2014
638,"['Cyberonics Inc', 'CYBERONICS INC']","[{'id': 'grid.497533.f', 'name': 'LivaNova (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9114262-B2,"['Imad Libbus', 'Badri Amurthur', 'Bruce H. Kenknight']",2015-08-25,5.0,Implantable device for evaluating autonomic cardiovascular drive in a patient suffering from chronic cardiac dysfunction,2014
639,"['Evonik Degussa GmbH', 'EVONIK INDUSTRIES AG']","[{'id': 'grid.420017.0', 'name': 'Evonik (Germany)', 'country_name': 'Germany'}]",Application,,DE-102013214713-A1,"['Tim Köhler', 'Mike Farwick', 'Matthias Mentel', 'Peter Lersch']",2015-01-29,1.0,Formulations containing sphinganine,2013
640,"['Novartis AG', 'Scripps Research Institute', 'SCHULTZ PETER', 'LAIRSON LUKE', 'DESHMUKH VISHAL', 'LYSSIOTIS COSTAS', 'SCRIPPS RESEARCH INST', 'IRM LLC']","[{'id': 'grid.419481.1', 'name': 'Novartis (Switzerland)', 'country_name': 'Switzerland'}, {'id': 'grid.214007.0', 'acronym': 'TSRI', 'name': 'Scripps Research Institute', 'country_name': 'United States'}]",Grant,2017.0,US-9592288-B2,"['Peter Schultz', 'Luke Lairson', 'Vishal Deshmukh', 'Costas Lyssiotis']",2017-03-14,,Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate,2012
641,['FRAUNHOFER GES ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E V'],"[{'id': 'grid.4561.6', 'acronym': 'FHG', 'name': 'Fraunhofer Society', 'country_name': 'Germany'}]",Application,,WO-2014064040-A1,"['OHLANDER, ANNA', 'KLINK, GERHARD', 'BOCK, KARLHEINZ', 'RUSSOM, Arman']",2014-05-01,,SYSTEM FOR CARRYING OUT A CONTACTLESS MEASUREMENT ON A SAMPLE AND SAMPLE CARRIER,2013
642,"['Universita degli Studi di Roma La Sapienza', 'Università degli Studi di Roma “La Sapienza”', 'UNIV DEGLI STUDI DI ROMA “LA SAPIENZA”']","[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Grant,2017.0,US-9827292-B2,"['Cinzia Marchese', 'Simona Ceccarelli', 'Antonio Angeloni']",2017-11-28,,Use of KGF in the treatment of menopausal disorders,2013
643,"['GENENTECH INC', 'UNIV TEXAS']","[{'id': 'grid.418158.1', 'acronym': 'Roche', 'name': 'Roche (United States)', 'country_name': 'United States'}, {'id': 'grid.55460.32', 'acronym': 'UT System', 'name': 'The University of Texas System', 'country_name': 'United States'}]",Application,,WO-2017079399-A1,"['MERCHANT, MARK', 'SAMPATH, DEEPAK', 'KONOPLEVA, Marina Yurievna', 'HAN, Lina']",2017-05-11,,COMBINATION OF BCL-2 INHIBITOR AND MEK INHIBITOR FOR THE TREATMENT OF CANCER,2016
644,"['Evonik Degussa GmbH', 'EVONIK DEGUSSA GMBH']","[{'id': 'grid.420017.0', 'name': 'Evonik (Germany)', 'country_name': 'Germany'}]",Grant,2018.0,US-9913789-B2,"['Tim Köhler', 'Mike Farwick', 'Matthias Mentel', 'Peter Lersch']",2018-03-13,,Formulations containing sphinganine,2014
645,"['Universita degli Studi di Roma La Sapienza', 'UNIVERSIT DEGLI STUDI DI ROMA LA SAPIENZA']","[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Application,,US-20150224172-A1,"['Cinzia Marchese', 'Simona Ceccarelli', 'Antonio Angeloni']",2015-08-13,1.0,USE OF KGF IN THE TREATMENT OF MENOPAUSAL DISORDERS,2013
646,"['Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eV', 'FRAUNHOFER GES ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E V']","[{'id': 'grid.4561.6', 'acronym': 'FHG', 'name': 'Fraunhofer Society', 'country_name': 'Germany'}]",Application,,DE-102012219656-A1,"['Anna Ohlander', 'Gerhard Klink', 'Karlheinz Bock', 'Aman Russom']",2014-04-30,3.0,A system for carrying out a contactless measurement on a sample and a sample carrier,2012
647,['COUNCIL SCIENT IND RES'],"[{'id': 'grid.418099.d', 'acronym': 'CSIR', 'name': 'Council of Scientific and Industrial Research', 'country_name': 'India'}]",Application,,WO-2014080429-A1,"['DHAKATE, Sanjay Rangnath', 'KUMAR, RAJEEV', 'MATHUR, RAKESH BEHARI', 'SAINI, PARVEEN']",2014-05-30,4.0,LIGHT WEIGHT CARBON FOAM AS ELECTROMAGNETIC INTERFERENCE (EMI) SHIELDING AND THERMAL INTERFACE MATERIAL,2013
648,"['VIDA DIAGNOSTICS Inc', 'VIDA DIAGNOSTICS INC']","[{'id': 'grid.439134.8', 'name': 'Vida Diagnostics (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9504529-B2,"['Philippe Raffy', 'Youbing YIN']",2016-11-29,2.0,Treatment outcome prediction for lung volume reduction procedures,2014
649,"['PERFECT LITHIUM CORP', 'VERBUM LLC', 'NANO ONE MATERIALS CORP', 'NANO ONE MAT CORP']",,Grant,2017.0,US-9698419-B1,"['Teresita Frianeza-Kullberg', 'Lennart H. Kullberg']",2017-07-04,2.0,Complexometric precursor formulation methodology for industrial production of fine and ultrafine powders and nanopowders of layered lithium mixed metal oxides for battery applications,2014
650,"['Volant Holdings GmbH', 'FAYAD JOSEPH M', 'VOLANT HOLDINGS GMBH']",,Grant,2017.0,US-9757346-B2,['Joseph M. Fayad'],2017-09-12,4.0,Compositions and methods for treating insulin resistance and non-insulin dependent diabetes mellitus (type II diabetes),2011
651,"['TYME Inc', 'TYME INC']",,Grant,2018.0,US-9895425-B2,['Steven Hoffman'],2018-02-20,1.0,Pharmaceutical compositions and methods,2016
652,"['Perfect Lithium Corp', 'NANO ONE MATERIALS CORP', 'NANO ONE MATERIALS CORP']",,Grant,2015.0,US-9136534-B2,['Teresita Frianeza-Kullberg'],2015-09-15,,Complexometric precursors formulation methodology for industrial production of high performance fine and ultrafine powders and nanopowders for specialized applications,2013
653,"['TYME Inc', 'HOFFMAN STEVEN']",,Grant,2013.0,US-8481498-B1,['Steven Hoffman'],2013-07-09,10.0,Pharmaceutical compositions and methods,2012
654,"['Apple Inc', 'APPLE INC']","[{'id': 'grid.455360.1', 'name': 'Apple (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10084187-B2,"['Hongli Dai', 'Huiming Wu', 'Dapeng Wang']",2018-09-25,3.0,Cathode active materials having improved particle morphologies,2017
655,"['TIANJIN B&M SCIENCE AND TECHNOLOGY JOINT-STOCK Co Ltd', 'Wildcat Discovery Technologies Inc', 'Wildcat discovery technologies inc', 'TIANJIN B & M SCIENCE & TECHNOLOGY JOINT STOCK CO LTD']","[{'id': 'grid.450247.0', 'name': 'Wildcat Discovery Technologies (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9034516-B2,"['Bin Li', 'Wei Tong', 'Jen Hsien YANG']",2015-05-19,,Materials prepared by metal extraction,2014
656,"['Wildcat Discovery Technologies Inc', 'Wildcat discovery technologies inc']","[{'id': 'grid.450247.0', 'name': 'Wildcat Discovery Technologies (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8795887-B2,"['Marissa Caldwell', 'Steven Kaye', 'Wei Tong', 'David Keogh', 'Chen Zheng']",2014-08-05,,Materials prepared by metal extraction,2013
657,"['Agency for Science Technology and Research, Singapore', 'AGENCY SCIENCE TECH & RES']","[{'id': 'grid.185448.4', 'acronym': 'A*STAR', 'name': 'Agency for Science, Technology and Research', 'country_name': 'Singapore'}]",Grant,2017.0,US-9637724-B2,['Peter Gagnon'],2017-05-02,2.0,Selective binding of biological targets to solid phase ureides,2014
658,"['LG Chem Ltd', 'LG CHEMICAL LTD']","[{'id': 'grid.464630.3', 'name': 'LG Corporation (South Korea)', 'country_name': 'South Korea'}]",Grant,2018.0,US-9972834-B2,"['Woo-Yeon Kong', 'Myung-Ki Lee', 'Min-Suk Kang', 'Sun-Sik Shin', 'Hye-Lim Jeon', 'Chi-Ho Jo', 'Geun-Gi Min', 'Wang-Mo Jung']",2018-05-15,,Cathode active material for lithium secondary battery and method for manufacturing the same,2014
659,['CONSIGLIO NAZIONALE RICERCHE'],"[{'id': 'grid.5326.2', 'acronym': 'CNR', 'name': 'National Research Council', 'country_name': 'Italy'}]",Application,,WO-2016051340-A1,"['CECI, Pierpaolo', 'FALVO, Elisabetta']",2016-04-07,1.0,"A FUSION PROTEIN, A NANOPARTICLE COMPOSED BY A PLURALITY OF MONOMERS OF SAID FUSION PROTEIN, AND USES THEREOF",2015
660,"['Yamo Pharmaceuticals LLC', 'HOFFMAN STEVEN']",,Grant,2017.0,US-9763903-B2,['Steven Hoffman'],2017-09-19,,Compositions and methods for treating intestinal hyperpermeability,2016
661,"['LG Chem Ltd', 'LG CHEMICAL LTD']","[{'id': 'grid.464630.3', 'name': 'LG Corporation (South Korea)', 'country_name': 'South Korea'}]",Application,,EP-2897201-A4,"['KONG WOO-YEON', 'LEE MYUNG-KI', 'KANG MIN-SUK', 'SHIN SUN-SIK', 'JEON HYE-LIM', 'JO CHI-HO', 'MIN GEUN-GI', 'JUNG WANG-MO']",2016-05-25,,CATHODE ACTIVE MATERIAL FOR LITHIUM SECONDARY BATTERY AND MANUFACTURING METHOD THEREFOR,2014
662,"['Bristol Myers Squibb Co', 'SQUIBB BRISTOL MYERS CO']","[{'id': 'grid.419971.3', 'acronym': 'BMS', 'name': 'Bristol-Myers Squibb (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10023519-B2,"['Yan Shi', 'Ying Wang', 'Peter T. W. Cheng', 'Shung C. Wu']",2018-07-17,,Cyclobutane containing carboxylic acid GPR120 modulators,2015
663,['BOEHRINGER INGELHEIM INT'],"[{'id': 'grid.420061.1', 'name': 'Boehringer Ingelheim (Germany)', 'country_name': 'Germany'}]",Application,,WO-2017055291-A1,"['SOLCA, FLAVIO', 'WEYER-CZERNILOFSKY, ULRIKE', 'LEE, Jae, Cheol', 'RHO, Jin, Kyung']",2017-04-06,1.0,ANTICANCER COMBINATION THERAPY,2016
664,"['PERFECT LITHIUM CORP', 'NANO ONE MATERIALS CORP', 'NANO ONE CORP', 'NANO ONE MATERIALS CORP']",,Grant,2015.0,US-9159999-B2,['Teresita Frianeza-Kullberg'],2015-10-13,,Complexometric precursor formulation methodology for industrial production of fine and ultrafine powders and nanopowders for lithium metal oxides for battery applications,2013
665,['BABRAHAM INST'],"[{'id': 'grid.418195.0', 'name': 'Babraham Institute', 'country_name': 'United Kingdom'}]",Application,,WO-2017208001-A1,"['FRASER, PETER', 'SCHOENFELDER, Stefan', 'SPIVAKOV, Mikhail']",2017-12-07,,BIOMARKERS FOR PLATELET DISORDERS,2017
666,"['Google LLC', 'GOOGLE INC']","[{'id': 'grid.420451.6', 'name': 'Google', 'country_name': 'United States'}]",Application,,EP-2680191-A3,"['SIPE, MICHAEL', 'SCHNEIDERMAN, HENRY WILL', 'NECHYBA, MICHAEL']",2017-06-28,,Facial recognition,2013
667,"['TYME Inc', 'TYME INC']",,Grant,2017.0,US-9549969-B2,['Steven Hoffman'],2017-01-24,1.0,Pharmaceutical compositions and methods,2015
668,"['TYME Inc', 'TYME INC']",,Grant,2018.0,US-10010590-B2,['Steven Hoffman'],2018-07-03,1.0,Pharmaceutical compositions and methods,2016
669,['APPLE INC'],"[{'id': 'grid.455360.1', 'name': 'Apple (United States)', 'country_name': 'United States'}]",Application,,WO-2017160856-A1,"['WU, HUIMING', 'DAI, HONGLI', 'WANG, DAPENG', 'JOHNSON, CHRISTOPHER S.', 'CARTER, JOHN DAVID', 'CUI, Yanjie', 'GUTIERREZ, ARTURO', 'IDDIR, Hakim H.', 'KROPF, Jeremy', 'LI, YAN', 'MARONI, VICTOR A.', 'VU, Anh D.', 'WANG, XIAOPING', 'YANG, Zhenzhen']",2017-09-21,,CATHODE ACTIVE MATERIALS FOR LITHIUM-ION BATTERIES,2017
670,['APPLE INC'],"[{'id': 'grid.455360.1', 'name': 'Apple (United States)', 'country_name': 'United States'}]",Application,,WO-2017160851-A1,"['DAI, HONGLI', 'PADHI, AKSHAYA K.', 'WU, HUIMING', 'WANG, DAPENG', 'JOHNSON, CHRISTOPHER S.', 'CARTER, JOHN DAVID', 'BETTGE, MARTIN', 'KIRCOVA, Ana', 'LIN, CHI-KAI', 'SHIN, YOUNGHO', 'WANG, XIAOPING']",2017-09-21,,CATHODE ACTIVE MATERIALS FOR LITHIUM-ION BATTERIES,2017
671,"['TYME Inc', 'TYME INC']",,Grant,2017.0,US-9585841-B2,['Steven Hoffman'],2017-03-07,,Tyrosine derivatives and compositions comprising them,2013
672,['HOFFMAN STEVEN'],,Grant,2016.0,US-9326962-B2,['Steven Hoffman'],2016-05-03,4.0,Compositions and methods for treating intestinal hyperpermeability,2014
673,"['STEVEN HOFFMAN', 'HOFFMAN STEVEN', 'STEVEN HOFFMAN']",,Grant,2017.0,US-9757348-B2,['Steven Hoffman'],2017-09-12,,Composition and methods for treating intestinal hyperpermeability,2016
674,"['UNIV PONTIFICIA CATOLICA CHILE', 'GONZALEZ ALFONSO', 'SOZA ANDREA', 'METZ CLAUDIA']","[{'id': 'grid.7870.8', 'acronym': 'PUC', 'name': 'Pontifical Catholic University of Chile', 'country_name': 'Chile'}]",Application,,WO-2012135970-A1,"['GONZALEZ, ALFONSO', 'SOZA, Andrea', 'METZ, Claudia']",2012-10-11,,"INHIBITORS OF PHOSPHATIDIC ACID PHOSPHOHYDROLASE (PAP), INCLUDING D-PROPRANOLOL AND ANALOGS THEREOF, ALONE OR IN COMBINATION WITH DESIPRAMINE, FOR THE TREATMENT OF CANCERS THAT DEPEND ON THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), ONCOGENIC VARIANTS THEREOF AND OTHER MEMBERS OF THE ERBB/HER FAMILY",2012
675,"['THORAXKLINIK HEIDELBERG GmbH', 'THORAXKLINIK HEIDELBERG GMBH']","[{'id': 'grid.5253.1', 'name': 'University Hospital Heidelberg', 'country_name': 'Germany'}]",Application,,EP-2982765-A1,"['SCHNEIDER, MARC', 'MEISTER, MICHAEL', 'MULEY, THOMAS']",2016-02-10,,Glycodelin as diagnostic and prognostic marker and for monitoring treatment of lung diseases,2014
676,"['Yamo Pharmaceuticals LLC', 'HOFFMAN STEVEN']",,Grant,2018.0,US-10085959-B2,['Steven Hoffman'],2018-10-02,,Compositions and methods for treating intestinal hyperpermeability,2017
677,"['Bristol Myers Squibb Co', 'SQUIBB BRISTOL MYERS CO']","[{'id': 'grid.419971.3', 'acronym': 'BMS', 'name': 'Bristol-Myers Squibb (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-8962660-B2,"['Hao Zhang', 'Peter T. W. Cheng', 'Sean Chen', 'Shiwei Tao', 'Shung C. Wu', 'Lidet A Negash']",2015-02-24,5.0,Oxabicyclo [2.2.2] acid GPR120 modulators,2014
678,['PLATT ADAM'],,Application,,WO-2015112619-A1,"['PLATT, ADAM']",2015-07-30,6.0,METHODS AND SYSTEMS FOR DETECTING GENETIC MUTATIONS,2015
679,"['Yamo Pharmaceuticals LLC', 'HOFFMAN STEVEN']",,Grant,2016.0,US-9308188-B2,['Steven Hoffman'],2016-04-12,1.0,Compositions and methods for treating intestinal hyperpermeability,2015
680,['FOND ST ITALIANO DI TECNOLOGIA'],,Application,,WO-2017060407-A1,"['CAPIGLIA, Claudio', 'PROIETTI ZACCARIA, Remo', 'GORIPARTI, Subrahmanyam', 'MIELE, Ermanno', 'DE ANGELIS, FRANCESCO']",2017-04-13,,DIRECT SYNTHESIS OF CARBON DOPED TiO2-BRONZE NANOSTRUCTURES AS ANODE MATERIALS FOR HIGH PERFORMANCE LITHIUM BATTERIES,2016
681,"['Radiant Opto Electronics Corp', 'RADIANT OPTO-ELECTRONICS CORP']",,Grant,2016.0,US-9432157-B2,"['Jon-Hong LIN', 'Chun-Yi SUN']",2016-08-30,,Adaptive control system and method,2014
682,['UNIV JOSEPH FOURIER'],"[{'id': 'grid.9621.c', 'acronym': 'UJF', 'name': 'Joseph Fourier University', 'country_name': 'France'}]",Application,,WO-2016034828-A1,"['DEMEILLIERS-DARBLADE, Christine, Arlette', 'OUNNAS, Faycal', 'DE LORGERIL, MICHEL', 'SALEN, PATRICIA']",2016-03-10,,TREATMENT OF HEPATIC AND CEREBELLAR TOXICITY INDUCED BY AT LEAST ONE POLLUTANT,2015
683,"['Nanyang Technological University', 'UNIV NANYANG TECH']","[{'id': 'grid.59025.3b', 'acronym': 'NTU', 'name': 'Nanyang Technological University', 'country_name': 'Singapore'}]",Grant,2018.0,US-9966726-B2,"['Guichuan Xing', 'Nripan Mathews', 'Subodh Gautam Mhaisalkar', 'Tze Chien Sum']",2018-05-08,,Emission source and method of forming the same,2014
684,"['Institut Of Batteries LLC', 'INST OF BATTERIES LLC']",,Application,,EP-3128580-A1,"['BAKENOV, Zhumabay', 'HARA, TORU', 'KURMANBAYEVA, Indira', 'MENTBAYEVA, Almagul', 'KONAROV, Aishuak']",2017-02-08,,LITHIUM METAL FREE SILICON/SULFUR BATTERY,2015
685,['DANA FARBER CANCER INST INC'],"[{'id': 'grid.65499.37', 'name': 'Dana-Farber Cancer Institute', 'country_name': 'United States'}]",Application,,WO-2013055911-A1,"['DEPINHO, RONALD, A.', 'PAIK, JI-HYE']",2013-04-18,,ZNF365/ZFP365 BIOMARKER PREDICTIVE OF ANTI-CANCER RESPONSE,2012
686,"['New York University', 'TORRES VICTOR J', 'ALONZO III FRANCIS', 'UNIV NEW YORK']","[{'id': 'grid.137628.9', 'acronym': 'NYU', 'name': 'New York University', 'country_name': 'United States'}]",Grant,2017.0,US-9783597-B2,"['Victor J. Torres', 'Francis ALONZO, III']",2017-10-10,,Methods of treating and preventing Staphylococcus aureus infections and associated conditions,2016
687,"['University of North Carolina at Chapel Hill', 'Dartmouth College', 'DARTMOUTH COLLEGE', 'UNIV NORTH CAROLINA CHAPEL HILL']","[{'id': 'grid.254880.3', 'name': 'Dartmouth College', 'country_name': 'United States'}, {'id': 'grid.10698.36', 'acronym': 'UNC', 'name': 'University of North Carolina at Chapel Hill', 'country_name': 'United States'}]",Grant,2017.0,US-9796985-B2,"['G. Eric Schaller', 'Hyo-Jung Kim', 'Joseph Kieber']",2017-10-24,,Compositions and method for modulating the sensitivity of plants to cytokinin,2014
688,"['Signal Pharmaceuticals LLC', 'SIGNAL PHARM LLC']","[{'id': 'grid.418722.a', 'acronym': 'Celgene', 'name': 'Celgene (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9783505-B2,"['Patrick Papa', 'Brian Edwin Cathers', 'Andrew Antony Calabrese', 'Brandon Wade Whitefield', 'Brydon Bennett', 'Daniel CASHION', 'Deborah Mortensen', 'Dehua Huang', 'Eduardo Torres', 'Jason Parnes', 'John Sapienza', 'Joshua Hansen', 'Katerina Leftheris', 'Matthew CORREA', 'Maria Mercedes DELGADO', 'Raj K. Raheja', 'Sogole Bahmanyar', 'Sayee Hegde', 'Stephen Norris', 'Veronique Plantevin-Krenitsky']",2017-10-10,,"Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith",2016
689,"['New York University', 'TORRES VICTOR J', 'ALONZO III FRANCIS', 'UNIV NEW YORK']","[{'id': 'grid.137628.9', 'acronym': 'NYU', 'name': 'New York University', 'country_name': 'United States'}]",Grant,2016.0,US-9481723-B2,"['Victor J. Torres', 'Francis ALONZO, III']",2016-11-01,,Methods of treating and preventing Staphylococcus aureus infections and associated conditions,2015
690,"['Nanyang Technological University', 'UNIV NANYANG TECH']","[{'id': 'grid.59025.3b', 'acronym': 'NTU', 'name': 'Nanyang Technological University', 'country_name': 'Singapore'}]",Grant,2018.0,US-9899793-B2,"['Guichuan Xing', 'Nripan Mathews', 'Subodh Gautam Mhaisalkar', 'Tze Chien Sum']",2018-02-20,,Emission source and method of forming the same,2016
691,"['Emory University', 'YOON YOUNG-SUP', 'CHENG XIAODONG', 'HAN JI WOONG', 'MAI ANTONELLO', 'UNIV EMORY']","[{'id': 'grid.189967.8', 'name': 'Emory University', 'country_name': 'United States'}]",Grant,2016.0,US-9458131-B2,"['Young-Sup Yoon', 'Xiaodong Cheng', 'Ji Woong Han', 'Antonello Mai']",2016-10-04,2.0,Compounds and compositions used to epigenetically transform cells and methods related thereto,2012
692,['SOFAR SPA'],"[{'id': 'grid.488371.1', 'name': 'Sofar (Italy)', 'country_name': 'Italy'}]",Application,,WO-2015162570-A1,"['BIFFI, Andrea']",2015-10-29,1.0,TOPICAL COMPOSITION FOR USE IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE,2015
693,"['Universita degli Studi di Roma La Sapienza', 'Università degli Studi di Roma “La Sapienza”', 'UNIV DEGLI STUDI DI ROMA “LA SAPIENZA”']","[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Grant,2017.0,US-9717170-B2,"['Maria Sabrina Sarto', 'Giovanni DE BELLIS', 'Alessio Tamburrano', ""Alessandro Giuseppe D'ALOIA""]",2017-07-25,,Graphene nanoplatelets- or graphite nanoplatelets-based nanocomposites for reducing electromagnetic interferences,2013
694,"['Arctic Robotics Oy', 'ARCTIC ROBOTICS OY']",,Application,,EP-3312560-A1,"['Oksanen, Niko', 'Isoaho, Pauli', 'Smital, Petr', 'Mai Vinh, Nguyen', 'Vassilyev, Artem', 'AHMAD, BILAL']",2018-04-25,,METHOD AND SYSTEM FOR INDOOR NAVIGATION,2016
695,"['Administrators of the Tulane Educational Fund', 'REIMERS ROBERT S', 'ENGLANDE JR ANDREW J', 'MURRAY NORMAN K', 'XU YUE', 'UNIV TULANE']","[{'id': 'grid.265219.b', 'name': 'Tulane University', 'country_name': 'United States'}]",Grant,2015.0,US-9199885-B2,"['Robert S. Reimers', 'Andrew J. ENGLANDE, JR.', 'Norman K. Murray', 'Yue Xu']",2015-12-01,,Utilization of iron salts to stabilize and/or disinfect biosolids,2014
696,"['Toshiba Corp', 'TOSHIBA KK']","[{'id': 'grid.410825.a', 'name': 'Toshiba (Japan)', 'country_name': 'Japan'}]",Application,,EP-2852062-A3,"['FUNAKI, HIDEYUKI', 'KIMURA, SHUNSUKE', 'Kawata, Go', 'ITAKURA, TETSURO', 'FURUTA, MASANORI']",2015-05-27,,Signal processing device and signal processing method,2014
697,"['HELMUT-SCHMIDT-UNIVERSITAT', 'Hamburg Innovation GmbH', 'Helmut Schmidt Universitat', 'HELMUT SCHMIDT UNIVERSITÄT', 'HAMBURG INNOVATION GMBH']","[{'id': 'grid.49096.32', 'acronym': 'HSU', 'name': 'Helmut Schmidt University', 'country_name': 'Germany'}]",Application,,EP-3081957-A1,"['Seeland, Felix', 'FRICK, KLAUS', 'Alpen, Mirco', 'HORN, JOACHIM']",2016-10-19,,SENSOR DEVICE WITH OPTO-ELECTRONIC SENSOR AND MEASURING RANGE EXTENSION,2016
698,['UNIVERSIT DEGLI STUDI DI ROMA LA SAPIENZA'],"[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Application,,WO-2014061048-A2,"['SARTO, MARIA SABRINA', 'DE BELLIS, Giovanni', 'TAMBURRANO, ALESSIO', ""D'ALOIA, Alessandro Giuseppe""]",2014-04-24,7.0,GNP-BASED POLYMERIC NANOCOMPOSITES FOR REDUCING ELECTROMAGNETIC INTERFERENCES,2013
699,"['Signal Pharmaceuticals LLC', 'SIGNAL PHARM LLC']","[{'id': 'grid.418722.a', 'acronym': 'Celgene', 'name': 'Celgene (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9156798-B2,"['Sogole Bahmanyar', 'Andrew Antony Calabrese', 'Daniel CASHION', 'Brian Edwin Cathers', 'Matthew CORREA', 'Maria Mercedes DELGADO', 'Joshua Hansen', 'Sayee Hegde', 'Dehua Huang', 'Katerina Leftheris', 'Deborah Mortensen', 'Stephen Norris', 'Patrick Papa', 'Jason Parnes', 'Veronique Plantevin-Krenitsky', 'Raj Kumar Raheja', 'John Sapienza', 'Eduardo Torres', 'Brandon Wade Whitefield']",2015-10-13,3.0,"Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith",2015
700,"['Idorsia Pharmaceuticals Ltd', 'ACTELION PHARMACEUTICALS LTD']","[{'id': 'grid.417650.1', 'name': 'Actelion (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2016.0,US-9266876-B2,"['Eva Caroff', 'Marcel Keller', 'Thierry Kimmerlin', 'Emmanuel Meyer']",2016-02-23,4.0,4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives,2013
701,['UNIVERSIT DEGLI STUDI DI ROMA LA SAPIENZA'],"[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Application,,WO-2014061048-A3,"['SARTO, MARIA SABRINA', 'DE BELLIS, Giovanni', 'TAMBURRANO, ALESSIO', ""D'ALOIA, Alessandro Giuseppe""]",2014-06-12,,GRAPHENE NANOPLATELETS- OR GRAPHITE NANOPLATELETS-BASED NANOCOMPOSITES FOR REDUCING ELECTROMAGNETIC INTERFERENCES,2013
702,['ARCTIC ROBOTICS OY'],,Application,,WO-2018073396-A1,"['Oksanen, Niko', 'Isoaho, Pauli', 'Smital, Petr', 'Mai Vinh, Nguyen', 'Vassilyev, Artem', 'AHMAD, BILAL']",2018-04-26,,METHOD AND SYSTEM FOR INDOOR NAVIGATION,2017
703,"['Radiant Opto Electronics Corp', 'RADIANT OPTO ELECTRONICS CORP']",,Application,,EP-2849399-A1,"['Lin, Jon-Hong', 'Sun, Chun-Yi']",2015-03-18,,Adaptive control system and method,2014
704,"['Canon Medical Systems Corp', 'TOSHIBA KK']","[{'id': 'grid.410825.a', 'name': 'Toshiba (Japan)', 'country_name': 'Japan'}]",Grant,2015.0,US-9160939-B2,"['Hideyuki Funaki', 'Shunsuke Kimura', 'Go KAWATA', 'Tetsuro Itakura', 'Masanori Furuta']",2015-10-13,16.0,Signal processing device and signal processing method,2014
705,"['Signal Pharmaceuticals LLC', 'SIGNAL PHARM LLC']","[{'id': 'grid.418722.a', 'acronym': 'Celgene', 'name': 'Celgene (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9556126-B2,"['Patrick Papa', 'Brian Edwin Cathers', 'Andrew Antony Calabrese', 'Brandon Wade Whitefield', 'Brydon Bennett', 'Daniel CASHION', 'Deborah Mortensen', 'Dehua Huang', 'Eduardo Torres', 'Jason Parnes', 'John Sapienza', 'Joshua Hansen', 'Katerina Leftheris', 'Matthew CORREA', 'Maria Mercedes DELGADO', 'Raj K. Raheja', 'Sogole Bahmanyar', 'Sayee Hegde', 'Stephen Norris', 'Veronique Plantevin-Krenitsky']",2017-01-31,3.0,"Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith",2014
706,"['PERFECT LITHIUM CORP', 'VERBUM LLC', 'NANO ONE MATERIALS CORP', 'NANO ONE MAT CORP']",,Grant,2017.0,US-9698419-B1,"['Teresita Frianeza-Kullberg', 'Lennart H. Kullberg']",2017-07-04,2.0,Complexometric precursor formulation methodology for industrial production of fine and ultrafine powders and nanopowders of layered lithium mixed metal oxides for battery applications,2014
707,"['Perfect Lithium Corp', 'NANO ONE MATERIALS CORP', 'NANO ONE MATERIALS CORP']",,Grant,2015.0,US-9136534-B2,['Teresita Frianeza-Kullberg'],2015-09-15,,Complexometric precursors formulation methodology for industrial production of high performance fine and ultrafine powders and nanopowders for specialized applications,2013
708,['UNIV YORK'],"[{'id': 'grid.5685.e', 'name': 'University of York', 'country_name': 'United Kingdom'}]",Application,,WO-2014083332-A1,"['COLLINS, MATTHEW JAMES', 'FIDDYMENT, Sarah Susana']",2014-06-05,,DRY EXTRACTION OF BIOMOLECULES USING A SOLID PHASE CHARGE CAPTURE MATRIX,2013
709,"['Cedars-Sinai Medical Center', 'CEDARS-SINAI MEDICAL CENTER']","[{'id': 'grid.50956.3f', 'name': 'Cedars-Sinai Medical Center', 'country_name': 'United States'}]",Grant,2017.0,US-9763999-B2,"['Eduardo Marban', 'Hee Cheol Cho']",2017-09-19,,Transcription factor-based generation of pacemaker cells and methods of using same,2012
710,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'LUTJENS ROBERT JOHANNES', 'FINN PATRICK TERRY', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8722894-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lutjens', 'Patrick Terry Finn']",2014-05-13,,"1,3-disubstituted-4-phenyl-1H-pyridin-2-ones",2008
711,"['Pangu Biopharma Ltd', 'ATyr Pharma Inc', 'CHIANG KYLE P', 'WATKINS JEFFRY DEAN', 'VASSEROT ALAIN PHILIPPE', 'QUINN CHERYL L', 'MENDLEIN JOHN D', 'LO WING-SZE', 'HONG FEI', 'GREENE LESLIE ANN', 'ATYR PHARMA INC', 'PANGU BIOPHARMA LTD']","[{'id': 'grid.427548.8', 'name': 'aTyr Pharma (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-8961960-B2,"['Kyle P. Chiang', 'Jeffry Dean Watkins', 'Alain Philippe Vasserot', 'Cheryl L. Quinn', 'John D. Mendlein', 'Wing-Sze Lo', 'Fei Hong', 'Leslie Ann Greene']",2015-02-24,10.0,"Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases",2011
712,"['HOFFMANN LA ROCHE', 'HOFFMANN LA ROCHE', 'UNIVERSITAETSKLINIKUM ULM', 'UNIV ZU KOELN']","[{'id': 'grid.410712.1', 'name': 'University Hospital Ulm', 'country_name': 'Germany'}, {'id': 'grid.6190.e', 'name': 'University of Cologne', 'country_name': 'Germany'}, {'id': 'grid.418158.1', 'acronym': 'Roche', 'name': 'Roche (United States)', 'country_name': 'United States'}, {'id': 'grid.417570.0', 'name': 'Roche (Switzerland)', 'country_name': 'Switzerland'}]",Application,,WO-2014068133-A1,"['HALLEK, MICHAEL', 'STILGENBAUER, STEPHAN', 'DÖHNER, Hartmut', 'KLEIN, CHRISTIAN', 'UMAÑA, Pable']",2014-05-08,,PREDICTIVE MARKER FOR CANCER TREATMENT,2013
713,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8691813-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald']",2014-04-08,,Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors,2009
714,"['UCL BUSINESS PLC', 'IANNETTI GIANDOMENICO']","[{'id': 'grid.83440.3b', 'acronym': 'UCL', 'name': 'University College London', 'country_name': 'United Kingdom'}]",Application,,WO-2013140106-A1,"['IANNETTI, Giandomenico']",2013-09-26,3.0,METHOD AND DEVICE FOR OBJECTIVE PAIN MEASUREMENT,2012
715,"['Pangu Biopharma Ltd', 'ATyr Pharma Inc', 'ATYR PHARMA INC', 'PANGU BIOPHARMA LTD']","[{'id': 'grid.427548.8', 'name': 'aTyr Pharma (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9896515-B2,"['Leslie Ann Greene', 'Kyle P. Chiang', 'Fei Hong', 'Alain P. Vasserot', 'Wing-Sze Lo', 'Jeffry D. Watkins', 'Cheryl L. Quinn', 'John D. Mendlein']",2018-02-20,,"Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases",2016
716,"['Lu Ru Band', 'LU RU BAND']",,Grant,2018.0,US-9925179-B2,['Ru-Band Lu'],2018-03-27,,Combination therapy for mental disorders,2017
717,"['PERFECT LITHIUM CORP', 'NANO ONE MATERIALS CORP', 'NANO ONE CORP', 'NANO ONE MATERIALS CORP']",,Grant,2015.0,US-9159999-B2,['Teresita Frianeza-Kullberg'],2015-10-13,,Complexometric precursor formulation methodology for industrial production of fine and ultrafine powders and nanopowders for lithium metal oxides for battery applications,2013
718,"['Cedars-Sinai Medical Center', 'CEDARS SINAI MEDICAL CENTER']","[{'id': 'grid.50956.3f', 'name': 'Cedars-Sinai Medical Center', 'country_name': 'United States'}]",Application,,EP-2776071-A4,"['MARBAN EDUARDO', 'CHO HEE CHEOL']",2015-07-29,,TRANSCRIPTION FACTOR-BASED GENERATION OF PACEMAKER CELLS AND METHODS OF USING SAME,2012
719,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8697689-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez']",2014-04-15,1.0,Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors,2009
720,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'LUTJENS ROBERT JOHANNES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-9067891-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lutjens']",2015-06-30,,"1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mGluR2-receptors",2012
721,"['Novartis AG', 'MPOFU SHEPHARD', 'RICHARDS HANNO', 'THANGAVELU KARTHINATHAN', 'MACHACEK MATTHIAS', 'NOVARTIS AG']","[{'id': 'grid.419481.1', 'name': 'Novartis (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2017.0,US-9744234-B2,"['Shephard Mpofu', 'Hanno Richards', 'Karthinathan Thangavelu', 'Matthias Machacek']",2017-08-29,,Methods of treating ankylosing spondylitis using IL-17 antagonists,2011
722,"['National Cheng Kung University', 'DCB-USA LLC', 'DCB USA LLC', 'UNIV NAT CHENG KUNG']","[{'id': 'grid.64523.36', 'acronym': 'NCKU', 'name': 'National Cheng Kung University', 'country_name': 'Taiwan'}]",Application,,EP-2964237-A4,"['HSIEH PATRICK CHING-HO', 'LAI CHIA-YUN']",2016-11-30,,METHODS FOR MAINTAINING POPULATION OF THERAPEUTIC CELLS IN TREATMENT SITE OF SUBJECT IN NEED OF CELL THERAPY,2014
723,"['NOVARTIS AG', 'JIRICEK JAN', 'KONDREDDI RAVINDER REDDY', 'SMITH PAUL WILLIAM']","[{'id': 'grid.419481.1', 'name': 'Novartis (Switzerland)', 'country_name': 'Switzerland'}]",Application,,WO-2014037900-A1,"['JIRICEK, JAN', 'KONDREDDI, RAVINDER REDDY', 'SMITH, PAUL WILLIAM']",2014-03-13,3.0,INDOLE CARBOXAMIDE DERIVATIVES AND USES THEREOF,2013
724,"['Novartis AG', 'JIRICEK JAN', 'KONDREDDI RAVINDER REDDY', 'SMITH PAUL WILLIAM', 'NOVARTIS AG']","[{'id': 'grid.419481.1', 'name': 'Novartis (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2016.0,US-9447039-B2,"['Jan Jiricek', 'Ravinder Reddy KONDREDDI', 'Paul William Smith']",2016-09-20,,Indole carboxamide derivatives and uses thereof,2013
725,"['Pangu Biopharma Ltd', 'ATyr Pharma Inc', 'ATYR PHARMA INC', 'PANGU BIOPHARMA LTD', 'ATYR PHARMA INC']","[{'id': 'grid.427548.8', 'name': 'aTyr Pharma (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9528103-B2,"['Leslie Ann Greene', 'Kyle P. Chiang', 'Fei Hong', 'Alain P. Vasserot', 'Wing-Sze Lo', 'Jeffry D. Watkins', 'Cheryl L. Quinn', 'John D. Mendlein']",2016-12-27,1.0,"Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases",2015
726,['QUALCOMM INC'],"[{'id': 'grid.430388.4', 'name': 'Qualcomm (United States)', 'country_name': 'United States'}]",Application,,WO-2014074890-A1,"['SONG, BONGYONG', 'CHAKRABORTY, KAUSHIK', 'SOLIMAN, SAMIR SALIB']",2014-05-15,,NETWORK LISTEN WITH SELF INTERFERENCE CANCELLATION,2013
727,"['Qualcomm Inc', 'PATEL CHIRAG SURESHBHAI', 'YAVUZ MEHMET', 'MAKH VANSH PAL SINGH', 'BLESSENT LUCA', 'MESHKATI FARHAD', 'QUALCOMM INC']","[{'id': 'grid.430388.4', 'name': 'Qualcomm (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9392562-B2,"['Chirag Sureshbhai Patel', 'Mehmet Yavuz', 'Vansh Pal Singh Makh', 'Luca Blessent', 'Farhad Meshkati']",2016-07-12,2.0,Idle access terminal-assisted time and/or frequency tracking,2010
728,"['Qualcomm Inc', 'SONG BONGYONG', 'CHAKRABORTY KAUSHIK', 'SOLIMAN SAMIR SALIB', 'QUALCOMM INC']","[{'id': 'grid.430388.4', 'name': 'Qualcomm (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9155057-B2,"['Bongyong SONG', 'Kaushik Chakraborty', 'Samir Salib Soliman']",2015-10-06,,Femtocell synchronization enhancements using access probes from cooperating mobiles,2012
729,"['Qualcomm Inc', 'SOLIMAN SAMIR SALIB', 'AWONIYI OLUFUNMILOLA O', 'CHAKRABORTY KAUSHIK', 'QUALCOMM INC']","[{'id': 'grid.430388.4', 'name': 'Qualcomm (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9271248-B2,"['Samir Salib Soliman', 'Olufunmilola O. Awoniyi', 'Kaushik Chakraborty']",2016-02-23,,System and method for timing and frequency synchronization by a Femto access point,2011
730,"['Qualcomm Inc', 'SOLIMAN SAMIR S', 'AWONIYI OLUFUNMILOLA O', 'QUALCOMM INC']","[{'id': 'grid.430388.4', 'name': 'Qualcomm (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9756553-B2,"['Samir S. Soliman', 'Olufunmilola O. Awoniyi']",2017-09-05,4.0,System and method for assisted network acquisition and search updates,2010
731,"['Qualcomm Inc', 'QUALCOMM INC']","[{'id': 'grid.430388.4', 'name': 'Qualcomm (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9237530-B2,"['Bongyong SONG', 'Kaushik Chakraborty', 'Samir Salib Soliman']",2016-01-12,,Network listen with self interference cancellation,2012
732,"['Fujitsu Ltd', 'FUJITSU LTD']","[{'id': 'grid.418251.b', 'name': 'Fujitsu (Japan)', 'country_name': 'Japan'}]",Application,,EP-3038399-A4,"['OYAMA TEPPEI', 'SHIMOMURA TSUYOSHI']",2016-08-24,,"RADIO COMMUNICATION METHOD, RADIO COMMUNICATION SYSTEM, RADIO TERMINAL, RADIO BASE STATION, AND CONTROL APPARATUS",2013
733,"['Commissariat a l Energie Atomique et aux Energies Alternatives', 'COMMISSARIAT ENERGIE ATOMIQUE', 'COMMISSARIAT À L ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES']","[{'id': 'grid.5583.b', 'acronym': 'CEA', 'name': 'Atomic Energy and Alternative Energies Commission', 'country_name': 'France'}]",Grant,2015.0,US-9220109-B2,"['Emilio Calvanese Strinati', 'Antonio DE DOMENICO', 'Jessica OUEIS']",2015-12-22,,Method for modifying the state of local access points in a cellular network,2014
734,"['Ecole Polytechnique Federale de Lausanne (EPFL)', 'Massachusetts Eye and Ear Infirmary', 'MASSACHUSETTS EYE & EAR INFIRMARY', 'ECOLE POLYTECHNIQUE FED LAUSANNE EPFL']","[{'id': 'grid.5333.6', 'acronym': 'EPFL', 'name': 'Swiss Federal Institute of Technology in Lausanne', 'country_name': 'Switzerland'}, {'id': 'grid.39479.30', 'name': 'Massachusetts Eye and Ear Infirmary', 'country_name': 'United States'}]",Grant,2018.0,US-10022042-B2,"['Konstantina Stankovic', 'Demetri Psaltis', 'Xin Yang', 'Ye Pu', 'Chia-Lung Hsieh']",2018-07-17,,Tissue and cellular imaging,2012
735,"['VKR Holding AS', 'VKR HOLDING AS']","[{'id': 'grid.480440.c', 'name': 'VKR Holding (Denmark)', 'country_name': 'Denmark'}]",Application,,EP-2717644-A1,"['NIELSEN, MARTIN SANDAL']",2014-04-09,3.0,Robust wireless building automation,2013
736,['UNIV OF DUNDEE'],"[{'id': 'grid.8241.f', 'name': 'University of Dundee', 'country_name': 'United Kingdom'}]",Application,,WO-2016193718-A1,"['CIŽMÁR, Tomáš']",2016-12-08,,IMPROVEMENTS RELATING TO MULTIMODE OPTICAL FIBRES,2016
737,"['Citizen Holdings Co Ltd', 'CITIZEN HOLDINGS CO LTD']","[{'id': 'grid.471098.3', 'name': 'Citizen (Japan)', 'country_name': 'Japan'}]",Application,,EP-2940499-A4,"['KATO SEIKO', 'IDE MASAFUMI']",2016-08-24,,OPTICAL ELEMENT,2013
738,"['Citizen Holdings Co Ltd', 'CITIZEN HOLDINGS CO LTD']","[{'id': 'grid.471098.3', 'name': 'Citizen (Japan)', 'country_name': 'Japan'}]",Grant,2016.0,US-9448360-B2,"['Seiko Kato', 'Masafumi Ide']",2016-09-20,,Optical element,2013
739,"['Ohio State University', 'UNIV OHIO STATE']","[{'id': 'grid.261331.4', 'acronym': 'OSU', 'name': 'The Ohio State University', 'country_name': 'United States'}]",Grant,2015.0,US-9057068-B1,"['Albert de la Chapelle', 'Ann-Kathrin Eisfeld']",2015-06-16,,Methods and compositions using miR-3151 in the diagnosis and treatment of cancer,2013
740,"['Qualcomm Inc', 'PATEL CHIRAG SURESHBHAI', 'YAVUZ MEHMET', 'MAKH VANSH PAL SINGH', 'BLESSENT LUCA', 'MESHKATI FARHAD', 'QUALCOMM INC']","[{'id': 'grid.430388.4', 'name': 'Qualcomm (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9642105-B2,"['Chirag Sureshbhai Patel', 'Mehmet Yavuz', 'Vansh Pal Singh Makh', 'Luca Blessent', 'Farhad Meshkati']",2017-05-02,1.0,Access terminal-assisted time and/or frequency tracking,2010
741,"['Qualcomm Inc', 'NAGARAJA SUMEETH', 'YAVUZ MEHMET', 'RADULESCU ANDREI D', 'SINGH DAMANJIT', 'CHEN JEN M', 'RAUBER PETER H', 'GHOLMIEH AZIZ', 'NANDA SANJIV', 'ZHAO LIJUN', 'QUALCOMM INC']","[{'id': 'grid.430388.4', 'name': 'Qualcomm (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9204349-B2,"['Sumeeth Nagaraja', 'Mehmet Yavuz', 'Andrei D. Radulescu', 'Damanjit Singh', 'Jen M. Chen', 'Peter H. Rauber', 'Aziz Gholmieh', 'Sanjiv Nanda', 'Lijun Zhao']",2015-12-01,6.0,Method and apparatus for facilitating a hand-in of user equipment to femto cells,2010
742,"['Commissariat a l Energie Atomique et aux Energies Alternatives', 'COMMISSARIAT L ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES']","[{'id': 'grid.5583.b', 'acronym': 'CEA', 'name': 'Atomic Energy and Alternative Energies Commission', 'country_name': 'France'}]",Application,,EP-2763469-A1,"['CALVANESE STRINATI, EMILIO', 'DE DOMENICO, ANTONIO', 'Oueis, Jessica']",2014-08-06,,Method for modifying the status of local access points in a cellular network,2014
743,['CROMA PHARMA GES M B H'],"[{'id': 'grid.476241.2', 'name': 'Croma Pharma (Austria)', 'country_name': 'Austria'}]",Application,,WO-2018083326-A1,"['PRINZ, MARTIN', 'HOFFER, MARTIN']",2018-05-11,,HYDROGEN SULFIDE RELEASING POLYMER COMPOUNDS,2017
744,"['SRC Inc', 'SRC INC']","[{'id': 'grid.410438.a', 'name': 'SRC', 'country_name': 'United States'}]",Grant,2017.0,US-9696421-B2,['Marcello M. DiStasio'],2017-07-04,,Through wall sensing system using WiFi/cellular radar,2014
745,"['MATRICARDI PIETRO', 'DI MEO CHIARA']",,Application,,WO-2015071873-A1,"['Matricardi, Pietro', 'DI MEO, CHIARA', 'VILLANI, CLAUDIO']",2015-05-21,1.0,NOVEL POLYMER PLATFORM TO PREPARE NANOHYDROGEL,2014
746,"['Rhodes Technologies', 'RHODES TECHNOLOGIES']",,Grant,2015.0,US-9127014-B2,"['Joshua Robert GIGUERE', 'Keith Edward MCCARTHY', 'Helge Alfred REISCH', 'Sergio Sandoval', 'Jake Larry Stymiest']",2015-09-08,5.0,Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof,2012
747,"['EISAI R&D MAN CO LTD', 'KEANEY GREGG F', 'WANG JOHN', 'GERARD BAUDOUIN', 'ARAI KENZO', 'LIU XIANG', 'ZHENG GUO ZHU', 'KIRA KAZUNOBU', 'TIVITMAHAISOON PARCHAREE', 'PRAJAPATI SUDEEP', 'GEARHART NICHOLAS C', 'KOTAKE YOSHIHIKO', 'NAGAO SATOSHI', 'KANADA SONABE REGINA MIKIE', 'MIYANO MASAYUKI', 'MURAI NORIO', 'BUONAMICI SILVIA', 'YU LIHUA', 'PARK EUNICE SUN', 'CHAN BETTY', 'SMITH PETER G', 'THOMAS MICHAEL P', 'Pazolli Ermira', 'Lim Kian Huat']","[{'id': 'grid.418765.9', 'name': 'Eisai (Japan)', 'country_name': 'Japan'}]",Application,,WO-2017087667-A1,"['KEANEY, GREGG F.', 'WANG, JOHN', 'GERARD, BAUDOUIN', 'ARAI, Kenzo', 'LIU, XIANG', 'ZHENG, GUO, ZHU', 'KIRA, KAZUNOBU', 'TIVITMAHAISOON, PARCHAREE', 'PRAJAPATI, Sudeep', 'KOTAKE, YOSHIHIKO', 'KANADA SONABE, Regina, Mikie', 'MIYANO, MASAYUKI', 'MURAI, NORIO', 'BUONAMICI, SILVIA', 'YU, LIHUA', 'PARK, Eunice, Sun', 'SMITH, PETER, G.', 'PAZOLLI, ERMIRA', 'LIM, Kian, Huat']",2017-05-26,,A SOLID STATE FORM OF PLADIENOLIDE PYRIDINE COMPOUNDS AND METHODS OF USE,2016
748,['NIOB SAGL'],,Application,,WO-2014199318-A3,"['DE RUGERIIS, Maria Cristina', 'MONTANARI, Elita', 'DI MEO, CHIARA', 'Matricardi, Pietro']",2015-02-05,,METHOD FOR PREPARING NANOHYDROGEL,2014
749,"['NIOB SAGL', 'NIOB SAGL']",,Grant,2017.0,US-9655972-B2,"[""Giorgia D'Arrigo"", 'Claudia Cencetti', 'Chiara Di Meo', 'Pietro Matricardi']",2017-05-23,,Method for the treatment of nanohydrogels,2014
750,"['Rhodes Technologies', 'RHODES TECH']",,Grant,2017.0,US-9657030-B2,"['Joshua Robert GIGUERE', 'Keith Edward MCCARTHY', 'Helge Alfred REISCH', 'Sergio Sandoval', 'Jake Larry Stymiest']",2017-05-23,,Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof,2015
751,['CÉZANNE S A S'],,Application,,WO-2017153381-A1,"['JARDIN-WATELET, Bénédicte', 'BOURGOIN, Nicolas', 'SZARVAS, TIBOR']",2017-09-14,,CHROMOGRANIN A AS A MARKER FOR BLADDER CANCER,2017
752,"['Pietro Matricardi', 'Chiara Di Meo', 'MATRICARDI PIETRO', 'DI MEO CHIARA']",,Grant,2018.0,US-10059811-B2,"['Pietro Matricardi', 'Chiara Di Meo', 'Claudio Villani']",2018-08-28,,Polymer platform to prepare nanohydrogel,2014
753,"['NIOB SAGL', 'NIOB SAGL']",,Grant,2017.0,US-9655978-B2,"['Maria Cristina De Rugeriis', 'Elita Montanari', 'Chiara Di Meo', 'Pietro Matricardi']",2017-05-23,,Method for preparing nanohydrogel,2014
754,"['Rhodes Technologies', 'RHODES TECH']",,Grant,2017.0,US-9593124-B2,"['Joshua Robert GIGUERE', 'Keith Edward MCCARTHY', 'Helge Alfred REISCH', 'Sergio Sandoval', 'Jake Larry Stymiest']",2017-03-14,,Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof,2015
755,['PCMS HOLDINGS INC'],,Application,,WO-2018093683-A1,"['JUELS, ARI']",2018-05-24,,SYSTEMS AND METHODS FOR DETECTION OF WIRELESS BEACON CLONING,2017
756,"['DANA-FARBER CANCER INST INC', 'WU CATHERINE JU-YING', 'LANDAU DAN-AVI']","[{'id': 'grid.65499.37', 'name': 'Dana-Farber Cancer Institute', 'country_name': 'United States'}]",Application,,WO-2017070497-A1,"['WU, Catherine, Ju-ying', 'LANDAU, Dan-avi']",2017-04-27,1.0,METHODS AND COMPOSITIONS FOR USE OF DRIVER MUTATIONS IN CLL,2016
757,['NIOB SAGL'],,Application,,WO-2014199319-A3,"[""D'ARRIGO, Giorgia"", 'CENCETTI, Claudia', 'DI MEO, CHIARA', 'Matricardi, Pietro']",2015-03-26,,METHOD FOR THE TREATMENT OF NANOHYDROGELS,2014
758,"['Rhodes Technologies', 'RHODES TECH']",,Grant,2016.0,US-9499557-B2,"['Joshua Robert GIGUERE', 'Keith Edward MCCARTHY', 'Helge Alfred REISCH', 'Sergio Sandoval', 'Jake Larry Stymiest']",2016-11-22,1.0,Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof,2015
759,"['EISAI R&D MAN CO LTD', 'KEANEY GREGG F', 'WANG JOHN', 'GERARD BAUDOUIN', 'ARAI KENZO', 'LIU XIANG', 'ZHENG GUO ZHU', 'KIRA KAZUNOBU', 'TIVITMAHAISOON PARCHAREE', 'PRAJAPATI SUDEEP', 'GEARHART NICHOLAS C', 'KOTAKE YOSHIHIKO', 'NAGAO SATOSHI', 'KANADA SONOBE REGINA', 'MIYANO MASAYUKI', 'MURAI NORIO']","[{'id': 'grid.418765.9', 'name': 'Eisai (Japan)', 'country_name': 'Japan'}]",Application,,WO-2015175594-A1,"['KEANEY, GREGG F.', 'WANG, JOHN', 'GERARD, BAUDOUIN', 'ARAI, Kenzo', 'LIU, XIANG', 'ZHENG, GUO ZHU', 'KIRA, KAZUNOBU', 'TIVITMAHAISOON, PARCHAREE', 'PRAJAPATI, Sudeep', 'GEARHART, Nicholas C.', 'KOTAKE, YOSHIHIKO', 'NAGAO, SATOSHI', 'KANADA SONOBE, Regina', 'MIYANO, MASAYUKI', 'MURAI, NORIO']",2015-11-19,2.0,PLADIENOLIDE PYRIDINE COMPOUNDS AND METHODS OF USE,2015
760,"['ROSSI DAVIDE', 'GAIDANO GIANLUCA', 'FOA ROBERT', 'TROVAGENE INC']",,Application,,WO-2013049750-A1,"['ROSSI, DAVIDE', 'GAIDANO, Gianluca', 'FOA, Robert']",2013-04-04,1.0,MUTATIONS IN SF3B1 AND CHRONIC LYMPHOCYTIC LEUKEMIA,2012
761,"['Eisai R&D Management Co Ltd', 'EISAI R&D MAN CO LTD']","[{'id': 'grid.418765.9', 'name': 'Eisai (Japan)', 'country_name': 'Japan'}]",Grant,2016.0,US-9481669-B2,"['Gregg F. Keaney', 'John Wang', 'Baudouin Gerard', 'Kenzo Arai', 'Xiang Liu', 'Guo Zhu Zheng', 'Kazunobu Kira', 'Parcharee Tivitmahaisoon', 'Sudeep Prajapati', 'Nicholas C. Gearhart', 'Yoshihiko Kotake', 'Satoshi Nagao', 'Regina Mikie Kanada Sonobe', 'Masayuki Miyano', 'Norio Murai', 'Silvia Buonamici', 'Lihua Yu', 'Eunice Sun Park', 'Betty Chan', 'Peter G. Smith', 'Michael P. Thomas', 'Ermira Pazolli', 'Kian Huat Lim']",2016-11-01,,Pladienolide pyridine compounds and methods of use,2015
762,"['Rhodes Technologies', 'RHODES TECH']",,Grant,2017.0,US-9624232-B2,"['Joshua Robert GIGUERE', 'Keith Edward MCCARTHY', 'Helge Alfred REISCH', 'Sergio Sandoval', 'Jake Larry Stymiest']",2017-04-18,,Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof,2015
763,"['Nocimed Inc', 'NOCIMED LLC']",,Grant,2016.0,US-9280718-B2,"['John P. Claude', 'James C. Peacock, III', 'Paul H. Kane']",2016-03-08,14.0,Systems and methods for automated voxelation of regions of interest for magnetic resonance spectroscopy,2013
764,"['University of North Carolina at Chapel Hill', 'UNIV NORTH CAROLINA']","[{'id': 'grid.410711.2', 'name': 'University of North Carolina System', 'country_name': 'United States'}, {'id': 'grid.10698.36', 'acronym': 'UNC', 'name': 'University of North Carolina at Chapel Hill', 'country_name': 'United States'}]",Application,,US-20110135610-A1,"['Lola M. Reid', 'Yunfang Wang', 'Vincenzo Cardinale', 'Eugenio Gaudio', 'Guido Carpino', 'Domenico Alvaro', 'Cai-Bin Cui']",2011-06-09,4.0,Multipotent stem cells from the extrahepatic biliary tree and methods of isolating same,2010
765,"['UAB BALTYMAS', 'CIPLYS EVALDAS', 'SLIBINSKAS RIMANTAS', 'SASNAUSKAS KESTUTIS', 'MICHALAK MAREK', 'GOLD LESLIE INA']",,Application,,WO-2014011723-A1,"['ČIPLYS, Evaldas', 'SLIBINSKAS, Rimantas', 'SASNAUSKAS, Kęstutis', 'MICHALAK, MAREK', 'GOLD, Leslie, Ina']",2014-01-16,,GENERATION OF NATIVE RECOMBINANT SECRETED HUMAN ENDOPLASMIC RETICULUM CHAPERONES BY USING THEIR NATIVE SIGNAL SEQUENCES IN YEAST EXPRESSION SYSTEMS,2013
766,"['California Institute of Technology', 'YUN SANG-HO', 'FIELDING ERIC JAMESON', 'WEBB FRANK H', 'SIMONS MARK', 'CALIFORNIA INST OF TECHN']","[{'id': 'grid.20861.3d', 'acronym': 'CIT', 'name': 'California Institute of Technology', 'country_name': 'United States'}]",Grant,2015.0,US-9207318-B2,"['Sang-Ho Yun', 'Eric Jameson Fielding', 'Frank H. Webb', 'Mark Simons']",2015-12-08,,Damage proxy map from interferometric synthetic aperture radar coherence,2012
767,['OXITEC LTD'],"[{'id': 'grid.437069.f', 'name': 'Oxitec (United Kingdom)', 'country_name': 'United Kingdom'}]",Application,,WO-2018029534-A1,"[""DAFA'ALLA, Tarig"", 'WARNER, SIMON', 'COLLADO, Amandine', 'SPINNER, Sian', 'MATZEN, Kelly', 'ALPHEY, LUKE']",2018-02-15,,"A SELF-LIMITING, SEX-SPECIFIC GENE AND METHODS OF USING",2017
768,"['Instituto Tecnologico de la Energia ITE', 'INST TECNOLOGICO DE LA EN ITE']","[{'id': 'grid.432423.0', 'acronym': 'ITE', 'name': 'Instituto Tecnológico de la Energía', 'country_name': 'Spain'}]",Application,,EP-2860790-A1,"['ZUBIZARRETA SAENZ DE ZAITEGUI, LEIRE', 'Gil Agustí, Maria Teresa', 'QUIJANO LÓPEZ, Alfredo', 'GARCIA PELLICER, MARTA']",2015-04-15,,Lithium polymeric membrane based on a semi-crystalline fluorinated polymeric matrix and a non-ionic surfactant,2014
769,"['Nocimed Inc', 'NOCIMED INC']",,Grant,2018.0,US-10045711-B2,"['James Clayton Peacock, III', 'John Patrick Claude', 'Paul Henry Kane', 'Ricardo Dario Pradenas']",2018-08-14,1.0,"Magnetic resonance spectroscopy pulse sequence, acquisition, and processing system and method",2016
770,"['INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECH MÉDICALE)', 'CENTRE NATIONAL DE LA RECHERCHE SCIENT - CNRS -', 'UNIV PARIS DESCARTES', 'HOPITAUX PARIS ASSIST PUBLIQUE']","[{'id': 'grid.10992.33', 'name': 'Paris Descartes University', 'country_name': 'France'}, {'id': 'grid.50550.35', 'acronym': 'AP-HP', 'name': 'Assistance Publique -Hopitaux De Paris', 'country_name': 'France'}]",Application,,WO-2018002147-A1,"['POLAK, MICHEL', 'KARIYAWASAM, Dulanjalee', 'CARRE, AURORE']",2018-01-04,,DETECTION OF BOREALIN MUTATIONS FOR DIAGNOSING THYROID DYSGENESIS,2017
771,"['Universitatsklinikum Hamburg-Eppendorf', 'Yeda Research and Development Co Ltd', 'YEDA RES & DEV', 'Universitätsklinikum Hamburg-Eppendorf']","[{'id': 'grid.471336.4', 'name': 'Yeda Research and Development (Israel)', 'country_name': 'Israel'}, {'id': 'grid.13648.38', 'acronym': 'UKE', 'name': 'University Medical Center Hamburg-Eppendorf', 'country_name': 'Germany'}]",Application,,EP-3263127-A1,"['OVADIA, ERAN', 'COHEN, IRUN R.', 'MARGALIT, RAANAN', 'PEVSNER-FISCHER, MEIRAV', 'HERKEL, JOHANNES']",2018-01-03,,USE OF AKT PHOSPHORYLATION AS A BIOMARKER FOR PROGNOSING NEURODEGENERATIVE DISEASES AND TREATING SAME,2012
772,"['IMRA America Inc', 'University of Michigan', 'UNIV MICHIGAN REGENTS', 'IMRA OF AMERICA INC']","[{'id': 'grid.472501.5', 'name': 'Aisin (United States)', 'country_name': 'United States'}, {'id': 'grid.214458.e', 'acronym': 'UM', 'name': 'University of Michigan', 'country_name': 'United States'}]",Grant,2017.0,US-9587071-B2,"['Duxin Sun', 'Hongwei Chen', 'Wei Qian', 'Yong Che', 'Masayuki Ito', 'Hayley Paholak', 'Kanokwan Sansanaphongpricha']",2017-03-07,1.0,Conjugated gold nanoparticles,2015
773,"['Universita degli Studi di Roma La Sapienza', 'University of North Carolina at Chapel Hill', 'UNIV NORTH CAROLINA', 'SAPIENZA UNI DI ROMA']","[{'id': 'grid.10698.36', 'acronym': 'UNC', 'name': 'University of North Carolina at Chapel Hill', 'country_name': 'United States'}, {'id': 'grid.410711.2', 'name': 'University of North Carolina System', 'country_name': 'United States'}, {'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Application,,EP-2494033-A4,"['REID LOLA M', 'WANG YUNFANG', 'CARDINALE VINCENZO', 'GAUDIO EUGENIO', 'CARPINO GUIDO', 'ALVARO DOMENICO', 'CUI CAI-BIN']",2015-07-29,,MULTIPOTENT STEM CELLS FROM THE EXTRAHEPATIC BILLARY TREE AND METHODS OF ISOLATING SAME,2010
774,['YISSUM RES DEV CO'],"[{'id': 'grid.9619.7', 'acronym': 'HUJI', 'name': 'Hebrew University of Jerusalem', 'country_name': 'Israel'}]",Application,,WO-2013128446-A1,"['EISENBERG, Hagai', 'SHAHAM, Assaf']",2013-09-06,2.0,DEPOLARISER,2013
775,"['Nocimed Inc', 'University of California', 'NOCIMED INC', 'UNIV CALIFORNIA']","[{'id': 'grid.30389.31', 'name': 'University of California System', 'country_name': 'United States'}]",Grant,2016.0,US-9392959-B2,"['James Clayton Peacock, III', 'John Patrick Claude', 'Paul Henry Kane', 'Jeffrey C. Lotz']",2016-07-19,7.0,MR spectroscopy system and method for diagnosing painful and non-painful intervertebral discs,2014
776,"['Nocimed Inc', 'NOCIMED LLC', 'NOCIMED INC']",,Grant,2017.0,US-9724013-B2,"['James Clayton Peacock, III', 'John Patrick Claude', 'Paul Henry Kane']",2017-08-08,5.0,MR spectroscopy system and method for diagnosing painful and non-painful intervertebral discs,2015
777,"['Nocimed Inc', 'NOCIMED INC']",,Grant,2017.0,US-9808177-B2,"['John Patrick Claude', 'James C. Peacock, III', 'Paul H. Kane']",2017-11-07,4.0,Systems and methods for automated voxelation of regions of interest for magnetic resonance spectroscopy,2016
778,"['Universitatsklinikum Hamburg-Eppendorf', 'Yeda Research and Development Co Ltd', 'YEDA RES & DEV', 'UNIVERSITÄTSKLINIKUM HAMBURG EPPENDORF']","[{'id': 'grid.13648.38', 'acronym': 'UKE', 'name': 'University Medical Center Hamburg-Eppendorf', 'country_name': 'Germany'}, {'id': 'grid.471336.4', 'name': 'Yeda Research and Development (Israel)', 'country_name': 'Israel'}]",Application,,EP-2715350-A4,"['OVADIA ERAN', 'COHEN IRUN R', 'HERKEL JOHANNES', 'MARGALIT RAANAN', 'PEVSNER-FISCHER MEIRAV']",2015-08-05,,USE OF AKT PHOSPHORYLATION AS A BIOMARKER FOR PROGNOSING NEURODEGENERATIVE DISEASES AND TREATING SAME,2012
779,"['ANTENNA Co INTERNATIONAL NV', 'THE ANTENNA COMPANY INT N V']",,Grant,2017.0,US-9716319-B2,"['Diego Caratelli', 'Johan Leo Alfons Gielis']",2017-07-25,,"Lens antenna, method for manufacturing and using such an antenna, and antenna system",2013
780,"['ANTENNA Co INTERNATIONAL NV', 'Antenna Co International', 'THE ANTENNA COMPANY INT N V', 'THE ANTENNA COMPANY INT']",,Grant,2017.0,US-9831562-B2,"['Diego Caratelli', 'Johan Leo Alfons Gielis']",2017-11-28,,"Lens antenna, method for manufacturing and using such an antenna, and antenna system",2013
781,"['UNIV DUNDEE', 'WATTS COLIN', 'VAN KASTEREN SANDER']","[{'id': 'grid.8241.f', 'name': 'University of Dundee', 'country_name': 'United Kingdom'}]",Application,,WO-2013024243-A1,"['WATTS, COLIN', 'VAN KASTEREN, SANDER']",2013-02-21,,INHIBITORS AGAINST ENDOSOMAL/LYSOSOMAL ENZYMES,2012
782,"['NOCIMED, INC.', 'NOCIMED LLC', 'NOCIMED INC']",,Grant,2016.0,US-9345421-B2,"['James Clayton Peacock, III', 'John Patrick Claude', 'Paul Henry Kane', 'Ricardo Dario Pradenas']",2016-05-24,11.0,"Magnetic resonance spectroscopy pulse sequence, acquisition, and processing system and method",2015
783,['AICURIS GMBH & CO KG'],"[{'id': 'grid.491702.9', 'name': 'AiCuris (Germany)', 'country_name': 'Germany'}]",Application,,WO-2014124978-A2,"['ITZHAKI, RUTH']",2014-08-21,2.0,HELICASE-PRIMASE INHIBITORS FOR USE IN A METHOD OF TREATING ALZHEIMER'S DISEASE,2014
784,['QUALCOMM INC'],"[{'id': 'grid.430388.4', 'name': 'Qualcomm (United States)', 'country_name': 'United States'}]",Application,,WO-2015095579-A1,"['LU, LIN', 'NADAKUDUTI, JAGADISH', 'GUCKIAN, PAUL']",2015-06-25,,COMPLIANCE ASSESSMENT OF HUMAN EXPOSURE FROM WIRELESS ELECTRIC VEHICLE CHARGING SYSTEM,2014
785,['CREATV MICROTECH INC'],"[{'id': 'grid.421632.0', 'name': 'Creatv MicroTech (United States)', 'country_name': 'United States'}]",Application,,WO-2016191532-A1,"['ADAMS, DANIEL', 'TANG, CHA-MEI']",2016-12-01,3.0,USE OF CIRCULATING TUMOR CELL MITOTIC INDEX IN CANCER STRATIFICATION AND DIAGNOSTICS,2016
786,"['PAYNE ADAM J', 'KURIEN BIJI T', 'SCOFIELD R HAL']",,Application,,WO-2013078477-A3,"['PAYNE, Adam, J.', 'KURIEN, Biji, T.', 'SCOFIELD, R., HAL']",2013-10-17,,SOLUBILIZATION OF CURCUMINOID COMPOUNDS AND PRODUCTS THEREOF,2012
787,"['Duchesnay Inc', 'DUCHESNAY INC']","[{'id': 'grid.487213.b', 'name': 'Duchesnay (Canada)', 'country_name': 'Canada'}]",Grant,2016.0,US-9439920-B2,"['Manon VRANDERICK', 'Jean-Luc ST-ONGE', 'Michele GALLO', 'Éric Gervais']",2016-09-13,2.0,Composition for the management of nausea and vomiting,2014
788,"['WiTricity Corp', 'QUALCOMM INC']","[{'id': 'grid.430388.4', 'name': 'Qualcomm (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9575108-B2,"['Lin Lu', 'Jagadish Nadakuduti', 'Paul Guckian']",2017-02-21,3.0,Compliance assessment of human exposure from wireless electric vehicle charging system using at least one phantom model,2014
789,['CEPHEID'],"[{'id': 'grid.433548.d', 'name': 'Cepheid (United States)', 'country_name': 'United States'}]",Application,,WO-2014159073-A1,"['DELFOUR, OLIVIER', 'MICHOT, BERNARD']",2014-10-02,1.0,METHODS OF DETECTING LUNG CANCER,2014
790,"['Hoffmann Andreas-Claudius', 'Schlaak Jorg Friedrich', 'HOFFMANN ANDREAS-CLAUDIUS', 'SCHLAAK JOERG FRIEDRICH']",,Application,,EP-2706357-A1,"['Hoffmann, Andreas-Claudius', 'SCHLAAK, Jörg Friedrich']",2014-03-12,1.0,Method for identifying subgroups of circulating tumor cells (CTCs) in a CTC population or a sample,2012
791,"[""INST NAT DE RECHERCHE EN SCIENCES ET TECHNOLOGIES POUR L'ENVIRONNEMENT ET L'AGRICULTURE IRSTEA""]","[{'id': 'grid.48142.3b', 'acronym': 'IRSTEA', 'name': 'National Research Institute of Science and Technology for Environment and Agriculture', 'country_name': 'France'}]",Application,,WO-2016051064-A1,"['BOUCHEZ, Théodore', 'BRIDIER, Arnaud', 'DESMOND, Elie']",2016-04-07,,METHOD AND DEVICE FOR CONTROLLING THE ACTIVITY OF A BIOELECTROCHEMICAL SYSTEM COMPRISING BOTH A BIOANODE AND A BIOCATHODE,2015
792,"['INSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE', 'UNIVERSITÉ DE MONTPELLIER 1']","[{'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}, {'id': 'grid.121334.6', 'acronym': 'UM', 'name': 'University of Montpellier', 'country_name': 'France'}]",Application,,WO-2015036552-A1,"['TAULAN-CADARS, Magali']",2015-03-19,6.0,METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS,2014
793,"[""INSTITUT NATIONAL DE RECHERCHE EN SCIENCES ET TECHNOLOGIES POUR L'ENVIRONNEMENT ET L'AGRICULTURE (IRSTEA)"", ""Inst Nat De Recherche En Sciences Et Technologies Pour L'environnement Et L'agriculture Irstea"", ""INST NAT DE RECHERCHE EN SCIENCES ET TECHNOLOGIES POUR L'ENVIRONNEMENT ET L'AGRICULTURE IRSTEA""]","[{'id': 'grid.48142.3b', 'acronym': 'IRSTEA', 'name': 'National Research Institute of Science and Technology for Environment and Agriculture', 'country_name': 'France'}]",Application,,FR-3026413-A1,"['BOUCHEZ THEODORE', 'BRIDIER ARNAUD', 'DESMOND ELIE']",2016-04-01,,Method and device for regulation of the activity of a system comprising both a bioelectrochemical bioanode and a biocathode,2014
794,"['Celgene Corp', 'CELGENE CORP']","[{'id': 'grid.418722.a', 'acronym': 'Celgene', 'name': 'Celgene (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9839632-B2,['Han W. Tun'],2017-12-12,,"Methods and compositions using 4-amino-2-(2,6-dioxo-piperidine-3-yl)-isoindoline-1,3-dione for treatment and management of central nervous system cancers",2014
795,"['Universita degli Studi di Roma La Sapienza', 'Università degli Studi di Roma “La Sapienza”', 'UNIV DEGLI STUDI DI ROMA “LA SAPIENZA”']","[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Grant,2017.0,US-9717170-B2,"['Maria Sabrina Sarto', 'Giovanni DE BELLIS', 'Alessio Tamburrano', ""Alessandro Giuseppe D'ALOIA""]",2017-07-25,,Graphene nanoplatelets- or graphite nanoplatelets-based nanocomposites for reducing electromagnetic interferences,2013
796,"['Universita degli Studi di Roma La Sapienza', 'UNIVERSIT DEGLI STUDI DI ROMA']","[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Application,,EP-2772801-A1,"['Nascetti, Andrea', 'Capaldo, Paola', 'Fratarcangeli, Francesca', 'Pieralice, Francesca', 'CRESPI, MATTIA GIOVANNI']",2014-09-03,,Matching procedure and device for the digital modelling of objects by stereoscopic images,2014
797,['LEAD DISCOVERY SIENA S R L'],,Application,,WO-2016066755-A2,"['BOTTA, MAURIZIO', 'ANGELUCCI, ADRIANO', 'DREASSI, Elena', 'SCHENONE, SILVIA', 'TINTORI, Cristina', 'VIGNAROLI, Giulia']",2016-05-06,,COMPOUNDS AND USES THEREOF,2015
798,"['UNIV AARHUS', 'REGION MIDTJYLLAND', 'UNIV SYDNEY', 'WESTMEAD HOSPITAL']","[{'id': 'grid.1013.3', 'acronym': 'USYD', 'name': 'University of Sydney', 'country_name': 'Australia'}, {'id': 'grid.413252.3', 'name': 'Westmead Hospital', 'country_name': 'Australia'}, {'id': 'grid.425869.4', 'name': 'Central Denmark Region', 'country_name': 'Denmark'}, {'id': 'grid.7048.b', 'acronym': 'AU', 'name': 'Aarhus University', 'country_name': 'Denmark'}]",Application,,WO-2015032414-A2,"['GRØNBÆK, Henning', 'KAZANKOV, Konstantin', 'MØLLER, Holger Jon', 'BIBBY, Bo Martin', 'GEORGE, JACOB']",2015-03-12,1.0,METHODS AND TOOLS FOR PREDICTING LIVER FIBROSIS,2014
799,"['HOFFMANN ANDREAS-CLAUDIUS', 'SCHLAAK JOERG FRIEDRICH']",,Application,,WO-2014037552-A1,"['Hoffmann, Andreas-Claudius', 'SCHLAAK, Jörg Friedrich']",2014-03-13,1.0,METHOD FOR IDENTIFYING SUBGROUPS OF CIRCULATING TUMOR CELLS (CTCS) IN THE CTC POPULATION OF A BIOLOGICAL SAMPLE,2013
800,"['AVIDIN CO LTD', 'SONEAS RES CO LTD', 'SYNAGING SAS']",,Application,,WO-2016162706-A1,"['PUSKÁS, László', 'KANIZSAI, Iván', 'Pillot, Thierry', 'GYURIS, Márió', 'Szabó, András', 'TAKÁCS, Ferenc', 'HACKLER, László']",2016-10-13,,ENANTIOMERS OF 8-HYDROXY QUINOLINE DERIVATIVES AND THE SYNTHESIS THEREOF,2016
801,['COVESTRO DEUTSCHLAND AG'],"[{'id': 'grid.471150.6', 'name': 'Covestro (Germany)', 'country_name': 'Germany'}]",Application,,WO-2018029200-A1,"['BULAN, ANDREAS', 'WEBER, RAINER', 'MUDDEMANN, Thorben']",2018-02-15,,PROCESS FOR THE ELECTROCHEMICAL PURIFICATION OF CHLORIDE-CONTAINING PROCESS SOLUTIONS,2017
802,['INSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE'],"[{'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}]",Application,,WO-2014118296-A1,"['MODJTAHEDI, NAZANINE', 'KROEMER, GUIDO']",2014-08-07,,METHODS FOR TREATING MITOCHONDRIAL DISORDERS AND NEURODEGENERATIVE DISORDERS,2014
803,"['Duchesnay Inc', 'DUCHESNAY INC']","[{'id': 'grid.487213.b', 'name': 'Duchesnay (Canada)', 'country_name': 'Canada'}]",Grant,2016.0,US-9452181-B2,"['Manon VRANDERICK', 'Jean-Luc ST-ONGE', 'Michele GALLO', 'Éric Gervais']",2016-09-27,1.0,Composition for the management of nausea and vomiting,2014
804,"['HOCHSCHULE ANHALT', 'HOCHSCHULE ANHALT']","[{'id': 'grid.427932.9', 'name': 'Anhalt University of Applied Sciences', 'country_name': 'Germany'}]",Application,,DE-102014013302-A1,"['Ingo Schellenberg', 'Kathrin Kabrodt', 'Helmut Baltruschat']",2016-03-10,,The active compound composition for combating plant diseases,2014
805,['UNIVERSIT DEGLI STUDI DI ROMA LA SAPIENZA'],"[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Application,,WO-2014061048-A2,"['SARTO, MARIA SABRINA', 'DE BELLIS, Giovanni', 'TAMBURRANO, ALESSIO', ""D'ALOIA, Alessandro Giuseppe""]",2014-04-24,7.0,GNP-BASED POLYMERIC NANOCOMPOSITES FOR REDUCING ELECTROMAGNETIC INTERFERENCES,2013
806,['YEDA RES & DEV'],"[{'id': 'grid.471336.4', 'name': 'Yeda Research and Development (Israel)', 'country_name': 'Israel'}]",Application,,WO-2013128453-A1,"['COHEN, IRUN R.', 'MARGALIT, RAANAN']",2013-09-06,,REGENERATION OF ISLET BETA CELLS BY HSP60 DERIVED PEPTIDES,2013
807,"['Alcatel Lucent SAS', 'ALCATEL LUCENT']","[{'id': 'grid.1441.0', 'name': 'Alcatel-Lucent (France)', 'country_name': 'France'}]",Application,,EP-3016458-A1,"['VALENTIN, STEFAN']",2016-05-04,,"Apparatus, Mobile Device, Base Station Transceiver, Adaptation Server, Method and Computer Program for providing information related to a predicted channel state",2014
808,['UNIVERSIT DEGLI STUDI DI ROMA LA SAPIENZA'],"[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Application,,WO-2014061048-A3,"['SARTO, MARIA SABRINA', 'DE BELLIS, Giovanni', 'TAMBURRANO, ALESSIO', ""D'ALOIA, Alessandro Giuseppe""]",2014-06-12,,GRAPHENE NANOPLATELETS- OR GRAPHITE NANOPLATELETS-BASED NANOCOMPOSITES FOR REDUCING ELECTROMAGNETIC INTERFERENCES,2013
809,"['Drexel University College of Medicine', 'Philadelphia Health and Education Corp', 'University of Pennsylvania', 'Inovio Pharmaceuticals Inc', 'KUTZLER MICHELE', 'BALIBAN SCOTT', 'WEINER DAVID B', 'SARDESAI NIRANJAN Y', 'KIM J JOSEPH', 'PHILADELPHIA HEALTH & EDUCATION CORP', 'INOVIO PHARMACEUTICALS INC', 'UNIV PENNSYLVANIA']","[{'id': 'grid.166341.7', 'name': 'Drexel University', 'country_name': 'United States'}, {'id': 'grid.29857.31', 'acronym': 'PSU', 'name': 'Pennsylvania State University', 'country_name': 'United States'}, {'id': 'grid.25879.31', 'name': 'University of Pennsylvania', 'country_name': 'United States'}, {'id': 'grid.421774.3', 'name': 'Inovio Pharmaceuticals (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9446112-B2,"['Michele Kutzler', 'Scott Baliban', 'David B. Weiner', 'Niranjan Y. Sardesai', 'J. Joseph Kim']",2016-09-20,,Clostridium difficile DNA vaccine,2012
810,['UNIV MANCHESTER'],"[{'id': 'grid.5379.8', 'name': 'University of Manchester', 'country_name': 'United Kingdom'}]",Application,,WO-2017144478-A1,"['CRUICKSHANK, Sheena', 'MCLAUGHLIN, John Thomas', 'BRASS, ANDREW MICHAEL', 'BRAMHALL, Michael Lyell']",2017-08-31,,INFLAMMATION BIOMARKER,2017
811,"['DEUTSCHES GEOFORSCHUNGSZENTRUM GFZ STIFTUNG DES OFFENTLICHEN RECHTS DES LANDES BRANDENBURG', 'DEUTSCHES GEOFORSCHUNGSZENTRUM -GFZ STIFTUNG DES OFFENTLICHEN RECHTS DES LANDES BRANDENBURG', 'DEUTSCHES GEOFORSCHUNGSZENTRUM GFZ STIFTUNG DES ÖFFENTLICHEN RECHTS DES LANDES BRANDENBURG']","[{'id': 'grid.23731.34', 'acronym': 'GFZ', 'name': 'Helmholtz Centre Potsdam - GFZ German Research Centre for Geosciences', 'country_name': 'Germany'}]",Grant,2014.0,DE-202013102692-U1,,2014-07-02,,Seismic measuring system,2013
812,"['Duchesnay Inc', 'DUCHESNAY INC']","[{'id': 'grid.487213.b', 'name': 'Duchesnay (Canada)', 'country_name': 'Canada'}]",Grant,2018.0,US-10028941-B2,"['Manon VRANDERICK', 'Jean-Luc ST-ONGE', 'Michele GALLO', 'Éric Gervais']",2018-07-24,,Composition for the management of nausea and vomiting,2014
813,"['Duke University', 'UNIV DUKE']","[{'id': 'grid.26009.3d', 'name': 'Duke University', 'country_name': 'United States'}]",Grant,2017.0,US-9738879-B2,"['Charles Gersbach', 'David Ousterout']",2017-08-22,,Genetic correction of mutated genes,2013
814,['CRISPR THERAPEUTICS AG'],,Application,,WO-2017093804-A3,"['COWAN, Chad, Albert', 'BOGORAD, Roman, Lvovitch', 'LI, JEFFREY', 'LUNDBERG, Ante, Sven', 'JOHN, Matthias, Johannes', 'STEBBINS, Jeffrey, William', 'NGUYEN, Thao, Thi']",2017-07-20,,MATERIALS AND METHODS FOR TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY,2016
815,"['University of California', 'UNIV CALIFORNIA']","[{'id': 'grid.30389.31', 'name': 'University of California System', 'country_name': 'United States'}]",Grant,2017.0,US-9539300-B2,"['Alan M. Fogelman', 'Srinivasa T. Reddy', 'Mohamad Navab']",2017-01-10,,Modulating disease through genetic engineering of plants,2013
816,"['Boehringer Ingelheim Vetmedica Inc', 'BOEHRINGER INGELHEIM VETMEDICA INC']","[{'id': 'grid.418412.a', 'acronym': 'Boehringer Ingelheim Pharmaceuticals', 'name': 'Boehringer Ingelheim (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10010603-B2,"['Vicky Fachinger', 'Knut Elbers', 'Axel Lischewski', 'Marion Kixmoeller', 'Francois-Xavier Orveillon', 'Isabelle Freiin Von Richthofen', 'Michael D. PIONTKOWSKI']",2018-07-03,,Treatment of pigs with PCV2 antigen,2016
817,"['Makino Milling Machine Co Ltd', 'MAKINO MILLING MACHINE']",,Application,,US-20160054724-A1,['Mitsunari Oda'],2016-02-25,1.0,"METHOD OF EVALUATING A MACHINED SURFACE OF A WORKPIECE, A CONTROLLING APPARATUS AND A MACHINE TOOL",2013
818,['AGENCY SCIENCE TECH & RES'],"[{'id': 'grid.185448.4', 'acronym': 'A*STAR', 'name': 'Agency for Science, Technology and Research', 'country_name': 'Singapore'}]",Application,,WO-2014062138-A1,"['ANG, Lay Teng', 'LOH, Kyle M.', 'LIM, BING']",2014-04-24,4.0,METHODS OF DIFFERENTIATING STEM CELLS INTO ONE OR MORE CELL LINEAGES,2013
819,"['Boehringer Ingelheim Vetmedica Inc', 'BOEHRINGER INGELHEIM VETMEDICA INC']","[{'id': 'grid.418412.a', 'acronym': 'Boehringer Ingelheim Pharmaceuticals', 'name': 'Boehringer Ingelheim (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9919041-B2,"['Marc Allan Eichmeyer', 'Gregory Paul Nitzel', 'Merrill Lynn Schaeffer']",2018-03-20,,PCV2 immunogenic compositions and methods of producing such compositions,2015
820,['GENOME RES LTD'],"[{'id': 'grid.10306.34', 'acronym': 'WTSI', 'name': 'Wellcome Sanger Institute', 'country_name': 'United Kingdom'}]",Application,,WO-2016142719-A1,"['SKARNES, William, C', 'KOUSTSOURAKIS, Manousos']",2016-09-15,8.0,BIALLELIC GENETIC MODIFICATION,2016
821,"['Intervet International BV', 'INTERVET INT BV']","[{'id': 'grid.491328.5', 'name': 'Merck (Netherlands)', 'country_name': 'Netherlands'}, {'id': 'grid.420097.8', 'acronym': 'MSD', 'name': 'MSD (Netherlands)', 'country_name': 'Netherlands'}]",Grant,2016.0,EP-2956167-B1,"['FACHINGER, VICKY', 'SNO, Melanie']",2016-10-19,,METHODS FOR THE RELEASE OF VIRUS-LIKE PARTICLES,2014
822,"['Boehringer Ingelheim Vetmedica Inc', 'BOEHRINGER INGELHEIM VETMEDICA INC']","[{'id': 'grid.418412.a', 'acronym': 'Boehringer Ingelheim Pharmaceuticals', 'name': 'Boehringer Ingelheim (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9925256-B2,"['Michael B. Roof', 'Phillip Wayne Hayes', 'Marc Allan Eichmeyer', 'Gregory Paul Nitzel']",2018-03-27,,Multivalent PCV2 immunogenic compositions and methods of producing such compositions,2015
823,"['Population Bio Inc', 'POPULATION BIO INC']",,Grant,2018.0,US-10059997-B2,"['Eli Hatchwell', 'Peggy S. Eis']",2018-08-28,1.0,Compositions and methods for discovery of causative mutations in genetic disorders,2014
824,"['VIB VZW', 'UNIV GENT', 'UNIV BRUXELLES']","[{'id': 'grid.5342.0', 'name': 'Ghent University', 'country_name': 'Belgium'}, {'id': 'grid.4989.c', 'acronym': 'ULB', 'name': 'Université Libre de Bruxelles', 'country_name': 'Belgium'}]",Application,,WO-2014033313-A1,"['DE PICKER, Ann', 'DE GREVE, HENRI', 'VIRDI, Vikram']",2014-03-06,1.0,PROTECTIVE ANTI-ETEC ANTIBODY,2013
825,"['SMARTEK INTERNATIONAL LLC', 'SMARTEK INT LLC']",,Grant,2017.0,US-9622971-B2,['Michael Farber'],2017-04-18,,Preparation of desiccated liposomes for use in compressible delivery systems,2013
826,"['Duke University', 'UNIV DUKE']","[{'id': 'grid.26009.3d', 'name': 'Duke University', 'country_name': 'United States'}]",Grant,2017.0,US-9828582-B2,"['Pablo Perez-Pinera', 'Charles Gersbach']",2017-11-28,,Compositions and methods for the induction and tuning of gene expression,2014
827,"['Boehringer Ingelheim Vetmedica Inc', 'BOEHRINGER INGELHEIM VETMEDICA INC']","[{'id': 'grid.418412.a', 'acronym': 'Boehringer Ingelheim Pharmaceuticals', 'name': 'Boehringer Ingelheim (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9925255-B2,"['Michael B. Roof', 'Phillip Wayne Hayes', 'Marc Allan Eichmeyer', 'Gregory Paul Nitzel']",2018-03-27,,Multivalent PCV2 immunogenic compositions and methods of producing such compositions,2015
828,"['BROAD INST INC', 'MASSACHUSETTS INST TECHNOLOGY']","[{'id': 'grid.116068.8', 'acronym': 'MIT', 'name': 'Massachusetts Institute of Technology', 'country_name': 'United States'}, {'id': 'grid.66859.34', 'name': 'Broad Institute', 'country_name': 'United States'}]",Application,,WO-2016094874-A1,"['DAHLMAN, James, E.', 'ZHANG, FENG']",2016-06-16,17.0,ESCORTED AND FUNCTIONALIZED GUIDES FOR CRISPR-CAS SYSTEMS,2015
829,"['Sangamo Therapeutics Inc', 'SANGAMO BIOSCIENCES INC']","[{'id': 'grid.421831.d', 'name': 'Sangamo BioSciences (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9574211-B2,"['Philip D. Gregory', 'Michael C. Holmes']",2017-02-21,1.0,Methods and compositions for prevention or treatment of a disease,2015
830,"['Boehringer Ingelheim Vetmedica Inc', 'BOEHRINGER INGELHEIM VETMEDICA INC']","[{'id': 'grid.418412.a', 'acronym': 'Boehringer Ingelheim Pharmaceuticals', 'name': 'Boehringer Ingelheim (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9943587-B2,"['Vicky Fachinger', 'Knut Elbers', 'Marion Kixmoeller', 'Francois Xavier Orveillon', 'Isabelle Freiin Von Richthofen', 'Axel Lischewski']",2018-04-17,,Prevention and treatment of sub-clinical PCVD,2016
831,"['US Department of Veterans Affairs', 'BioVentures LLC', 'BOARD OF TRUSTEES UNIV OF ARKANSAS', 'BIOVENTURES LLC']","[{'id': 'grid.418356.d', 'acronym': 'VA ', 'name': 'United States Department of Veterans Affairs', 'country_name': 'United States'}, {'id': 'grid.194632.b', 'name': 'University of Arkansas System', 'country_name': 'United States'}]",Grant,2017.0,US-9650674-B2,"['Alexei G. Basnakian', 'Yevgeniy Apostolov']",2017-05-16,,Nucleic acid probes and methods of using the same,2013
832,['PCMS HOLDINGS INC'],,Application,,WO-2018093683-A1,"['JUELS, ARI']",2018-05-24,,SYSTEMS AND METHODS FOR DETECTION OF WIRELESS BEACON CLONING,2017
833,"['Population Bio Inc', 'POPULATION BIO INC']",,Grant,2018.0,US-9976180-B2,"['Eli Hatchwell', 'Peggy S. Eis']",2018-05-22,,Methods for detecting a genetic variation in subjects with parkinsonism,2013
834,"['Boehringer Ingelheim Vetmedica Inc', 'BOEHRINGER INGELHEIM VETMEDICA INC']","[{'id': 'grid.418412.a', 'acronym': 'Boehringer Ingelheim Pharmaceuticals', 'name': 'Boehringer Ingelheim (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10010604-B2,"['Vicky Fachinger', 'Knut Elbers', 'Marion Kixmoeller', 'Francois-Xavier Orveillon', 'Isabelle Freiin Von Richthofen', 'Axel Lischewski']",2018-07-03,,Treatment of PRDC in pigs,2016
835,"['Makino Milling Machine Co Ltd', 'MAKINO MILLING MACHINE']",,Grant,2018.0,US-10018989-B2,['Mitsunari Oda'],2018-07-10,,"Method of evaluating a machined surface of a workpiece, a controlling apparatus and a machine tool",2013
836,"['UNIV SYDDANSK', 'MOLLENHAUER JAN', 'SCHMIDT STEFFEN', 'SCHADENDORF DIRK']","[{'id': 'grid.10825.3e', 'acronym': 'SDU', 'name': 'University of Southern Denmark', 'country_name': 'Denmark'}]",Application,,WO-2012079578-A1,"['MOLLENHAUER, JAN', 'SCHMIDT, STEFFEN', 'SCHADENDORF, DIRK']",2012-06-21,3.0,SELECTIVE KILLING OF CANCER CELLS,2011
837,"['Mayo Foundation for Medical Education and Research', 'HOUGH DAVID M', 'YU LIFENG', 'FLETCHER JOEL G', 'MCCOLLOUGH CYNTHIA H', 'MAYO FOUNDATION']","[{'id': 'grid.417467.7', 'name': 'Mayo Clinic', 'country_name': 'United States'}, {'id': 'grid.66875.3a', 'name': 'Mayo Clinic', 'country_name': 'United States'}]",Grant,2015.0,US-9173617-B2,"['David M. Hough', 'Lifeng Yu', 'Joel G. Fletcher', 'Cynthia H. McCollough']",2015-11-03,2.0,Method for controlling radiation dose and intravenous contrast dose in computed tomography imaging,2012
838,"['Universite de Nantes', 'Institut National de la Sante et de la Recherche Medicale INSERM', 'INSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE', 'Université de Nantes']","[{'id': 'grid.4817.a', 'name': 'University of Nantes', 'country_name': 'France'}, {'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}]",Application,,EP-3059307-A1,"['NGUYEN, Tuan Huy', 'Fourrier, Angélique']",2016-08-24,1.0,Use of a laminin for differentiating pluripotent cells into hepatocyte lineage cells,2015
839,"['NOVARTIS AG', 'GLASS DAVID JONATHAN', 'GONG CHENGUANG', 'LI ZHIZHONG']","[{'id': 'grid.419481.1', 'name': 'Novartis (Switzerland)', 'country_name': 'Switzerland'}]",Application,,WO-2015020960-A1,"['GLASS, DAVID JONATHAN', 'GONG, Chenguang', 'LI, ZHIZHONG']",2015-02-12,,NOVEL LNCRNA POLYNUCLEOTIDES,2014
840,"['Boehringer Ingelheim Vetmedica Inc', 'BOEHRINGER INGELHEIM VETMEDICA INC']","[{'id': 'grid.418412.a', 'acronym': 'Boehringer Ingelheim Pharmaceuticals', 'name': 'Boehringer Ingelheim (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9987349-B2,"['Michael B Roof', 'Phillip Wayne Hayes', 'Marc Allan Eichmeyer', 'Gregory Paul Nitzel', 'Merrill Lynn Schaeffer']",2018-06-05,,Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs,2016
841,"['Helsinn Healthcare SA', 'HELSINN HEALTHCARE SA', 'HELSINN HEALTHCARE SA']","[{'id': 'grid.467402.3', 'name': 'Helsinn (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-9186357-B2,"['Fabio Trento', 'Sergio Cantoreggi', 'Giorgia Rossi', 'Roberta Cannella', 'Daniele Bonadeo']",2015-11-17,,Compositions and methods for treating centrally mediated nausea and vomiting,2013
842,"['Aurin Biotech Inc', 'AURIN BIOTECH INC']",,Grant,2014.0,US-8877808-B2,"['Patrick L. McGeer', 'Moonhee Lee', 'Douglas N. Bell']",2014-11-04,,Protection against skin diseases by aurin tricarboxylic acid and its derivatives,2012
843,"['Astellas Institute for Regenerative Medicine', 'ADVANCED CELL TECH INC', 'OCATA THERAPEUTICS INC']","[{'id': 'grid.421980.6', 'acronym': 'ACT', 'name': 'Advanced Cell Technology (United States)', 'country_name': 'United States'}, {'id': 'grid.423286.9', 'acronym': 'Astellas Pharma', 'name': 'Astellas Pharma (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-8962321-B2,"['Erin Anne KIMBREL', 'Robert Lanza', 'Jianlin Chu', 'Nicholas Arthur KOURIS']",2015-02-24,6.0,Mesenchymal stromal cells and uses related thereto,2012
844,"['Universite de Nantes', 'Chu Nantes', 'UNIV NANTES', 'CHU NANTES']","[{'id': 'grid.277151.7', 'acronym': 'CHU', 'name': 'Centre Hospitalier Universitaire de Nantes', 'country_name': 'France'}, {'id': 'grid.4817.a', 'name': 'University of Nantes', 'country_name': 'France'}]",Application,,EP-2606905-A1,"['HEYMANN, DOMINIQUE', 'Teletchea, Stéphane', 'STRESING, Verena']",2013-06-26,2.0,Peptides targeting Receptor activator of nuclear factor-kappa B (RANK) and their applications,2011
845,"['Astellas Institute for Regenerative Medicine', 'ADVANCED CELL TECH INC', 'OCATA THERAPEUTICS INC']","[{'id': 'grid.421980.6', 'acronym': 'ACT', 'name': 'Advanced Cell Technology (United States)', 'country_name': 'United States'}, {'id': 'grid.423286.9', 'acronym': 'Astellas Pharma', 'name': 'Astellas Pharma (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-8961956-B2,"['Erin Anne KIMBREL', 'Robert Lanza', 'Jianlin Chu', 'Nicholas Arthur KOURIS']",2015-02-24,3.0,Mesenchymal stromal cells and uses related thereto,2013
846,['SUED CHEMIE IP GMBH & CO KG'],"[{'id': 'grid.433370.0', 'name': 'Clariant (Germany)', 'country_name': 'Germany'}]",Application,,WO-2013072059-A1,"['LAUMANN, ANDREAS', 'HOLZAPFEL, MICHAEL', 'WENDRICH, GENOVEFA']",2013-05-23,,DOPED LITHIUM TITANIUM SPINEL COMPOUND AND ELECTRODE COMPRISING SAME,2012
847,"['OFRAN YANAY', 'NIMROD GUY', 'FISCHMAN SHARON', 'HERMAN ASAEL']",,Application,,WO-2016086185-A1,"['OFRAN, Yanay', 'NIMROD, Guy', 'FISCHMAN, Sharon', 'HERMAN, ASAEL']",2016-06-02,2.0,COMPUTER ASSISTED ANTIBODY RE-EPITOPING,2015
848,"['Helsinn Healthcare SA', 'HELSINN HEALTHCARE SA', 'HELSINN HEALTHCARE SA']","[{'id': 'grid.467402.3', 'name': 'Helsinn (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-8951969-B2,"['Fabio Trento', 'Sergio Cantoreggi', 'Giorgia Rossi', 'Roberta Cannella', 'Daniele Bonadeo']",2015-02-10,,Compositions and methods for treating centrally mediated nausea and vomiting,2013
849,"['Sanofi SA', 'SANOFI SA']","[{'id': 'grid.417924.d', 'name': 'Sanofi (France)', 'country_name': 'France'}]",Grant,2017.0,US-9676864-B2,"['Herve Bouchard', 'Alain Commercon', 'Claudia FROMOND', 'Vincent Mikol', 'Fabienne Parker', 'Ingrid Sassoon', 'Daniel Tavares']",2017-06-13,1.0,Antibodies that specifically bind to the EphA2 receptor,2014
850,['Universität Bern'],"[{'id': 'grid.5734.5', 'acronym': 'UB', 'name': 'University of Bern', 'country_name': 'Switzerland'}]",Application,,WO-2017125593-A1,"['KIEFER, KLAUS']",2017-07-27,,"MAGNETIC RESONANCE IMAGING METHOD, PARTICULARLY FOR DETECTING NEURONAL ACTIVITY IN A SUBJECT'S BRAIN",2017
851,"['Clariant International Ltd', 'SUED CHEMIE IP GMBH & CO KG']","[{'id': 'grid.433370.0', 'name': 'Clariant (Germany)', 'country_name': 'Germany'}]",Application,,EP-2595224-A1,"['LAUMANN, ANDREAS', 'HOLZAPFEL, MICHAEL', 'WENDRICH, GENOVEFA']",2013-05-22,2.0,Doped lithium titanium spinel compound and electrode comprising the same,2011
852,"['Helsinn Healthcare SA', 'TRENTO FABIO', 'CANTOREGGI SERGIO', 'ROSSI GIORGIA', 'CANNELLA ROBERTA', 'BONADEO DANIELE', 'HELSINN HEALTHCARE SA']","[{'id': 'grid.467402.3', 'name': 'Helsinn (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8623826-B2,"['Fabio Trento', 'Sergio Cantoreggi', 'Giorgia Rossi', 'Roberta Cannella', 'Daniele Bonadeo']",2014-01-07,,Compositions and methods for treating centrally mediated nausea and vomiting,2011
853,"['Universita degli Studi di Roma La Sapienza', 'UNIV ROMA']","[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Application,,EP-2064556-A2,"['FRATI, LUIGI', 'MATTIELLO, TERESA', 'PULCINELLI, FABIO MARIA']",2009-06-03,,METHOD TO IDENTIFY AND TREAT SUBJECTS RESISTANT TO ACETYL SALICYLIC ACID,2007
854,"['Bern Universitaet', 'Universität Bern']","[{'id': 'grid.5734.5', 'acronym': 'UB', 'name': 'University of Bern', 'country_name': 'Switzerland'}]",Application,,EP-3196666-A1,['The designation of the inventor has not yet been filed'],2017-07-26,,MAGNETIC RESONANCE IMAGING METHOD FOR DETECTING NEURONAL ACTIVITY IN A SUBJECT'S BRAIN,2016
855,"['TELEFONICA SA', 'FERNANDEZ-PALACIOS JUAN', 'GONZALEZ OSCAR', 'JIMENEZ JAVIER']","[{'id': 'grid.426313.1', 'name': 'Telefónica (Spain)', 'country_name': 'Spain'}]",Application,,WO-2012095263-A1,"['FERNÁNDEZ-PALACIOS, Juan', 'GONZÁLEZ, Oscar', 'JIMÉNEZ, Javier']",2012-07-19,,A MULTILAYER COMMUNICATIONS NETWORK SYSTEM FOR DISTRIBUTING MULTICAST SERVICES AND A METHOD FOR SUCH A DISTRIBUTION,2011
856,"['UNIV NANTES', 'CHU NANTES']","[{'id': 'grid.277151.7', 'acronym': 'CHU', 'name': 'Centre Hospitalier Universitaire de Nantes', 'country_name': 'France'}, {'id': 'grid.4817.a', 'name': 'University of Nantes', 'country_name': 'France'}]",Application,,WO-2013093039-A1,"['HEYMANN, DOMINIQUE', 'Teletchea, Stéphane', 'STRESING, Verena']",2013-06-27,1.0,PEPTIDES TARGETING RECEPTOR ACTIVATOR OF NUCLEAR FACTOR -KAPPA B (RANK) AND THEIR APPLICATIONS,2012
857,['PASTEUR INSTITUT'],"[{'id': 'grid.428999.7', 'name': 'Pasteur Institute', 'country_name': 'France'}]",Application,,WO-2015010744-A1,"['ROGGE, Lars', 'DOUGADOS, Maxime', 'BIANCHI, ELISABETTA']",2015-01-29,2.0,SERONEGATIVE SPONDYLOARTHROPATHY DIAGNOSIS AND TREATMENT,2013
858,"['Institut National de la Sante et de la Recherche Medicale INSERM', 'INSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE']","[{'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}]",Application,,EP-2813850-A1,"['VITTECOQ, OLIVIER', 'Laguerre, Thierry', 'Cosette, Pascal', 'BOYER, OLIVIER', 'Le Loët, Xavier', 'Hardouin, Julie', 'Obry, Antoine']",2014-12-17,,Methods for predicting rheumatoid arthritis treatment response,2013
859,"['Aurin Biotech Inc', 'AURIN BIOTECH INC']",,Grant,2017.0,US-9751824-B2,"['Patrick L. McGeer', 'Moonhee Lee', 'Edith G. McGeer']",2017-09-05,,"Acetyl salicyclic acid dimers, synthesis thereof, and uses thereof to prevent and treat complement-mediated disorders",2014
860,"['IBC Pharmaceuticals Inc', 'IBC PHARMACEUTICALS INC']","[{'id': 'grid.468843.5', 'acronym': 'IBC', 'name': 'International Business College - Fort Wayne', 'country_name': 'United States'}, {'id': 'grid.469475.d', 'acronym': 'IBC', 'name': 'International Business College - Indianapolis', 'country_name': 'United States'}]",Grant,2018.0,US-10022427-B2,"['Chien-Hsing Chang', 'David M. Goldenberg', 'Donglin Liu']",2018-07-17,,Interferon lambda-antibody complexes,2016
861,"['INST NAT SANTE RECH MED', 'UNIV ROUEN', 'CENTRE NAT RECH SCIENT']","[{'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}, {'id': 'grid.4444.0', 'acronym': 'CNRS', 'name': 'French National Centre for Scientific Research', 'country_name': 'France'}, {'id': 'grid.10400.35', 'name': 'University of Rouen', 'country_name': 'France'}]",Application,,WO-2014198727-A3,"['VITTECOQ, OLIVIER', 'LEQUERRE, THIERRY', 'Cosette, Pascal', 'BOYER, OLIVIER', 'Le Loët, Xavier', 'Hardouin, Julie', 'Obry, Antoine']",2015-02-05,,METHODS FOR PREDICTING RHEUMATOID ARTHRITIS TREATMENT RESPONSE,2014
862,"['IST SUPERIORE SANITA', 'UNIV DEGLI STUDI ANNUNZIO']","[{'id': 'grid.412451.7', 'name': 'University of Chieti-Pescara', 'country_name': 'Italy'}]",Application,,WO-2013072946-A1,"['SUPERTI, Fabiana E. D.', 'AGAMENNONE, Mariangela', 'AMMENDOLIA, Maria Grazia', 'PIETRANTONI, Agostina', 'LANNUTTI, Fabio']",2013-05-23,,LACTOFERRIN DERIVED PEPTIDES FOR USE AS BROAD- SPECTRUM INHIBITORS OF INFLUENZA VIRUS INFECTION,2012
863,"['Bern Universitaet', 'Universität Bern']","[{'id': 'grid.5734.5', 'acronym': 'UB', 'name': 'University of Bern', 'country_name': 'Switzerland'}]",Application,,EP-2975424-A1,['The designation of the inventor has not yet been filed'],2016-01-20,,Magnetic resonance imaging method for detecting neuronal activity in a subject's brain,2014
864,"['IBC Pharmaceuticals Inc', 'IBC PHARMACEUTICALS INC']","[{'id': 'grid.469475.d', 'acronym': 'IBC', 'name': 'International Business College - Indianapolis', 'country_name': 'United States'}, {'id': 'grid.468843.5', 'acronym': 'IBC', 'name': 'International Business College - Fort Wayne', 'country_name': 'United States'}]",Grant,2016.0,US-9272029-B2,"['Chien-Hsing Chang', 'David M. Goldenberg', 'Donglin Liu']",2016-03-01,,Interferon lambada-antibody complexes,2013
865,"['Helsinn Healthcare SA', 'HELSINN HEALTHCARE SA']","[{'id': 'grid.467402.3', 'name': 'Helsinn (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2018.0,US-9943515-B2,"['Fabio Trento', 'Sergio Cantoreggi', 'Giorgia Rossi', 'Roberta Cannella', 'Daniele Bonadeo']",2018-04-17,,Compositions and methods for treating centrally mediated nausea and vomiting,2016
866,"['University of Georgia Research Foundation Inc (UGARF)', 'NAIR VASU', 'OKELLO MAURICE O', 'NISHONOV ABDUMALIK A', 'MISHRA SANJAYKUMAR', 'UNIV GEORGIA']","[{'id': 'grid.213876.9', 'acronym': 'UGA', 'name': 'University of Georgia', 'country_name': 'United States'}]",Grant,2014.0,US-8703801-B2,"['Vasu Nair', 'Maurice O. Okello', 'Abdumalik A. Nishonov', 'Sanjaykumar Mishra']",2014-04-22,1.0,Pyridinone hydroxycyclopentyl carboxamides: HIV integrase inhibitors with therapeutic applications,2010
867,"['Pulcinelli, Fabio Maria', 'Frati, Luigi', 'PULCINELLI FABIO MARIA', 'FRATI LUIGI']",,Grant,2017.0,EP-2064556-B1,"['PULCINELLI, FABIO MARIA', 'FRATI, LUIGI', 'MATTIELLO, TERESA']",2017-05-10,,METHOD TO IDENTIFY AND TREAT SUBJECTS RESISTANT TO ACETYL SALICYLIC ACID,2007
868,"['Colorado State University Research Foundation', 'COLORADO STATE UNIV RESEARCH FOUNDATION']","[{'id': 'grid.47894.36', 'acronym': 'CSU', 'name': 'Colorado State University', 'country_name': 'United States'}]",Grant,2018.0,US-9933437-B2,"['Thomas R. Hansen', 'Jessica Prenni', 'Torrance M. Nett', 'Kevin McSweeney', 'Jared Romero']",2018-04-03,1.0,Early determination of pregnancy status in ruminants,2014
869,"['CASA LUKER SA', 'Casa Luker S A', 'CASA LUKER S A', 'RENGIFO RAUL CUERO']",,Application,,EP-2877584-A4,['CUERO RENGIFO RAUL'],2016-03-30,,METHODS FOR INCREASING THE PRODUCTION OF PHENOLIC COMPOUNDS FROM THEOBROMA CACAO,2013
870,['MODERNA THERAPEUTICS INC'],"[{'id': 'grid.479574.c', 'name': 'Moderna Therapeutics (United States)', 'country_name': 'United States'}]",Application,,WO-2014113089-A3,"['HOGE, Stephen G.', 'CHAKRABORTY, TIRTHA', 'FREDERICK, JOSHUA P.', 'JOHN, MATTHIAS', 'DE FOUGEROLLES, ANTONIN']",2014-09-12,,SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES,2013
871,"['BARMARSA RESEARCH LLC', 'BARMARSA RES LLC']",,Grant,2016.0,US-9254308-B2,['Fred L. Shaw'],2016-02-09,,Kits and methods for the treatment of cancer using gliadin peptides,2014
872,"['INST NAT SANTE RECH MED', 'CT HOSPITALIER UNIVERSITAIRE VAUDOIS']","[{'id': 'grid.8515.9', 'acronym': 'CHUV', 'name': 'University Hospital of Lausanne', 'country_name': 'Switzerland'}, {'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}]",Application,,WO-2013150002-A1,"['ABEL, LAURENT', 'BOCHUD, PIERRE-YVES']",2013-10-10,1.0,METHODS AND KITS FOR DETERMINING IF A SUBJECT IS PREDISPOSED TO FAST PROGRESSION OF LIVER FIBROSIS,2013
873,['GA GENERIC ASSAYS GMBH'],"[{'id': 'grid.452429.c', 'acronym': 'GA', 'name': 'Generic Assays (Germany)', 'country_name': 'Germany'}]",Application,,WO-2016005354-A1,"['ROGGENBUCK, DIRK']",2016-01-14,1.0,AUTOANTIBODY PROFILING IN APS,2015
874,"['ITERATIVE THERAPEUTICS Inc', 'ARNASON BARRY G W', 'JENSEN MARK A', 'WHITE DAVID M', 'ITERATIVE THERAPEUTICS INC']",,Grant,2015.0,US-8986698-B2,"['Barry G. W. Arnason', 'Mark A. Jensen', 'David M. White']",2015-03-24,7.0,Method of using fusion proteins,2011
875,"['HOFFMANN LA ROCHE', 'HOFFMANN LA ROCHE', 'UNIVERSITAETSKLINIKUM ULM', 'UNIV ZU KOELN']","[{'id': 'grid.410712.1', 'name': 'University Hospital Ulm', 'country_name': 'Germany'}, {'id': 'grid.6190.e', 'name': 'University of Cologne', 'country_name': 'Germany'}, {'id': 'grid.418158.1', 'acronym': 'Roche', 'name': 'Roche (United States)', 'country_name': 'United States'}, {'id': 'grid.417570.0', 'name': 'Roche (Switzerland)', 'country_name': 'Switzerland'}]",Application,,WO-2014068133-A1,"['HALLEK, MICHAEL', 'STILGENBAUER, STEPHAN', 'DÖHNER, Hartmut', 'KLEIN, CHRISTIAN', 'UMAÑA, Pable']",2014-05-08,,PREDICTIVE MARKER FOR CANCER TREATMENT,2013
876,"['UNIV PARIS CURIE', 'SASSOON DAVID', 'MARAZZI GIOVANNA', 'BESSON VANESSA']","[{'id': 'grid.462844.8', 'name': 'Sorbonne University', 'country_name': 'France'}]",Application,,WO-2012168459-A1,"['Sassoon, David', 'Marazzi, Giovanna', 'Besson, Vanessa']",2012-12-13,,METHODS FOR IDENTIFYING ADULT STEM CELLS,2012
877,"['King Saud University', 'UNIV KING SAUD']","[{'id': 'grid.56302.32', 'acronym': 'KSU', 'name': 'King Saud University', 'country_name': 'Saudi Arabia'}]",Grant,2016.0,US-9345734-B2,"['Asma Majed Alenad', 'Nabila Abdul-Aziz Al-Jaber']",2016-05-24,,"Achillea fragrantissima extract, method for preparing Achillea fragrantissima extract and method for treating chronic myeloid leukemia",2013
878,"['Universite Pierre et Marie Curie (Paris 6)', 'UNIV PARIS CURIE']","[{'id': 'grid.462844.8', 'name': 'Sorbonne University', 'country_name': 'France'}]",Application,,EP-2533045-A1,"['Sassoon, David', 'Marazzi, Giovanna', 'Besson, Vanessa']",2012-12-12,1.0,Methods for identifying adult stem cells,2011
879,"['Sloan-Kettering Institute for Cancer Research', 'SLOAN KETTERING INST CANCER']","[{'id': 'grid.51462.34', 'acronym': 'MSK', 'name': 'Memorial Sloan Kettering Cancer Center', 'country_name': 'United States'}]",Application,,EP-2802648-A4,"['ORRICHIO ELISA', 'WENDEL HANS-GUIDO']",2015-07-29,,CANCER-SPECIFIC SUICIDE GENE FOR CELL-BASED AND GENE THERAPY,2013
880,['BABRAHAM INST'],"[{'id': 'grid.418195.0', 'name': 'Babraham Institute', 'country_name': 'United Kingdom'}]",Application,,WO-2017208001-A1,"['FRASER, PETER', 'SCHOENFELDER, Stefan', 'SPIVAKOV, Mikhail']",2017-12-07,,BIOMARKERS FOR PLATELET DISORDERS,2017
881,"['University of Michigan', 'UNIV MICHIGAN REGENTS']","[{'id': 'grid.214458.e', 'acronym': 'UM', 'name': 'University of Michigan', 'country_name': 'United States'}]",Grant,2017.0,US-9657350-B2,"['Kojo Elenitoba-Johnson', 'Thirunavukkarasu Velusamy', 'Nallasivam Palanisamy', 'Anagh Sahasrabuddhe', 'Megan Lim', 'Arul Chinnaiyan']",2017-05-23,,RNA chimeras in human leukemia and lymphoma,2014
882,"['BARMARSA RESEARCH LLC', 'BARMARSA RES LLC']",,Grant,2017.0,US-9669068-B2,['Fred L. Shaw'],2017-06-06,,Methods for the treatment of cancer using gliadin peptides,2016
883,['ISIS INNOVATION'],"[{'id': 'grid.4991.5', 'name': 'University of Oxford', 'country_name': 'United Kingdom'}]",Application,,WO-2013186541-A1,"['FUGGER, LARS', 'MCVEAN, GILEAN', 'DENDRON, Calliopi, Athena', 'GREGORY, Adam, Patrick', 'ATTFIELD, Kathrine, Elizabeth']",2013-12-19,,BIOMARKER FOR DETERMINING THE SUITABILITY OF ANTI -TUMOUR NECROSIS FACTOR (ANTI-TNF) THERAPY IN THE TREATMENT OF AUTOIMMUNE DISEASES,2013
884,"['CSL Ltd', 'CSL Behring GmbH', 'PANOUSIS CON', 'RAYZMAN VERONIKA', 'NASH ANDREW', 'WILSON MICHAEL', 'SCHMIDBAUER STEFAN', 'NOLTE MARC', 'CSL BEHRING GMBH', 'CSL LTD']","[{'id': 'grid.420252.3', 'name': 'CSL Behring (Germany)', 'country_name': 'Germany'}, {'id': 'grid.1135.6', 'name': 'CSL (Australia)', 'country_name': 'Australia'}]",Grant,2016.0,US-9518127-B2,"['Con Panousis', 'Veronika Rayzman', 'Andrew Nash', 'Michael Wilson', 'Stefan Schmidbauer', 'Marc Nolte']",2016-12-13,,Inhibitory anti-factor XII/XIIA monoclonal antibodies and their uses,2012
885,"['ITERATIVE THERAPEUTICS Inc', 'ITERATIVE THERAPEUTICS INC']",,Grant,2015.0,US-9127063-B2,"['Barry G. W. Arnason', 'Mark A. Jensen', 'David M. White']",2015-09-08,,Nucleic acids related to fusion proteins,2013
886,"['ROSSI DAVIDE', 'GAIDANO GIANLUCA', 'FOA ROBERT', 'TROVAGENE INC']",,Application,,WO-2013049750-A1,"['ROSSI, DAVIDE', 'GAIDANO, Gianluca', 'FOA, Robert']",2013-04-04,1.0,MUTATIONS IN SF3B1 AND CHRONIC LYMPHOCYTIC LEUKEMIA,2012
887,"['BROAD INST INC', 'MASSACHUSETTS INST TECHNOLOGY', 'HARVARD COLLEGE', ""THE BRIGHAM AND WOMEN'S HOSPITAL INC"", 'UNIV CALIFORNIA']","[{'id': 'grid.62560.37', 'acronym': 'BWH', 'name': ""Brigham and Women's Hospital"", 'country_name': 'United States'}, {'id': 'grid.116068.8', 'acronym': 'MIT', 'name': 'Massachusetts Institute of Technology', 'country_name': 'United States'}, {'id': 'grid.38142.3c', 'name': 'Harvard University', 'country_name': 'United States'}, {'id': 'grid.66859.34', 'name': 'Broad Institute', 'country_name': 'United States'}, {'id': 'grid.30389.31', 'name': 'University of California System', 'country_name': 'United States'}]",Application,,WO-2016138488-A2,"['REGEV, AVIV', 'KUCHROO, VIJAY, K.', 'GAUBLOMME, Jellert', 'Lee, Youjin', 'WANG, CHAO', 'YOSEF, Nir', 'PARK, HONGKUN', 'KAMINSKI, James']",2016-09-01,2.0,"T CELL BALANCE GENE EXPRESSION, COMPOSITIONS OF MATTERS AND METHODS OF USE THEREOF",2016
888,['CANCER REC TECH LTD'],"[{'id': 'grid.432780.a', 'acronym': 'CRT', 'name': 'Cancer Research Technology', 'country_name': 'United Kingdom'}]",Application,,WO-2014111704-A1,"['BANHAM, ALISON HILARY', 'HARRIS, ADRIAN LLEWELLYN', 'HANDFORD, Penelope Ann', 'LEA, Susan Mary']",2014-07-24,4.0,ANTIBODIES THAT BIND TO JAGGED 1,2014
889,"['CASA LUKER SA', 'RENGIFO RAUL CUERO', 'CASA LUKER S A']",,Grant,2016.0,US-9428759-B2,['Raul Cuero Rengifo'],2016-08-30,,Methods for increasing the production of phenolic compounds from Theobroma cacao ,2013
890,['UNIVERSIT DEGLI STUDI DI ROMA LA SAPIENZA'],"[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Application,,WO-2014162304-A1,"['MECHELLI, Rosella', 'POLICANO, Claudia', 'UMETON, Renato', 'SALVETTI, MARCO', 'RISTORI, GIOVANNI']",2014-10-09,,"EPSTEIN BARR VIRUS GENOTIPIC VARIANTS AND USES THEREOF AS RISK PREDICTORS, BIOMARKERS AND THERAPEUTIC TARGETS OF MULTIPLE SCLEROSIS",2014
891,"['SABANCI UENIVERSITESI', 'KAYAHAN HUESEYIN', 'GUERBUEZ YASAR']",,Application,,WO-2013127450-A1,"['KAYAHAN, Hüseyin', 'GÜRBÜZ, Yasar']",2013-09-06,2.0,SELF-RESET ASYNCHRONOUS PULSE FREQUENCY MODULATED DROIC WITH EXTENDED COUNTING AND HAVING REDUCED QUANTIZATION NOISE,2012
892,"['NOVARTIS AG', 'KORTEBEIN PATRICK', 'ROOKS DANIEL', 'KLICKSTEIN LLOYD B', 'ROUBENOFF RONENN', 'GLASS DAVID', 'TRIFILIEFF ESTELLE', 'PAPANICOLAOU DIMITRIS']","[{'id': 'grid.419481.1', 'name': 'Novartis (Switzerland)', 'country_name': 'Switzerland'}]",Application,,WO-2016092439-A1,"['KORTEBEIN, Patrick', 'ROOKS, Daniel', 'KLICKSTEIN, LLOYD B.', 'ROUBENOFF, RONENN', 'GLASS, DAVID', 'TRIFILIEFF, ESTELLE', 'PAPANICOLAOU, Dimitris']",2016-06-16,6.0,MYOSTATIN OR ACTIVIN ANTAGONISTS FOR THE TREATMENT OF SARCOPENIA,2015
893,"['MUSC Foundation for Research Development', 'MUSC FOUND FOR RES DEV']","[{'id': 'grid.259828.c', 'acronym': 'MUSC', 'name': 'Medical University of South Carolina', 'country_name': 'United States'}]",Grant,2015.0,US-9186391-B2,"['Patrick M. Woster', 'Isuru R. KUMARASINGHE']",2015-11-17,,Cyclic peptide inhibitors of lysine-specific demethylase 1,2014
894,"['Insmed Inc', 'GUPTA RENU', 'INSMED INC']","[{'id': 'grid.418728.0', 'name': 'Insmed (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9333214-B2,['Renu Gupta'],2016-05-10,14.0,Method for treating pulmonary disorders with liposomal amikacin formulations,2012
895,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9695167-B2,"['Liangxing Wu', 'Xiaozhao Wang', 'Wenqing Yao', 'Colin Zhang']",2017-07-04,10.0,"Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors",2015
896,"['Janssen Cilag SA', 'Vanderbilt University', 'UNIV VANDERBILT']","[{'id': 'grid.152326.1', 'name': 'Vanderbilt University', 'country_name': 'United States'}]",Grant,2014.0,US-8901125-B2,"['P. Jeffrey Conn', 'Craig W. Lindsley', 'Shaun R. Stauffer', 'José Manuel Bartolomé-Nebreda', 'Susana Conde-Ceide', 'Gregor James MacDonald', 'Han Min Tong', 'Miguel Angel Pena-Piñón', 'Manuel Jesús Alcázar-Vaca', 'José Ignacio Andrés-Gil']",2014-12-02,1.0,Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mGluR5 receptors,2013
897,"['ISTITUTO NAZ DI FISICA NUCLEARE', 'UNIV ROMA']",,Application,,WO-2015173841-A3,"['PANI, ROBERTO', 'ORSOLINI CENCELLI, Valentino', 'FABBRI, ANDREA']",2016-01-07,,ECHO-SCINTIGRAPHIC PROBE FOR MEDICAL APPLICATIONS AND RELEVANT DIAGNOSTIC METHOD,2015
898,"['University of Alabama at Birmingham Research Foundation', 'UAB RESEARCH FOUNDATION']","[{'id': 'grid.265892.2', 'acronym': 'UAB', 'name': 'University of Alabama at Birmingham', 'country_name': 'United States'}]",Application,,EP-2803119-A4,"['ARUMUGAM ANITHA', 'MARTYSHKIN DMITRY V', 'FEDOROV VLADIMIR V', 'HILTON DAVID J', 'MIROV SERGEY B']",2016-01-06,,MIDDLE-INFRARED VOLUMETRIC BRAGG GRATING BASED ON ALKALIHALIDE COLOR CENTER CRYSTALS,2013
899,"['Shizuoka University NUC', 'UNIV SHIZUOKA NAT UNIV CORP']","[{'id': 'grid.263536.7', 'name': 'Shizuoka University', 'country_name': 'Japan'}, {'id': 'grid.469280.1', 'name': 'University of Shizuoka', 'country_name': 'Japan'}]",Application,,EP-2857939-A4,['EBISAWA YOSHINOBU'],2016-09-14,,"PUPIL DETECTION METHOD, CORNEAL REFLEX DETECTION METHOD, FACIAL POSTURE DETECTION METHOD, AND PUPIL TRACKING METHOD",2013
900,"['Janssen Pharmaceuticals Inc', 'CID-NÚÑEZ JOSÉ MARIA', 'TRABANCO-SUÁREZ ANDRÉS AVELINO', 'VEGA RAMIRO JUAN ANTONIO', 'OEHLRICH DANIEL', 'TRESADERN GARY JOHN', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC']",,Grant,2015.0,US-8993591-B2,"['José Maria Cid-Núñez', 'Andrés Avelino Trabanco-Suárez', 'Juan Antonio Vega Ramiro', 'Daniel Oehlrich', 'Gary John Tresadern', 'Gregor James MacDonald']",2015-03-31,1.0,"1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors",2011
901,"['Janssen Pharmaceuticals Inc', 'CID-NÚÑEZ JOSÉ MARIA', 'TRABANCO-SUÁREZ ANDRÉS AVELINO', 'VEGA RAMIRO JUAN ANTONIO', 'OEHLRICH DANIEL', 'TRESADERN GARY JOHN', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC']",,Grant,2016.0,US-9271967-B2,"['José Maria Cid-Núñez', 'Andrés Avelino Trabanco-Suárez', 'Juan Antonio Vega Ramiro', 'Daniel Oehlrich', 'Gary John Tresadern', 'Gregor James MacDonald']",2016-03-01,1.0,"1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2011
902,['FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RES'],"[{'id': 'grid.482245.d', 'acronym': 'FMI', 'name': 'Friedrich Miescher Institute', 'country_name': 'Switzerland'}]",Application,,WO-2018083608-A1,"['GASSER, SUSAN M.', 'SEEBER, Andrew', 'HAUER, Michael Hermann']",2018-05-11,,METHODS FOR INCREASING THE FREQUENCY OF GENE TARGETING BY CHROMATIN MODIFICATION,2017
903,"['Janssen Pharmaceutica NV', 'Addex Therapeutics Ltd', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA']","[{'id': 'grid.419619.2', 'name': 'Janssen (Belgium)', 'country_name': 'Belgium'}, {'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8906939-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey']",2014-12-09,,3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives,2008
904,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'LUTJENS ROBERT JOHANNES', 'FINN PATRICK TERRY', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8722894-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lutjens', 'Patrick Terry Finn']",2014-05-13,,"1,3-disubstituted-4-phenyl-1H-pyridin-2-ones",2008
905,"['Janssen Pharmaceutica NV', 'JANSSEN PHARMACEUTICA NV']","[{'id': 'grid.419619.2', 'name': 'Janssen (Belgium)', 'country_name': 'Belgium'}]",Grant,2017.0,US-9708315-B2,"['José Maria Cid-Núñez', 'Andrés Avelino Trabanco-Suárez', 'Marc André Ceusters', 'Hilde Lavreysen']",2017-07-18,1.0,"1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of MGLUR2 receptors",2014
906,"['Insmed Inc', 'INSMED INC']","[{'id': 'grid.418728.0', 'name': 'Insmed (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9549939-B2,['Jeff Weers'],2017-01-24,10.0,Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof,2016
907,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9994546-B2,"['Liangxing Wu', 'Wenqing Yao']",2018-06-12,5.0,Cyclopropylamines as LSD1 inhibitors,2016
908,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'OEHLRICH DANIEL', 'TRABANCO-SUAREZ ANDRES AVELINO', 'TRESADERN GARY JOHN', 'VEGA RAMIRO JUAN ANTONIO', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-8937060-B2,"['Jose Maria Cid-Nunez', 'Daniel Oehlrich', 'Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Gregor James MacDonald']",2015-01-20,9.0,"1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders",2010
909,"['Insmed Inc', 'INSMED INC']","[{'id': 'grid.418728.0', 'name': 'Insmed (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9402845-B2,['Jeff Weers'],2016-08-02,14.0,Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof,2016
910,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-9132122-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lütjens', 'Terry Patrick Finn']",2015-09-15,,"1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones",2013
911,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'LUTJENS ROBERT JOHANNES', 'FINN PATRICK TERRY', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8748621-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lutjens', 'Patrick Terry Finn']",2014-06-10,,"1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones",2012
912,"['Insmed Inc', 'INSMED INC']","[{'id': 'grid.418728.0', 'name': 'Insmed (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9724301-B2,['Renu Gupta'],2017-08-08,5.0,Methods of treating pulmonary disorders with liposomal amikacin formulations,2015
913,"['Insmed Inc', 'INSMED INC']","[{'id': 'grid.418728.0', 'name': 'Insmed (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9511082-B2,['Jeff Weers'],2016-12-06,10.0,Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof,2016
914,"['Insmed Inc', 'GUPTA RENU', 'INSMED INC']","[{'id': 'grid.418728.0', 'name': 'Insmed (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9119783-B2,['Renu Gupta'],2015-09-01,17.0,Method of treating pulmonary disorders with liposomal amikacin formulations,2012
915,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10047086-B2,"['Liangxing Wu', 'Leah C. Konkol', 'Neil Lajkiewicz', 'Liang Lu', 'Meizhong Xu', 'Wenqing Yao', 'Zhiyong Yu', 'Colin Zhang', 'Chunhong He']",2018-08-14,,Imidazopyridines and imidazopyrazines as LSD1 inhibitors,2017
916,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-9085577-B2,"['Jose Maria Cid-Nunez', 'Ana Isabel De Lucas Olivares', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald']",2015-07-21,,"7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2014
917,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'DE LUCAS OLIVARES ANA ISABEL', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-8946205-B2,"['Jose Maria Cid-Nunez', 'Ana Isabel De Lucas Olivares', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald']",2015-02-03,1.0,"1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2010
918,"['Vanderbilt University', 'CONN P JEFFREY', 'LINDSLEY CRAIG W', 'STAUFFER SHAUN R', 'MANKA JASON', 'JACOBS JON', 'ZHOU YA', 'BARTOLOMÉ-NEBREDA JOSÉ MANUEL', 'MACDONALD GREGOR JAMES', 'CONDE-CEIDE SUSANA', 'JONES CARRIE K', 'UNIV VANDERBILT']","[{'id': 'grid.152326.1', 'name': 'Vanderbilt University', 'country_name': 'United States'}]",Grant,2014.0,US-8853237-B2,"['P. Jeffrey Conn', 'Craig W. Lindsley', 'Shaun R. Stauffer', 'Jason Manka', 'Jon Jacobs', 'Ya Zhou', 'José Manuel Bartolomé-Nebreda', 'Gregor James MacDonald', 'Susana Conde-Ceide', 'Carrie K. Jones']",2014-10-07,1.0,Naphthyridinone analogs as mGluR5 positive allosteric modulators,2011
919,"['Vanderbilt University', 'CONN P JEFFREY', 'LINDSLEY CRAIG W', 'STAUFFER SHAUN R', 'MANKA JASON', 'JACOBS JON', 'ZHOU YA', 'BARTOLOMÉ-NEBREDA JOSÉ MANUEL', 'MACDONALD GREGOR JAMES', 'CONDE-CEIDE SUSANA', 'DAWSON ERIC S', 'UNIV VANDERBILT']","[{'id': 'grid.152326.1', 'name': 'Vanderbilt University', 'country_name': 'United States'}]",Grant,2014.0,US-8710074-B2,"['P. Jeffrey Conn', 'Craig W. Lindsley', 'Shaun R. Stauffer', 'Jason Manka', 'Jon Jacobs', 'Ya Zhou', 'José Manuel Bartolomé-Nebreda', 'Gregor James MacDonald', 'Susana Conde-Ceide', 'Eric S. Dawson']",2014-04-29,2.0,Dihydronaphthyridinyl(organo)methanone analogs as positive allosteric mGluR5 modulators,2012
920,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2016.0,US-9266834-B2,"['Hassan Julien Imogai', 'Jose Maria Cid-Nunez', 'Jose Ignacio Andres-Gil', 'Andres Avelino Trabanco-Suarez', 'JULEN OYARZABAL SANTAMARINA', 'Frank Matthias Dautzenberg', 'Gregor James MacDonald', 'SHRILEY ELIZABETH PULLAN', 'Robert Johannes Lutjens', 'Guillaume Albert Jacques Duvey', 'Vanthea Nhem', 'Terry Patrick Finn', 'Gagik Melikyan']",2016-02-23,,"1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors",2014
921,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'LUTJENS ROBERT JOHANNES', 'FINN TERRY PATRICK', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-9114138-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lutjens', 'Terry Patrick Finn']",2015-08-25,,"1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones",2008
922,"['PARI Pharma GmbH', 'Insmed Inc', 'INSMED INC']","[{'id': 'grid.476581.9', 'name': 'PARI (Germany)', 'country_name': 'Germany'}, {'id': 'grid.418728.0', 'name': 'Insmed (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9566234-B2,"['Walter Perkins', 'Vladimir Malinin', 'Xingong Li', 'Brian Miller', 'Dominique Seidel', 'Philipp Holzmann', 'Harald Schulz', 'Michael Hahn']",2017-02-14,,Systems for treating pulmonary infections,2013
923,"['SATORI PHARMACEUTICALS INC', 'BRONK BRIAN SCOTT', 'AUSTIN WESLEY FRANCIS', 'CREASER STEFFEN PHILLIP', 'FULLER NATHAN OLIVER', 'HUBBS JED LEE', 'IVES JEFFREY LEE', 'SHEN RUICHAO']",,Application,,WO-2013036679-A1,"['BRONK, BRIAN, SCOTT', 'AUSTIN, WESLEY, FRANCIS', 'CREASER, STEFFEN, PHILLIP', 'FULLER, NATHAN, OLIVER', 'HUBBS, JED, LEE', 'IVES, JEFFREY, LEE', 'SHEN, RUICHAO']",2013-03-14,,COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS,2012
924,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9758523-B2,"['Liangxing Wu', 'Xiaozhao Wang', 'Wenqing Yao', 'Colin Zhang']",2017-09-12,7.0,Triazolopyridines and triazolopyrazines as LSD1 inhibitors,2015
925,"['Insmed Inc', 'INSMED INC']","[{'id': 'grid.418728.0', 'name': 'Insmed (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9895385-B2,"['Gina Eagle', 'Renu Gupta']",2018-02-20,5.0,Methods for treating pulmonary non-tuberculous mycobacterial infections,2015
926,"['Insmed Inc', 'INSMED INC']","[{'id': 'grid.418728.0', 'name': 'Insmed (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9549925-B2,['Jeff Weers'],2017-01-24,10.0,Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof,2016
927,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9944647-B2,"['Chunhong He', 'Zhenwu Li', 'Liangxing Wu', 'Wenqing Yao', 'Fenglei Zhang']",2018-04-17,7.0,Heterocyclic compounds as LSD1 inhibitors,2016
928,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'DE LUCAS OLIVARES ANA ISABEL', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8716480-B2,"['Jose Maria Cid-Nunez', 'Ana Isabel De Lucas Olivares', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald']",2014-05-06,1.0,"7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2010
929,"['Eberhard Karls Universitaet Tuebingen', 'EBERHARD KARLS UNI TUBINGEN']","[{'id': 'grid.10392.39', 'name': 'University of Tübingen', 'country_name': 'Germany'}]",Application,,GB-2503004-A,"['JEHLE ANNA KRISTINA', 'LIPSCHIS MARTIN', 'ALBERT MARKUS', 'FELIX GEORG']",2013-12-18,1.0,Chimeric pattern recognition receptors for bacterial plant pathogens such as Xanthomonas,2012
930,"['Insmed Inc', 'INSMED INC']","[{'id': 'grid.418728.0', 'name': 'Insmed (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9827317-B2,"['Lawrence T. Boni', 'Brian S. Miller', 'Vladimir Malinin', 'Xingong Li']",2017-11-28,5.0,Sustained release of antiinfectives,2014
931,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8697689-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez']",2014-04-15,1.0,Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors,2009
932,"['Janssen Cilag SA', 'Janssen Pharmaceuticals Inc', 'CID-NÚÑEZ JOSÉ MARIA', 'TRABANCO-SUÁREZ ANDRÉS AVELINO', 'VEGA RAMIRO JUAN ANTONIO', 'OEHLRICH DANIEL', 'TRESADERN GARY JOHN', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC']",,Grant,2015.0,US-9012448-B2,"['José Maria Cid-Núñez', 'Andrés Avelino Trabanco-Suárez', 'Juan Antonio Vega Ramiro', 'Daniel Oehlrich', 'Gary John Tresadern', 'Gregor James MacDonald']",2015-04-21,8.0,"1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors",2011
933,"['Janssen Pharmaceutica NV', 'Addex Therapeutics Ltd', 'TRABANCO-SUAREZ ANDRES AVELINO', 'TRESADERN GARY JOHN', 'VEGA RAMIRO JUAN ANTONIO', 'CID-NUNEZ JOSE MARIA', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}, {'id': 'grid.419619.2', 'name': 'Janssen (Belgium)', 'country_name': 'Belgium'}]",Grant,2014.0,US-8785486-B2,"['Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Jose Maria Cid-Nunez']",2014-07-22,,"Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2008
934,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9493450-B2,"['Liangxing Wu', 'Chunhong He', 'Leah C. Konkol', 'Ding-Quan Qian', 'Wenqing Yao']",2016-11-15,11.0,Cyclopropylamines as LSD1 inhibitors,2015
935,"['Insmed Inc', 'INSMED INC']","[{'id': 'grid.418728.0', 'name': 'Insmed (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9737555-B2,['Renu Gupta'],2017-08-22,5.0,Method of treating pulmonary disorders with liposomal amikacin formulations,2015
936,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'LUTJENS ROBERT JOHANNES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-9067891-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lutjens']",2015-06-30,,"1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mGluR2-receptors",2012
937,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9527835-B2,"['Liangxing Wu', 'Chunhong He', 'Ding-Quan Qian', 'Bo Shen', 'Wenqing Yao']",2016-12-27,11.0,Cyclopropylamines as LSD1 inhibitors,2015
938,"['Insmed Inc', 'GUPTA RENU', 'INSMED INC']","[{'id': 'grid.418728.0', 'name': 'Insmed (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9114081-B2,['Renu Gupta'],2015-08-25,17.0,Methods of treating pulmonary disorders with liposomal amikacin formulations,2008
939,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2016.0,US-9226930-B2,"['Jose Maria Cid-Nunez', 'Daniel Oehlrich', 'Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Gregor James MacDonald']",2016-01-05,1.0,"1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders",2014
940,"['Insmed Inc', 'INSMED INC']","[{'id': 'grid.418728.0', 'name': 'Insmed (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9925205-B2,['Vladimir Malinin'],2018-03-27,5.0,Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods of use thereof,2014
941,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8691849-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez']",2014-04-08,,3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors,2009
942,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9695180-B2,"['Liangxing Wu', 'Joel R. Courter', 'Chunhong He', 'Jingwei Li', 'Liang Lu', 'Yaping Sun', 'Xiaozhao Wang', 'Wenqing Yao', 'Colin Zhang', 'Jincong Zhuo']",2017-07-04,10.0,"Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors",2015
943,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA', 'ADDEX PHARMA, S.A.']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2018.0,US-10071095-B2,"['Jose Maria Cid-Nunez', 'Daniel Oehlrich', 'Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Gregor James MACDONOLD']",2018-09-11,,"1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders",2017
944,"['Samsung Electronics Co Ltd', 'SAMSUNG ELECTRONICS CO LTD']","[{'id': 'grid.419666.a', 'name': 'Samsung (South Korea)', 'country_name': 'South Korea'}]",Application,,EP-2752760-A3,"['SEO, MAN KEUN', 'KIM, DAE WOOK', 'SON, HONG RAK', 'KONG, JUN JIN']",2015-07-29,,Method of compressing data and devices for performing the same,2013
945,"['Janssen Cilag SA', 'Vanderbilt University', 'UNIV VANDERBILT']","[{'id': 'grid.152326.1', 'name': 'Vanderbilt University', 'country_name': 'United States'}]",Grant,2015.0,US-9029366-B2,"['P. Jeffrey Conn', 'Craig W. Lindsley', 'Shaun R. Stauffer', 'José Manuel Bartolomé-Nebreda', 'Susana Conde-Ceide', 'Gregor James MacDonald', 'Han Min Tong', 'Miguel Angel Pena-Piñón', 'Manuel Jesús Alcázar-Vaca', 'José Ignacio Andrés-Gil']",2015-05-12,1.0,Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mGluR5 receptors,2013
946,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9670210-B2,"['Liangxing Wu', 'Chunhong He', 'Wenqing Yao', 'Fenglei Zhang']",2017-06-06,9.0,Cyclopropylamines as LSD1 inhibitors,2015
947,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9695168-B2,"['Liangxing Wu', 'Leah C. Konkol', 'Neil Lajkiewicz', 'Liang Lu', 'Meizhong Xu', 'Wenqing Yao', 'Zhiyong Yu', 'Colin Zhang', 'Chunhong He']",2017-07-04,10.0,"Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors",2015
948,"['Insmed Inc', 'INSMED INC']","[{'id': 'grid.418728.0', 'name': 'Insmed (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10064882-B2,['Renu Gupta'],2018-09-04,3.0,Methods of treating pulmonary disorders with liposomal amikacin formulations,2017
949,"['Alexion Pharmaceuticals Inc', 'ALEXION PHARMA INC']","[{'id': 'grid.422288.6', 'name': 'Alexion Pharmaceuticals (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9862767-B2,"['Russell P. Rother', 'Yan Yan']",2018-01-09,,Therapeutic methods using anti-CD200 antibodies,2015
950,"['British Columbia Cancer Agency (BCCA)', 'BRITISH COLUMBIA CANCER AGENCY BRANCH']","[{'id': 'grid.248762.d', 'acronym': 'BCCA', 'name': 'BC Cancer Agency', 'country_name': 'Canada'}]",Grant,2017.0,US-9552457-B2,"['Steven J. M. Jones', 'Oleksandr Yakovenko', 'Silvia Thoene', 'Pierre Yulmin Cheung', 'Jianghong An']",2017-01-24,,Reprogramming effector protein interactions to correct epigenetic defects in cancer,2013
951,"['STATE UNIVERSITY OF YEREVAN', 'Addex Therapeutics Ltd', 'Janssen Cilag SA', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'ANDRES-GIL JOSE IGNACIO', 'TRABANCO-SUAREZ ANDRES AVELINO', 'OYARZABAL SANTAMARINA JULEN', 'DAUTZENBERG FRANK MATTHIAS', 'MACDONALD GREGOR JAMES', 'PULLAN SHIRLEY ELIZABETH', 'LUTJENS ROBERT JOHANNES', 'DUVEY GUILLAUME ALBERT JACQUES', 'NHEM VANTHEA', 'FINN TERRY PATRICK', 'MELIKYAN GAGIK', 'MUTEL VINCENT', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}, {'id': 'grid.21072.36', 'acronym': 'YSU', 'name': 'Yerevan State University', 'country_name': 'Armenia'}]",Grant,2014.0,US-8841323-B2,"['Hassan Julien Imogai', 'Jose Maria Cid-Nunez', 'Jose Ignacio Andres-Gil', 'Andres Avelino Trabanco-Suarez', 'Julen Oyarzabal Santamarina', 'Frank Matthias Dautzenberg', 'Gregor James MacDonald', 'Shirley Elizabeth Pullan', 'Robert Johannes Lutjens', 'Guillaume Albert Jacques Duvey', 'Vanthea Nhem', 'Terry Patrick Finn', 'Gagik Melikyan']",2014-09-23,,"1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors",2007
952,"['Incyte Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9493442-B2,"['Liangxing Wu', 'Joel R. Courter', 'Chunhong He', 'Bo Shen', 'Xiaozhao Wang', 'Wenqing Yao', 'Fenglei Zhang']",2016-11-15,11.0,Cyclopropylamines as LSD1 inhibitors,2015
953,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2017.0,US-9737533-B2,"['Jose Maria Cid-Nunez', 'Daniel Oehlrich', 'Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Gregor James MacDonald']",2017-08-22,1.0,"1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders",2015
954,['UNIV TEXAS'],"[{'id': 'grid.55460.32', 'acronym': 'UT System', 'name': 'The University of Texas System', 'country_name': 'United States'}]",Application,,WO-2013123411-A1,"['WAGNER, KLAUS, W.', 'LEE, Min, Gyu']",2013-08-22,5.0,METHODS FOR DIAGNOSING AND TREATING CANCER,2013
955,['DCB-USA LLC'],,Application,,WO-2017200966-A1,"['TENG, CHE-MING', 'LIOU, JING-PING', 'PAN, SHIOW-LIN', 'YANG, CHIA-RON']",2017-11-23,,HISTONE DEACETYLASE 6 INHIBITORS AND USE THEREOF,2017
956,"['University Health Network', 'DIAMANDIS ELEFTHERIOS P', 'CHO CHAN-KYUNG JANE', 'MARTINEZ MORILLO EDUARDO', 'UNIV HEALTH NETWORK']","[{'id': 'grid.231844.8', 'acronym': 'UHN', 'name': 'University Health Network', 'country_name': 'Canada'}]",Grant,2013.0,US-8574860-B2,"['Eleftherios P. Diamandis', 'Chan-Kyung Jane Cho', 'Eduardo Martinez Morillo']",2013-11-05,,Biomarkers for the detection and screening of down syndrome,2012
957,"['Acea Therapeutics Inc', 'ACEA BIOSCIENCES INC']","[{'id': 'grid.427615.3', 'name': 'ACEA Biosciences (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9034885-B2,"['Xiao Xu', 'Xiaobo Wang', 'Long Mao', 'Li Zhao', 'Biao Xi']",2015-05-19,3.0,EGFR modulators and uses thereof,2013
958,"['Hoffmann Andreas-Claudius', 'Schlaak Jorg Friedrich', 'HOFFMANN ANDREAS-CLAUDIUS', 'SCHLAAK JOERG FRIEDRICH']",,Application,,EP-2706357-A1,"['Hoffmann, Andreas-Claudius', 'SCHLAAK, Jörg Friedrich']",2014-03-12,1.0,Method for identifying subgroups of circulating tumor cells (CTCs) in a CTC population or a sample,2012
959,"['REGION NORDJYLLAND AALBORG SYGEHUS', 'AALBORG UNIV']","[{'id': 'grid.27530.33', 'name': 'Aalborg Hospital', 'country_name': 'Denmark'}, {'id': 'grid.5117.2', 'acronym': 'AAU', 'name': 'Aalborg University', 'country_name': 'Denmark'}]",Application,,WO-2016188530-A1,"['MALTESEN, Raluca Georgiana', 'RASMUSSEN, Bodil Steen', 'WIMMER, Reinhard', 'PEDERSEN, Shona', 'KRISTENSEN, Søren Risom', 'HANIFA, Munsoor Ali']",2016-12-01,,BIOMARKERS FOR PREDICTION OF DEVELOPMENT OF HYPOXEMIA DUE TO ACUTE LUNG INJURY,2016
960,"['Chiba University NUC', 'UNIV CHIBA NAT UNIV CORP']","[{'id': 'grid.136304.3', 'name': 'Chiba University', 'country_name': 'Japan'}]",Application,,EP-2706406-A4,"['OMATSU TAKASHIGE', 'MIYAMOTO KATSUHIKO']",2014-04-16,,OPTICAL VORTEX LASER VIBRATION METHOD AND OPTICAL VORTEX LASER VIBRATION DEVICE,2012
961,"['Scripps Health', 'SCRIPPS HEALTH']","[{'id': 'grid.419722.b', 'name': 'Scripps Health', 'country_name': 'United States'}]",Application,,EP-2943205-A4,"['COLWELL CLIFFORD', 'D LIMA DARRYL']",2016-10-26,,TISSUE ARRAY PRINTING,2014
962,"['Chiba University NUC', 'UNIV CHIBA NAT UNIV CORP']","[{'id': 'grid.136304.3', 'name': 'Chiba University', 'country_name': 'Japan'}]",Application,,EP-2706406-A2,"['OMATSU, TAKASHIGE', 'MIYAMOTO, KATSUHIKO']",2014-03-12,,OPTICAL VORTEX LASER VIBRATION METHOD AND OPTICAL VORTEX LASER VIBRATION DEVICE,2012
963,['UNIV DO PORTO'],"[{'id': 'grid.5808.5', 'name': 'University of Porto', 'country_name': 'Portugal'}]",Application,,WO-2013150450-A1,"['AVERIL BAKER THOMPSON, Gertrude', 'PIMENTA DA SILVA, Eliane', 'BARROS COSTA MARQUES, Sara Andreia', 'OSÓRIO, Hugo', 'VALE CARVALHEIRA, Júlio Gil']",2013-10-10,,"HCV HOMOLOG FRAGMENTS, CELL-LINES AND APPLICATIONS THEREOF",2013
964,['NOVARTIS AG'],"[{'id': 'grid.419481.1', 'name': 'Novartis (Switzerland)', 'country_name': 'Switzerland'}]",Application,,WO-2017081624-A1,"['KLICKSTEIN, LLOYD B.', 'ROUBENOFF, RONENN', 'FEIGE, Jerome', 'TRIFILIEFF, ESTELLE']",2017-05-18,,"USES OF MYOSTATIN ANTAGONISTS, COMBINATIONS CONTAINING THEM AND USES THEREOF",2016
965,['GALDERMA SA'],"[{'id': 'grid.419905.0', 'name': 'Nestlé (Switzerland)', 'country_name': 'Switzerland'}]",Application,,WO-2015181365-A1,"['BOITEAU, JEAN-GUY']",2015-12-03,6.0,CYCLODEXTRIN-GRAFTED HYALURONIC ACID CROSSLINKED WITH DEXTRAN AND USES THEREOF,2015
966,"['INFINITEC ACTIVOS SL', 'INFINITEC ACTIVOS S L', 'PEPTIDEPHARMA NOVA S L']",,Application,,US-20160250128-A1,"['Marisabel Mourelle Mancini', 'Magdalena Carceller Margeli']",2016-09-01,1.0,TARGETED CAPSULES FOR THE DELIVERY OF SKIN WHITENING AGENTS IN THE SKIN,2014
967,"['Siwa Corp', 'GRUBER LEWIS', 'SIWA CORP']",,Grant,2017.0,US-9649376-B2,['Lewis Gruber'],2017-05-16,3.0,Selective removal of age-modified cells for treatment of atherosclerosis,2011
968,"['SERVICIO ANDALUZ DE SALUD', 'UNIV DE CÓRDOBA']","[{'id': 'grid.418355.e', 'acronym': 'SAS', 'name': 'Andalusian Health Service', 'country_name': 'Spain'}, {'id': 'grid.411901.c', 'acronym': 'UCO', 'name': 'University of Córdoba', 'country_name': 'Spain'}]",Application,,WO-2016097443-A1,"['GARCÍA-REVILLO GARCÍA, José', 'CANIS LÓPEZ, Miguel', 'ROMERO MATA, Noelia']",2016-06-23,,PROCEDURE FOR THE ACQUISITION OF DATA FOR THE DETECTION OF ANGIOGENESIS IN LOWER LIMBS,2015
969,"['LSIP LLC', 'NAT CT NEUROLOGY & PSYCHIATRY']",,Application,,EP-2540829-A1,"['HASHIDO KAZUO', 'MIZUNO HIDEYA']",2013-01-02,2.0,"MARKER FOR DETECTION OF MYOGENIC DISEASES, AND METHOD FOR DETECTION OF THE DISEASES USING SAME",2011
970,"['AVEO Pharmaceuticals Inc', 'AVEO PHARMACEUTICALS INC']","[{'id': 'grid.427642.1', 'name': 'AVEO Pharmaceuticals (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9725505-B2,"['Lorena Lerner', 'Sandra Abbott', 'Ailin Bai', 'Ting Chen', 'Maria I. Chiu', 'Qing Liu', 'Laura Poling', 'Nianjun Tao', 'Solly Weiler', 'Zhigang Weng', 'William M. Winston, Jr.', 'Jeno Gyuris']",2017-08-08,,Methods of treatment using anti-GDF15 antibodies,2015
971,"['HOFFMANN ANDREAS-CLAUDIUS', 'SCHLAAK JOERG FRIEDRICH']",,Application,,WO-2014037552-A1,"['Hoffmann, Andreas-Claudius', 'SCHLAAK, Jörg Friedrich']",2014-03-13,1.0,METHOD FOR IDENTIFYING SUBGROUPS OF CIRCULATING TUMOR CELLS (CTCS) IN THE CTC POPULATION OF A BIOLOGICAL SAMPLE,2013
972,"['GENETHON', 'GENETHON']","[{'id': 'grid.419946.7', 'name': 'Genethon (France)', 'country_name': 'France'}]",Application,,FR-2984358-A1,"['JEANSON-LEH LAURENCE', 'ISRAELI DAVID', 'AMOR FATIMA', 'VOIT THOMAS']",2013-06-21,,Methods for the diagnosis of muscular dystrophies,2011
973,"['Acea Therapeutics Inc', 'ACEA BIOSCIENCES INC']","[{'id': 'grid.427615.3', 'name': 'ACEA Biosciences (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9763949-B2,"['Xiao Xu', 'Xiaobo Wang', 'Long Mao', 'Li Zhao', 'Biao Xi']",2017-09-19,,EGFR modulators and uses thereof,2015
974,['CYPRUS INST OF NEUROLOGY AND GENETICS'],"[{'id': 'grid.417705.0', 'acronym': 'CING', 'name': 'Cyprus Institute of Neurology and Genetics', 'country_name': 'Cyprus'}]",Application,,WO-2014006505-A1,"['PHYLACTOU, Leonidas, A.', 'KOUTSOULIDOU, Andrie']",2014-01-09,,MIRNA BIOMARKERS FOR MYOTONIC DYSTROPHY AND METHODS OF USE THEREOF,2013
975,"['UNIV ROMA', 'BRUZZESE CLAUDIO']",,Application,,WO-2013024499-A1,"['BRUZZESE, Claudio']",2013-02-21,1.0,METHOD FOR MEASUREMENT OF MAGNETIC GAP REDUCTION IN THREE-PHASE SYNCHRONOUS MACHINES,2012
976,"['Acea Therapeutics Inc', 'ACEA BIOSCIENCES INC', 'ACEA BIOSCIENCES INC']","[{'id': 'grid.427615.3', 'name': 'ACEA Biosciences (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8685988-B2,"['Xiao Xu', 'Xiaobo Wang', 'Long Mao', 'Li Zhao', 'Biao Xi']",2014-04-01,3.0,EGFR modulators and uses thereof,2013
977,"['Siwa Corp', 'SIWA CORP']",,Grant,2018.0,US-9993535-B2,['Lewis S. Gruber'],2018-06-12,2.0,Method and composition for treating sarcopenia,2015
978,"['GENETHON', 'ASS INST DE MYOLOGIE']","[{'id': 'grid.418250.a', 'name': 'Institute of Myology', 'country_name': 'France'}, {'id': 'grid.419946.7', 'name': 'Genethon (France)', 'country_name': 'France'}]",Application,,WO-2013087907-A1,"['JEANSON-LEH, Laurence', 'ISRAELI, DAVID', 'AMOR, Fatima', 'VOIT, THOMAS']",2013-06-20,7.0,METHODS FOR DIAGNOSIS AND THERAPEUTIC FOLLOW‑UP OF MUSCULAR DYSTROPHIES,2012
979,"['UNI DEGIL STUDI DI ROMA LA SAPIENZA', 'BRUZZESE CLAUDIO']",,Application,,WO-2013024500-A1,"['BRUZZESE, Claudio']",2013-02-21,2.0,METHOD FOR ONLINE EVALUATION OF FAILURE CAUSED BY ROTORIC ECCENTRICITY GENERATORS AND SYNCHRONOUS MOTORS,2012
980,"['UNIV SOUTHAMPTON', 'AGENCY SCIENCE TECH & RES']","[{'id': 'grid.185448.4', 'acronym': 'A*STAR', 'name': 'Agency for Science, Technology and Research', 'country_name': 'Singapore'}, {'id': 'grid.5491.9', 'name': 'University of Southampton', 'country_name': 'United Kingdom'}]",Application,,WO-2015030677-A3,"['LILLYCROP, Karen Ann', 'GODFREY, Keith Malcolm', 'HOLBROOK, Joanna Dawn']",2016-08-25,,A METHOD OF PREDICTING ONE OR MORE NEURO-DEVELOPMENTAL PHENOTYPES OF A SUBJECT,2014
981,"['Acea Therapeutics Inc', 'ACEA BIOSCIENCES INC']","[{'id': 'grid.427615.3', 'name': 'ACEA Biosciences (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9920074-B2,"['Xiao Xu', 'Xiaobo Wang', 'Long Mao', 'Li Zhao', 'Biao Xi']",2018-03-20,,Heterocyclic compounds and uses thereof,2016
982,"['Acea Therapeutics Inc', 'ACEA BIOSCIENCES INC']","[{'id': 'grid.427615.3', 'name': 'ACEA Biosciences (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9586965-B2,"['Xiao Xu', 'Xiaobo Wang', 'Long Mao', 'Li Zhao', 'Biao Xi']",2017-03-07,,"Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases",2013
983,['UNIV ROMA'],,Application,,WO-2016024246-A1,"['FILIPPINI, ANTONIO', 'FAVIA, Annarita', 'ESPOSITO, Bianca', 'ZIPARO, ELIO', 'PALOMBI, Fioretta']",2016-02-18,5.0,A THERAPEUTIC USE OF NAADP AND/OR TCP2 ANTAGONISTS,2015
984,"['Centre National de la Recherche Scientifique CNRS', 'Universite de Bordeaux', 'UNIV BORDEAUX', 'CENTRE NAT RECH SCIENT']","[{'id': 'grid.4444.0', 'acronym': 'CNRS', 'name': 'French National Centre for Scientific Research', 'country_name': 'France'}, {'id': 'grid.412041.2', 'name': 'University of Bordeaux', 'country_name': 'France'}]",Application,,EP-3229026-A1,"['FAUSTIN, BENJAMIN']",2017-10-11,,BIOMARKERS FOR THE DIAGNOSIS OF INFLAMMATION-RELATED DISEASES,2016
985,"['Acea Therapeutics Inc', 'ACEA BIOSCIENCES INC']","[{'id': 'grid.427615.3', 'name': 'ACEA Biosciences (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9464089-B2,"['Xiao Xu', 'Xiaobo Wang', 'Long Mao', 'Li Zhao', 'Biao Xi']",2016-10-11,,Heterocyclic compounds and uses thereof,2014
986,"['GIANNAKAKOU PARASKEVI', 'PLYMATE STEPHEN R']",,Application,,WO-2014047285-A1,"['GIANNAKAKOU, PARASKEVI', 'PLYMATE, STEPHEN, R.']",2014-03-27,6.0,IDENTIFYING TAXANE SENSITIVITY IN PROSTATE CANCER PATIENTS,2013
987,"['Sony Interactive Entertainment Inc', 'Econugenics Inc', 'ELIAZ ISAAC', 'ECONUGENICS INC']",,Grant,2016.0,US-9427449-B2,['Isaac Eliaz'],2016-08-30,2.0,Binding of galectin-3 by low molecular weight pectin,2011
988,['ACEA BIOSCIENCES INC'],"[{'id': 'grid.427615.3', 'name': 'ACEA Biosciences (United States)', 'country_name': 'United States'}]",Application,,WO-2013106792-A1,"['XU, XIAO', 'WANG, XIAOBO', 'MAO, LONG', 'ZHAO, LI', 'XI, BIAO', 'XU, Wanhong', 'TANG, WEI']",2013-07-18,11.0,HETEROCYCLIC COMPOUNDS AND USES AS ANTICANCER AGENTS.,2013
989,"['LSIP LLC', 'LSIP LLC']",,Grant,2015.0,EP-2540829-B1,"['HASHIDO KAZUO', 'MIZUNO HIDEYA']",2015-11-25,,"MARKER FOR DETECTION OF MYOGENIC DISEASES, AND METHOD FOR DETECTION OF THE DISEASES USING SAME",2011
990,"['UVIC IND PARTNERSHIPS Inc', 'NANDI SUBHASIS', 'CHELVAN ILAMPARITHI THIRUMARAI']",,Grant,2016.0,US-9389276-B2,"['Subhasis Nandi', 'Ilamparithi Thirumarai Chelvan']",2016-07-12,2.0,Fault diagnosis of electric machines,2012
991,"['University of South Florida', 'UNIV SOUTH FLORIDA']","[{'id': 'grid.170693.a', 'acronym': 'USF', 'name': 'University of South Florida', 'country_name': 'United States'}]",Grant,2015.0,US-9089589-B2,"['Shyam S. Mohapatra', 'Jia-Wang Wang']",2015-07-28,1.0,Micro-RNAs modulating immunity and inflammation,2013
992,"['NOVARTIS AG', 'KORTEBEIN PATRICK', 'ROOKS DANIEL', 'KLICKSTEIN LLOYD B', 'ROUBENOFF RONENN', 'GLASS DAVID', 'TRIFILIEFF ESTELLE', 'PAPANICOLAOU DIMITRIS']","[{'id': 'grid.419481.1', 'name': 'Novartis (Switzerland)', 'country_name': 'Switzerland'}]",Application,,WO-2016092439-A1,"['KORTEBEIN, Patrick', 'ROOKS, Daniel', 'KLICKSTEIN, LLOYD B.', 'ROUBENOFF, RONENN', 'GLASS, DAVID', 'TRIFILIEFF, ESTELLE', 'PAPANICOLAOU, Dimitris']",2016-06-16,6.0,MYOSTATIN OR ACTIVIN ANTAGONISTS FOR THE TREATMENT OF SARCOPENIA,2015
993,"['AVEO Pharmaceuticals Inc', 'AVEO PHARMACEUTICALS INC']","[{'id': 'grid.427642.1', 'name': 'AVEO Pharmaceuticals (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9175076-B2,"['Lorena Lerner', 'Sandra Abbott', 'Ailin Bai', 'Ting Chen', 'Maria Isabel Chiu', 'Qing Liu', 'Laura Poling', 'Nianjun Tao', 'Solly Weiler', 'Zhigang Weng', 'William M. Winston, Jr.', 'Jeno Gyuris']",2015-11-03,1.0,Anti-GDF15 antibodies,2013
994,"['Amarin Pharmaceuticals Ireland Ltd', 'AMARIN PHARMACEUTICALS IE LTD']",,Grant,2018.0,US-9918955-B2,['Paresh Soni'],2018-03-20,,Methods of reducing the risk of a cardiovascular event in a subject on statin therapy,2017
995,"['PERFECT LITHIUM CORP', 'VERBUM LLC', 'NANO ONE MATERIALS CORP', 'NANO ONE MAT CORP']",,Grant,2017.0,US-9698419-B1,"['Teresita Frianeza-Kullberg', 'Lennart H. Kullberg']",2017-07-04,2.0,Complexometric precursor formulation methodology for industrial production of fine and ultrafine powders and nanopowders of layered lithium mixed metal oxides for battery applications,2014
996,"['UT-Battelle LLC', 'UT-BATTELLE LLC']","[{'id': 'grid.422038.f', 'name': 'UT-Battelle', 'country_name': 'United States'}]",Grant,2017.0,US-9768885-B2,['Bing Qi'],2017-09-19,,Pilot-aided feedforward data recovery in optical coherent communications,2015
997,"['Perfect Lithium Corp', 'NANO ONE MATERIALS CORP', 'NANO ONE MATERIALS CORP']",,Grant,2015.0,US-9136534-B2,['Teresita Frianeza-Kullberg'],2015-09-15,,Complexometric precursors formulation methodology for industrial production of high performance fine and ultrafine powders and nanopowders for specialized applications,2013
998,"['Amarin Pharmaceuticals Ireland Ltd', 'AMARIN PHARMACEUTICALS IE LTD']",,Grant,2018.0,US-10016386-B2,['Paresh Soni'],2018-07-10,,Methods of reducing the risk of a cardiovascular event in a subject on statin therapy,2018
999,"['Amarin Pharmaceuticals Ireland Ltd', 'AMARIN PHARMACEUTICALS IE LTD']",,Grant,2018.0,US-9855240-B2,['Joseph S. Zakrzewski'],2018-01-02,1.0,Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof,2016
1000,"['ANCHORED RSK3 INHIBITORS LLC', 'ANCHORED RSK3 INHIBITORS LLC']",,Grant,2018.0,US-9937228-B2,"['Michael S Kapiloff', 'Jinliang Li', 'Michael Kritzer', 'Catherine PASSARIELLO', 'Kimberly DODGE-KAFKA']",2018-04-10,,Treatment of myocardial infarction by inhibiting the action of mAKAPβ,2015
1001,"['ANCHORED RSK3 INHIBITORS LLC', 'ANCHORED RSK3 INHIBITORS LLC']",,Grant,2015.0,US-9132174-B2,"['Michael S Kapiloff', 'Jinliang Li', 'Michael Kritzer', 'Catherine PASSARIELLO', 'Kimberly DODGE-KAFKA']",2015-09-15,,Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3),2014
1002,"['Telefonaktiebolaget LM Ericsson AB', 'ERICSSON TELEFON AB L M']","[{'id': 'grid.28287.37', 'name': 'Ericsson (Sweden)', 'country_name': 'Sweden'}]",Application,,EP-2884696-A1,"['CÖSTER, Rickard', 'HUANG, VINCENT']",2015-06-17,,Sketch based monitoring of a communication network,2013
1003,"['Amarin Pharmaceuticals Ireland Ltd', 'AMARIN PHARMACEUTICALS IE LTD']",,Grant,2018.0,US-10010517-B2,"['Mehar Manku', 'Ian Osterloh', 'Pierre Wicker', 'Rene Braeckman', 'Paresh Soni']",2018-07-03,,Stable pharmaceutical composition and methods of using same,2017
1004,"['PERFECT LITHIUM CORP', 'NANO ONE MATERIALS CORP', 'NANO ONE CORP', 'NANO ONE MATERIALS CORP']",,Grant,2015.0,US-9159999-B2,['Teresita Frianeza-Kullberg'],2015-10-13,,Complexometric precursor formulation methodology for industrial production of fine and ultrafine powders and nanopowders for lithium metal oxides for battery applications,2013
1005,"['Google LLC', 'GOOGLE INC', 'GOOGLE INC']","[{'id': 'grid.420451.6', 'name': 'Google', 'country_name': 'United States'}]",Application,,US-20140164369-A1,"['Matthew J. Nichols', 'Nikunj Bhagat', 'Ian Porteous']",2014-06-12,4.0,ITEM COUNT APPROXIMATION,2013
1006,"['Incyte Holdings Corp', 'INCYTE CORP']","[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8895571-B2,"['Taisheng Huang', 'Hao Feng', 'Lingquan Kong', 'Anlai Wang', 'Hai Fen Ye', 'Chu-Biao Xue']",2014-11-25,,Isoindolinone and pyrrolopyridinone derivatives as Akt inhibitors,2012
1007,"['Sloan-Kettering Institute for Cancer Research', 'MEMORIAL SLOAN KETTERING CANCER CENTER']","[{'id': 'grid.51462.34', 'acronym': 'MSK', 'name': 'Memorial Sloan Kettering Cancer Center', 'country_name': 'United States'}]",Grant,2018.0,US-9889135-B2,"['Andrew Koff', 'Aimee Crago', 'David Liu', 'Marta Kovatcheva', 'Samuel Singer', 'Gary K. Schwartz', 'Mark A. Dickson', 'Mary Elizabeth Klein']",2018-02-13,,Companion diagnostic for CDK4 inhibitors,2015
1008,"['International Business Machines Corp', 'IBM']","[{'id': 'grid.410484.d', 'name': 'IBM (United States)', 'country_name': 'United States'}]",Application,,US-20150171966-A1,['Mariusz A. Rokicki'],2015-06-18,,REGENERATOR PLACEMENT USING A POLYNOMIAL-TIME ALGORITHM,2013
1009,"['Amarin Pharmaceuticals Ireland Ltd', 'AMARIN PHARMACEUTICALS IE LTD']",,Application,,US-20140004183-A1,"['Paresh Soni', 'Rene Braeckman', 'William Stirtan']",2014-01-02,39.0,METHODS FOR TREATING CARDIOVASCULAR DISEASE IN STATIN-TOLERANT SUBJECTS,2013
1010,"['Amarin Pharmaceuticals Ireland Ltd', 'AMARIN PHARMACEUTICALS IE LTD']",,Grant,2017.0,US-9827219-B2,"['Mehar Manku', 'Ian Osterloh', 'Pierre Wicker', 'Rene Braeckman', 'Paresh Soni']",2017-11-28,,Compositions and methods for lowering levels of high-sensitivity C-reactive protein (HS-CRP) in a subject,2013
1011,"['UNIVERSIT DEGLI STUDI DI ROMA LA SAPIENZA', 'IST FISIOTERAP OSPITALROMA', 'FRANCESCHIN MARCO', 'CASAGRANDE VALENTINA']","[{'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Application,,WO-2014057511-A1,"['FRANCESCHIN, MARCO', 'CASAGRANDE, Valentina', 'ORTAGGI, GIANCARLO', 'BIANCO, Armando, Doriano', 'BIROCCIO, Annamaria']",2014-04-17,,USE OF EMICORONS AS SELECTIVE INDUCERS OF DAMAGE TO THE TELOMERE DNA,2013
1012,['STEIGERWALT ROBERT DAVIS JR'],,Application,,WO-2013114418-A1,"['STEIGERWALT, Robert, Davis Jr.']",2013-08-08,,TRANSDERMAL ADMINISTRATION OF PROSTAGLANDIN E1 FOR THE TREATMENT OF OCULAR ISCHEMIA,2013
1013,['CISCO TECH INC'],"[{'id': 'grid.421222.5', 'name': 'Cisco Systems (United States)', 'country_name': 'United States'}]",Application,,WO-2015168115-A1,"['HUI, Jonathan, W.', 'VASSEUR, JEAN-PHILIPPE', 'HONG, WEI']",2015-11-05,,METHODS AND APPARATUSES FOR ROUTING OVER MULTIPLE INPUT MULTIPLE OUTPUT POWER LINE COMMUNICATION NETWORKS,2015
1014,['INCYTE CORP'],"[{'id': 'grid.417921.8', 'acronym': 'Incyte', 'name': 'Incyte (United States)', 'country_name': 'United States'}]",Application,,WO-2013056015-A1,"['HUANG, TAISHENG', 'FENG, HAO', 'KONG, Lingquan', 'WANG, ANLAI', 'YE, HAI FEN', 'XUE, CHU-BIAO']",2013-04-18,4.0,ISOINDOLINONE AND PYRROLOPYRIDINONE DERIVATIVES AS AKT INHIBITORS,2012
1015,"['Amarin Pharmaceuticals Ireland Ltd', 'AMARIN PHARMACEUTICALS IE LTD']",,Grant,2018.0,US-9918954-B2,['Paresh Soni'],2018-03-20,2.0,Methods of reducing the risk of a cardiovascular event in a subject on statin therapy,2017
1016,"['Consiglio Nazionale Delle Richerche', 'CONSIGLIO NAZIONALE RICERCHE']","[{'id': 'grid.5326.2', 'acronym': 'CNR', 'name': 'National Research Council', 'country_name': 'Italy'}]",Application,,EP-2481816-A1,"['GATTI, MAURIZIO', 'Somma, Maria Patrizia', 'Di Cunto, Ferdinando', 'Provero, Paolo', 'Damasco, Christian', 'Lembo, Antonio']",2012-08-01,1.0,Markers to predict survival of breast cancer patients and uses thereof,2012
1017,['UNIV NORTH CAROLINA CHAPEL HILL'],"[{'id': 'grid.10698.36', 'acronym': 'UNC', 'name': 'University of North Carolina at Chapel Hill', 'country_name': 'United States'}]",Application,,WO-2017196668-A1,"['HANSON, Ariel Dawn', 'YAMAUCHI, MITSUO', 'WAUTHIER, Eliane Lucie', 'DINH, TIMOTHY ANH-HIEU', 'SETHUPATHY, PRAVEEN', 'REID, LOLA M.']",2017-11-16,,COMPOSITIONS AND METHODS FOR BIOENGINEERED TISSUES,2017
1018,"['INSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE', 'UNIV PARIS XI PARIS SUD', 'UNIVERSITÉ DE RENNES', 'UNIVERSITÉ PARIS DESCARTES']","[{'id': 'grid.410368.8', 'name': 'University of Rennes 1', 'country_name': 'France'}, {'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}, {'id': 'grid.10992.33', 'name': 'Paris Descartes University', 'country_name': 'France'}, {'id': 'grid.5842.b', 'name': 'University of Paris-Sud', 'country_name': 'France'}]",Application,,WO-2015140257-A1,"['DUBART KUPPERSCHMITT, ANNE', 'WEBER BENAROUS, Anne', 'CORLU, ANNE', 'DIANAT, Noushin']",2015-09-24,2.0,A METHOD FOR INDUCING HUMAN CHOLANGIOCYTE DIFFERENTIATION,2015
1019,"['Randox Laboratories Ltd', 'RANDOX LAB LTD']","[{'id': 'grid.437205.7', 'name': 'Randox (United Kingdom)', 'country_name': 'United Kingdom'}]",Application,,US-20140336141-A1,"['Maria Zellner', 'Ellen Umlauf']",2014-11-13,,MAO-B INHIBITORS DERIVED FROM THE ONE-CARBON CYCLE,2012
1020,"['National Health Research Institutes', 'NAT HEALTH RESEARCH INSTITUTES']","[{'id': 'grid.59784.37', 'acronym': 'NHRI', 'name': 'National Health Research Institutes', 'country_name': 'Taiwan'}]",Application,,EP-2997181-A4,"['TSAI, KUN-CHIH KELVIN', 'LI, Chi-Rong', 'HSU, Chung-Chi']",2017-04-12,,METHODS OF PROGNOSTICALLY CLASSIFYING AND TREATING GLANDULAR CANCERS,2014
1021,['UNIV MASSACHUSETTS'],"[{'id': 'grid.266684.8', 'name': 'University of Massachusetts System', 'country_name': 'United States'}]",Application,,WO-2016144917-A1,"['CEOL, Craig Joseph', 'VENKATESAN, Arvind Murali']",2016-09-15,,TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY,2016
1022,"[""Children's National Medical Center"", 'HOFFMAN ERIC', 'FIORILLO ALYSON', 'REVERAGEN BIOPHARMA INC']","[{'id': 'grid.430142.0', 'name': 'ReveraGen BioPharma (United States)', 'country_name': 'United States'}, {'id': 'grid.239560.b', 'acronym': 'CNMC', 'name': 'Children’s National Health System', 'country_name': 'United States'}]",Grant,2017.0,US-9637738-B2,"['Eric Hoffman', 'Alyson Fiorillo']",2017-05-02,1.0,Methods and agents to increase therapeutic dystrophin expression in muscle,2014
1023,['TAKARA BIO EUROPE AB'],"[{'id': 'grid.427935.e', 'name': 'Takara (Sweden)', 'country_name': 'Sweden'}]",Application,,WO-2016193441-A2,"['KÜPPERS-MUNTHER, Barbara']",2016-12-08,1.0,MATURATION OF MAMMALIAN HEPATOCYTES,2016
1024,['CEMM FORSCHUNGSZENTRUM FÜR MOLEKULARE MEDIZIN GMBH'],,Application,,WO-2016079321-A1,"['BERGTHALER, ANDREAS', 'SCHLIEHE, Christopher']",2016-05-26,2.0,ANTAGONISTS OF SETDB2 FOR USE IN THE THERAPY OF INFECTIOUS DISEASES,2015
1025,"['Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eV', 'FRAUNHOFER GES ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E V']","[{'id': 'grid.4561.6', 'acronym': 'FHG', 'name': 'Fraunhofer Society', 'country_name': 'Germany'}]",Grant,2015.0,DE-102011017734-B4,['Bruno Demissie'],2015-10-08,,Method and apparatus for determining a time delay and a frequency shift between a on a moving subject scattered radio signal and the unscattered radio signal or a scattered radio signal in a known manner in a multi-path signal,2011
1026,"['University of Michigan', 'HAYES DANIEL', 'UNIV MICHIGAN']","[{'id': 'grid.214458.e', 'acronym': 'UM', 'name': 'University of Michigan', 'country_name': 'United States'}]",Grant,2014.0,US-8790878-B2,['Daniel Hayes'],2014-07-29,,Diagnosis and treatment of breast cancer,2011
1027,"['Hanyang University Industry-University Cooperation Foundation (IUCF)', 'FOUNDATION HANYANG UNIVERSITY INDUSTRY UNIVERSITY COOPERATION', 'IUCF HYU']","[{'id': 'grid.49606.3d', 'name': 'Hanyang University', 'country_name': 'South Korea'}]",Application,,US-20140127575-A1,"['Bruno Scrosati', 'Yang Kook Sun', 'Jung Hoon Kim', 'Hun-Gi Jung', 'Jusef Hassoun']",2014-05-08,1.0,POSITIVE ACTIVE MATERIAL FOR LITHIUM SULFUR BATTERY AND LITHIUM SULFUR BATTERY COMPRISING SAME,2013
1028,"['Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eV', 'FRAUNHOFER GES FORSCHUNG']","[{'id': 'grid.4561.6', 'acronym': 'FHG', 'name': 'Fraunhofer Society', 'country_name': 'Germany'}]",Application,,DE-102011017734-A1,['Bruno Demissie'],2012-10-31,,"Method for determining time delay and frequency shift of radio signal between scattered radio signal from moving object and scattered multipath radio signal, involves processing matrix of channel vectors satisfying selection criterion",2011
1029,"['Sumitomo Bakelite Co Ltd', 'SUMITOMO BAKELITE CO']","[{'id': 'grid.459998.0', 'name': 'Sumitomo Bakelite (Japan)', 'country_name': 'Japan'}]",Application,,EP-2818549-A4,"['MURAKAMI YOSHIKI', 'OCHIYA TAKAHIRO']",2015-09-02,,METHOD FOR CLASSIFYING TEST BODY FLUID SAMPLE,2013
1030,"['Institut National de la Sante et de la Recherche Medicale INSERM', 'Universite Paris Descartes (Paris 5)', 'INST NAT SANTE RECH MED', 'UNIV PARIS DESCARTES', 'INST NAT SANTE RECH MED']","[{'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}, {'id': 'grid.10992.33', 'name': 'Paris Descartes University', 'country_name': 'France'}]",Grant,2015.0,US-9193971-B2,"['Alain Tedgui', 'Xavier Loyer', 'Pierre-Emmanuel Rautou']",2015-11-24,,Methods for the treatment of nonalcoholic steatohepatitis,2013
1031,"['University of North Carolina at Chapel Hill', 'UNIV NORTH CAROLINA', 'GIGACYTE LLC']","[{'id': 'grid.10698.36', 'acronym': 'UNC', 'name': 'University of North Carolina at Chapel Hill', 'country_name': 'United States'}, {'id': 'grid.410711.2', 'name': 'University of North Carolina System', 'country_name': 'United States'}]",Application,,EP-2588027-A4,"['ROACH MARSHA LYNN', 'MALAVARCA RICHARD HAROLD', 'WANG YUNFANG', 'REID LOLA CYNTHIA MCADAMS']",2013-12-11,,BIOMATRIX SCAFFOLDS FOR INDUSTRIAL SCALE DISPERSAL,2011
1032,"['OncoMed Pharmaceuticals Inc', 'ONCOMED PHARM INC', 'ONCOMED PHARM INC']","[{'id': 'grid.467496.e', 'name': 'OncoMed (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9610348-B2,['Austin L. Gurney'],2017-04-04,1.0,Compositions and methods for treating and diagnosing cancer,2014
1033,"['University of North Carolina at Chapel Hill', 'UNIV NORTH CAROLINA', 'GIGACYTE LLC']","[{'id': 'grid.410711.2', 'name': 'University of North Carolina System', 'country_name': 'United States'}, {'id': 'grid.10698.36', 'acronym': 'UNC', 'name': 'University of North Carolina at Chapel Hill', 'country_name': 'United States'}]",Application,,EP-2588027-A1,"['ROACH, MARSHA LYNN', 'MALAVARCA, RICHARD HAROLD', 'WANG, YUNFANG', 'REID, LOLA CYNTHIA MCADAMS']",2013-05-08,,BIOMATRIX SCAFFOLDS FOR INDUSTRIAL SCALE DISPERSAL,2011
1034,"['University of Michigan', 'UNIV MICHIGAN']","[{'id': 'grid.214458.e', 'acronym': 'UM', 'name': 'University of Michigan', 'country_name': 'United States'}]",Application,,EP-2591363-A4,['HAYES DANIEL'],2014-01-22,,DIAGNOSIS AND TREATMENT OF BREAST CANCER,2011
1035,['UNIV NORTH CAROLINA CHAPEL HILL'],"[{'id': 'grid.10698.36', 'acronym': 'UNC', 'name': 'University of North Carolina at Chapel Hill', 'country_name': 'United States'}]",Application,,WO-2017196668-A1,"['HANSON, Ariel Dawn', 'YAMAUCHI, MITSUO', 'WAUTHIER, Eliane Lucie', 'DINH, TIMOTHY ANH-HIEU', 'SETHUPATHY, PRAVEEN', 'REID, LOLA M.']",2017-11-16,,COMPOSITIONS AND METHODS FOR BIOENGINEERED TISSUES,2017
1036,"['University of Kansas', 'UNIV OF KANSAS']","[{'id': 'grid.266515.3', 'acronym': 'KU', 'name': 'University of Kansas', 'country_name': 'United States'}]",Grant,2017.0,US-9573983-B2,"['Teruna J. Siahaan', 'Prakash Manikwar', 'Paul Kipkemboi Kiptoo', 'Ahmed Badawi', 'Barlas Buyuktimkin', 'John M. Stewart']",2017-02-21,,Compositions including I-domain antigen conjugate compounds and methods for treatment of autoimmune disorders,2013
1037,"['OncoMed Pharmaceuticals Inc', 'ONCOMED PHARM INC']","[{'id': 'grid.467496.e', 'name': 'OncoMed (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9717794-B2,"['Austin L. Gurney', 'Aaron K. Sato']",2017-08-01,,Compositions and methods for treating and diagnosing cancer,2015
1038,['NEKTAR THERAPEUTICS'],"[{'id': 'grid.476522.0', 'name': 'Nektar Therapeutics (United States)', 'country_name': 'United States'}]",Application,,WO-2014194289-A1,"['HOCH, UTE', 'BREW, CHRISTINE, TAYLOR', 'HARRISON, Stephen, David', 'FRY, DENNIS, G.', 'DAVIS, DARREN, W.']",2014-12-04,1.0,METHOD FOR PREDICTING AND EVALUATING RESPONSIVENESS TO CANCER TREATMENT WITH DNA-DAMAGING CHEMOTHERAPEUTIC AGENTS,2014
1039,"['University of Michigan', 'UNIV MICHIGAN REGENTS']","[{'id': 'grid.214458.e', 'acronym': 'UM', 'name': 'University of Michigan', 'country_name': 'United States'}]",Application,,EP-3306321-A1,"['HAYES, DANIEL']",2018-04-11,,DIAGNOSIS AND TREATMENT OF BREAST CANCER,2011
1040,"['OncoMed Pharmaceuticals Inc', 'ONCOMED PHARM INC']","[{'id': 'grid.467496.e', 'name': 'OncoMed (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9644034-B2,"['Austin L. Gurney', 'Fumiko Takada Axelrod', 'Timothy Charles Hoey', 'Cecile Chartier-Courtaud']",2017-05-09,,Anti-RSPO2 antibodies and uses thereof,2015
1041,"['OncoMed Pharmaceuticals Inc', 'ONCOMED PHARM INC']","[{'id': 'grid.467496.e', 'name': 'OncoMed (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10064937-B2,['Jennifer Anne Cain'],2018-09-04,,Treatment of dermal fibrosis,2015
1042,"['University of North Carolina at Chapel Hill', 'UNIV NORTH CAROLINA CHAPEL HILL']","[{'id': 'grid.10698.36', 'acronym': 'UNC', 'name': 'University of North Carolina at Chapel Hill', 'country_name': 'United States'}]",Application,,EP-3192862-A1,"['WANG, YUNFANG', 'REID, LOLA CYNTHIA MCADAMS', 'WANG, YUNFANG', 'YAMAUCHI, MITSUO', 'CUI, CAI-BIN', 'WERNER, MICHAEL, EDWARD']",2017-07-19,,BIOMATRIX SCAFFOLDS,2011
1043,"['University of North Carolina at Chapel Hill', 'WANG YUNFANG', 'REID LOLA CYNTHIA MCADAMS', 'YAMAUCHI MITSUO', 'CUI CAI-BIN', 'WANG ANDREW ZHUANG', 'WERNER MICHAEL EDWARD', 'UNIV NORTH CAROLINA']","[{'id': 'grid.10698.36', 'acronym': 'UNC', 'name': 'University of North Carolina at Chapel Hill', 'country_name': 'United States'}, {'id': 'grid.410711.2', 'name': 'University of North Carolina System', 'country_name': 'United States'}]",Grant,2014.0,US-8802081-B2,"['Yunfang Wang', 'Lola Cynthia McAdams Reid', 'Mitsuo Yamauchi', 'Cai-Bin Cui', 'Andrew Zhuang Wang', 'Michael Edward Werner']",2014-08-12,2.0,Biomatrix scaffolds,2011
1044,"['University of North Carolina at Chapel Hill', 'UNIV NORTH CAROLINA CHAPEL HILL', 'ROACH MARSHA LYNN', 'MALAVARCA RICHARD HAROLD']","[{'id': 'grid.10698.36', 'acronym': 'UNC', 'name': 'University of North Carolina at Chapel Hill', 'country_name': 'United States'}]",Application,,EP-3216444-A1,"['ROACH, MARSHA LYNN', 'MALAVARCA, RICHARD HAROLD', 'WANG, YUNFANG', 'REID, LOLA CYNTHIA MCADAMS']",2017-09-13,,BIOMATRIX SCAFFOLDS FOR INDUSTRIAL SCALE DISPERSAL,2011
1045,"['OncoMed Pharmaceuticals Inc', 'ONCOMED PHARM INC']","[{'id': 'grid.467496.e', 'name': 'OncoMed (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9598497-B2,"['Austin L. Gurney', 'Christopher J. Bond']",2017-03-21,1.0,RSPO3 binding agents and uses thereof,2015
1046,"['IBC Pharmaceuticals Inc', 'IBC PHARMACEUTICALS INC']","[{'id': 'grid.469475.d', 'acronym': 'IBC', 'name': 'International Business College - Indianapolis', 'country_name': 'United States'}, {'id': 'grid.468843.5', 'acronym': 'IBC', 'name': 'International Business College - Fort Wayne', 'country_name': 'United States'}]",Grant,2018.0,US-9872920-B2,"['Chien-Hsing Chang', 'David M. Goldenberg', 'William J. McBride', 'EDMUND A. ROSSI']",2018-01-23,,PEGylation by the dock and lock (DNL) technique,2016
1047,"['INSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)', 'CHRU (CENTRE HOSPITALIER RÉGIONAL UNIVERSITAIRE) DE LILLE', 'UNIVERSITÉ DE LILLE 1', 'Université Lille 2 Droit et Santé']","[{'id': 'grid.4461.7', 'name': 'Lille 1 University', 'country_name': 'France'}, {'id': 'grid.410463.4', 'name': 'Centre Hospitalier Regional et Universitaire de Lille', 'country_name': 'France'}, {'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}, {'id': 'grid.16780.38', 'name': 'Université Lille 2 Droit et Santé', 'country_name': 'France'}]",Application,,WO-2017182580-A1,"['PREVOT, Vincent', 'MESSINA, Andrea']",2017-10-26,,METHODS FOR THE DIAGNOSIS AND THE TREATMENT OF REPRODUCTION-RELATED DISORDERS AND METHODS FOR CONTRACEPTION,2017
1048,"['University of Chicago', 'METS LAURENS', 'UNIV CHICAGO']","[{'id': 'grid.170205.1', 'acronym': 'UC', 'name': 'University of Chicago', 'country_name': 'United States'}]",Grant,2016.0,US-9428745-B2,['Laurens Mets'],2016-08-30,,Methanothermobacter thermautotrophicus strain and variants thereof,2012
1049,"['AVM Biotechnology LLC', 'DEISHER THERESA A', 'AVM BIOTECHNOLOGY LLC']","[{'id': 'grid.427663.2', 'name': 'AVM Biotechnology (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9512200-B2,['Theresa A. Deisher'],2016-12-06,,Personalized production of biologics and method for reprogramming somatic cells,2012
1050,"['University of North Carolina at Chapel Hill', 'ROACH MARSHA LYNN', 'MALAVARCA RICHARD HAROLD', 'WANG YUNFANG', 'REID LOLA CYNTHIA MCADAMS', 'UNIV NORTH CAROLINA', 'PHOENIXSONGS BIOLOG']","[{'id': 'grid.10698.36', 'acronym': 'UNC', 'name': 'University of North Carolina at Chapel Hill', 'country_name': 'United States'}, {'id': 'grid.410711.2', 'name': 'University of North Carolina System', 'country_name': 'United States'}]",Grant,2015.0,US-9102913-B2,"['Marsha Lynn Roach', 'Richard Harold Malavarca', 'Yunfang Wang', 'Lola Cynthia McAdams Reid']",2015-08-11,1.0,Biomatrix scaffolds for industrial scale dispersal,2011
1051,['RHEINISCH WESTFÄLISCHE TECH HOCHSCHULE RWTH AACHEN'],"[{'id': 'grid.1957.a', 'acronym': 'RWTH', 'name': 'RWTH Aachen University', 'country_name': 'Germany'}]",Application,,WO-2016124165-A1,"['WOTRUBA, HERMANN', 'NEUBERT, Kilian', 'Vraetz, Tobias', 'Boos, Franz Domenic', 'NIENHAUS, KARL', 'Baltes, Ralph', 'Knapp, Henning']",2016-08-11,,METHOD AND ARRANGEMENT FOR ANALYSIS OF A MATERIAL FLOW,2015
1052,"['University of Michigan', 'UNIV MICHIGAN REGENTS']","[{'id': 'grid.214458.e', 'acronym': 'UM', 'name': 'University of Michigan', 'country_name': 'United States'}]",Grant,2017.0,US-9568476-B2,['Daniel Hayes'],2017-02-14,,Diagnosis and treatment of breast cancer,2014
1053,"['Industrial Technology Research Institute', 'LIAO CHUN-JEN', 'WANG WEN-HSI', 'YANG MING-CHIA', 'LIAO WEI-JU', 'IND TECH RES INST']","[{'id': 'grid.418030.e', 'acronym': 'ITRI', 'name': 'Industrial Technology Research Institute', 'country_name': 'Taiwan'}]",Grant,2015.0,US-8946305-B2,"['Chun-Jen Liao', 'Wen-Hsi Wang', 'Ming-Chia Yang', 'Wei-Ju Liao']",2015-02-03,,"Method for crosslinking a colloid, and crosslinked colloid therefrom",2012
1054,"['University of Massachusetts (UMass)', 'NEVIN KELLY', 'LOVLEY DEREK', 'UNIV MASSACHUSETTS']","[{'id': 'grid.266684.8', 'name': 'University of Massachusetts System', 'country_name': 'United States'}]",Grant,2014.0,US-8663852-B2,"['Kelly Nevin', 'Derek Lovley']",2014-03-04,3.0,Aerobic microbial fuel cell,2010
1055,['BIOTICA TECH LTD'],,Application,,WO-2013093493-A1,"['GREGORY, MATTHEW ALAN', 'MOSS, STEVEN JAMES', 'WILKINSON, BARRIE']",2013-06-27,1.0,NOVEL RAPAMYCIN ANALOGUE,2012
1056,['NAT UNIV CORP YOKOHAMA NAT UNI'],"[{'id': 'grid.268446.a', 'acronym': 'YNU', 'name': 'Yokohama National University', 'country_name': 'Japan'}]",Application,,WO-2016068043-A1,"['渡邉\u3000正義', '獨古\u3000薫', '李 ▲テツ▼', '張 世国']",2016-05-06,1.0,"METHOD FOR PRODUCING CATHODE MATERIAL FOR LITHIUM-SULFUR BATTERY, CATHODE MATERIAL FOR LITHIUM-SULFUR BATTERY, AND LITHIUM-SULFUR BATTERY",2015
1057,"['Nektar Therapeutics', 'NEKTAR THERAPEUTICS']","[{'id': 'grid.476522.0', 'name': 'Nektar Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9863949-B2,"['Ute Hoch', 'Christine Taylor Brew', 'Stephen David Harrison', 'Dennis G. Fry', 'Darren W. Davis']",2018-01-09,,Method for predicting and evaluating responsiveness to cancer treatment with DNA-damaging chemotherapeutic agents,2014
1058,"['Bayer Intellectual Property GmbH', 'Bayer HealthCare LLC', 'SCHÜCKLER FRITZ', 'Wollenschläger Axel', 'BAYER HEALTHCARE LLC']","[{'id': 'grid.419670.d', 'acronym': 'Bayer Healthcare', 'name': 'Bayer (United States)', 'country_name': 'United States'}, {'id': 'grid.420044.6', 'name': 'Bayer (Germany)', 'country_name': 'Germany'}]",Grant,2017.0,US-9737488-B2,"['Fritz Schückler', 'Axel Wollenschläger']",2017-08-22,,Pharmaceutical composition for the treatment of cancer,2006
1059,"['University of Michigan', 'UNIV MICHIGAN']","[{'id': 'grid.214458.e', 'acronym': 'UM', 'name': 'University of Michigan', 'country_name': 'United States'}]",Application,,EP-2591363-A2,"['HAYES, DANIEL']",2013-05-15,,DIAGNOSIS AND TREATMENT OF BREAST CANCER,2011
1060,['TAKARA BIO EUROPE AB'],"[{'id': 'grid.427935.e', 'name': 'Takara (Sweden)', 'country_name': 'Sweden'}]",Application,,WO-2016193441-A2,"['KÜPPERS-MUNTHER, Barbara']",2016-12-08,1.0,MATURATION OF MAMMALIAN HEPATOCYTES,2016
1061,"['Ultrasound Medical Devices Inc', 'ULTRASOUND MEDICAL DEVICES INC']",,Application,,US-20130253319-A1,"['James Hamilton', 'Eric J. Sieczka', 'Eric T. LARSON']",2013-09-26,4.0,METHOD AND SYSTEM FOR ACQUIRING AND ANALYZING MULTIPLE IMAGE DATA LOOPS,2013
1062,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9362568-B2,['Hongjie Dai'],2016-06-07,,Battery with hybrid electrocatalysts,2014
1063,"['JABER INNOVATION Srl', 'JABER INNOVATION S R L']",,Application,,US-20150376300-A1,"['Stefania COMETA', 'Domenico Milesi', 'Giuseppe Iannaccone']",2015-12-31,,BIODEGRADABLE SUPERABSORBENT HYDROGELS,2014
1064,['UNIV DANMARKS TEKNISKE'],"[{'id': 'grid.5170.3', 'acronym': 'DTU', 'name': 'Technical University of Denmark', 'country_name': 'Denmark'}]",Application,,WO-2013097869-A1,"['GLÜCKSTAD, Jesper', 'PALIMA, Darwin']",2013-07-04,3.0,SYSTEM FOR MANIPULATING AND OPTICALLY TARGETING MICRO OBJECTS,2012
1065,"['GlaxoSmithKline Intellectual Property Development Ltd', 'GLAXOSMITHKLINE IP DEV LTD']","[{'id': 'grid.418236.a', 'acronym': 'GSK', 'name': 'GlaxoSmithKline (United Kingdom)', 'country_name': 'United Kingdom'}]",Grant,2018.0,US-9988376-B2,"['Sebastien Andre Campos', 'John David Harling', 'Afjal Hussain Miah', 'Ian Edward David Smith']",2018-06-05,,Benzothiophene derivatives as estrogen receptor inhibitors,2014
1066,"['University of Washington', 'UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION']","[{'id': 'grid.34477.33', 'acronym': 'UW', 'name': 'University of Washington', 'country_name': 'United States'}]",Grant,2016.0,US-9515310-B2,"['Guozhong Cao', 'Yanyi Liu']",2016-12-06,,V2O5 electrodes with high power and energy densities,2013
1067,"['Analog Devices Inc', 'ANALOG DEVICES INC']","[{'id': 'grid.455526.5', 'acronym': 'ADI', 'name': 'Analog Devices (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9143089-B2,['Daniel F. Kelly'],2015-09-22,,Active cascode circuit using backgate control,2013
1068,"['UNIV DANMARKS TEKNISKE', 'GLUECKSTAD JESPER', 'PALIMA DARWIN']","[{'id': 'grid.5170.3', 'acronym': 'DTU', 'name': 'Technical University of Denmark', 'country_name': 'Denmark'}]",Application,,WO-2012155919-A1,"['GLÜCKSTAD, Jesper', 'PALIMA, Darwin']",2012-11-22,2.0,A MICRODEVICE FOR EMITTING ELECTROMAGNETIC RADIATION,2012
1069,"['Analog Devices Inc', 'ANALOG DEVICES INC']","[{'id': 'grid.455526.5', 'acronym': 'ADI', 'name': 'Analog Devices (United States)', 'country_name': 'United States'}]",Application,,EP-2779437-A1,"['KELLY, DANIEL F.']",2014-09-17,,Active Cascode Circuit using Backgate Control,2014
1070,"['University of Washington', 'UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION']","[{'id': 'grid.34477.33', 'acronym': 'UW', 'name': 'University of Washington', 'country_name': 'United States'}]",Grant,2018.0,US-9997778-B2,"['Guozhong Cao', 'Yanwei LI']",2018-06-12,,Polycrystalline vanadium oxide nanosheets,2013
1071,['UNIV KING ABDULLAH SCI & TECH'],"[{'id': 'grid.45672.32', 'acronym': 'KAUST', 'name': 'King Abdullah University of Science and Technology', 'country_name': 'Saudi Arabia'}]",Application,,WO-2017103783-A1,"['LI, LAIN-JONG', 'MING, Jun']",2017-06-22,,"LITHIUM-SULFUR BATTERY, A DUAL BLOCKING LAYER, METHODS OF MAKING, AND METHODS OF USE THEREOF",2016
1072,"['GlaxoSmithKline Intellectual Property Development Ltd', 'GLAXOSMITHKLINE IP DEV LTD']","[{'id': 'grid.418236.a', 'acronym': 'GSK', 'name': 'GlaxoSmithKline (United Kingdom)', 'country_name': 'United Kingdom'}]",Grant,2018.0,US-9993514-B2,"['Sebastien Andre Campos', 'John David Harling']",2018-06-12,,Compounds,2014
1073,"['Koninklijke Philips NV', 'KONINKL PHILIPS NV']","[{'id': 'grid.417284.c', 'name': 'Philips (Netherlands)', 'country_name': 'Netherlands'}]",Grant,2016.0,US-9326735-B2,['Jens Muhlsteff'],2016-05-03,,Method and apparatus for monitoring cardiac output of a patient in a home environment,2013
1074,['UNIV DANMARKS TEKNISKE'],"[{'id': 'grid.5170.3', 'acronym': 'DTU', 'name': 'Technical University of Denmark', 'country_name': 'Denmark'}]",Application,,WO-2014108135-A1,"['GLÜCKSTAD, Jesper']",2014-07-17,,AN OPTICALLY GUIDED MICRODEVICE COMPRISING A NANOWIRE,2014
1075,"['Yale University', 'UNIV YALE']","[{'id': 'grid.47100.32', 'name': 'Yale University', 'country_name': 'United States'}]",Grant,2018.0,US-9938264-B2,"['Craig Crews', 'Momar TOURE', 'Eunhwa Ko', 'Saul Jaime-Figueroa']",2018-04-10,,Proteolysis targeting chimera compounds and methods of preparing and using same,2016
1076,"['Medtronic Inc', 'MEDTRONIC INC']","[{'id': 'grid.419673.e', 'acronym': 'Medtronic', 'name': 'Medtronic (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9211413-B2,"['Paul D. Ziegler', 'Lilian Kornet', 'Xiaohong Zhou', 'Richard N. M. Cornelussen', 'Robert Stadler', 'Eduardo Warman', 'Karen J. Kleckner', 'Alberto Della Scala']",2015-12-15,3.0,Preventing use of vagal stimulation parameters,2014
1077,"['Medtronic Inc', 'CORNELUSSEN RICHARD N M', 'ZHOU XIAOHONG', 'STADLER ROBERT', 'KORNET LILIAN', 'MEDTRONIC INC']","[{'id': 'grid.419673.e', 'acronym': 'Medtronic', 'name': 'Medtronic (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8781583-B2,"['Richard N. M. Cornelussen', 'Xiaohong Zhou', 'Robert Stadler', 'Lilian Kornet']",2014-07-15,18.0,Vagal stimulation,2012
1078,"['IASOMAI AB', 'PARASASSI TIZIANA', 'PORPORA MARIA GRAZIA', 'IASOMAI AB']",,Application,,US-20120238627-A1,"['Tiziana Parasassi', 'Maria Grazia Porpora']",2012-09-20,,N-ACETYL-L-CYSTEINE FOR THE TREATMENT OF ENDOMETRIOSIS,2012
1079,"['NEC Corp', 'NEC CORP']","[{'id': 'grid.420377.5', 'name': 'NEC Corporation (Japan)', 'country_name': 'Japan'}]",Application,,EP-2654278-A1,"['HARA, YUTAKA', 'KOJIMA, MASAHIKO']",2013-10-23,1.0,"NETWORK MAINTENANCE SYSTEM, METHOD AND DEVICE",2011
1080,"['Medtronic Inc', 'MEDTRONIC INC']","[{'id': 'grid.419673.e', 'acronym': 'Medtronic', 'name': 'Medtronic (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9468764-B2,"['Xiaochong Zhou', 'John Edward Burnes', 'Lilian Kornet', 'Richard N. M. Cornelussen']",2016-10-18,1.0,Nerve signal differentiation in cardiac therapy,2014
1081,"['Medtronic Inc', 'MEDTRONIC INC']","[{'id': 'grid.419673.e', 'acronym': 'Medtronic', 'name': 'Medtronic (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9155893-B2,"['Xiaohong Zhou', 'Lilian Kornet', 'Richard N. M. Cornelussen', 'Paul D. Ziegler', 'Robert Stadler', 'Eduardo Warman', 'Karen J. Kleckner', 'Lucy Nichols', 'Alberto Della Scala']",2015-10-13,1.0,Use of preventative vagal stimulation in treatment of acute myocardial infarction or ischemia,2014
1082,['PIZETA GROUP S R L'],,Application,,WO-2014166947-A1,"['DE SETA, Francesco', 'Leonardi, Lucio']",2014-10-16,,COMPOSITION FOR THE TREATMENT OF ENDOMETRIOSIS,2014
1083,"['Medtronic Inc', 'BUSCHMAN HENDRIK PETER JOHAN', 'BURNES JOHN EDWARD', 'CORNELUSSEN RICHARD N M', 'HILL MICHAEL ROLAND SCOTT', 'KORNET LILIAN', 'ORDELMAN SIMONE CORNELIA MARIA ANNA', 'VELTINK PETRUS HERMANUS', 'MEDTRONIC INC']","[{'id': 'grid.419673.e', 'acronym': 'Medtronic', 'name': 'Medtronic (United States)', 'country_name': 'United States'}]",Grant,2013.0,US-8406868-B2,"['Hendrik Peter Johan Buschman', 'John Edward Burnes', 'Richard N. M. Cornelussen', 'Michael Roland Scott Hill', 'Lilian Kornet', 'Simone Cornelia Maria Anna Ordelman', 'Petrus Hermanus Veltink']",2013-03-26,21.0,Therapy using perturbation and effect of physiological systems,2011
1084,"['CELLAY Inc', 'CELLAY INC']",,Grant,2015.0,US-9145584-B2,['Joan Aurich-Costa'],2015-09-29,,Methods and kits for room temperature in situ detection of a target nucleic acid in a biological sample,2012
1085,"['Medtronic Inc', 'BUSCHMAN HENDRIK PETER JOHAN', 'CORNELUSSEN RICHARD N M', 'HILL MICHAEL ROLAND SCOTT', 'KORNET LILIAN', 'ORDELMAN SIMONE CORNELIA MARIA ANNA', 'VELTINK PETRUS HERMANUS', 'MEDTRONIC INC']","[{'id': 'grid.419673.e', 'acronym': 'Medtronic', 'name': 'Medtronic (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8888699-B2,"['Hendrik Peter Johan Buschman', 'Richard N. M. Cornelussen', 'Michael Roland Scott Hill', 'Lilian Kornet', 'Simone Cornelia Maria Anna Ordelman', 'Petrus Hermanus Veltink']",2014-11-18,4.0,Therapy using perturbation and effect of physiological systems,2011
1086,"['UT-Battelle LLC', 'UT-BATTELLE LLC']","[{'id': 'grid.422038.f', 'name': 'UT-Battelle', 'country_name': 'United States'}]",Grant,2016.0,US-9466834-B2,"['Chengdu Liang', 'Nancy J. Dudney', 'Zhan Lin', 'Zengcai Liu']",2016-10-11,,Lithium-conducting sulfur compound cathode for lithium-sulfur batteries,2013
1087,"['Pizeta Group Srl', 'PIZETA GROUP S R L']",,Application,,EP-2789345-A1,"['De Seta, Freancesco', 'Leonardi, Lucio']",2014-10-15,1.0,Composition for the treatment of endometriosis,2013
1088,"['Medtronic Inc', 'ZHOU XIAOHONG', 'KORNET LILIAN', 'CORNELUSSEN RICHARD N M', 'ZIEGLER PAUL D', 'STADLER ROBERT', 'WARMAN EDUARDO', 'KLECKNER KAREN J', 'NICHOLS LUCY', 'SCALA ALBERTO DELLA', 'MEDTRONIC INC']","[{'id': 'grid.419673.e', 'acronym': 'Medtronic', 'name': 'Medtronic (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8706223-B2,"['Xiaohong Zhou', 'Lilian Kornet', 'Richard N. M. Cornelussen', 'Paul D. Ziegler', 'Robert Stadler', 'Eduardo Warman', 'Karen J. Kleckner', 'Lucy Nichols', 'Alberto Della Scala']",2014-04-22,20.0,Preventative vagal stimulation,2012
1089,['CELLAY INC'],,Application,,WO-2013090386-A3,"['AURICH-COSTA, JOAN']",2013-08-22,,METHODS AND KITS FOR ROOM TEMPERATURE IN SITU DETECTION OF A TARGET NUCLEIC ACID IN A BIOLOGICAL SAMPLE,2012
1090,['IASOMAI AB'],,Application,,WO-2014072350-A1,"['LUNDEBERG, THOMAS', 'PARASASSI, TIZIANA', 'PITTALUGA, Eugenia', 'BRUNELLI, ROBERTO']",2014-05-15,,N-ACETYL-L-CYSTEINE FOR USE IN IN VITRO FERTILIZATION,2013
1091,"['Medtronic Inc', 'ZHOU XIAOHONG', 'BURNES JOHN EDWARD', 'KORNET LILIAN', 'CORNELUSSEN RICHARD N M', 'MEDTRONIC INC']","[{'id': 'grid.419673.e', 'acronym': 'Medtronic', 'name': 'Medtronic (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8639327-B2,"['Xiaohong Zhou', 'John Edward Burnes', 'Lilian Kornet', 'Richard N. M. Cornelussen']",2014-01-28,7.0,Nerve signal differentiation in cardiac therapy,2010
1092,"['IASOMAI AB', 'PARASASSI TIZIANA', 'PORPORA MARIA GRAZIA', 'IASOMAI AB']",,Grant,2014.0,US-8637573-B2,"['Tiziana Parasassi', 'Maria Grazia Porpora']",2014-01-28,3.0,N-acetyl-L-cysteine for the treatment of endometriosis,2012
1093,"['NEC Corp', 'NEC CORP']","[{'id': 'grid.420377.5', 'name': 'NEC Corporation (Japan)', 'country_name': 'Japan'}]",Application,,EP-2654278-A4,"['HARA YUTAKA', 'KOJIMA MASAHIKO']",2014-05-14,,"NETWORK MAINTENANCE SYSTEM, METHOD AND DEVICE",2011
1094,"['IASOMAI AB', 'IASOMAI AB']",,Grant,2017.0,US-9585854-B2,"['Thomas Lundeberg', 'Tiziana Parasassi', 'Eugenia Pittaluga', 'Roberto Brunelli']",2017-03-07,,N-acetyl-L-cysteine for use in in vitro fertilization,2013
1095,"['Medtronic Inc', 'KORNET LILIAN', 'CORNELUSSEN RICHARD N M', 'ZIEGLER PAUL D', 'ZHOU XIAOHONG', 'WARMAN EDUARDO', 'KLECKNER KAREN J', 'NICHOLS LUCY', 'DELLA SCALA ALBERTO', 'MEDTRONIC INC']","[{'id': 'grid.419673.e', 'acronym': 'Medtronic', 'name': 'Medtronic (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8725259-B2,"['Lilian Kornet', 'Richard N. M. Cornelussen', 'Paul D. Ziegler', 'Xiaohong Zhou', 'Eduardo Warman', 'Karen J. Kleckner', 'Lucy Nichols', 'Alberto Della Scala']",2014-05-13,18.0,Vagal stimulation,2012
1096,"['Medtronic Inc', 'ZHOU XIAOHONG', 'STADLER ROBERT', 'CORNELUSSEN RICHARD N M', 'KORNET LILIAN', 'ZIEGLER PAUL D', 'KLECKNER KAREN J', 'DELLA SCALA ALBERTO', 'MEDTRONIC INC']","[{'id': 'grid.419673.e', 'acronym': 'Medtronic', 'name': 'Medtronic (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8718763-B2,"['Xiaohong Zhou', 'Robert Stadler', 'Richard N. M. Cornelussen', 'Lilian Kornet', 'Paul D. Ziegler', 'Karen J. Kleckner', 'Alberto Della Scala']",2014-05-06,16.0,Vagal stimulation,2012
1097,"['Institut National de la Recherche Scientifique (INRS)', 'INST NAT DE LA RECH SCIENT (INRS)']","[{'id': 'grid.418084.1', 'acronym': 'INRS', 'name': 'National Institute of Scientific Research', 'country_name': 'Canada'}]",Grant,2016.0,US-9440189-B2,"['Guy Mercier', 'Jean-Francois Blais', 'Emmanuelle Cecchi', 'Sanoopkumar Puthiya Veetil', 'Louis-Cesar Pasquier', 'Sandra Kentish']",2016-09-13,2.0,Carbon dioxide chemical sequestration from industrial emissions by carbonation,2013
1098,"['Medtronic Inc', 'BUSCHMAN HENDRIK PETER JOHAN', 'BURNES JOHN EDWARD', 'CORNELUSSEN RICHARD N M', 'HILL MICHAEL ROLAND SCOTT', 'KORNET LILIAN', 'ORDELMAN SIMONE CORNELIA MARIA ANNA', 'VELTINK PETRUS HERMANUS', 'MEDTRONIC INC']","[{'id': 'grid.419673.e', 'acronym': 'Medtronic', 'name': 'Medtronic (United States)', 'country_name': 'United States'}]",Grant,2013.0,US-8423134-B2,"['Hendrik Peter Johan Buschman', 'John Edward Burnes', 'Richard N. M. Cornelussen', 'Michael Roland Scott Hill', 'Lilian Kornet', 'Simone Cornelia Maria Anna Ordelman', 'Petrus Hermanus Veltink']",2013-04-16,26.0,Therapy using perturbation and effect of physiological systems,2011
1099,"['Ohio State Innovation Foundation', 'OHIO STATE INNOVATION FOUNDATION']",,Grant,2018.0,US-10022342-B2,"['Flavia Pichiorri', 'Craig Hofmeister']",2018-07-17,,Methods and compositions for treating multiple myeloma,2016
1100,"['Hydro-Quebec', 'HYDRO-QUéBEC']","[{'id': 'grid.13606.32', 'name': 'Hydro-Québec', 'country_name': 'Canada'}]",Application,,EP-3011615-A4,"['ZAGHIB, KARIM', 'KIM, Chisu', 'GUERFI, ABDELBAST', 'BARRAY, FRANCIS', 'GAGNON, CATHERINE', 'TROTTIER, JULIE']",2017-02-22,,ALL-SOLID-STATE LITHIUM-SULPHUR ELECTROCHEMICAL CELLS AND PRODUCTION METHODS THEREOF,2014
1101,"['Neurostim Solutions LLC', 'CREASEY GRAHAM H', 'TOONG HOO MIN', 'Neurostim Solutions LLC']",,Grant,2018.0,US-10016600-B2,"['Graham H. Creasey', 'Hoo-min Toong']",2018-07-10,1.0,Topical neurological stimulation,2014
1102,"['Medtronic Inc', 'ZIEGLER PAUL D', 'KORNET LILIAN', 'ZHOU XIAOHONG', 'CORNELUSSEN RICHARD N M', 'STADLER ROBERT', 'WARMAN EDUARDO', 'KLECKNER KAREN J', 'SCALA ALBERTO DELLA', 'MEDTRONIC INC']","[{'id': 'grid.419673.e', 'acronym': 'Medtronic', 'name': 'Medtronic (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8781582-B2,"['Paul D. Ziegler', 'Lilian Kornet', 'Xiaohong Zhou', 'Richard N. M. Cornelussen', 'Robert Stadler', 'Eduardo Warman', 'Karen J. Kleckner', 'Alberto Della Scala']",2014-07-15,18.0,Vagal stimulation,2012
1103,"['AF 30 APRIL 2003 AS', 'LEO Laboroatories Ltd', 'LEO LABORATORIES LTD']","[{'id': 'grid.473207.5', 'name': 'Leo Pharma (Ireland)', 'country_name': 'Ireland'}]",Grant,2018.0,US-9861603-B2,"['Marc Barry Brown', 'Michael Edward Donald Crothers', 'Tahir Nazir']",2018-01-09,,Therapeutic compositions,2016
1104,"['GENZYME POLYCLONALS S A S', 'BERNAUD JANINE', 'BLOY CHRISTIAN', 'MATHIAS-CHAPON VIRGINIE', 'RIGAL DOMINIQUE']",,Application,,WO-2012143516-A1,"['BERNAUD, Janine', 'BLOY, CHRISTIAN', 'MATHIAS-CHAPON, Virginie', 'RIGAL, DOMINIQUE']",2012-10-26,,"AMPLIFICATION OF REGULATORY T CELLS BY MEANS OF ANTI-THYMOCYTE IMMUNOGLOBULINS WITH CYTOKINE, INHIBITOR OF TOR PROTEIN KINASE AND/OR DIFFERENTIATING AGENT",2012
1105,['GIULIANI SPA'],,Application,,WO-2014033765-A1,"['GUILIANI, Giammaria', 'BENEDEUSI, Anna', 'DI CAGNO, RAFFAELLA', 'RIZZELLO, CARLO GIUSEPPE', 'DE ANGELIS, MARIA', 'GOBBETTI, MARCO', 'CASSONE, ANGELA']",2014-03-06,,METHOD FOR PARTIAL DEGRADATION OF GLUTEN,2013
1106,"['University of Washington', 'UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION']","[{'id': 'grid.34477.33', 'acronym': 'UW', 'name': 'University of Washington', 'country_name': 'United States'}]",Grant,2016.0,US-9515310-B2,"['Guozhong Cao', 'Yanyi Liu']",2016-12-06,,V2O5 electrodes with high power and energy densities,2013
1107,"['University of Maryland, College Park', 'HAFEZI MOHAMMAD', 'RABL PETER', 'UNIV MARYLAND']","[{'id': 'grid.164295.d', 'acronym': 'UMCP', 'name': 'University of Maryland, College Park', 'country_name': 'United States'}]",Grant,2015.0,US-9128246-B2,"['Mohammad Hafezi', 'Peter Rabl']",2015-09-08,1.0,"Systems, methods, and devices for optomechanically induced non-reciprocity",2012
1108,"['Cincinnati Children s Hospital Medical Center', ""CHILDREN'S HOSPITAL MEDICAL CENTER""]","[{'id': 'grid.2515.3', 'name': ""Boston Children's Hospital"", 'country_name': 'United States'}, {'id': 'grid.239573.9', 'acronym': 'CCHMC', 'name': ""Cincinnati Children's Hospital Medical Center"", 'country_name': 'United States'}, {'id': 'grid.414016.6', 'name': ""UCSF Benioff Children's Hospital"", 'country_name': 'United States'}]",Grant,2018.0,US-9855273-B2,"['Daniel Starczynowski', 'Garrett W. Rhyasen']",2018-01-02,1.0,Combination therapy for MDS,2016
1109,"['Centre Hospitalier Univ Bordeaux', 'Centre National de la Recherche Scientifique CNRS', 'Centre Hospitalier Universitaire de Bordeaux', 'Universite de Bordeaux', 'UNIVERSITÉ DE BORDEAUX', 'CENTRE NAT DE LA RECH SCIENT -CNRS-', 'CENTRE HOSPITALIER UNIV BORDEAUX']","[{'id': 'grid.42399.35', 'acronym': 'CHU', 'name': 'Centre Hospitalier Universitaire de Bordeaux', 'country_name': 'France'}, {'id': 'grid.412041.2', 'name': 'University of Bordeaux', 'country_name': 'France'}, {'id': 'grid.4444.0', 'acronym': 'CNRS', 'name': 'French National Centre for Scientific Research', 'country_name': 'France'}]",Application,,EP-3195881-A1,"['TRUCHETET, Marie-Élise', 'CONTIN-BORDES, Cécile', 'BLANCO, PATRICK', 'SCHAEVERBEKE, Thierry', 'BARNETCHE, Thomas']",2017-07-26,,"SUBSTANCE THAT INHIBITS P2Y12 RECEPTOR, FOR USE IN THE PREVENTIVE TREATMENT OF SYSTEMIC SCLEROSIS IN PATIENTS WITH RAYNAUD'S PHENOMENON AND A DYSIMMUNITY",2016
1110,"['Microsoft Technology Licensing LLC', 'MICROSOFT TECHNOLOGY LICENSING LLC']","[{'id': 'grid.419815.0', 'name': 'Microsoft (United States)', 'country_name': 'United States'}]",Application,,EP-2659357-A4,"['MACLAURIN MATTHEW BRET', 'MOORE GEORGE', 'MURILLO OSCAR E']",2015-08-19,,SUPPORTING INTELLIGENT USER INTERFACE INTERACTIONS,2011
1111,"['Cincinnati Children s Hospital Medical Center', ""CHILDREN'S HOSPITAL MEDICAL CENTER""]","[{'id': 'grid.414016.6', 'name': ""UCSF Benioff Children's Hospital"", 'country_name': 'United States'}, {'id': 'grid.239573.9', 'acronym': 'CCHMC', 'name': ""Cincinnati Children's Hospital Medical Center"", 'country_name': 'United States'}, {'id': 'grid.2515.3', 'name': ""Boston Children's Hospital"", 'country_name': 'United States'}]",Grant,2016.0,US-9504706-B2,"['Daniel Starczynowski', 'Garrett W. Rhyasen']",2016-11-29,1.0,Combination therapy for MDS,2015
1112,"['University of South Florida', 'US Department of Veterans Affairs', 'TAN JUN', 'LUO DEYAN', 'SHYTLE ROLAND DOUGLAS', 'UNIV SOUTH FLORIDA']","[{'id': 'grid.170693.a', 'acronym': 'USF', 'name': 'University of South Florida', 'country_name': 'United States'}, {'id': 'grid.418356.d', 'acronym': 'VA ', 'name': 'United States Department of Veterans Affairs', 'country_name': 'United States'}]",Grant,2014.0,US-8778894-B2,"['Jun Tan', 'Deyan Luo', 'Roland Douglas Shytle']",2014-07-15,1.0,Luteolin and diosmin/diosmetin as novel STAT3 inhibitors for treating autism,2013
1113,"['SAP SE', 'SAP SE']","[{'id': 'grid.19008.30', 'acronym': 'SAP', 'name': 'Systems Applications & Products in Data Processing (Germany)', 'country_name': 'Germany'}]",Grant,2017.0,US-9842375-B2,['Ting Wang'],2017-12-12,,Flexible fare bus framework to reduce bus bunching,2014
1114,"['University of Washington', 'UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION']","[{'id': 'grid.34477.33', 'acronym': 'UW', 'name': 'University of Washington', 'country_name': 'United States'}]",Grant,2018.0,US-9997778-B2,"['Guozhong Cao', 'Yanwei LI']",2018-06-12,,Polycrystalline vanadium oxide nanosheets,2013
1115,"['Bayer Intellectual Property GmbH', 'GOLZ STEFAN', 'DELBECK MARTINA', 'MEIER HEINRICH', 'GEERTS ANDREAS', 'MONDRITZKI THOMAS', 'TRUEBEL HUBERT', 'BAYER IP GMBH']","[{'id': 'grid.420044.6', 'name': 'Bayer (Germany)', 'country_name': 'Germany'}]",Grant,2018.0,US-9943522-B2,"['Stefan Golz', 'Martina Delbeck', 'Heinrich Meier', 'Andreas Geerts', 'Thomas Mondritzki', 'Hubert Trübel']",2018-04-17,,Use of cathepsin K inhibition for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure,2012
1116,"['GENZYME POLYCLONALS Sas', 'Genzyme Polyclonals S A S', 'GENZYME POLYCLONALS S A S']",,Application,,FR-2974369-A1,"['BERNAUD JANINE', 'BLOY CHRISTIAN', 'MATHIAS CHAPON VIRGINIE', 'RIGAL DOMINIQUE']",2012-10-26,,Amplification of t cells regulatory with the aid of immune globulins - thymocytes,2011
1117,"['UNIV PARIS DESCARTES', 'CENTRE NAT DE LA RECH SCIENT (CNRS)', 'INST NAT DE LA SANTE ET DE LA RECH MEDICALE (INSERM)', 'ASSIST PUBLIQUE - HOPITAUX DE PARIS']","[{'id': 'grid.50550.35', 'acronym': 'AP-HP', 'name': 'Assistance Publique -Hopitaux De Paris', 'country_name': 'France'}, {'id': 'grid.10992.33', 'name': 'Paris Descartes University', 'country_name': 'France'}, {'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}, {'id': 'grid.4444.0', 'acronym': 'CNRS', 'name': 'French National Centre for Scientific Research', 'country_name': 'France'}]",Application,,WO-2017089593-A1,"['AVOUAC, Jérôme', 'ALLANORE, Yannick']",2017-06-01,,INHIBITORS FOR TREATING OR PREVENTING A PULMONARY ARTERIAL HYPERTENSION IN SYSTEMIC SCLEROSIS PATIENTS AND METHOD FOR DIAGNOSING SAID DISEASE,2016
1118,"['Cincinnati Children s Hospital Medical Center', 'CHILDRENS HOSP MEDICAL CENTER']","[{'id': 'grid.239573.9', 'acronym': 'CCHMC', 'name': ""Cincinnati Children's Hospital Medical Center"", 'country_name': 'United States'}]",Grant,2015.0,US-9168257-B2,"['Daniel Starczynowski', 'Garrett W. Rhyasen']",2015-10-27,3.0,Combination therapy for MDS,2014
1119,"['Advanced Lithium Electrochemistry Co Ltd', 'ADVANCED LITHIUM ELECTROCHEMISTRY CO LTD']",,Application,,EP-2687482-A4,"['CHANG SHENGSHIH', 'HSIEH HANWEI', 'LIN YUANKAI']",2014-08-13,,CATHODE MATERIAL HAVING DOUBLE-LAYER CARBON COATING AND PREPARATION METHOD THEREFOR,2012
1120,"['NOVARTIS AG', 'WANG YING']","[{'id': 'grid.419481.1', 'name': 'Novartis (Switzerland)', 'country_name': 'Switzerland'}]",Application,,WO-2013077907-A1,"['WANG, YING']",2013-05-30,53.0,METHODS OF TREATING PSORIATIC ARTHRITIS (PSA) USING IL-17 ANTAGONISTS AND PSA RESPONSE OR NON- RESPONSE ALLELES,2012
1121,"['Advanced Lithium Electrochemistry Co Ltd', 'ADVANCED LITHIUM ELECTROCHEMISTRY CO LTD']",,Application,,EP-2687482-A1,"['CHANG, Shengshih', 'HSIEH, Hanwei', 'LIN, Yuankai']",2014-01-22,,CATHODE MATERIAL HAVING DOUBLE-LAYER CARBON COATING AND PREPARATION METHOD THEREFOR,2012
1122,"['LEO Laboroatories Ltd', 'LEO LABORATORIES LTD']","[{'id': 'grid.473207.5', 'name': 'Leo Pharma (Ireland)', 'country_name': 'Ireland'}]",Grant,2017.0,US-9603822-B2,"['Marc Barry Brown', 'Michael Edward Donald Crothers', 'Tahir Nazir']",2017-03-28,,Therapeutic compositions,2016
1123,"['Randox Laboratories Ltd', 'RANDOX LABORATORIES LTD']","[{'id': 'grid.437205.7', 'name': 'Randox (United Kingdom)', 'country_name': 'United Kingdom'}]",Grant,2017.0,US-9671415-B2,"['Ivan McConnell', 'Peter Fitzgerald', 'Philip Lowry', 'Elouard Benchikh']",2017-06-06,,Immunoassay for pyrrolidinophenones,2015
1124,"['Arizona State University', 'ARIZONA BOARD OF REGENTS A BODY CORP OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STA']","[{'id': 'grid.134563.6', 'acronym': 'UA', 'name': 'University of Arizona', 'country_name': 'United States'}, {'id': 'grid.215654.1', 'acronym': 'ASU', 'name': 'Arizona State University', 'country_name': 'United States'}]",Grant,2017.0,US-9738621-B2,"['Dong-kyun Seo', 'Ki-Wan Jeon']",2017-08-22,,Multifunctional materials and composites,2013
1125,"['Universita degli Studi di Roma La Sapienza', 'University of Houston System', 'MCDERMOTT ALISON', 'MANGONI MARIALUISA']","[{'id': 'grid.187082.4', 'acronym': 'UHS', 'name': 'University of Houston System', 'country_name': 'United States'}, {'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Application,,US-20150104492-A1,"['Alison McDermott', 'Marialuisa Mangoni']",2015-04-16,1.0,Esculentin 1a  Derivatives and Uses Thereof,2014
1126,"['University of Alaska Fairbanks', 'UNIV OF ALASKA FAIRBANKS']","[{'id': 'grid.70738.3b', 'acronym': 'UAF', 'name': 'University of Alaska Fairbanks', 'country_name': 'United States'}]",Grant,2016.0,US-9436784-B2,"['Keith W. Cunningham', 'Peter Webley']",2016-09-06,,Validating and calibrating a forecast model,2014
1127,"['UNIV FERRARA', 'I C G E B INTERNAT CT FOR GENETIC ENGINEERING AND BIOTECHNOLOGY', 'PAGANI FRANCO', 'PINOTTI MIRKO']","[{'id': 'grid.8484.0', 'name': 'University of Ferrara', 'country_name': 'Italy'}]",Application,,WO-2012049665-A1,"['PAGANI, FRANCO', 'PINOTTI, MIRKO']",2012-04-19,3.0,"A MODIFIED HUMAN U1SNRNA MOLECULE, A GENE ENCODING FOR THE MODIFIED HUMAN U1SNRNA MOLECULE, AN EXPRESSION VECTOR INCLUDING THE GENE, AND THE USE THEREOF IN GENE THERAPY",2011
1128,"['UNIV LELAND STANFORD JUNIOR', 'BLAU HELEN M', 'COSGROVE BENJAMIN D', 'GILBERT PENNEY M']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Application,,WO-2012141971-A2,"['BLAU, HELEN M.', 'COSGROVE, Benjamin D.', 'GILBERT, PENNEY M.']",2012-10-18,2.0,METHODS AND COMPOSITIONS FOR REJUVENATION AND EXPANSION OF STEM CELLS,2012
1129,"['University of Washington', 'UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION']","[{'id': 'grid.34477.33', 'acronym': 'UW', 'name': 'University of Washington', 'country_name': 'United States'}]",Grant,2018.0,US-10028675-B2,"['Shwetak N Patel', 'Mayank Goel', 'Eric C. Larson']",2018-07-24,,"Sound-based spirometric devices, systems and methods",2013
1130,"['SYNPLOID BIOTEK, LLC', 'PERKINS EDWARD', 'GREENE AMY']",,Application,,EP-3256582-A4,"['PERKINS, EDWARD', 'GREENE, AMY']",2018-06-20,,COMPOSITIONS AND METHODS FOR MONITORING IN REAL-TIME CONSTRUCTION AND BIOENGINEERING OF MAMMALIAN SYNTHETIC CHROMOSOMES,2016
1131,"['University of California', 'UNIV CALIFORNIA']","[{'id': 'grid.30389.31', 'name': 'University of California System', 'country_name': 'United States'}]",Grant,2015.0,US-9163215-B2,"['Irina M. Conboy', 'Preeti Paliwal']",2015-10-20,,Generation of lineage-restricted progenitor cells from differentiated cells,2012
1132,"['Universita degli Studi di Ferrara', 'PAGANI FRANCO', 'PINOTTI MIRKO', 'UNIVERSITA′ DEGLI STUDI DI FERRARA']","[{'id': 'grid.8484.0', 'name': 'University of Ferrara', 'country_name': 'Italy'}]",Grant,2015.0,US-9074207-B2,"['Franco Pagani', 'Mirko Pinotti']",2015-07-07,1.0,"Modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy",2011
1133,"['GENETHON', 'GENETHON']","[{'id': 'grid.419946.7', 'name': 'Genethon (France)', 'country_name': 'France'}]",Application,,FR-2984358-A1,"['JEANSON-LEH LAURENCE', 'ISRAELI DAVID', 'AMOR FATIMA', 'VOIT THOMAS']",2013-06-21,,Methods for the diagnosis of muscular dystrophies,2011
1134,"['Universita Di Ferrara', 'UNIV DI FERRARA']","[{'id': 'grid.8484.0', 'name': 'University of Ferrara', 'country_name': 'Italy'}]",Grant,2017.0,US-9669109-B1,"['Franco Pagani', 'Mirko Pinotti']",2017-06-06,,"Modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy of familial dysautonomia and spinal muscular atrophy",2015
1135,"['Nippon Shinyaku Co Ltd', 'National Center of Neurology and Psychiatry', 'NIPPON SHINYAKU CO LTD', 'NAT CENTER OF NEUROLOGY AND PSYCHIATRY']","[{'id': 'grid.420045.7', 'name': 'Nippon Shinyaku (Japan)', 'country_name': 'Japan'}, {'id': 'grid.419280.6', 'acronym': 'NCNP', 'name': 'National Center of Neurology and Psychiatry', 'country_name': 'Japan'}]",Grant,2018.0,US-9988629-B2,"['Tatsushi WAKAYAMA', 'Haruna Seo', 'Youhei Satou', ""Shin'ichi Takeda"", 'Tetsuya Nagata']",2018-06-05,,Antisense nucleic acids,2015
1136,['UCL BUSINESS PLC'],"[{'id': 'grid.83440.3b', 'acronym': 'UCL', 'name': 'University College London', 'country_name': 'United Kingdom'}]",Application,,WO-2013057485-A1,"['KHOO, Bernard', 'OWEN, James Stuart', 'SIMONS, PAUL']",2013-04-25,2.0,ANTI SENSE OLIGONUCLEOTIDES FOR APOB EXON- SKIPPING,2012
1137,"['GENETHON', 'ASS INST DE MYOLOGIE']","[{'id': 'grid.418250.a', 'name': 'Institute of Myology', 'country_name': 'France'}, {'id': 'grid.419946.7', 'name': 'Genethon (France)', 'country_name': 'France'}]",Application,,WO-2013087907-A1,"['JEANSON-LEH, Laurence', 'ISRAELI, DAVID', 'AMOR, Fatima', 'VOIT, THOMAS']",2013-06-20,7.0,METHODS FOR DIAGNOSIS AND THERAPEUTIC FOLLOW‑UP OF MUSCULAR DYSTROPHIES,2012
1138,"['Universita degli Studi di Roma La Sapienza', 'University of Houston System', 'MCDERMOTT ALISON', 'MANGONI MARIALUISA', 'UNIV HOUSTON SYSTEM', 'UNIV DEGLI STUDI DI ROMA LA SAPIENZA']","[{'id': 'grid.187082.4', 'acronym': 'UHS', 'name': 'University of Houston System', 'country_name': 'United States'}, {'id': 'grid.7841.a', 'name': 'Sapienza University of Rome', 'country_name': 'Italy'}]",Grant,2018.0,US-10059752-B2,"['Alison McDermott', 'Marialuisa Mangoni']",2018-08-28,,Esculentin 1a derivatives and uses thereof,2014
1139,"['UNIV LELAND STANFORD JUNIOR', 'BLAU HELEN M', 'COSGROVE BENJAMIN D', 'GILBERT PENNEY M']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Application,,WO-2012141971-A3,"['BLAU, HELEN M.', 'COSGROVE, Benjamin D.', 'GILBERT, PENNEY M.']",2014-05-01,,METHODS AND COMPOSITIONS FOR REJUVENATION AND EXPANSION OF STEM CELLS,2012
1140,"['BIORESTORATIVE THERAPIES Inc', 'BIORESTORATIVE THERAPIES INC']",,Grant,2017.0,AU-2012275335-B2,"['BULL, DAVID A.', 'PATEL, AMIT N.', 'SILVA, FRANCISCO JAVIER', 'WEINREB, Mark']",2017-04-20,,Brown fat cell compositions and methods,2012
1141,"['National Aeronautics and Space Administration (NASA)', 'NASA']","[{'id': 'grid.238252.c', 'acronym': 'NASA', 'name': 'National Aeronautics and Space Administration', 'country_name': 'United States'}]",Grant,2015.0,US-9051063-B1,"['Max L. Blosser', 'Carl C. Poteet', 'Stan A. Bouslog']",2015-06-09,,Space vehicle heat shield having edgewise strips of ablative material,2013
1142,"['NIPPON SHINYAKU CO LTD', 'NAT CT NEUROLOGY & PSYCHIATRY']","[{'id': 'grid.420045.7', 'name': 'Nippon Shinyaku (Japan)', 'country_name': 'Japan'}]",Application,,WO-2015137409-A1,"['若山 達志', '瀬尾 春奈', '佐藤 洋平', '武田\u3000伸一', '永田\u3000哲也']",2015-09-17,6.0,ANTISENSE NUCLEIC ACID,2015
1143,"['KONINKL PHILIPS ELECTRONICS NV', 'SHI WILLIAM TAO', 'JANKOVIC LADISLAV']","[{'id': 'grid.417284.c', 'name': 'Philips (Netherlands)', 'country_name': 'Netherlands'}]",Application,,WO-2012085751-A1,"['SHI, WILLIAM TAO', 'JANKOVIC, LADISLAV']",2012-06-28,1.0,PHOTO-ACOUSTIC SIGNAL ENHANCEMENT WITH MICROBUBBLE-BASED CONTRAST AGENTS,2011
1144,"['FOND I R C C S ISTITUTO NEUROLOGICO CARLO BESTA', 'DE CURTIS MARCO', 'GNATKOVSKYY VADYM']","[{'id': 'grid.417894.7', 'name': 'Carlo Besta Neurological Institute', 'country_name': 'Italy'}]",Application,,WO-2012042036-A1,"['DE CURTIS, MARCO', 'GNATKOVSKYY, VADYM']",2012-04-05,,METHOD AND DEVICE FOR CONVERTING TIME-VARYING SIGNALS ACQUIRED OVER A LARGE NUMBER OF RECORDING CHANNELS,2011
1145,"['Agensys Inc', 'Seattle Genetics Inc', 'SATPAYEV DAULET', 'MORRISON ROBERT KENDALL', 'MORRISON KAREN JANE MEYRICK', 'GUDAS JEAN', 'JAKOBOVITS AYA', 'TORGOV MICHAEL', 'AN ZILI', 'SEATTLE GENETICS INC', 'AGENSYS INC']","[{'id': 'grid.438014.a', 'name': 'Seattle Genetics (United States)', 'country_name': 'United States'}, {'id': 'grid.423286.9', 'acronym': 'Astellas Pharma', 'name': 'Astellas Pharma (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8637642-B2,"['Daulet SATPAYEV', 'Robert Kendall Morrison', 'Karen Jane Meyrick Morrison', 'Jean Gudas', 'Aya Jakobovits', 'Michael Torgov', 'Zili An']",2014-01-28,,Antibody drug conjugates (ADC) that bind to 191P4D12 proteins,2011
1146,"['Academia Sinica', 'Taipei Medical University', 'UNIV TAIPEI MEDICAL', 'ACADEMIA SINICA']","[{'id': 'grid.28665.3f', 'name': 'Academia Sinica', 'country_name': 'Taiwan'}, {'id': 'grid.412896.0', 'acronym': 'TMU', 'name': 'Taipei Medical University', 'country_name': 'Taiwan'}]",Grant,2016.0,US-9229012-B2,"['Wei-Chung Yang', 'Hwei-Jiung Wang', 'Shui-Tsung CHEN', 'Ken-Fen LU', 'MING-CHI PENG']",2016-01-05,,Specific A1AT monoclonal antibodies for detection of endometriosis,2013
1147,['JEJU NAT UNIVERSITY INDUSTRY ACADEMIC'],,Application,,WO-2014204064-A1,"['조문제', '김영미', '호만틴', '김소미', '고동수', '임융호']",2014-12-24,,NOVEL FLAVONOID AND USE THEREOF,2013
1148,['IDI INTEGRATORI DIETETICI ITALIANI S R L'],,Application,,WO-2015173666-A1,"['BOTTINO, Pietro']",2015-11-19,,A FORMULATION FOR AMELIORATING PREMATURE EJACULATION,2015
1149,"['National Technology and Engineering Solutions of Sandia LLC', 'SANDIA CORP']","[{'id': 'grid.419474.b', 'name': 'Lockheed Martin (United States)', 'country_name': 'United States'}, {'id': 'grid.420747.2', 'name': 'Honeywell (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9641154-B2,"['Roy H. Olsson', 'Thomas A. Friedmann', 'Sara Jensen Homeijer', 'Michael Wiwi', 'Khalid Mikhiel Hattar', 'Blythe Clark', 'Todd Bauer', 'Stuart B. Van Deusen']",2017-05-02,1.0,Single crystal micromechanical resonator,2016
1150,"['Agensys Inc', 'Seattle Genetics Inc', 'AGENSYS INC', 'SEATTLE GENETICS INC']","[{'id': 'grid.423286.9', 'acronym': 'Astellas Pharma', 'name': 'Astellas Pharma (United States)', 'country_name': 'United States'}, {'id': 'grid.438014.a', 'name': 'Seattle Genetics (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9314538-B2,"['Daulet SATPAYEV', 'Robert Kendall Morrison', 'Karen Jane Meyrick Morrison', 'Jean Gudas', 'Aya Jakobovits', 'Michael Torgov', 'Zili An']",2016-04-19,,Nucleic acid molecules encoding antibody drug conjugates (ADC) that bind to 191P4D12 proteins,2015
1151,"['TAMPERE UNIVERSITY OF TECHNOLOGY', 'University of Vermont', 'KAUFFMAN STUART', 'NIIRANEN SAMULI', 'VATTAY GÁBOR', 'UNIV VERMONT', 'TAMPERE UNIVERSITY OF TECHNOLOGY']","[{'id': 'grid.59062.38', 'acronym': 'UVM', 'name': 'University of Vermont', 'country_name': 'United States'}, {'id': 'grid.6986.1', 'acronym': 'TUT', 'name': 'Tampere University of Technology', 'country_name': 'Finland'}]",Grant,2014.0,US-8849580-B2,"['Stuart Kauffman', 'Samuli Niiranen', 'Gábor Vattay']",2014-09-30,5.0,Uses of systems with degrees of freedom poised between fully quantum and fully classical states,2011
1152,"['INST NAT SANTE RECH MED', 'UNIV MONTPELLIER 1', 'CT HOSPITALIER UNIVERSITAIRE MONTPELLIER']","[{'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}, {'id': 'grid.121334.6', 'acronym': 'UM', 'name': 'University of Montpellier', 'country_name': 'France'}, {'id': 'grid.157868.5', 'acronym': 'CHRU MTP', 'name': 'University Hospital of Montpellier', 'country_name': 'France'}]",Application,,WO-2013087917-A1,"['RUBBO, Pierre-Alain', 'NAGOT, Nicolas', 'TUAILLON, Edouard', 'VAN DE PERRE, Philippe']",2013-06-20,,METHODS AND KITS FOR DIAGNOSING LATENT TUBERCULOSIS INFECTION,2012
1153,"['Academia Sinica', 'Taipei Medical University', 'UNIV TAIPEI MEDICAL', 'ACADEMIA SINICA']","[{'id': 'grid.412896.0', 'acronym': 'TMU', 'name': 'Taipei Medical University', 'country_name': 'Taiwan'}, {'id': 'grid.28665.3f', 'name': 'Academia Sinica', 'country_name': 'Taiwan'}]",Application,,EP-2663865-A4,"['YANG WEI-CHUNG', 'WANG HWEI-JIUNG', 'CHEN SHUI-TSUNG', 'LU KEN-FEN', 'PENG MING-CHI']",2014-09-24,,SPECIFIC A1AT MONOCLONAL ANTIBODIES FOR DETECTION OF ENDOMETRIOSIS,2012
1154,"['Ionis Pharmaceuticals Inc', 'IONIS PHARMACEUTICALS INC']","[{'id': 'grid.282569.2', 'name': 'Ionis Pharmaceuticals (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9340784-B2,"['Brett P. Monia', 'Michael L. McCaleb', 'Susan M. Freier', 'Shuling Guo']",2016-05-17,2.0,Methods and compositions for modulating alpha-1-antitrypsin expression,2013
1155,"['Agensys Inc', 'Seattle Genetics Inc', 'AGENSYS INC', 'SEATTLE GENETICS INC']","[{'id': 'grid.423286.9', 'acronym': 'Astellas Pharma', 'name': 'Astellas Pharma (United States)', 'country_name': 'United States'}, {'id': 'grid.438014.a', 'name': 'Seattle Genetics (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9962454-B2,"['Daulet SATPAYEV', 'Robert Kendall Morrison', 'Karen Jane Meyrick Morrison', 'Jean Gudas', 'Aya Jakobovits', 'Michael Torgov', 'Zili An']",2018-05-08,,Antibody drug conjugates (ADC) that bind to 191P4D12 proteins,2016
1156,"['UNIV ROMA', 'DE LUCA CRISTINA', 'FRANCISCI SILVIA', 'FRONTALI LAURA', 'MONTANARI ARIANNA']",,Application,,WO-2012089570-A1,"['DE LUCA, Cristina', 'FRANCISCI, Silvia', 'FRONTALI, LAURA', 'MONTANARI, Arianna']",2012-07-05,,PEPTIDE MOLECULES FOR TREATING MITOCHONDRIAL PATHOLOGIES,2011
1157,"['Agensys Inc', 'Seattle Genetics Inc', 'AGENSYS INC', 'SEATTLE GENETICS INC']","[{'id': 'grid.423286.9', 'acronym': 'Astellas Pharma', 'name': 'Astellas Pharma (United States)', 'country_name': 'United States'}, {'id': 'grid.438014.a', 'name': 'Seattle Genetics (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9078931-B2,"['Daulet SATPAYEV', 'Robert Kendall Morrison', 'Karen Jane Meyrick Morrison', 'Jean Gudas', 'Aya Jakobovits', 'Michael Torgov', 'Zili An']",2015-07-14,1.0,Antibody drug conjugates (ADC) that bind to 191P4D12 proteins,2013
1158,"['Bionanoplus SL', 'BIONANOPLUS S L']",,Application,,EP-2625966-A1,"['SALMAN, HESHAM H.A.', 'Goñi Azcàrate, Izaskun', 'ESPARZA CATALÁN, Irene']",2013-08-14,,Nanoparticles comprising a vegetable hydrophobic protein and a water miscible non-volatile organic solvent and uses thereof,2012
1159,"['SYNGENTA PARTICIPATIONS AG', 'ZAMBACH WERNER', 'STIERLI DANIEL', 'NEBEL KURT', 'BORTOLATO ANDREA', 'MASSOL-FRIEH CLARA']","[{'id': 'grid.420222.4', 'name': 'Syngenta (Switzerland)', 'country_name': 'Switzerland'}]",Application,,WO-2012038521-A1,"['ZAMBACH, WERNER', 'STIERLI, DANIEL', 'NEBEL, KURT', 'BORTOLATO, ANDREA', 'MASSOL-FRIEH, CLARA']",2012-03-29,,NOVEL MICROBIOCIDES,2011
1160,"['Princeton University', 'UNIV PRINCETON']","[{'id': 'grid.16750.35', 'name': 'Princeton University', 'country_name': 'United States'}]",Grant,2017.0,US-9752175-B2,"['Bonnie L. Bassler', 'Howard A. Stone', 'Knut Drescher', 'Yi Shen']",2017-09-05,,Systems and methods to detect biofilm streamer growth and their uses,2015
1161,['BIONANOPLUS S L'],,Application,,WO-2013120856-A1,"['SALMAN, HESHAM H.A.', 'GOÑI AZCÁRATE, Izaskun', 'ESPARZA CATALÁN, Irene']",2013-08-22,3.0,NANOPARTICLES COMPRISING A VEGETABLE HYDROPHOBIC PROTEIN AND A WATER MISCIBLE NON-VOLATILE ORGANIC SOLVENT AND USES THEREOF,2013
1162,"['AbbVie Deutschland GmbH and Co KG', 'AbbVie Inc', 'ABBVIE INC']","[{'id': 'grid.431072.3', 'acronym': 'Abbvie Biotherapeutics, Inc', 'name': 'AbbVie (United States)', 'country_name': 'United States'}, {'id': 'grid.467162.0', 'name': 'AbbVie (Germany)', 'country_name': 'Germany'}]",Grant,2018.0,US-10017517-B2,"['Thomas B. Borchardt', 'Ahmad Y. Sheikh']",2018-07-10,3.0,"Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluorethyl)pyrrolidine-1-carboxamide and solid state forms thereof",2018
1163,"['Leland Stanford Junior University', 'DEISSEROTH KARL', 'ZHANG FENG', 'MISHELEVICH DAVID J', 'SCHNEIDER M BRET', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2018.0,US-10052497-B2,"['Karl Deisseroth', 'Feng Zhang', 'David J. Mishelevich', 'M. Bret Schneider']",2018-08-21,,System for optical stimulation of target cells,2008
1164,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9453215-B2,"['Karl Deisseroth', 'Raag D. Airan']",2016-09-27,6.0,"Cell line, system and method for optical control of secondary messengers",2015
1165,"['Leland Stanford Junior University', 'DEISSEROTH KARL', 'TYE KAY', 'FENNO LIEF', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2015.0,US-8932562-B2,"['Karl Deisseroth', 'Kay Tye', 'Lief Fenno']",2015-01-13,28.0,Optically controlled CNS dysfunction,2011
1166,"['Leland Stanford Junior University', 'SCHNEIDER M BRET', 'DEISSEROTH KARL', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2015.0,US-8956363-B2,"['M. Bret Schneider', 'Karl Deisseroth']",2015-02-17,28.0,"Methods, systems and devices for optical stimulation of target cells using an optical transmission element",2009
1167,"['Leland Stanford Junior University', 'DEISSEROTH KARL', 'BOYDEN EDWARD S', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2015.0,US-9101690-B2,"['Karl Deisseroth', 'Edward S. Boyden']",2015-08-11,24.0,Light-activated cation channel and uses thereof,2012
1168,"['AbbVie Inc', 'ABBVIE INC']","[{'id': 'grid.431072.3', 'acronym': 'Abbvie Biotherapeutics, Inc', 'name': 'AbbVie (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9963459-B1,"['Jayanthy Jayanth', 'Patrick J. Marroum', 'Peter T. Mayer', 'Mohamed-Eslam F. Mohamed', 'Ahmed A. Othman']",2018-05-08,3.0,"Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-alpla]pyrrolo[2,3-e]-pyrazin-8-YL)-N-(2,2,2-Trifluoroethyl)pyrrol and solid state forms thereof",2017
1169,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9308392-B2,"['Karl Deisseroth', 'Scott L. Delp', 'Michael E. Llewellyn', 'Christine A. McLeavey Payne']",2016-04-12,14.0,Materials and approaches for optical stimulation of the peripheral nervous system,2013
1170,"['Bend Research Inc', 'Endocyte Inc', 'BEND RES INC']","[{'id': 'grid.421008.f', 'acronym': 'ECYT', 'name': 'Endocyte (United States)', 'country_name': 'United States'}, {'id': 'grid.423227.2', 'name': 'Capsugel (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9568449-B2,"['Brandon J. Downey', 'Jeffery F. Breit', 'Lisa Graham', 'Adam S. Carroll']",2017-02-14,,Dielectric spectroscopy methods and apparatus,2013
1171,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2018.0,US-10046174-B2,"['Karl Deisseroth', 'ALEXANDER ARAVANIS', 'Feng Zhang', 'M. Bret Schneider', 'Jaimie M. Henderson']",2018-08-14,,System for electrically stimulating target neuronal cells of a living animal in vivo,2013
1172,"['CHDI Foundation Inc', 'CHDI FOUNDATION INC']","[{'id': 'grid.453209.9', 'name': 'CHDI Foundation', 'country_name': 'United States'}]",Grant,2018.0,US-9855267-B2,"['Celia Dominguez', 'Perla Breccia', 'Christopher A. Luckhurst', 'Roland W. Bürli', 'Andrew J. Stott']",2018-01-02,,Histone deacetylase inhibitors and compositions and methods of use thereof,2016
1173,"['Mirna Therapeutics Inc', 'BADER ANDREAS G', 'WIGGINS JASON F', 'PATRAWALA LUBNA', 'KELNAR KEVIN', 'BYROM MIKE', 'BROWN DAVID', 'MIRNA THERAPEUTICS INC']","[{'id': 'grid.421440.7', 'name': 'Mirna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2011.0,US-8071562-B2,"['Andreas G. Bader', 'Jason F. Wiggins', 'Lubna Patrawala', 'Kevin Kelnar', 'Mike Byrom', 'David Brown']",2011-12-06,35.0,MiR-124 regulated genes and pathways as targets for therapeutic intervention,2008
1174,"['AbbVie Inc', 'ABBVIE INC']","[{'id': 'grid.431072.3', 'acronym': 'Abbvie Biotherapeutics, Inc', 'name': 'AbbVie (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9879018-B2,"['Mathew M. Mulhern', 'Lars Fredrick Nordstroem', 'Ahmad Y. Sheikh']",2018-01-30,4.0,"Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl and solid state forms thereof",2017
1175,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2014.0,US-8815582-B2,"['Karl Deisseroth', 'Feng Zhang', 'Viviana Gradinaru']",2014-08-26,53.0,Mammalian cell expressing Volvox carteri light-activated ion channel protein (VChR1),2012
1176,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2018.0,US-10087223-B2,"['Karl Deisseroth', 'Feng Zhang', 'Viviana Gradinaru']",2018-10-02,,Opsin polypeptides and methods of use thereof,2018
1177,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9359449-B2,"['Karl Deisseroth', 'Feng Zhang', 'Viviana Gradinaru']",2016-06-07,38.0,Light-sensitive ion-passing molecules,2012
1178,['CHUGAI PHARMACEUTICAL CO LTD'],"[{'id': 'grid.418587.7', 'name': 'Roche (Japan)', 'country_name': 'Japan'}]",Application,,WO-2015083764-A1,"['井川 智之', '丹波 茂郎', '清水 駿', '辰巳 加奈子', '門野 正次郎', '河内 宏樹', '大原 一宏', '松下 正行', '江村 岳', '上村 将樹']",2015-06-11,1.0,"ANTIGEN-BINDING MOLECULES, THE ANTIGEN-BINDING ACTIVITY OF WHICH VARIES ACCORDING TO THE CONCENTRATION OF COMPOUNDS, AND LIBRARIES OF SAID MOLECULES",2014
1179,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2015.0,US-9187745-B2,"['Karl Deisseroth', 'Feng Zhang', 'Edward Boyden']",2015-11-17,23.0,System for optical stimulation of target cells,2015
1180,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9360472-B2,"['Karl Deisseroth', 'Feng Zhang', 'Viviana Gradinaru', 'M. Bret Schneider']",2016-06-07,10.0,"Cell line, system and method for optical-based screening of ion-channel modulators",2013
1181,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2014.0,US-8864805-B2,"['Karl Deisseroth', 'Feng Zhang', 'Edward Boyden']",2014-10-21,29.0,System for optical stimulation of target cells,2013
1182,"['Chugai Pharmaceutical Co Ltd', 'IGAWA TOMOYUKI', 'TSUNODA HIROYUKI', 'TACHIBANA TATSUHIKO', 'KURAMOCHI TAICHI', 'CHUGAI PHARMACEUTICAL CO LTD']","[{'id': 'grid.418587.7', 'name': 'Roche (Japan)', 'country_name': 'Japan'}]",Grant,2015.0,US-9096651-B2,"['Tomoyuki Igawa', 'Hiroyuki Tsunoda', 'Tatsuhiko Tachibana', 'Taichi Kuramochi']",2015-08-04,23.0,Method of modifying isoelectric point of antibody via amino acid substitution in CDR,2008
1183,"['Johns Hopkins University', 'Mirna Therapeutics Inc', 'MIRNA THERAPEUTICS INC']","[{'id': 'grid.21107.35', 'acronym': 'JHU', 'name': 'Johns Hopkins University', 'country_name': 'United States'}, {'id': 'grid.421440.7', 'name': 'Mirna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9365852-B2,"['Jikui Shen', 'Kevin Kelnar', 'Jeffrey Shelton', 'David Brown', 'Peter Campochiaro']",2016-06-14,1.0,Compositions and methods related to miRNA modulation of neovascularization or angiogenesis,2015
1184,"['Leland Stanford Junior University', 'DEISSEROTH KARL', 'BOYDEN EDWARD S', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9278159-B2,"['Karl Deisseroth', 'Edward S. Boyden']",2016-03-08,23.0,Light-activated cation channel and uses thereof,2006
1185,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9249234-B2,"['Karl Deisseroth', 'Feng Zhang', 'Viviana Gradinaru']",2016-02-02,34.0,Light-sensitive ion-passing molecules,2012
1186,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2018.0,US-10064912-B2,"['Karl Deisseroth', 'Ofer Yizhar', 'Lisa Gunaydin', 'Peter Hegemann', 'Andre Berndt']",2018-09-04,6.0,Optically-based stimulation of target cells and modifications thereto,2016
1187,"['Leland Stanford Junior University', 'DEISSEROTH KARL', 'BOYDEN EDWARD S', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2018.0,US-10036758-B2,"['Karl Deisseroth', 'Edward S. Boyden']",2018-07-31,,Delivery of a light-activated cation channel into the brain of a subject,2010
1188,"['REDPATH EQUITYHOLDER REPRESENTATIVE LLC', 'ADAI ALEX', 'Szafransak-Schwarzbach Anna', 'ANDRUSS BERNARD', 'HAHN STEPHAN ALBRECHT', 'INTERPACE DIAGNOSTICS LLC']",,Grant,2017.0,US-9644241-B2,"['Alex Adai', 'Anna Szafransak-Schwarzbach', 'Bernard Andruss', 'Stephan Albrecht Hahn']",2017-05-09,,Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease,2012
1189,"['Nutricia NV', 'NUTRICIA NV']","[{'id': 'grid.423979.2', 'name': 'Danone (Netherlands)', 'country_name': 'Netherlands'}]",Grant,2018.0,US-10045999-B2,"['Marion-Eve Adeline Jourdan', 'Yvette Charlotte Luiking', 'George Verlaan', 'Sovianne Ter Borg']",2018-08-14,,Nutritional composition for the stimulation of muscle protein synthesis,2015
1190,"['Primal Fusion Inc', 'SWEENEY PETER JOSEPH', 'ILYAS IHAB FRANCIS']",,Application,,US-20130246328-A1,"['Peter Joseph Sweeney', 'Ihab Francis Ilyas']",2013-09-19,26.0,METHODS AND DEVICES FOR CUSTOMIZING KNOWLEDGE REPRESENTATION SYSTEMS,2013
1191,"['Leland Stanford Junior University', 'DEISSEROTH KARL', 'ZHANG FENG', 'GRADINARU VIVIANA', 'SCHNEIDER M BRET', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9274099-B2,"['Karl Deisseroth', 'Feng Zhang', 'Viviana Gradinaru', 'M. Bret Schneider']",2016-03-01,23.0,Screening test drugs to identify their effects on cell membrane voltage-gated ion channel,2008
1192,"['Leland Stanford Junior University', 'DEISSEROTH KARL', 'SCHNEIDER M BRET', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2018.0,US-10035027-B2,"['Karl Deisseroth', 'M. Bret Schneider']",2018-07-31,1.0,Device and method for ultrasonic neuromodulation via stereotactic frame based technique,2008
1193,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9249200-B2,"['Karl Deisseroth', 'Feng Zhang', 'Viviana Gradinaru']",2016-02-02,23.0,Expression vector comprising a nucleotide sequence encoding a Volvox carteri light-activated ion channel protein (VChR1) and implantable device thereof,2014
1194,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2017.0,US-9604073-B2,"['Karl Deisseroth', 'Feng Zhang', 'Viviana Gradinaru']",2017-03-28,27.0,Light-sensitive ion-passing molecules,2016
1195,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2017.0,US-9829492-B2,"['Karl Deisseroth', 'Edward S. Boyden']",2017-11-28,3.0,Implantable prosthetic device comprising a cell expressing a channelrhodopsin,2015
1196,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9421258-B2,"['Karl Deisseroth', 'Kay Tye', 'Lief Fenno']",2016-08-23,10.0,Optically controlled CNS dysfunction,2014
1197,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2018.0,US-9969783-B2,"['Karl Deisseroth', 'Feng Zhang', 'Viviana Gradinaru']",2018-05-15,1.0,Opsin polypeptides and methods of use thereof,2017
1198,['GELITA AG'],"[{'id': 'grid.491740.f', 'name': 'Gelita (Germany)', 'country_name': 'Germany'}]",Application,,WO-2014183989-A1,"['HAUSMANNS, STEPHAN', 'KNEFÉLI, HANS-CHRISTOPH', 'OESSER, STEFFEN', 'FRECH, HANS-ULRICH']",2014-11-20,,ACTIVE SUBSTANCE FOR TREATING SARCOPENIA,2014
1199,"['NORGINE BV', 'HALPHEN MARC', 'GRUSS HANS-JURGEN', 'COX IAN', 'COCKETT ALASDAIR', 'STEIN PETER', 'UNGAR ALEX', 'NORGINE BV']",,Grant,2017.0,US-9592252-B2,"['Marc Halphen', 'Hans-Jurgen Gruss', 'Ian Cox', 'Alasdair Cockett', 'Peter Stein', 'Alex Ungar']",2017-03-14,,Colonoscopy—preparation,2012
1200,"['CHDI Foundation Inc', 'BÜRLI ROLAND W', 'STOTT ANDREW J', 'BRECCIA PERLA', 'DOMINGUEZ CELIA', 'MUÑOZ-SANJUÀN IGNACIO', 'LUCKHURST CHRISTOPHER A', 'HUGHES SAMANTHA J', 'HAUGHAN ALAN F', 'CHDI FOUNDATION INC']","[{'id': 'grid.453209.9', 'name': 'CHDI Foundation', 'country_name': 'United States'}]",Grant,2017.0,US-9765054-B2,"['Roland W. Bürli', 'Andrew J. Stott', 'Perla Breccia', 'Celia Dominguez', 'Ignacio Muñoz-Sanjuàn', 'Christopher A. Luckhurst', 'Samantha J. Hughes', 'Alan F. Haughan']",2017-09-19,,Histone deacetylase inhibitors and compositions and methods of use thereof,2012
1201,"['Asuragen Inc', 'BROWN DAVID', 'CONRAD RICK', 'DEVROE ERIC', 'GOLDRICK MARIANNA', 'KEIGER KERRI', 'LABOURIER EMMANUEL', 'MOON IVONNE', 'POWERS PATRICIA', 'SHELTON JEFFREY', 'SHINGARA JACLYN', 'ASURAGEN INC']","[{'id': 'grid.422997.3', 'name': 'Asuragen (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10047388-B2,"['David Brown', 'Rick Conrad', 'Eric Devroe', 'Marianna Goldrick', 'Kerri Keiger', 'Emmanuel Labourier', 'Ivonne Moon', 'Patricia Powers', 'Jeffrey Shelton', 'Jaclyn Shingara']",2018-08-14,,Methods and compositions involving MicroRNA,2013
1202,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2018.0,US-10018695-B2,"['Karl Deisseroth', 'Jin Hyung Lee']",2018-07-10,,Optogenetic magnetic resonance imaging,2017
1203,"['METHYLATION SCIENCES INTERNATIONAL Srl', 'METHYLATION SCIENCES INT SRL']",,Grant,2018.0,US-9925208-B2,"['Dechi Guan', 'I. David MacDonald']",2018-03-27,,Compositions comprising S-adenosylmethionine and a gallic acid ester,2015
1204,['NTZ LAB LTD'],,Application,,WO-2015013777-A3,"['TZVETKOV, NIKOLAY']",2016-01-14,,SUBSTITUTED BENZAMIDE DERIVATIVES AS IN VITRO MAO-B INHIBITORS,2014
1205,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2015.0,US-8962589-B2,"['Karl Deisseroth', 'Raag D. Airan']",2015-02-24,27.0,"Cell line, system and method for optical control of secondary messengers",2013
1206,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9340589-B2,"['Karl Deisseroth', 'Ofer Yizhar', 'Lief Fenno', 'Peter Hegemann', 'Matthias Prigge']",2016-05-17,14.0,Light-activated chimeric opsins and methods of using the same,2015
1207,['CHUGAI PHARMACEUTICAL CO LTD'],"[{'id': 'grid.418587.7', 'name': 'Roche (Japan)', 'country_name': 'Japan'}]",Application,,WO-2013180200-A1,"['井川 智之', '丹波 茂郎', '辰巳 加奈子', '清水 駿', '門野 正次郎']",2013-12-05,5.0,TARGET-TISSUE-SPECIFIC ANTIGEN-BINDING MOLECULE,2013
1208,"['Leland Stanford Junior University', 'DEISSEROTH KARL', 'ARAVANIS ALEXANDER', 'ZHANG FENG', 'SCHNEIDER M BRET', 'HENDERSON JAIMIE M', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9238150-B2,"['Karl Deisseroth', 'ALEXANDER ARAVANIS', 'Feng Zhang', 'M. Bret Schneider', 'Jaimie M. Henderson']",2016-01-19,23.0,Optical tissue interface method and apparatus for stimulating cells,2008
1209,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9458208-B2,"['Karl Deisseroth', 'Ofer Yizhar', 'Lisa Gunaydin', 'Peter Hegemann', 'Andre Berndt']",2016-10-04,25.0,Optically-based stimulation of target cells and modifications thereto,2014
1210,"['Primal Fusion Inc', 'PRIMAL FUSION INC']",,Grant,2017.0,US-9576241-B2,"['Peter Joseph Sweeney', 'Ihab Francis Ilyas']",2017-02-21,2.0,Methods and devices for customizing knowledge representation systems,2015
1211,"['AbbVie Inc', 'ABBVIE INC']","[{'id': 'grid.431072.3', 'acronym': 'Abbvie Biotherapeutics, Inc', 'name': 'AbbVie (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9879019-B2,"['Lars Frederick NORDSTROEM', 'Ahmad Y. Sheikh']",2018-01-30,4.0,"Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof",2017
1212,"['Asuragen Inc', 'ASURAGEN INC']","[{'id': 'grid.422997.3', 'name': 'Asuragen (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9506061-B2,"['David Brown', 'Lance Ford', 'Angie Cheng', 'Rich Jarvis', 'Mike Byrom', 'Dmitriy Ovcharenko', 'Eric Devroe', 'Kevin Kelnar']",2016-11-29,2.0,Methods and compositions involving miRNA and miRNA inhibitor molecules,2015
1213,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9394347-B2,"['Karl Deisseroth', 'Feng Zhang', 'Viviana Gradinaru']",2016-07-19,17.0,Methods for treating parkinson's disease by optically stimulating target cells,2015
1214,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2017.0,US-9840541-B2,"['Karl Deisseroth', 'Feng Zhang', 'Viviana Gradinaru']",2017-12-12,3.0,Opsin polypeptides and methods of use thereof,2016
1215,"['Asuragen Inc', 'BROWN DAVID', 'CONRAD RICK', 'DEVROE ERIC', 'GOLDRICK MARIANNA', 'KEIGER KERRI', 'LABOURIER EMMANUEL', 'MOON IVONNE', 'POWERS PATRICIA', 'SHELTON JEFFREY', 'SHINGARA JACLYN', 'ASURAGEN INC']","[{'id': 'grid.422997.3', 'name': 'Asuragen (United States)', 'country_name': 'United States'}]",Grant,2013.0,US-8568971-B2,"['David Brown', 'Rick Conrad', 'Eric Devroe', 'Marianna Goldrick', 'Kerri Keiger', 'Emmanuel Labourier', 'Ivonne Moon', 'Patricia Powers', 'Jeffrey Shelton', 'Jaclyn Shingara']",2013-10-29,8.0,Methods and compositions involving microRNA,2010
1216,"['Chugai Pharmaceutical Co Ltd', 'CHUGAI PHARMACEUTICAL CO LTD']","[{'id': 'grid.418587.7', 'name': 'Roche (Japan)', 'country_name': 'Japan'}]",Grant,2017.0,US-9828429-B2,"['Tomoyuki Igawa', 'Hiroyuki Tsunoda', 'Tatsuhiko Tachibana', 'Taichi Kuramochi']",2017-11-28,2.0,Method of modifying isoelectric point of antibody via amino acid substitution in CDR,2015
1217,"['""NTZ LAB"" Ltd', 'Ntz Lab Ltd', '“NTZ LAB” LTD']",,Grant,2017.0,US-9738640-B2,['Nikolay TZVETKOV'],2017-08-22,,Substituted benzamide derivatives as in vitro MAO-B inhibitors,2014
1218,"['Asuragen Inc', 'ASURAGEN INC']","[{'id': 'grid.422997.3', 'name': 'Asuragen (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9080215-B2,"['Sylvie Beaudenon-Huibregtse', 'Emmanuel Labourier', 'Laura Elizondo']",2015-07-14,,MicroRNAs differentially expressed in cervical cancer and uses thereof,2013
1219,"['NORGINE BV', 'NORGINE BV']",,Grant,2018.0,US-10016504-B2,"['Lucy Clayton', 'Alasdair Cockett', 'Mark Christodoulou', 'Ian Davidson', 'Lynn Farrag', 'Marc Halphen', 'Leighton Jones', 'Vanik Petrossian', 'Peter Stein', 'David Tisi', 'Alex Ungar', 'Jeffrey Worthington']",2018-07-10,,Compositions,2017
1220,"['Leland Stanford Junior University', 'DEISSEROTH KARL', 'ZHANG FENG', 'GRADINARU VIVIANA', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2015.0,US-9079940-B2,"['Karl Deisseroth', 'Feng Zhang', 'Viviana Gradinaru']",2015-07-14,33.0,Light-sensitive ion-passing molecules,2011
1221,"['Chugai Pharmaceutical Co Ltd', 'CHUGAI PHARMACEUTICAL CO LTD']","[{'id': 'grid.418587.7', 'name': 'Roche (Japan)', 'country_name': 'Japan'}]",Grant,2018.0,US-9890377-B2,"['Tomoyuki Igawa', 'Shinya Ishii', 'Atsuhiko Maeda', 'Takashi Nakai']",2018-02-13,2.0,Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly,2013
1222,"['NORGINE BV', 'NORGINE BV']",,Grant,2017.0,US-9707297-B2,"['Lucy Clayton', 'Alasdair Cockett', 'Mark Christodoulou', 'Ian Davidson', 'Lynn Farrag', 'Marc Halphen', 'Leighton Jones', 'Vanik Petrossian', 'Peter Stein', 'David Tisi', 'Alex Ungar', 'Jeffrey Worthington']",2017-07-18,2.0,Compositions,2016
1223,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9271674-B2,"['Karl Deisseroth', 'Jin Hyung Lee']",2016-03-01,25.0,Optogenetic magnetic resonance imaging,2014
1224,"['Leland Stanford Junior University', 'DEISSEROTH KARL', 'SCHNEIDER M BRET', 'MISHELEVICH DAVID J', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2015.0,US-8926959-B2,"['Karl Deisseroth', 'M. Bret Schneider', 'David J. Mishelevich']",2015-01-06,42.0,System for optical stimulation of target cells,2007
1225,['INSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE'],"[{'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}]",Application,,WO-2014118296-A1,"['MODJTAHEDI, NAZANINE', 'KROEMER, GUIDO']",2014-08-07,,METHODS FOR TREATING MITOCHONDRIAL DISORDERS AND NEURODEGENERATIVE DISORDERS,2014
1226,"['Leland Stanford Junior University', 'DEISSEROTH KARL', 'AIRAN RAAG D', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2014.0,US-8729040-B2,"['Karl Deisseroth', 'Raag D. Airan']",2014-05-20,32.0,"Cell line, system and method for optical control of secondary messengers",2009
1227,"['Chugai Pharmaceutical Co Ltd', 'CHUGAI PHARMACEUTICAL CO LTD']","[{'id': 'grid.418587.7', 'name': 'Roche (Japan)', 'country_name': 'Japan'}]",Grant,2018.0,US-9868948-B2,"['Tomoyuki Igawa', 'Shinya Ishii', 'Atsuhiko Maeda', 'Takashi Nakai']",2018-01-16,2.0,Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly,2013
1228,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2017.0,US-9636380-B2,"['Stephan Lammel', 'ByungKook Lim', 'Robert C. Malenka']",2017-05-02,12.0,Optogenetic control of inputs to the ventral tegmental area,2014
1229,"['Leland Stanford Junior University', 'DEISSEROTH KARL', 'ANIKEEVA POLINA', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9522288-B2,"['Karl Deisseroth', 'Polina Anikeeva']",2016-12-20,25.0,Upconversion of light for use in optogenetic methods,2011
1230,"['Leland Stanford Junior University', 'DEISSEROTH KARL', 'BOYDEN EDWARD S', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2014.0,US-8906360-B2,"['Karl Deisseroth', 'Edward S. Boyden']",2014-12-09,57.0,Light-activated cation channel and uses thereof,2006
1231,"['Leland Stanford Junior University', 'DELP SCOTT L', 'LLEWELLYN MICHAEL E', 'DEISSEROTH KARL', 'MCLEAVEY PAYNE CHRISTINE A', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2015.0,US-9101759-B2,"['Scott L. Delp', 'Michael E. Llewellyn', 'Karl Deisseroth', 'Christine A. McLeavey Payne']",2015-08-11,23.0,Materials and approaches for optical stimulation of the peripheral nervous system,2009
1232,['PROTAGEN AG'],"[{'id': 'grid.437356.0', 'name': 'Protagen (Germany)', 'country_name': 'Germany'}]",Application,,WO-2017216323-A2,"['BUDDE, PETRA', 'LÜKING, Angelika', 'SCHULZ-KNAPPE, PETER', 'ZUCHT, HANS-DIETER']",2017-12-21,,MARKER SEQUENCES FOR MANAGING THE THERAPY OF RHEUMATOID ARTHRITIS PATIENTS,2017
1233,['GRAHAM L DOUGLAS'],,Grant,2016.0,US-9387246-B2,['L. Douglas Graham'],2016-07-12,,Treatment methods for rheumatoid arthritis,2014
1234,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2017.0,US-9693692-B2,"['Karl Deisseroth', 'Raag D. Airan', 'Leslie A. Meltzer']",2017-07-04,5.0,"System, method and applications involving identification of biological circuits such as neurological characteristics",2013
1235,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2014.0,US-8834546-B2,"['Karl Deisseroth', 'Jin Hyung Lee']",2014-09-16,29.0,Optogenetic magnetic resonance imaging,2013
1236,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2015.0,US-9084885-B2,"['Karl Deisseroth', 'M. Bret Schneider']",2015-07-21,23.0,"Methods, systems and devices for optical stimulation of target cells using an optical transmission element",2013
1237,"['Asuragen Inc', 'ASURAGEN INC', 'BEAUDENON-HUIBREGTSE SYLVIE', 'LABOURIER EMMANUEL', 'ELIZONDO LAURA']","[{'id': 'grid.422997.3', 'name': 'Asuragen (United States)', 'country_name': 'United States'}]",Grant,2013.0,US-8361714-B2,"['Sylvie Beaudenon-Huibregtse', 'Emmanuel Labourier', 'Laura Elizondo']",2013-01-29,1.0,Micrornas differentially expressed in cervical cancer and uses thereof,2008
1238,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9365628-B2,"['Karl Deisseroth', 'Feng Zhang']",2016-06-14,19.0,Opsin polypeptides and methods of use thereof,2012
1239,"['University of North Florida', 'LAALI KENNETH K', 'UNIV NORTH FLORIDA']","[{'id': 'grid.266865.9', 'acronym': 'UNF', 'name': 'University of North Florida', 'country_name': 'United States'}]",Grant,2016.0,US-9238660-B1,['Kenneth K. Laali'],2016-01-19,,Synthesis of 4-(pentafluorosulfanyl)benzenediazonium tetrafluoroborate and analogs and their application for the preparation of SF5-aromatics,2014
1240,"['Leland Stanford Junior University', 'DEISSEROTH KARL', 'GOSHEN INBAL', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2018.0,US-10086012-B2,"['Karl Deisseroth', 'Inbal Goshen']",2018-10-02,,Control and characterization of memory function,2011
1241,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9284353-B2,"['Karl Deisseroth', 'Feng Zhang', 'Viviana Gradinaru']",2016-03-15,20.0,Mammalian codon optimized nucleotide sequence that encodes a variant opsin polypeptide derived from Natromonas pharaonis (NpHR),2013
1242,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2018.0,US-9855442-B2,"['Karl Deisseroth', 'Feng Zhang', 'Viviana Gradinaru']",2018-01-02,3.0,Method for optically controlling a neuron with a mammalian codon optimized nucleotide sequence that encodes a variant opsin polypeptide derived from natromonas pharaonis (NpHR),2016
1243,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2018.0,US-9878176-B2,"['Karl Deisseroth', 'Feng Zhang', 'Viviana Gradinaru']",2018-01-30,2.0,System utilizing Volvox carteri light-activated ion channel protein (VChR1) for optical stimulation of target cells,2016
1244,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2017.0,US-9615789-B2,"['Karl Deisseroth', 'Jin Hyung Lee']",2017-04-11,6.0,Optogenetic magnetic resonance imaging,2016
1245,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9309296-B2,"['Karl Deisseroth', 'Ofer Yizhar', 'Lisa Gunaydin', 'Peter Hegemann', 'Andre Berndt']",2016-04-12,18.0,Optically-based stimulation of target cells and modifications thereto,2013
1246,"['Asuragen Inc', 'ASURAGEN INC']","[{'id': 'grid.422997.3', 'name': 'Asuragen (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9447414-B2,"['David Brown', 'Lance Ford', 'Angie Cheng', 'Rich Jarvis', 'Mike Byrom', 'Dmitriy Ovcharenko', 'Eric Devroe', 'Kevin Kelnar']",2016-09-20,1.0,Methods and compositions involving miRNA and miRNA inhibitor molecules,2015
1247,"['Applied Biosystems LLC', 'Asuragen Inc', 'BROWN DAVID', 'FORD LANCE', 'CHENG ANGIE', 'JARVIS RICH', 'BYROM MIKE', 'OVCHARENKO DMITRIY', 'DEVROE ERIC', 'KELNAR KEVIN', 'ASURAGEN INC']","[{'id': 'grid.418190.5', 'acronym': 'Life Technologies', 'name': 'Thermo Fisher Scientific (United States)', 'country_name': 'United States'}, {'id': 'grid.422997.3', 'name': 'Asuragen (United States)', 'country_name': 'United States'}]",Grant,2012.0,US-8173611-B2,"['David Brown', 'Lance Ford', 'Angie Cheng', 'Rich Jarvis', 'Mike Byrom', 'Dmitriy Ovcharenko', 'Eric Devroe', 'Kevin Kelnar']",2012-05-08,24.0,Methods and compositions involving miRNA and miRNA inhibitor molecules,2005
1248,"[""Brigham and Women's Hospital"", 'BRIGHAM & WOMENS HOSPITAL INC']","[{'id': 'grid.62560.37', 'acronym': 'BWH', 'name': ""Brigham and Women's Hospital"", 'country_name': 'United States'}]",Grant,2018.0,US-9951331-B2,['Anna M. Krichevsky'],2018-04-24,,Targeting microRNA-26a/b for the treatment of neurodegenerative disease,2014
1249,"['Nutricia NV', 'NUTRICIA NV']","[{'id': 'grid.423979.2', 'name': 'Danone (Netherlands)', 'country_name': 'Netherlands'}]",Grant,2018.0,US-9961932-B2,"['Peter Johan Marie WEIJS', 'Johan DE VOGEL', 'George Verlaan', 'Marion Jourdan']",2018-05-08,,Muscle preservation in overweight or obese adult during weight loss program,2013
1250,"['Protagen AG', 'PROTAGEN AG']","[{'id': 'grid.437356.0', 'name': 'Protagen (Germany)', 'country_name': 'Germany'}]",Application,,EP-3258268-A1,"['LÜKING, Angelika', 'SCHULZ-KNAPPE, PETER', 'BUDDE, PETRA', 'ZUCHT, HANS-DIETER']",2017-12-20,,MARKER SEQUENCES FOR MANAGING TREATMENT OF PATIENTS SUFFERING FROM RHEUMATOID ARTHRITIS,2016
1251,"['Leland Stanford Junior University', 'DEISSEROTH KARL', 'WITTEN ILANA', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2018.0,US-9992981-B2,"['Karl Deisseroth', 'Ilana Witten']",2018-06-12,,Optogenetic control of reward-related behaviors,2011
1252,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2015.0,US-9175095-B2,"['Karl Deisseroth', 'Ofer Yizhar', 'Lief Fenno', 'Peter Hegemann', 'Matthias Prigge']",2015-11-03,33.0,Light-activated chimeric opsins and methods of using the same,2013
1253,"['Johns Hopkins University', 'Mirna Therapeutics Inc', 'SHEN JIKUI', 'KELNAR KEVIN', 'SHELTON JEFFREY', 'BROWN DAVID', 'CAMPOCHIARO PETER', 'UNIV JOHNS HOPKINS', 'MIRNA THERAPEUTICS INC']","[{'id': 'grid.21107.35', 'acronym': 'JHU', 'name': 'Johns Hopkins University', 'country_name': 'United States'}, {'id': 'grid.421440.7', 'name': 'Mirna Therapeutics (United States)', 'country_name': 'United States'}]",Grant,2012.0,US-8258111-B2,"['Jikui Shen', 'Kevin Kelnar', 'Jeffrey Shelton', 'David Brown', 'Peter Campochiaro']",2012-09-04,14.0,Compositions and methods related to miRNA modulation of neovascularization or angiogenesis,2009
1254,"['Primal Fusion Inc', 'SWEENEY PETER JOSEPH', 'ILYAS IHAB FRANCIS', 'PRIMAL FUSION INC']",,Grant,2016.0,US-9235806-B2,"['Peter Joseph Sweeney', 'Ihab Francis Ilyas']",2016-01-12,13.0,Methods and devices for customizing knowledge representation systems,2013
1255,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2017.0,US-9850290-B2,"['Karl Deisseroth', 'Ofer Yizhar', 'Lief Fenno', 'Peter Hegemann', 'Matthias Prigge']",2017-12-26,7.0,Light-activated chimeric opsins and methods of using the same,2016
1256,"['Asuragen Inc', 'ASURAGEN INC']","[{'id': 'grid.422997.3', 'name': 'Asuragen (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8765709-B2,"['David Brown', 'Lance Ford', 'Angie Cheng', 'Rich Jarvis', 'Mike Byrom', 'Dmitriy Ovcharenko', 'Eric Devroe', 'Kevin Kelnar']",2014-07-01,1.0,Methods and compositions involving miRNA and miRNA inhibitor molecules,2013
1257,"['Mima Therapeutics Inc', 'Asuragen Inc', 'BROWN DAVID', 'FORD LANCE', 'CHENG ANGIE', 'JARVIS RICH', 'BYROM MIKE', 'OVCHARENKO DMITRIY', 'DEVROE ERIC', 'KELNAR KEVIN', 'MIMA THERAPEUTICS INC']","[{'id': 'grid.422997.3', 'name': 'Asuragen (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-8946177-B2,"['David Brown', 'Lance Ford', 'Angie Cheng', 'Rich Jarvis', 'Mike Byrom', 'Dmitriy Ovcharenko', 'Eric Devroe', 'Kevin Kelnar']",2015-02-03,9.0,Methods and compositions involving miRNA and miRNA inhibitor molecules,2011
1258,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2016.0,US-9505817-B2,"['Karl Deisseroth', 'Feng Zhang', 'Viviana Gradinaru']",2016-11-29,6.0,Opsin polypeptides and methods of use thereof,2016
1259,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2018.0,US-10071132-B2,"['Karl Deisseroth', 'Ofer Yizhar', 'Lisa Gunaydin', 'Peter Hegemann', 'Andre Berndt']",2018-09-11,6.0,Optically-based stimulation of target cells and modifications thereto,2016
1260,"['AbbVie Inc', 'ABBVIE INC']","[{'id': 'grid.431072.3', 'acronym': 'Abbvie Biotherapeutics, Inc', 'name': 'AbbVie (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9951080-B2,['Ayman ALLIAN'],2018-04-24,3.0,"Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-alpha]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof",2017
1261,"['Leland Stanford Junior University', 'UNIV LELAND STANFORD JUNIOR']","[{'id': 'grid.168010.e', 'acronym': 'SU', 'name': 'Stanford University', 'country_name': 'United States'}]",Grant,2018.0,US-9968652-B2,"['Karl Deisseroth', 'Kay Tye', 'Lief Fenno']",2018-05-15,6.0,Optically-controlled CNS dysfunction,2016
1262,"['Asuragen Inc', 'BROWN DAVID', 'CONRAD RICK', 'DEVROE ERIC', 'GOLDRICK MARIANNA', 'KEIGER KERRI', 'LABOURIER EMMANUEL', 'MOON IVONNE', 'POWERS PATRICIA', 'SHELTON JEFFREY', 'SHINGARA JACLYN', 'ASURAGEN INC']","[{'id': 'grid.422997.3', 'name': 'Asuragen (United States)', 'country_name': 'United States'}]",Grant,2013.0,US-8465914-B2,"['David Brown', 'Rick Conrad', 'Eric Devroe', 'Marianna Goldrick', 'Kerri Keiger', 'Emmanuel Labourier', 'Ivonne Moon', 'Patricia Powers', 'Jeffrey Shelton', 'Jaclyn Shingara']",2013-06-18,8.0,Method and compositions involving microRNA,2012
1263,"['Array Biopharma Inc', 'ARRAY BIOPHARMA INC']","[{'id': 'grid.467148.8', 'name': 'Array BioPharma (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9763941-B2,"['Daya Verma', 'Yogita Krishnamachari', 'Xiaohong Shen', 'Hanchen Lee', 'Ping Li', 'Rajinder Singh', 'LayChoo Tan']",2017-09-19,,Method of treating melanoma by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate,2016
1264,"['Childrens Hospital of Philadelphia', ""THE CHILDREN'S HOSPITAL OF PHILADELPHIA""]","[{'id': 'grid.239552.a', 'acronym': 'CHOP', 'name': ""Children's Hospital of Philadelphia"", 'country_name': 'United States'}]",Grant,2017.0,AU-2017201900-B2,"['ELIA, JOSEPHINE', 'GLESSNER, JOSEPH', 'HAKONARSON, HAKON']",2017-10-12,,"ASSOCIATION OF RARE RECURRENT GENETIC VARIATIONS TO ATTENTION-DEFICIT, HYPERACTIVITY DISORDER (ADHD) AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME",2017
1265,"['Alnylam Pharmaceuticals Inc', 'ALNYLAM PHARMACEUTICALS INC']","[{'id': 'grid.417897.4', 'name': 'Alnylam Pharmaceuticals (United States)', 'country_name': 'United States'}]",Application,,EP-2723865-A4,"['SAH DINAH', 'BUMCROT DAVID', 'SEHGAL ALFICA']",2014-12-24,,ASSAYS AND METHODS FOR DETERMINING ACTIVITY OF A THERAPEUTIC AGENT IN A SUBJECT,2012
1266,"['Novartis AG', 'Array Biopharma Inc', 'ARRAY BIOPHARMA INC', 'ARRAY BIOPHARMA INC']","[{'id': 'grid.467148.8', 'name': 'Array BioPharma (United States)', 'country_name': 'United States'}, {'id': 'grid.419481.1', 'name': 'Novartis (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2018.0,US-10005761-B2,"['Shenlin Huang', 'Xianming Jin', 'Zuosheng Liu', 'Daniel Poon', 'John Tellew', 'Yongqin Wan', 'Xing Wang', 'Yongping Xie']",2018-06-26,,Compounds and compositions as protein kinase inhibitors,2016
1267,"['LanzaTech New Zealand Ltd', 'LANZATECH NEW ZEALAND LTD']",,Grant,2014.0,US-8900836-B2,['Sean Dennis Simpson'],2014-12-02,,Acid production by fermentation,2012
1268,"['Merkle Inc', 'MERKLE INC', 'MERKLE INC']",,Grant,2017.0,US-9741047-B1,"['Robert Lee Wood', 'Futoshi Yumoto', 'Thomas D. Lacki']",2017-08-22,,System and method for creating segmentation of a population,2016
1269,"['Novartis AG', 'Array Biopharma Inc', 'ARRAY BIOPHARMA INC']","[{'id': 'grid.419481.1', 'name': 'Novartis (Switzerland)', 'country_name': 'Switzerland'}, {'id': 'grid.467148.8', 'name': 'Array BioPharma (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9850229-B2,"['Shenlin Huang', 'Xianming Jin', 'Zuosheng Liu', 'Daniel Poon', 'John Tellew', 'Yongqin Wan', 'Xing Wang', 'Yongping Xie']",2017-12-26,,Compounds and compositions as protein kinase inhibitors,2016
1270,"['Novartis AG', 'Array Biopharma Inc', 'ARRAY BIOPHARMA INC']","[{'id': 'grid.467148.8', 'name': 'Array BioPharma (United States)', 'country_name': 'United States'}, {'id': 'grid.419481.1', 'name': 'Novartis (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2017.0,US-9850230-B2,"['Shenlin Huang', 'Xianming Jin', 'Zuosheng Liu', 'Daniel Poon', 'John Tellew', 'Yongqin Wan', 'Xing Wang', 'Yongping Xie']",2017-12-26,,Compounds and compositions as protein kinase inhibitors,2016
1271,"['GROVES JOHN T', 'LIU WEI', 'UNIV PRINCETON', 'HUANG XIONGYI']","[{'id': 'grid.16750.35', 'name': 'Princeton University', 'country_name': 'United States'}]",Application,,WO-2013028639-A1,"['GROVES, JOHN T.', 'LIU, WEI', 'HUANG, Xiongyi']",2013-02-28,23.0,C-HALOGEN BOND FORMATION,2012
1272,"['Alnylam Pharmaceuticals Inc', 'ALNYLAM PHARMACEUTICALS INC']","[{'id': 'grid.417897.4', 'name': 'Alnylam Pharmaceuticals (United States)', 'country_name': 'United States'}]",Application,,EP-2723865-A1,"['SAH, DINAH', 'BUMCROT, DAVID', 'SEHGAL, ALFICA']",2014-04-30,,ASSAYS AND METHODS FOR DETERMINING ACTIVITY OF A THERAPEUTIC AGENT IN A SUBJECT,2012
1273,"['Eberhard Karls Universitaet Tuebingen', 'EBERHARD KARIS UNI TUBINGEN']","[{'id': 'grid.10392.39', 'name': 'University of Tübingen', 'country_name': 'Germany'}]",Application,,GB-2505718-A9,"['ALBERT MARKUS', 'FELIX GEORG', 'JEHLE KRISTINA', 'STARK REBEKKA']",2014-03-26,,Artificial plant receptors and ligands,2012
1274,['UNIV ERASMUS MEDICAL CT'],"[{'id': 'grid.5645.2', 'name': 'Erasmus University Medical Center', 'country_name': 'Netherlands'}]",Application,,WO-2015190931-A1,"['VAN DONGEN, JACOBUS JOHANNES MARIA', 'VAN DER VELDEN, VINCENT HENRICUS JOHANNES']",2015-12-17,,MEANS AND METHODS FOR PREDICTING AN EXTRAMEDULLARY RELAPSE IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL),2015
1275,"['Novartis AG', 'Array Biopharma Inc', 'NOVARTIS AG']","[{'id': 'grid.419481.1', 'name': 'Novartis (Switzerland)', 'country_name': 'Switzerland'}, {'id': 'grid.467148.8', 'name': 'Array BioPharma (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9314464-B2,"['Shenlin Huang', 'Xianming Jin', 'Zuosheng Liu', 'Daniel Poon', 'John Tellew', 'Yongqin Wan', 'Xing Wang', 'Yongping Xie']",2016-04-19,1.0,Compounds and compositions as protein kinase inhibitors,2013
1276,"['Array Biopharma Inc', 'VERMA DAYA', 'KRISHNAMACHAN YOGITA', 'SHEN XIAOHONG', 'LEE HANCHEN', 'LI PING', 'SINGH RAJINDER', 'TAN LAYCHOO', 'NOVARTIS AG']","[{'id': 'grid.419481.1', 'name': 'Novartis (Switzerland)', 'country_name': 'Switzerland'}, {'id': 'grid.467148.8', 'name': 'Array BioPharma (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9387208-B2,"['Daya Verma', 'Yogita Krishnamachan', 'Xiaohong Shen', 'Hanchen Lee', 'Ping Li', 'Rajinder Singh', 'LayChoo Tan']",2016-07-12,4.0,Pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate,2012
1277,"['Novartis AG', 'Scripps Research Institute', 'SCHULTZ PETER', 'LAIRSON LUKE', 'DESHMUKH VISHAL', 'LYSSIOTIS COSTAS', 'SCRIPPS RESEARCH INST', 'IRM LLC']","[{'id': 'grid.419481.1', 'name': 'Novartis (Switzerland)', 'country_name': 'Switzerland'}, {'id': 'grid.214007.0', 'acronym': 'TSRI', 'name': 'Scripps Research Institute', 'country_name': 'United States'}]",Grant,2017.0,US-9592288-B2,"['Peter Schultz', 'Luke Lairson', 'Vishal Deshmukh', 'Costas Lyssiotis']",2017-03-14,,Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate,2012
1278,"['Nestec SA', 'NESTEC SA']","[{'id': 'grid.419905.0', 'name': 'Nestlé (Switzerland)', 'country_name': 'Switzerland'}]",Application,,US-20160166638-A1,"['Peter Kastenmayer', 'Sunil Kochhar', 'Serge Andre Dominique Rezzi']",2016-06-16,,LACTOFERRIN-OSTEOPONTIN-IRON COMPLEX,2014
1279,"['MUSC Foundation for Research Development', 'MUSC FOUNDATION FOR RES DEVELOPMENT', 'MEDICAL UNIV OF SOUTH CAROLINA']","[{'id': 'grid.259828.c', 'acronym': 'MUSC', 'name': 'Medical University of South Carolina', 'country_name': 'United States'}]",Grant,2018.0,US-9879251-B2,"['Harold D. May', 'Christopher W. Marshall', 'Edward V. Labelle']",2018-01-30,,Microbial electrosynthetic cells,2013
1280,['UNIV PRINCETON'],"[{'id': 'grid.16750.35', 'name': 'Princeton University', 'country_name': 'United States'}]",Application,,WO-2015054476-A1,"['GROVES, JOHN T.', 'LIU, WEI', 'HUANG, Xiongyi']",2015-04-16,,C-HALOGEN BOND FORMATION,2014
1281,"['Childrens Hospital of Philadelphia', 'CHILDRENS HOSPITAL PHILADELPHIA']","[{'id': 'grid.239552.a', 'acronym': 'CHOP', 'name': ""Children's Hospital of Philadelphia"", 'country_name': 'United States'}]",Grant,2018.0,US-9884057-B2,"['Hakon Hakonarson', 'Charlly Kao']",2018-02-06,,Nonselective metabotropic glutamate receptor activators for treatment of attention deficit disorder and 22Q syndrome,2016
1282,"['Childrens Hospital of Philadelphia', 'PHILADELPHIA CHILDREN HOSPITAL']","[{'id': 'grid.239552.a', 'acronym': 'CHOP', 'name': ""Children's Hospital of Philadelphia"", 'country_name': 'United States'}]",Application,,EP-2609220-A4,"['GLESSNER JOSEPH', 'ELIA JOSEPHINE', 'HAKONARSON HAKON']",2014-01-22,,"ASSOCIATION OF RARE RECURRENT GENETIC VARIATIONS TO ATTENTION-DEFICIT, HYPERACTIVITY DISORDER (ADHD) AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME",2011
1283,"['Novartis AG', 'Array Biopharma Inc', 'ARRAY BIOPHARMA INC']","[{'id': 'grid.467148.8', 'name': 'Array BioPharma (United States)', 'country_name': 'United States'}, {'id': 'grid.419481.1', 'name': 'Novartis (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2017.0,US-9593099-B2,"['Shenlin Huang', 'Xianming Jin', 'Zuosheng Liu', 'Daniel Poon', 'John Tellew', 'Yongqin Wan', 'Xing Wang', 'Yongping Xie']",2017-03-14,1.0,Compounds and compositions as protein kinase inhibitors,2016
1284,"['FUNDAÇ O UNIVERSIDADE DE CAXIAS DO SUL', 'UBEA']","[{'id': 'grid.286784.7', 'acronym': 'UCS', 'name': 'University of Caxias Do Sul', 'country_name': 'Brazil'}]",Application,,WO-2015081410-A1,"['HENRIQUES, João Antonio Pêgas', 'FALAVIGNA, Asdrubal', 'FIGUEIRÓ, Manuela', 'ELY, Mariana Roesch', 'DE AGUIAR, Israel Silveira', 'MACHADO, Denise Cantarelli']",2015-06-11,,"ADULT MESENCHYMAL STEM CELL CULTURE METHOD, KIT, COMPOSITION AND USES",2014
1285,"['BIOTHERANOSTICS INC', 'SCHNABEL CATHERINE A', 'ZHANG YI', 'ERLANDER MARK G']",,Application,,WO-2014160645-A2,"['SCHNABEL, CATHERINE, A.', 'ZHANG, YI', 'ERLANDER, MARK, G.']",2014-10-02,,NEUROENDOCRINE TUMORS,2014
1286,"['Childrens Hospital of Philadelphia', 'PHILADELPHIA CHILDREN HOSPITAL']","[{'id': 'grid.239552.a', 'acronym': 'CHOP', 'name': ""Children's Hospital of Philadelphia"", 'country_name': 'United States'}]",Application,,EP-2609220-A1,"['GLESSNER, JOSEPH', 'ELIA, JOSEPHINE', 'HAKONARSON, HAKON']",2013-07-03,,"ASSOCIATION OF RARE RECURRENT GENETIC VARIATIONS TO ATTENTION-DEFICIT, HYPERACTIVITY DISORDER (ADHD) AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME",2011
1287,"['Johns Hopkins University', 'GALLAGHER MICHELA', 'HABERMAN REBECCA', 'KOH MING TENG', 'UNIV JOHNS HOPKINS']","[{'id': 'grid.21107.35', 'acronym': 'JHU', 'name': 'Johns Hopkins University', 'country_name': 'United States'}]",Grant,2013.0,US-8604075-B2,"['Michela Gallagher', 'Rebecca Haberman', 'Ming Teng Koh']",2013-12-10,3.0,Methods and compositions for improving cognitive function,2011
1288,"['Institut National de la Sante et de la Recherche Medicale INSERM', 'OREGA BIOTECH']","[{'id': 'grid.7429.8', 'acronym': 'INSERM', 'name': 'French Institute of Health and Medical Research', 'country_name': 'France'}, {'id': 'grid.464032.7', 'name': 'OREGA Biotech (France)', 'country_name': 'France'}]",Grant,2017.0,US-9834601-B2,"['Gilles Alberici', 'Jeremy Bastid', 'Armand Bensussan', 'Nathalie Bonnefoy', 'Jean-Francois Eliaou']",2017-12-05,,Antagonists of IL-17 isoforms and their uses,2013
1289,"['University of Chicago', 'METS LAURENS', 'UNIV CHICAGO']","[{'id': 'grid.170205.1', 'acronym': 'UC', 'name': 'University of Chicago', 'country_name': 'United States'}]",Grant,2016.0,US-9428745-B2,['Laurens Mets'],2016-08-30,,Methanothermobacter thermautotrophicus strain and variants thereof,2012
1290,"['UNIV CORNELL', 'STEALTH PEPTIDES INT INC']","[{'id': 'grid.5386.8', 'acronym': 'CU', 'name': 'Cornell University', 'country_name': 'United States'}]",Application,,WO-2013059071-A1,"['WILSON, D. TRAVIS', 'SZETO, HAZEL H.', 'BIRK, Alex']",2013-04-25,4.0,AROMATIC-CATIONIC PEPTIDES AND USES OF SAME,2012
1291,"['Eisai R&D Management Co Ltd', 'DEZSO ZOLTAN', 'KUMAR PAVAN', 'EISAI R&D MAN CO LTD']","[{'id': 'grid.418765.9', 'name': 'Eisai (Japan)', 'country_name': 'Japan'}]",Grant,2017.0,US-9771617-B2,"['Zoltan Dezso', 'Pavan Kumar']",2017-09-26,,Microrna biomarkers indicative of alzheimer's disease,2012
1292,"['GROVES JOHN T', 'LIU WEI', 'UNIV PRINCETON']","[{'id': 'grid.16750.35', 'name': 'Princeton University', 'country_name': 'United States'}]",Application,,WO-2013081685-A1,"['GROVES, JOHN T.', 'LIU, WEI']",2013-06-06,,C-HALOGEN BOND FORMATION,2012
1293,"['ACOBIOM', 'CENTRE HOSPITALIER UNIVERSITAIRE NIMES', 'CT HOSPITALIER UNIVERSITAIRE NIMES', 'ACOBIOM']","[{'id': 'grid.437785.a', 'name': 'Acobiom (France)', 'country_name': 'France'}, {'id': 'grid.411165.6', 'name': 'Centre Hospitalier Universitaire De Nîmes', 'country_name': 'France'}]",Grant,2016.0,EP-2814982-B1,"['PIQUEMAL, DAVID', 'JOURDAN, ERIC', 'COMMES, Thérèse', 'BOU SAMRA, Elias']",2016-10-05,,NEW METHOD FOR PROGNOSING THE SURVIVAL OF PATIENTS SUFFERING FROM CHRONIC MYELOMONOCYTIC LEUKAEMIA,2013
1294,"['Universitaet des Saarlandes DE', 'SIEMENS AG', 'UNIV SAARLAND']","[{'id': 'grid.5406.7', 'name': 'Siemens (Germany)', 'country_name': 'Germany'}, {'id': 'grid.11749.3a', 'name': 'Saarland University', 'country_name': 'Germany'}]",Grant,2018.0,US-10011873-B2,"['Andreas Keller', 'Cord Friedrich Stähler', 'Jan Kirsten', 'Eckart Meese', 'Christina Backes', 'Petra Leidinger']",2018-07-03,,Diagnostic miRNA markers for Parkinson disease,2013
1295,['BIOCOD BIOTECNOLOGIA LTDA'],,Application,,WO-2016154690-A1,"['PEREIRA DE SOUZA, Carolina', 'GODOY ASSUMPÇÃO, Juliana', 'BRANT CAMPOS, Catharina']",2016-10-06,,BIOMARKERS FOR CLASSIFYING ACUTE LEUKEMIAS,2015
1296,"['Novartis AG', 'Array Biopharma Inc', 'ARRAY BIOPHARMA INC']","[{'id': 'grid.467148.8', 'name': 'Array BioPharma (United States)', 'country_name': 'United States'}, {'id': 'grid.419481.1', 'name': 'Novartis (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2017.0,US-9593100-B2,"['Shenlin Huang', 'Xianming Jin', 'Zuosheng Liu', 'Daniel Poon', 'John Tellew', 'Yongqin Wan', 'Xing Wang', 'Yongping Xie']",2017-03-14,1.0,Compounds and compositions as protein kinase inhibitors,2016
1297,"['Eberhard Karls Universitaet Tuebingen', 'EBERHARD KARLS UNI TUBINGEN']","[{'id': 'grid.10392.39', 'name': 'University of Tübingen', 'country_name': 'Germany'}]",Application,,GB-2505718-A,"['ALBERT MARKUS', 'FELIX GEORG', 'JEHLE KRISTINA', 'STARK REBEKKA']",2014-03-12,,Chimeric plant receptors comprising LRR domains from two different receptors,2012
1298,"['University of South Florida', 'UNIV SOUTH FLORIDA']","[{'id': 'grid.170693.a', 'acronym': 'USF', 'name': 'University of South Florida', 'country_name': 'United States'}]",Grant,2015.0,US-9089589-B2,"['Shyam S. Mohapatra', 'Jia-Wang Wang']",2015-07-28,1.0,Micro-RNAs modulating immunity and inflammation,2013
1299,['SIEMENS AG'],"[{'id': 'grid.5406.7', 'name': 'Siemens (Germany)', 'country_name': 'Germany'}]",Application,,WO-2014075822-A1,"['KELLER, ANDREAS', 'Stähler, Cord Friedrich', 'Kirsten, Jan', 'MEESE, ECKART', 'Backes, Christina', 'LEIDINGER, Petra']",2014-05-22,6.0,NEW DIAGNOSTIC MIRNA MARKERS FOR PARKINSON DISEASE,2013
1300,['FOND ST ITALIANO DI TECNOLOGIA'],,Application,,WO-2017060407-A1,"['CAPIGLIA, Claudio', 'PROIETTI ZACCARIA, Remo', 'GORIPARTI, Subrahmanyam', 'MIELE, Ermanno', 'DE ANGELIS, FRANCESCO']",2017-04-13,,DIRECT SYNTHESIS OF CARBON DOPED TiO2-BRONZE NANOSTRUCTURES AS ANODE MATERIALS FOR HIGH PERFORMANCE LITHIUM BATTERIES,2016
1301,"['UNIV COLUMBIA', 'UNIV INDIANA RES & TECH CORP']","[{'id': 'grid.257413.6', 'acronym': 'IUPUI', 'name': 'Indiana University – Purdue University Indianapolis', 'country_name': 'United States'}, {'id': 'grid.21729.3f', 'acronym': 'CU', 'name': 'Columbia University', 'country_name': 'United States'}]",Application,,WO-2014071168-A2,"['MARKS, ANDREW, R.', 'GUISE, THERESA, A.']",2014-05-08,,"ADMINISTERING INHIBITORS OF TGFBETA SIGNALING, BENZOTHIAZEPINE DERIVATIVES OR COMBINATIONS THEREOF TO IMPROVE MUSCLE FUNCTION IN CANCER PATIENTS",2013
1302,"['Velocys Inc', 'LEVINESS STEPHEN CLAUDE', 'GREAGER IVAN', 'VELOCYS INC']","[{'id': 'grid.427273.7', 'name': 'Oxford Catalysts Group (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9994763-B2,"['Stephen Claude Leviness', 'Ivan Greager']",2018-06-12,,Generation of hydrocarbon fuels having a reduced environmental impact,2016
1303,"['Case Western Reserve University', 'UNIV CASE WESTERN RESERVE']","[{'id': 'grid.67105.35', 'acronym': 'CWRU', 'name': 'Case Western Reserve University', 'country_name': 'United States'}]",Grant,2018.0,US-10004471-B2,"['Anant Madabhushi', 'Mahdi Orooji', 'Mirabela Rusu', 'Philip Linden', 'Robert Gilkeson', 'Nathaniel Mason Braman']",2018-06-26,,Decision support for disease characterization and treatment response with disease and peri-disease radiomics,2016
1304,"['Bionorica SE', 'BIONORICA SE']","[{'id': 'grid.476113.6', 'name': 'Bionorica (Germany)', 'country_name': 'Germany'}]",Application,,EP-2620155-A1,"['Wuttke, Wolfgang.', 'Seidlová-Wuttke, Dana.']",2013-07-31,,Medicine containing Cimicifuga for use in the treatment of sarcopenia and myocardial weakness,2012
1305,"['University of California', 'University of Illinois', 'BP Corporation North America Inc', 'UNIV CALIFORNIA', 'UNIV ILLINOIS', 'BP CORP NORTH AMERICA INC']","[{'id': 'grid.411030.7', 'name': 'University of Illinois System', 'country_name': 'United States'}, {'id': 'grid.30389.31', 'name': 'University of California System', 'country_name': 'United States'}, {'id': 'grid.431411.2', 'name': 'BP (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8765410-B2,"['N. Louise Glass', 'Chaoguang Tian', 'William T. Beeson, IV', 'Huimin Zhao', 'Jing Du', 'Jin Ho Choi', 'James H. Doudna Cate', 'Jonathan M. Galazka', 'Suk-Jin Ha', 'Yong-Su Jin', 'Soo Rin Kim', 'Sijin Li', 'XiaoMin Yang']",2014-07-01,1.0,"Methods and compositions for improving sugar transport, mixed sugar fermentation, and production of biofuels",2013
1306,"['MathWorks Inc', 'MATHWORKS INC']","[{'id': 'grid.471101.2', 'name': 'MathWorks (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9268536-B2,"['David Maclay', 'Matej URBAS']",2016-02-23,,Behavior invariant optimization of maximum execution times for model simulation,2014
1307,"['University of California', 'University of Illinois', 'BP Corporation North America Inc', 'UNIV CALIFORNIA', 'UNIV ILLINOIS', 'BP CORP NORTH AMERICA INC']","[{'id': 'grid.30389.31', 'name': 'University of California System', 'country_name': 'United States'}, {'id': 'grid.431411.2', 'name': 'BP (United States)', 'country_name': 'United States'}, {'id': 'grid.411030.7', 'name': 'University of Illinois System', 'country_name': 'United States'}]",Grant,2015.0,US-9012177-B2,"['N. Louise Glass', 'Chaoguang Tian', 'William T. Beeson, IV', 'Huimin Zhao', 'Jing Du', 'Jin Ho Choi', 'James H. Doudna Cate', 'Jonathan M. Galazka', 'Suk-Jin Ha', 'Yong-Su Jin', 'Soo Rin Kim', 'Sijin Li', 'XiaoMin Yang']",2015-04-21,1.0,"Methods and compositions for improving sugar transport, mixed sugar fermentation, and production of biofuels",2014
1308,"['Cirrus Logic International Semiconductor Ltd', 'Cirrus Logic Inc', 'CIRRUS LOGIC INT SEMICONDUCTOR LTD', 'CIRRUS LOGIC INC']","[{'id': 'grid.471095.e', 'name': 'Cirrus Logic (United States)', 'country_name': 'United States'}, {'id': 'grid.422749.e', 'name': 'Cirrus Logic International (United Kingdom)', 'country_name': 'United Kingdom'}]",Grant,2018.0,US-9917557-B1,"['Lei Zhu', 'Xin Zhao', 'Tejasvi Das', 'Alan Mark Morton', 'Xiaofan Fei']",2018-03-13,3.0,Calibration for amplifier with configurable final output stage,2017
1309,"['Johns Hopkins University', 'MCNUTT TODD R', 'TAYLOR RUSSELL H', 'KAZHDAN MICHAEL', 'WU BINBIN', 'SIMARI PATRICIO', 'UNIV JOHNS HOPKINS']","[{'id': 'grid.21107.35', 'acronym': 'JHU', 'name': 'Johns Hopkins University', 'country_name': 'United States'}]",Grant,2014.0,US-8688618-B2,"['Todd R. McNutt', 'Russell H. Taylor', 'Michael Kazhdan', 'Binbin WU', 'Patricio Simari']",2014-04-01,6.0,Method and system for determining treatment plans,2010
1310,"['International Business Machines Corp', 'GUO SHANG Q', 'PALAKODETI RAMESH S', 'PURI RAJEEV', 'ROSU DANIELA', 'VENUGOPAL CASHCHAKANITHARA', 'WU FREDERICK Y', 'ZENG SAI', 'IBM']","[{'id': 'grid.410484.d', 'name': 'IBM (United States)', 'country_name': 'United States'}]",Application,,US-20140053073-A1,"['Shang Q. Guo', 'Ramesh S. Palakodeti', 'Rajeev Puri', 'Daniela Rosu', 'Cashchakanithara Venugopal', 'Frederick Y. Wu', 'Sai Zeng']",2014-02-20,4.0,"AUTOMATED, CONTROLLED DISTRIBUTION AND EXECUTION OF COMMANDS AND SCRIPTS",2012
1311,"['Cirrus Logic International Semiconductor Ltd', 'Cirrus Logic Inc', 'CIRRUS LOGIC INT SEMICONDUCTOR LTD', 'CIRRUS LOGIC INC']","[{'id': 'grid.471095.e', 'name': 'Cirrus Logic (United States)', 'country_name': 'United States'}, {'id': 'grid.422749.e', 'name': 'Cirrus Logic International (United Kingdom)', 'country_name': 'United Kingdom'}]",Grant,2018.0,US-9880802-B2,"['Aniruddha Satoskar', 'Daniel J. Allen', 'Edmund Mark Schneider', 'Tejasvi Das', 'Ku He', 'John L. Melanson']",2018-01-30,,Systems and methods for reducing audio artifacts from switching between paths of a multi-path signal processing system,2016
1312,"['Cirrus Logic International Semiconductor Ltd', 'Cirrus Logic Inc', 'CIRRUS LOGIC INT SEMICONDUCTOR LTD', 'CIRRUS LOGIC INC']","[{'id': 'grid.422749.e', 'name': 'Cirrus Logic International (United Kingdom)', 'country_name': 'United Kingdom'}, {'id': 'grid.471095.e', 'name': 'Cirrus Logic (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9998826-B2,['Aniruddha Satoskar'],2018-06-12,,Optimization of performance and power in audio system,2016
1313,"['Cirrus Logic Inc', 'CIRRUS LOGIC INT SEMICONDUCTOR LTD', 'CIRRUS LOGIC INC']","[{'id': 'grid.471095.e', 'name': 'Cirrus Logic (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9967665-B2,"['Tejasvi Das', 'Ku He', 'John L. Melanson']",2018-05-08,,Adaptation of dynamic range enhancement based on noise floor of signal,2016
1314,['SPHINGOTEC GMBH'],,Application,,WO-2018007588-A1,"['BERGMANN, ANDREAS', 'VOORS, Adriaan']",2018-01-11,,ADRENOMEDULLIN FOR ASSESSING CONGESTION IN A SUBJECT WITH ACUTE HEART FAILURE,2017
1315,"['Janssen Pharmaceuticals Inc', 'CID-NÚÑEZ JOSÉ MARIA', 'TRABANCO-SUÁREZ ANDRÉS AVELINO', 'VEGA RAMIRO JUAN ANTONIO', 'OEHLRICH DANIEL', 'TRESADERN GARY JOHN', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC']",,Grant,2015.0,US-8993591-B2,"['José Maria Cid-Núñez', 'Andrés Avelino Trabanco-Suárez', 'Juan Antonio Vega Ramiro', 'Daniel Oehlrich', 'Gary John Tresadern', 'Gregor James MacDonald']",2015-03-31,1.0,"1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors",2011
1316,"['Janssen Pharmaceuticals Inc', 'CID-NÚÑEZ JOSÉ MARIA', 'TRABANCO-SUÁREZ ANDRÉS AVELINO', 'VEGA RAMIRO JUAN ANTONIO', 'OEHLRICH DANIEL', 'TRESADERN GARY JOHN', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC']",,Grant,2016.0,US-9271967-B2,"['José Maria Cid-Núñez', 'Andrés Avelino Trabanco-Suárez', 'Juan Antonio Vega Ramiro', 'Daniel Oehlrich', 'Gary John Tresadern', 'Gregor James MacDonald']",2016-03-01,1.0,"1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2011
1317,"['Janssen Pharmaceutica NV', 'Addex Therapeutics Ltd', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA']","[{'id': 'grid.419619.2', 'name': 'Janssen (Belgium)', 'country_name': 'Belgium'}, {'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8906939-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey']",2014-12-09,,3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives,2008
1318,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'LUTJENS ROBERT JOHANNES', 'FINN PATRICK TERRY', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8722894-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lutjens', 'Patrick Terry Finn']",2014-05-13,,"1,3-disubstituted-4-phenyl-1H-pyridin-2-ones",2008
1319,"['Janssen Pharmaceutica NV', 'JANSSEN PHARMACEUTICA NV']","[{'id': 'grid.419619.2', 'name': 'Janssen (Belgium)', 'country_name': 'Belgium'}]",Grant,2017.0,US-9708315-B2,"['José Maria Cid-Núñez', 'Andrés Avelino Trabanco-Suárez', 'Marc André Ceusters', 'Hilde Lavreysen']",2017-07-18,1.0,"1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of MGLUR2 receptors",2014
1320,"['Cardiac Pacemakers Inc', 'THAKUR PRAMODSINGH HIRASINGH', 'PATANGAY ABHILASH', 'STOLEN CRAIG', 'MEYER TIMOTHY', 'CARDIAC PACEMAKERS INC']","[{'id': 'grid.418905.1', 'acronym': 'BSC', 'name': 'Boston Scientific (United States)', 'country_name': 'United States'}]",Grant,2013.0,US-8602996-B2,"['Pramodsingh Hirasingh Thakur', 'Abhilash Patangay', 'Craig Stolen', 'Timothy Meyer']",2013-12-10,1.0,Integrating device-based sensors and bedside biomarker assays to detect worsening heart failure,2011
1321,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'OEHLRICH DANIEL', 'TRABANCO-SUAREZ ANDRES AVELINO', 'TRESADERN GARY JOHN', 'VEGA RAMIRO JUAN ANTONIO', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-8937060-B2,"['Jose Maria Cid-Nunez', 'Daniel Oehlrich', 'Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Gregor James MacDonald']",2015-01-20,9.0,"1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders",2010
1322,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-9132122-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lütjens', 'Terry Patrick Finn']",2015-09-15,,"1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones",2013
1323,"['Enovix Corp', 'SPOTNITZ ROBERT', 'LAHIRI ASHOK', 'ENOVIX CORP']",,Grant,2017.0,US-9843027-B1,"['Robert Spotnitz', 'Ashok Lahiri']",2017-12-12,,Battery cell having package anode plate in contact with a plurality of dies,2010
1324,"['Allergan Pharmaceuticals International Ltd', 'ALLERGAN PHARMACEUTICALS INT LTD']","[{'id': 'grid.472734.1', 'name': 'Allergan (Ireland)', 'country_name': 'Ireland'}]",Grant,2017.0,US-9795569-B2,"['Brendan Muldoon', 'Ryan Gerald Loughlin', 'Gerarde SWEENEY', 'Emma Karen BOYD']",2017-10-24,,Pharmaceutical soft gelatin capsule dosage form with modified guar gum,2014
1325,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'LUTJENS ROBERT JOHANNES', 'FINN PATRICK TERRY', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8748621-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lutjens', 'Patrick Terry Finn']",2014-06-10,,"1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones",2012
1326,"['UNIV RAMOT', 'NELSON NATHAN', 'YACOBY IFTACH', 'GAZIT EHUD', 'BENHAR ITAI']","[{'id': 'grid.12136.37', 'acronym': 'TAU', 'name': 'Tel Aviv University', 'country_name': 'Israel'}]",Application,,WO-2010137019-A1,"['NELSON, NATHAN', 'YACOBY, IFTACH', 'GAZIT, EHUD', 'BENHAR, ITAI']",2010-12-02,,PHOTOCATALYTIC HYDROGEN PRODUCTION IN CYANOBACTERIA,2010
1327,"['International Business Machines Corp', 'GUO SHANG Q', 'PALAKODETI RAMESH S', 'PURI RAJEEV', 'ROSU DANIELA', 'VENUGOPAL CASHCHAKANITHARA', 'WU FREDERICK Y', 'ZENG SAI', 'IBM']","[{'id': 'grid.410484.d', 'name': 'IBM (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9262208-B2,"['Shang Q. Guo', 'Ramesh S. Palakodeti', 'Rajeev Puri', 'Daniela Rosu', 'Cashchakanithara Venugopal', 'Frederick Y. Wu', 'Sai Zeng']",2016-02-16,,"Automated, controlled distribution and execution of commands and scripts",2012
1328,"['Cirrus Logic International Semiconductor Ltd', 'Cirrus Logic Inc', 'CIRRUS LOGIC INT SEMICONDUCTOR LTD', 'CIRRUS LOGIC INC']","[{'id': 'grid.422749.e', 'name': 'Cirrus Logic International (United Kingdom)', 'country_name': 'United Kingdom'}, {'id': 'grid.471095.e', 'name': 'Cirrus Logic (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9813814-B1,"['Aniruddha Satoskar', 'Tejasvi Das', 'Ku He']",2017-11-07,10.0,Enhancing dynamic range based on spectral content of signal,2016
1329,"['Actimed Therapeutics Ltd', 'MYOTEC THERAPEUTICS Ltd', 'SPRINGER JOCHEN', 'ANKER STEFAN', 'COATS ANDREW', 'BEADLE JOHN', 'PSIOXUS THERAPEUTICS LTD']","[{'id': 'grid.476643.4', 'name': 'PsiOxus Therapeutics (United Kingdom)', 'country_name': 'United Kingdom'}]",Grant,2014.0,US-8835485-B2,"['Jochen Springer', 'Stefan Anker', 'Andrew Coats', 'John Beadle']",2014-09-16,,Prevention and treatment of sarcopenia,2010
1330,"['Cirrus Logic International Semiconductor Ltd', 'Cirrus Logic Inc', 'CIRRUS LOGIC INT SEMICONDUCTOR LTD', 'CIRRUS LOGIC INC']","[{'id': 'grid.471095.e', 'name': 'Cirrus Logic (United States)', 'country_name': 'United States'}, {'id': 'grid.422749.e', 'name': 'Cirrus Logic International (United Kingdom)', 'country_name': 'United Kingdom'}]",Grant,2018.0,US-9955254-B2,"['Tejasvi Das', 'John L. Melanson']",2018-04-24,,Systems and methods for preventing distortion due to supply-based modulation index changes in an audio playback system,2015
1331,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-9085577-B2,"['Jose Maria Cid-Nunez', 'Ana Isabel De Lucas Olivares', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald']",2015-07-21,,"7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2014
1332,"['AVEO Pharmaceuticals Inc', 'AVEO PHARMACEUTICALS INC']","[{'id': 'grid.427642.1', 'name': 'AVEO Pharmaceuticals (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9725505-B2,"['Lorena Lerner', 'Sandra Abbott', 'Ailin Bai', 'Ting Chen', 'Maria I. Chiu', 'Qing Liu', 'Laura Poling', 'Nianjun Tao', 'Solly Weiler', 'Zhigang Weng', 'William M. Winston, Jr.', 'Jeno Gyuris']",2017-08-08,,Methods of treatment using anti-GDF15 antibodies,2015
1333,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'DE LUCAS OLIVARES ANA ISABEL', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-8946205-B2,"['Jose Maria Cid-Nunez', 'Ana Isabel De Lucas Olivares', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald']",2015-02-03,1.0,"1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2010
1334,"['Johns Hopkins University', 'SGOUROS GEORGE', 'SONG HONG', 'PRIDEAUX ANDREW', 'HOBBS ROBERT', 'UNIV JOHNS HOPKINS']","[{'id': 'grid.21107.35', 'acronym': 'JHU', 'name': 'Johns Hopkins University', 'country_name': 'United States'}]",Grant,2016.0,US-9387344-B2,"['George Sgouros', 'Hong Song', 'Andrew Prideaux', 'Robert Hobbs']",2016-07-12,1.0,Methods for determining absorbed dose information,2007
1335,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2016.0,US-9266834-B2,"['Hassan Julien Imogai', 'Jose Maria Cid-Nunez', 'Jose Ignacio Andres-Gil', 'Andres Avelino Trabanco-Suarez', 'JULEN OYARZABAL SANTAMARINA', 'Frank Matthias Dautzenberg', 'Gregor James MacDonald', 'SHRILEY ELIZABETH PULLAN', 'Robert Johannes Lutjens', 'Guillaume Albert Jacques Duvey', 'Vanthea Nhem', 'Terry Patrick Finn', 'Gagik Melikyan']",2016-02-23,,"1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors",2014
1336,"['AGRONOMIQUE INST NAT RECH', 'CONSIGLIO NAZIONALE RICERCHE', 'MARTIN FRANCIS', 'MURAT-FURMINIEUX CLAUDE', 'PAOLOCCI FRANCESCO', 'RUBINI ANDREA', 'RICCIONI CLAUDIA', 'BELFIORI BEATRICE', 'ARCIONI SERGIO']","[{'id': 'grid.5326.2', 'acronym': 'CNR', 'name': 'National Research Council', 'country_name': 'Italy'}, {'id': 'grid.414548.8', 'acronym': 'INRA ', 'name': 'French National Institute for Agricultural Research', 'country_name': 'France'}]",Application,,WO-2012032098-A1,"['Arcioni, Sergio', 'Belfiori, Béatrice', 'MARTIN, Françis', 'Murat-Furminieux, Claude', 'Paolocci, Francesco', 'Riccioni, Claudia', 'Rubini, Andrea']",2012-03-15,,MOLECULAR METHOD FOR THE IDENTIFICATION OF MATING TYPE GENES OF TRUFFLES SPECIES,2011
1337,['BABRAHAM INST'],"[{'id': 'grid.418195.0', 'name': 'Babraham Institute', 'country_name': 'United Kingdom'}]",Application,,WO-2017208001-A1,"['FRASER, PETER', 'SCHOENFELDER, Stefan', 'SPIVAKOV, Mikhail']",2017-12-07,,BIOMARKERS FOR PLATELET DISORDERS,2017
1338,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'LUTJENS ROBERT JOHANNES', 'FINN TERRY PATRICK', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-9114138-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lutjens', 'Terry Patrick Finn']",2015-08-25,,"1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones",2008
1339,"['Case Western Reserve University', 'UNIV CASE WESTERN RESERVE']","[{'id': 'grid.67105.35', 'acronym': 'CWRU', 'name': 'Case Western Reserve University', 'country_name': 'United States'}]",Grant,2018.0,US-10064594-B2,"['Anant Madabhushi', 'Mahdi Orooji', 'Mirabela Rusu', 'Philip Linden', 'Robert Gilkeson', 'Nathaniel Mason Braman', 'Mehdi Alilou']",2018-09-04,,Characterizing disease and treatment response with quantitative vessel tortuosity radiomics,2016
1340,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'DE LUCAS OLIVARES ANA ISABEL', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8716480-B2,"['Jose Maria Cid-Nunez', 'Ana Isabel De Lucas Olivares', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald']",2014-05-06,1.0,"7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2010
1341,"['Cardiac Pacemakers Inc', 'CARDIAC PACEMAKERS INC']","[{'id': 'grid.418905.1', 'acronym': 'BSC', 'name': 'Boston Scientific (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9232897-B2,"['Pramodsingh Hirasingh Thakur', 'Abhilash Patangay', 'Craig Stolen', 'Timothy Meyer']",2016-01-12,2.0,Integrating device-based sensors and bedside biomarker assays to detect worsening heart failure,2013
1342,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8697689-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez']",2014-04-15,1.0,Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors,2009
1343,"['Janssen Cilag SA', 'Janssen Pharmaceuticals Inc', 'CID-NÚÑEZ JOSÉ MARIA', 'TRABANCO-SUÁREZ ANDRÉS AVELINO', 'VEGA RAMIRO JUAN ANTONIO', 'OEHLRICH DANIEL', 'TRESADERN GARY JOHN', 'MACDONALD GREGOR JAMES', 'JANSSEN PHARMACEUTICALS INC']",,Grant,2015.0,US-9012448-B2,"['José Maria Cid-Núñez', 'Andrés Avelino Trabanco-Suárez', 'Juan Antonio Vega Ramiro', 'Daniel Oehlrich', 'Gary John Tresadern', 'Gregor James MacDonald']",2015-04-21,8.0,"1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors",2011
1344,"['Cirrus Logic International Semiconductor Ltd', 'Cirrus Logic Inc', 'CIRRUS LOGIC INT SEMICONDUCTOR LTD', 'CIRRUS LOGIC INC']","[{'id': 'grid.422749.e', 'name': 'Cirrus Logic International (United Kingdom)', 'country_name': 'United Kingdom'}, {'id': 'grid.471095.e', 'name': 'Cirrus Logic (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10008992-B1,"['Lei Zhu', 'Xin Zhao', 'Alan Mark Morton', 'Tejasvi Das', 'Ku He', 'Xiaofan Fei']",2018-06-26,,Switching in amplifier with configurable final output stage,2017
1345,['BIONORICA SE'],"[{'id': 'grid.476113.6', 'name': 'Bionorica (Germany)', 'country_name': 'Germany'}]",Application,,WO-2013113772-A1,"['WUTTKE, WOLFGANG', 'SEIDLOVÁ-WUTTKE, Dana']",2013-08-08,,MEDICATION CONTAINING CIMICIFUGA FOR USE IN THE TREATMENT OF SARCOPENIA AND MYOCARDIAL INSUFFICIENCY,2013
1346,"['Institut National de la Recherche Agronomique INRA', 'Consiglio Nazionale Delle Richerche', 'AGRONOMIQUE INST NAT RECH', 'CONSIGLIO NAZIONALE RICERCHE']","[{'id': 'grid.414548.8', 'acronym': 'INRA ', 'name': 'French National Institute for Agricultural Research', 'country_name': 'France'}, {'id': 'grid.5326.2', 'acronym': 'CNR', 'name': 'National Research Council', 'country_name': 'Italy'}]",Application,,EP-2426215-A1,"['MARTIN, FRANCIS', 'Murat-Furminieux, Claude', 'Paolocci, Francesco', 'Rubini, Andrea', 'Riccioni, Claudia', 'Belfiori, Béatrice', 'Arcioni, Sergio']",2012-03-07,,Molecular method for the identification of mating type genes of truffles species,2010
1347,"['Allergan Pharmaceuticals International Ltd', 'ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD']","[{'id': 'grid.472734.1', 'name': 'Allergan (Ireland)', 'country_name': 'Ireland'}]",Grant,2017.0,US-9820946-B2,"['Brendan Muldoon', 'Ryan Gerald Loughlin', 'Gerarde SWEENEY', 'Emma Karen BOYD']",2017-11-21,,Pharmaceutical soft gelatin capsule dosage form with modified guar gum,2014
1348,"['Janssen Pharmaceutica NV', 'Addex Therapeutics Ltd', 'TRABANCO-SUAREZ ANDRES AVELINO', 'TRESADERN GARY JOHN', 'VEGA RAMIRO JUAN ANTONIO', 'CID-NUNEZ JOSE MARIA', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}, {'id': 'grid.419619.2', 'name': 'Janssen (Belgium)', 'country_name': 'Belgium'}]",Grant,2014.0,US-8785486-B2,"['Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Jose Maria Cid-Nunez']",2014-07-22,,"Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors",2008
1349,"['International Business Machines Corp', 'GUO SHANG Q', 'PALAKODETI RAMESH S', 'PURI RAJEEV', 'ROSU DANIELA', 'VENUGOPAL CASHCHAKANITHARA', 'WU FREDERICK Y', 'ZENG SAI', 'IBM']","[{'id': 'grid.410484.d', 'name': 'IBM (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9135056-B2,"['Shang Q. Guo', 'Ramesh S. Palakodeti', 'Rajeev Puri', 'Daniela Rosu', 'Cashchakanithara Venugopal', 'Frederick Y. Wu', 'Sai Zeng']",2015-09-15,,"Automated, controlled distribution and execution of commands and scripts",2012
1350,"['Telefonaktiebolaget LM Ericsson AB', 'ST ERICSSON SA']","[{'id': 'grid.425975.8', 'name': 'STMicroelectronics (Switzerland)', 'country_name': 'Switzerland'}, {'id': 'grid.28287.37', 'name': 'Ericsson (Sweden)', 'country_name': 'Sweden'}]",Grant,2016.0,US-9287874-B2,"['Pierangelo Confalonieri', 'Federico Guanziroli']",2016-03-15,,Level-shifting device,2013
1351,"['Cirrus Logic International Semiconductor Ltd', 'Cirrus Logic Inc', 'CIRRUS LOGIC INT SEMICONDUCTOR LTD', 'CIRRUS LOGIC INC']","[{'id': 'grid.422749.e', 'name': 'Cirrus Logic International (United Kingdom)', 'country_name': 'United Kingdom'}, {'id': 'grid.471095.e', 'name': 'Cirrus Logic (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9959856-B2,"['Aniruddha Satoskar', 'Daniel J. Allen', 'Edmund Mark Schneider']",2018-05-01,,Systems and methods for reducing artifacts and improving performance of a multi-path analog-to-digital converter,2015
1352,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'MACDONALD GREGOR JAMES', 'DUVEY GUILLAUME ALBERT JACQUES', 'LUTJENS ROBERT JOHANNES', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2015.0,US-9067891-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez', 'Gregor James MacDonald', 'Guillaume Albert Jacques Duvey', 'Robert Johannes Lutjens']",2015-06-30,,"1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mGluR2-receptors",2012
1353,"['Cirrus Logic International Semiconductor Ltd', 'Cirrus Logic Inc', 'CIRRUS LOGIC INT SEMICONDUCTOR LTD', 'CIRRUS LOGIC INC']","[{'id': 'grid.422749.e', 'name': 'Cirrus Logic International (United Kingdom)', 'country_name': 'United Kingdom'}, {'id': 'grid.471095.e', 'name': 'Cirrus Logic (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9807504-B2,"['John L. Melanson', 'Aniruddha Satoskar']",2017-10-31,11.0,Multi-path analog front end and analog-to-digital converter for a signal processing system with low-pass filter between paths,2016
1354,"['University of Illinois', 'Northwestern University', 'UNIV ILLINOIS', 'UNIV NORTHWESTERN']","[{'id': 'grid.411030.7', 'name': 'University of Illinois System', 'country_name': 'United States'}, {'id': 'grid.16753.36', 'acronym': 'NU', 'name': 'Northwestern University', 'country_name': 'United States'}]",Grant,2017.0,US-9613911-B2,"['John A. Rogers', 'Jonathan Fan', 'Woon-Hong Yeo', 'Yewang SU', 'Yonggang Huang', 'Yihui Zhang']",2017-04-04,7.0,Self-similar and fractal design for stretchable electronics,2014
1355,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2016.0,US-9226930-B2,"['Jose Maria Cid-Nunez', 'Daniel Oehlrich', 'Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Gregor James MacDonald']",2016-01-05,1.0,"1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders",2014
1356,"['Cirrus Logic International Semiconductor Ltd', 'Cirrus Logic Inc', 'CIRRUS LOGIC INT SEMICONDUCTOR LTD', 'CIRRUS LOGIC INC']","[{'id': 'grid.422749.e', 'name': 'Cirrus Logic International (United Kingdom)', 'country_name': 'United Kingdom'}, {'id': 'grid.471095.e', 'name': 'Cirrus Logic (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9929703-B1,"['Xin Zhao', 'Tejasvi Das', 'Xiaofan Fei', 'Alan Mark Morton']",2018-03-27,3.0,Amplifier with configurable final output stage,2016
1357,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'TRABANCO-SUAREZ ANDRES AVELINO', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8691849-B2,"['Jose Maria Cid-Nunez', 'Andres Avelino Trabanco-Suarez']",2014-04-08,,3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors,2009
1358,"['CHEN ZHONGWEI', 'CHEN ZHU']",,Grant,2017.0,US-9590253-B2,"['Zhongwei Chen', 'Zhu Chen']",2017-03-07,,Core-shell structured bifunctional catalysts for metal air battery/fuel cell,2013
1359,"['Velocys Inc', 'LEVINESS STEPHEN CLAUDE', 'GREAGER IVAN', 'VELOCYS INC']","[{'id': 'grid.427273.7', 'name': 'Oxford Catalysts Group (United States)', 'country_name': 'United States'}]",Application,,US-20160289545-A1,"['Stephen Claude Leviness', 'Ivan Greager']",2016-10-06,,Generation of Hydrocarbon Fuels Having a Reduced Environmental Impact,2016
1360,['LIGAND PHARM INC'],"[{'id': 'grid.418267.e', 'name': 'Ligand Pharmaceuticals (United States)', 'country_name': 'United States'}]",Application,,WO-2013134311-A1,"['ZHI, LIN']",2013-09-12,,STEROID HORMONE AND CHOLESTEROL PATHWAYS AS ONE UNIFIED HOMESTATIC SYSTEM,2013
1361,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA', 'ADDEX PHARMA, S.A.']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2018.0,US-10071095-B2,"['Jose Maria Cid-Nunez', 'Daniel Oehlrich', 'Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Gregor James MACDONOLD']",2018-09-11,,"1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders",2017
1362,"['UNIV ANTWERPEN', 'AUGUSTYNS KOEN', 'VAN DER VEKEN PIETER', 'MESSAGIE JONAS', 'JOOSSENS JURGEN', 'LAMBEIR ANNE-MARIE']","[{'id': 'grid.5284.b', 'name': 'University of Antwerp', 'country_name': 'Belgium'}]",Application,,WO-2012152807-A1,"['AUGUSTYNS, KOEN', 'JOOSSENS, JURGEN', 'LAMBEIR, ANNE-MARIE', 'MESSAGIE, Jonas', 'VAN DER VEKEN, PIETER']",2012-11-15,2.0,ACTIVITY-BASED PROBES FOR THE UROKINASE PLASMINOGEN ACTIVATOR,2012
1363,"['MathWorks Inc', 'MATHWORKS INC']","[{'id': 'grid.471101.2', 'name': 'MathWorks (United States)', 'country_name': 'United States'}]",Application,,US-20140365992-A1,"['David Maclay', 'Matej URBAS']",2014-12-11,2.0,BEHAVIOR INVARIANT OPTIMIZATION OF MAXIMUM EXECUTION TIMES FOR MODEL SIMULATION,2014
1364,"['Pfizer Inc', 'PFIZER']","[{'id': 'grid.410513.2', 'acronym': 'Pfizer', 'name': 'Pfizer (United States)', 'country_name': 'United States'}]",Application,,US-20070248611-A1,"['Chia-Yang Lin', 'Arnon Rosenthal', 'Jennifer Stratton']",2007-10-25,5.0,METHODS WANTED FOR TREATING UNWANTED WEIGHT LOSS OR EATING DISORDERS BY ADMINISTERING A TRKB AGONIST,2007
1365,"['University of California', 'University of Illinois', 'BP Corporation North America Inc', 'GLASS N LOUISE', 'TIAN CHAOGUANG', 'BEESON IV WILLIAM T', 'ZHAO HUIMIN', 'DU JING', 'CHOI JIN HO', 'DOUDNA CATE JAMES H', 'GALAZKA JONATHAN M', 'HA SUK-JIN', 'JIN YONG-SU', 'KIM SOO RIN', 'LI SIJIN', 'YANG XIAOMIN', 'UNIV CALIFORNIA', 'UNIV ILLINOIS', 'BP CORP NORTH AMERICA INC']","[{'id': 'grid.30389.31', 'name': 'University of California System', 'country_name': 'United States'}, {'id': 'grid.411030.7', 'name': 'University of Illinois System', 'country_name': 'United States'}, {'id': 'grid.431411.2', 'name': 'BP (United States)', 'country_name': 'United States'}]",Grant,2013.0,US-8431360-B2,"['N. Louise Glass', 'Chaoguang Tian', 'William T. Beeson, IV', 'Huimin Zhao', 'Jing Du', 'Jin Ho Choi', 'James H. Doudna Cate', 'Jonathan M. Galazka', 'Suk-Jin Ha', 'Yong-Su Jin', 'Soo Rin Kim', 'Sijin Li', 'XiaoMin Yang']",2013-04-30,7.0,"Methods and compositions for improving sugar transport, mixed sugar fermentation, and production of biofuels",2010
1366,"['ANGUS CHEMICAL', 'GREEN GEORGE D', 'SWEDO RAYMOND']","[{'id': 'grid.418574.b', 'name': 'Dow Chemical Company (United States)', 'country_name': 'United States'}]",Application,,WO-2013003538-A1,"['GREEN, GEORGE D.', 'SWEDO, RAYMOND']",2013-01-03,2.0,BIPHENOL ETHER COMPOUNDS,2012
1367,"['CIRRUS LOGIC INT SEMICONDUCTOR LTD', 'ZHAO XIN']",,Application,,WO-2018063878-A1,"['ZHAO, XIN', 'DAS, TEJASVI', 'FEI, XIAOFAN', 'MORTON, ALAN MARK']",2018-04-05,,AMPLIFIER WITH CONFIGURABLE FINAL OUTPUT STAGE,2017
1368,"['Johns Hopkins University', 'SGOUROS GEORGE', 'HOBBS ROBERT', 'UNIV JOHNS HOPKINS']","[{'id': 'grid.21107.35', 'acronym': 'JHU', 'name': 'Johns Hopkins University', 'country_name': 'United States'}]",Grant,2017.0,US-9757084-B2,"['George Sgouros', 'Robert Hobbs']",2017-09-12,,Method and system for administering radiopharmaceutical therapy (RPT),2011
1369,"['STATE UNIVERSITY OF YEREVAN', 'Addex Therapeutics Ltd', 'Janssen Cilag SA', 'Janssen Pharmaceuticals Inc', 'CID-NUNEZ JOSE MARIA', 'ANDRES-GIL JOSE IGNACIO', 'TRABANCO-SUAREZ ANDRES AVELINO', 'OYARZABAL SANTAMARINA JULEN', 'DAUTZENBERG FRANK MATTHIAS', 'MACDONALD GREGOR JAMES', 'PULLAN SHIRLEY ELIZABETH', 'LUTJENS ROBERT JOHANNES', 'DUVEY GUILLAUME ALBERT JACQUES', 'NHEM VANTHEA', 'FINN TERRY PATRICK', 'MELIKYAN GAGIK', 'MUTEL VINCENT', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}, {'id': 'grid.21072.36', 'acronym': 'YSU', 'name': 'Yerevan State University', 'country_name': 'Armenia'}]",Grant,2014.0,US-8841323-B2,"['Hassan Julien Imogai', 'Jose Maria Cid-Nunez', 'Jose Ignacio Andres-Gil', 'Andres Avelino Trabanco-Suarez', 'Julen Oyarzabal Santamarina', 'Frank Matthias Dautzenberg', 'Gregor James MacDonald', 'Shirley Elizabeth Pullan', 'Robert Johannes Lutjens', 'Guillaume Albert Jacques Duvey', 'Vanthea Nhem', 'Terry Patrick Finn', 'Gagik Melikyan']",2014-09-23,,"1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors",2007
1370,"['Cirrus Logic Inc', 'CIRRUS LOGIC INC']","[{'id': 'grid.471095.e', 'name': 'Cirrus Logic (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9998823-B2,"['Ku He', 'Tejasvi Das', 'John L. Melanson', 'Anniruddha Satoskar']",2018-06-12,,Systems and methods for reduction of audio artifacts in an audio system with dynamic range enhancement,2014
1371,"['Empire Technology Development LLC', 'CASASANTA VINCENZO', 'EMPIRE TECHNOLOGY DEV LLC']","[{'id': 'grid.254444.7', 'acronym': 'WSU', 'name': 'Wayne State University', 'country_name': 'United States'}, {'id': 'grid.480111.d', 'name': 'ConvergeOne (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9350012-B2,['Vincenzo Casasanta'],2016-05-24,,Rechargeable organosodium polymer battery,2011
1372,"['BRAIN Biotechnology Research and Information Network AG', 'BRAIN BIOTECHNOLOGY RES & INFORMATION NETWORK AG']",,Grant,2017.0,US-9585865-B2,"['Michael Krohn', 'Holger Zinke']",2017-03-07,,Small molecule modulators of the cold and menthol receptor TRPM8,2014
1373,"['Wistar Institute, The', 'WISTAR INST']","[{'id': 'grid.251075.4', 'name': 'The Wistar Institute', 'country_name': 'United States'}]",Grant,2018.0,US-9903870-B2,"['David W. Speicher', 'Hsin Yao Tang', 'Lynn A. Beer']",2018-02-27,,Methods and compositions for the diagnosis of ovarian cancer,2013
1374,"['Addex Therapeutics Ltd', 'Janssen Pharmaceuticals Inc', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMACEUTICALS SA', 'JANSSEN PHARMACEUTICALS INC', 'ADDEX PHARMA SA']","[{'id': 'grid.488228.c', 'name': 'Addex Therapeutics (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2017.0,US-9737533-B2,"['Jose Maria Cid-Nunez', 'Daniel Oehlrich', 'Andres Avelino Trabanco-Suarez', 'Gary John Tresadern', 'Juan Antonio Vega Ramiro', 'Gregor James MacDonald']",2017-08-22,1.0,"1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders",2015
1375,"['AVEO Pharmaceuticals Inc', 'AVEO PHARMACEUTICALS INC']","[{'id': 'grid.427642.1', 'name': 'AVEO Pharmaceuticals (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9175076-B2,"['Lorena Lerner', 'Sandra Abbott', 'Ailin Bai', 'Ting Chen', 'Maria Isabel Chiu', 'Qing Liu', 'Laura Poling', 'Nianjun Tao', 'Solly Weiler', 'Zhigang Weng', 'William M. Winston, Jr.', 'Jeno Gyuris']",2015-11-03,1.0,Anti-GDF15 antibodies,2013
1376,"['JOSLIN DAIBETES CENTER', 'SANOFI SA']","[{'id': 'grid.417924.d', 'name': 'Sanofi (France)', 'country_name': 'France'}]",Application,,EP-2769732-A1,"['LOHMANN MATTHIAS DR', 'GUILLEMOT JEAN CLAUDE', 'LOYAUX DENIS', 'ROHIT KULKARNI PROF DR', 'ABDELFATTAH EL QUAAMARI DR', 'The designation of the inventor has not yet been filed']",2014-08-27,,Serpins: methods of therapeutic beta-cell regeneration and function,2013
1377,"['ADAPTIVE BIOTECHNOLOGIES CORP', 'ADAPTIVE BIOTECHNOLOGIES CORP', 'HUTCHINSON FRED CANCER RES', 'ADAPTIVE BIOTECHNOLOGIES CORP']","[{'id': 'grid.270240.3', 'acronym': 'FHCRC', 'name': 'Fred Hutchinson Cancer Research Center', 'country_name': 'United States'}, {'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9824179-B2,"['Anna M. Sherwood', 'Harlan S. Robins']",2017-11-21,,Diagnosis of lymphoid malignancies and minimal residual disease detection,2012
1378,"['ADAPTIVE BIOTECHNOLOGIES CORP', 'ADAPTIVE BIOTECHNOLOGIES CORP']","[{'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9499865-B2,"['Malek Faham', 'Mark Klinger']",2016-11-22,,Detection and measurement of tissue-infiltrating lymphocytes,2012
1379,"['Rockwood Lithium GmbH', 'WIETELMANN I ULRICH PETER', 'Rockwood Lithium GmbH']","[{'id': 'grid.437402.6', 'name': 'Rockwood Lithium (Germany)', 'country_name': 'Germany'}]",Grant,2015.0,US-9023252-B2,"['Ulrich Peter Wietelmann, I']",2015-05-05,,Method for producing a carbon-coated lithium sulfide and use thereof,2012
1380,"['Sanofi SA', 'SANOFI SA']","[{'id': 'grid.417924.d', 'name': 'Sanofi (France)', 'country_name': 'France'}]",Application,,EP-2851086-A1,"['LOHMANN DR MATTHIAS', 'GUILLEMOT JEAN CLAUDE', 'LOYAUX DENIS', 'KULKARNI PROF DR ROHIT', 'EL OUAAMARI DR ABDELFATTAH', 'The designation of the inventor has not yet been filed']",2015-03-25,,Serpins: methods of therapeutic ß-cell regeneration and function,2013
1381,"['ADAPTIVE BIOTECHNOLOGIES CORP', 'SEQUENTA INC', 'SEQUENTA LLC']","[{'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9228232-B2,"['Malek Faham', 'Thomas Willis']",2016-01-05,15.0,Methods of monitoring conditions by sequence analysis,2014
1382,"['Sion Power Corp', 'SION POWER CORP']","[{'id': 'grid.422265.5', 'name': 'Sion Power (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9077041-B2,"['Savannah V. Burnside', 'Christopher T. S. Campbell', 'Chariclea Scordilis-Kelley', 'William F. Wilkening']",2015-07-07,8.0,Electrode structure for electrochemical cell,2013
1383,"['RVX Therapeutics Inc', 'Zenith Epigenetics Ltd', 'LIU SHUANG', 'DUFFY BRYAN CORDELL', 'QUINN JOHN FREDERICK', 'JIANG MAY XIAOWU', 'WANG RUIFANG', 'MARTIN GREGORY SCOTT', 'ZHAO HE', 'MOLINO BRUCE FRANCIS', 'YOUNG PETER RONALD', 'ZENITH EPIGENETICS CORP']",,Grant,2016.0,US-9271978-B2,"['Shuang Liu', 'Bryan Cordell Duffy', 'John Frederick Quinn', 'May Xiaowu JIANG', 'Ruifang Wang', 'Gregory Scott Martin', 'He Zhao', 'Bruce Francis Molino', 'Peter Ronald Young']",2016-03-01,13.0,Heterocyclic compounds as bromodomain inhibitors,2013
1384,"['Sion Power Corp', 'SION POWER CORP', 'BASF SE']","[{'id': 'grid.3319.8', 'name': 'BASF (Germany)', 'country_name': 'Germany'}, {'id': 'grid.422265.5', 'name': 'Sion Power (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9577267-B2,"['Chariclea Scordilis-Kelley', 'Ruediger Schmidt', 'Holger Schneider', 'Tracy Earl Kelley', 'Savannah V. Burnside-Joubert', 'Klaus Leitner', 'Heino Sommer', 'Jan Tomforde', 'Alexander Panchenko']",2017-02-21,6.0,Electrode structure and method for making same,2015
1385,"['RVX Therapeutics Inc', 'Zenith Epigenetics Ltd', 'ZENITH EPIGENETICS CORP', 'ZENITH EPIGENETICS LTD']",,Grant,2017.0,US-9636328-B2,"['Shuang Liu', 'John Frederick Quinn', 'Bryan Cordell Duffy', 'Ruifang Wang', 'May Xiaowu JIANG', 'Gregory Scott Martin', 'He Zhao', 'Michael Ellis', 'Gregory Steven Wagner', 'Peter Ronald Young']",2017-05-02,10.0,Substituted bicyclic compounds as bromodomain inhibitors,2014
1386,"['F Hoffmann-La Roche AG', 'FRENCH DOROTHY', 'SIEBEL CHRISTIAN W', 'HUNTZICKER ERIK', 'GENENTHECH INC']","[{'id': 'grid.417570.0', 'name': 'Roche (Switzerland)', 'country_name': 'Switzerland'}]",Application,,US-20130089562-A1,"['Dorothy French', 'Christian W. Siebel', 'Erik Huntzicker']",2013-04-11,6.0,METHODS OF TREATING LIVER CONDITIONS USING NOTCH2 ANTAGONISTS,2012
1387,"['ADAPTIVE BIOTECHNOLOGIES CORP', 'ADAPTIVE BIOTECHNOLOGIES CORP']","[{'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9347099-B2,"['Malek Faham', 'Thomas Willis']",2016-05-24,1.0,Single cell analysis by polymerase cycling assembly,2013
1388,"['University of Arizona', 'UNIV ARIZONA']","[{'id': 'grid.134563.6', 'acronym': 'UA', 'name': 'University of Arizona', 'country_name': 'United States'}]",Grant,2017.0,US-9567439-B1,"['Dong-Chul Pyun', 'Richard S. Glass', 'M. Bonner Denton']",2017-02-14,6.0,Sulfur composites and polymeric materials from elemental sulfur,2015
1389,"['RVX Therapeutics Inc', 'Zenith Epigenetics Ltd', 'FAIRFAX DAVID JOHN', 'DUFFY BRYAN CORDELL', 'MARTIN GREGORY SCOTT', 'QUINN JOHN FREDERICK', 'LIU SHUANG', 'WAGNER GREGORY STEVEN', 'YOUNG PETER RONALD', 'ZENITH EPIGENETICS CORP']",,Grant,2015.0,US-9073878-B2,"['David John Fairfax', 'Bryan Cordell Duffy', 'Gregory Scott Martin', 'John Frederick Quinn', 'Shuang Liu', 'Gregory Steven Wagner', 'Peter Ronald Young']",2015-07-07,15.0,Cyclic amines as bromodomain inhibitors,2013
1390,"['Regeneron Pharmaceuticals Inc', 'REGENERON PHARMA']","[{'id': 'grid.418961.3', 'name': 'Regeneron (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9706759-B2,"['Lynn MacDonald', 'Cagan Gurer', 'Karolina A. Hosiawa', 'Sean Stevens', 'Andrew J. Murphy']",2017-07-18,,Humanized light chain mice,2012
1391,['REGENERON PHARMA'],"[{'id': 'grid.418961.3', 'name': 'Regeneron (United States)', 'country_name': 'United States'}]",Application,,WO-2013059230-A1,"['MACDONALD, LYNN', 'MCWHIRTER, JOHN', 'GURER, CAGAN', 'HOSIAWA, KAROLINA, A.', 'MURPHY, ANDREW, J.']",2013-04-25,34.0,RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN MICE,2012
1392,"['Rockwood Lithium GmbH', 'Rockwood Lithium GmbH']","[{'id': 'grid.437402.6', 'name': 'Rockwood Lithium (Germany)', 'country_name': 'Germany'}]",Grant,2016.0,US-9496545-B2,"['Ulrich Wietelmann', 'Ute Emmel', 'Christoph Hartnig', 'Sebastian Lang']",2016-11-15,,"Li2S@C-coated lithium metal product, method for the production thereof, and use",2012
1393,"['ADAPTIVE BIOTECHNOLOGIES CORP', 'ADAPTIVE BIOTECHNOLOGIES CORP']","[{'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10066265-B2,"['Mark Klinger', 'Malek Faham']",2018-09-04,2.0,Determining antigen-specific t-cells,2014
1394,['ZENITH EPIGENETICS CORP'],,Application,,WO-2015004534-A2,"['LIU, SHUANG', 'QUINN, John, Frederick', 'DUFFY, Bryan, Cordell', 'WANG, Ruifang', 'JIANG, MAY, XIAOWU', 'MARTIN, Gregory, Scott', 'ZHAO, HE', 'ELLIS, MICHAEL', 'WAGNER, Gregory, Steven', 'YOUNG, PETER, RONALD']",2015-01-15,33.0,NOVEL SUBSTITUTED BICYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS,2014
1395,"['Sion Power Corp', 'SION POWER CORP']","[{'id': 'grid.422265.5', 'name': 'Sion Power (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-8936870-B2,"['John D. Affinito', 'Gregory K. Lowe']",2015-01-20,22.0,Electrode structure and method for making the same,2012
1396,"['ADAPTIVE BIOTECHNOLOGIES CORP', 'MOORHEAD MARTIN', 'FAHAM MALEK', 'WILLIS THOMAS', 'SEQUENTA INC']","[{'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9043160-B1,"['Martin Moorhead', 'Malek Faham', 'Thomas Willis']",2015-05-26,26.0,Method of determining clonotypes and clonotype profiles,2011
1397,"['RVX Therapeutics Inc', 'Zenith Epigenetics Ltd', 'ZENITH EPIGENETICS CORP', 'ZENITH EPIGENETICS LTD']",,Grant,2017.0,US-9663520-B2,"['John Frederick Quinn', 'Bryan Cordell Duffy', 'Shuang Liu', 'Ruifang Wang', 'May Xiaowu JIANG', 'Gregory Scott Martin', 'Gregory Steven Wagner', 'Peter Ronald Young']",2017-05-30,9.0,Bicyclic bromodomain inhibitors,2015
1398,"['ADAPTIVE BIOTECHNOLOGIES CORP', 'ADAPTIVE BIOTECHNOLOGIES CORP']","[{'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9708657-B2,"['Thomas Asbury', 'Kieran Hervold', 'Chitra Kotwaliwale', 'Malek Faham', 'Martin Moorhead', 'Li Weng', 'Tobias Wittkop', 'Jianbiao Zheng']",2017-07-18,8.0,Method for generating clonotype profiles using sequence tags,2014
1399,"['Regeneron Pharmaceuticals Inc', 'REGENERON PHARMA']","[{'id': 'grid.418961.3', 'name': 'Regeneron (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10072095-B2,"['Lynn MacDonald', 'Sean Stevens', 'Andrew J. Murphy', 'Margaret Karow']",2018-09-11,,ADAM6 mice,2015
1400,"['ADAPTIVE BIOTECHNOLOGIES CORP', 'ADAPTIVE BIOTECHNOLOGIES CORP']","[{'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9523129-B2,"['Malek Faham', 'Martin Moorhead', 'Thomas Willis']",2016-12-20,,Sequence analysis of complex amplicons,2014
1401,"['Rockwood Lithium GmbH', 'WIETELMANN ULRICH', 'Rockwood Lithium GmbH']","[{'id': 'grid.437402.6', 'name': 'Rockwood Lithium (Germany)', 'country_name': 'Germany'}]",Grant,2015.0,US-9147883-B2,['Ulrich Wietelmann'],2015-09-29,,Method for producing a carbon-coated lithium sulfide and use thereof,2012
1402,"['INST SYSTEMS BIOLOGY', 'HOOD LEROY', 'WANG KAI', 'LEE INYOUL', 'ZHOU YONG', 'CHO JI HOON', 'GHOSH DHIMANKRISHNA']","[{'id': 'grid.64212.33', 'acronym': 'ISB', 'name': 'Institute for Systems Biology', 'country_name': 'United States'}]",Application,,WO-2014039893-A1,"['HOOD, LEROY', 'WANG, KAI', 'LEE, INYOUL', 'ZHOU, YONG', 'CHO, JI HOON', 'GHOSH, Dhimankrishna']",2014-03-13,8.0,MARKERS AND METHODS FOR DETECTING POSTTRAUMATIC STRESS DISORDER (PTSD),2013
1403,"['Oncternal Therapeutics Inc', 'GTX INC']","[{'id': 'grid.476408.9', 'name': 'GTx (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9744149-B2,"['James T. Dalton', 'Mitchell S. Steiner', 'Ramesh Narayanan', 'Sunjoo Ahn']",2017-08-29,,Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs),2015
1404,"['RVX Therapeutics Inc', 'Zenith Epigenetics Ltd', 'FAIRFAX DAVID JOHN', 'DUFFY BRYAN CORDELL', 'MARTIN GREGORY SCOTT', 'QUINN JOHN FREDERICK', 'LIU SHUANG', 'WAGNER GREGORY STEVEN', 'YOUNG PETER RONALD', 'ZENITH EPIGENETICS CORP']",,Grant,2016.0,US-9278940-B2,"['David John Fairfax', 'Bryan Cordell Duffy', 'Gregory Scott Martin', 'John Frederick Quinn', 'Shuang Liu', 'Gregory Steven Wagner', 'Peter Ronald Young']",2016-03-08,16.0,Cyclic amines as bromodomain inhibitors,2015
1405,"['RVX Therapeutics Inc', 'Zenith Epigenetics Ltd', 'ZENITH EPIGENETICS LTD']",,Grant,2017.0,US-9662311-B2,"['Shuang Liu', 'John Frederick Quinn', 'Bryan Cordell Duffy', 'Ruifang Wang', 'May Xiaowu JIANG', 'Gregory Scott Martin', 'He Zhao', 'Michael Ellis', 'Gregory Steven Wagner', 'Peter Ronald Young']",2017-05-30,13.0,Substituted bicyclic compounds as bromodomain inhibitors,2014
1406,"['Stealth BioTherapeutics Corp', 'STEALTH BIOTHERAPEUTICS CORP']",,Grant,2017.0,US-9549963-B2,"['Liping Liu', 'Shibo Tang', 'Xiaoling Liang']",2017-01-24,3.0,Methods and compositions for preventing or treating ophthalmic conditions,2015
1407,"['GIELIS JOHAN', 'CARATELLI DIEGO']",,Application,,WO-2011161548-A2,"['GIELIS, JOHAN', 'CARATELLI, DIEGO']",2011-12-29,9.0,COMPUTER IMPLEMENTED TOOL BOX SYSTEMS AND METHODS,2011
1408,"['Friedrich-Alexander-Universitat Erlangen-Nurnberg (friedrich Alexander University)', 'Friedrich Alexander Univeritaet Erlangen Nuernberg (FAU)', 'University of Central Florida Research Foundation Inc (UCFRF)', 'UNIV CENTRAL FLORIDA RES FOUND INC', 'FRIEDRICH ALEXANDER UNIV']","[{'id': 'grid.5330.5', 'acronym': 'FAU', 'name': 'University of Erlangen-Nuremberg', 'country_name': 'Germany'}, {'id': 'grid.170430.1', 'acronym': 'UCF', 'name': 'University of Central Florida', 'country_name': 'United States'}]",Grant,2017.0,US-9629822-B2,"['Otto Phanstiel, IV', 'Nuska Tschammer']",2017-04-25,,Flavonoid based antiviral targets,2013
1409,"['University of South Florida', 'ALCANTAR NORMA A', 'Falahat Rana', 'WIRANOWSKA MARZENNA', 'TOOMEY RYAN G', 'UNIV SOUTH FLORIDA']","[{'id': 'grid.170693.a', 'acronym': 'USF', 'name': 'University of South Florida', 'country_name': 'United States'}]",Grant,2016.0,US-9522114-B1,"['Norma A. Alcantar', 'Rana Falahat', 'Marzenna Wiranowska', 'Ryan G. Toomey']",2016-12-20,,Enhanced targeted drug delivery system via chitosan hydrogel and chlorotoxin,2015
1410,['REGENERON PHARMA'],"[{'id': 'grid.418961.3', 'name': 'Regeneron (United States)', 'country_name': 'United States'}]",Application,,WO-2013187953-A1,"['MACDONALD, LYNN', 'MCWHIRTHER, John', 'TU, NAXIN', 'STEVENS, SEAN', 'MURPHY, ANDREW, J.']",2013-12-19,5.0,HUMANIZED NON-HUMAN ANIMALS WITH RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN LOCI,2013
1411,"['Sion Power Corp', 'AFFINITO JOHN D', 'SCORDILIS-KELLEY CHARICLEA', 'MIKHAYLIK YURIY V', 'SION POWER CORP']","[{'id': 'grid.422265.5', 'name': 'Sion Power (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9548492-B2,"['John D. Affinito', 'Chariclea Scordilis-Kelley', 'Yuriy V. Mikhaylik']",2017-01-17,13.0,Plating technique for electrode,2012
1412,"['ADAPTIVE BIOTECHNOLOGIES CORP', 'ADAPTIVE BIOTECHNOLOGIES CORP']","[{'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10077473-B2,"['Thomas Asbury', 'Kieran Hervold', 'Chitra Kotwaliwale', 'Malek Faham', 'Martin Moorhead', 'Li Weng', 'Tobias Wittkop', 'Jianbiao Zheng']",2018-09-18,2.0,Method for genotyping clonotype profiles using sequence tags,2017
1413,"['Sion Power Corp', 'SION POWER CORP']","[{'id': 'grid.422265.5', 'name': 'Sion Power (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9559348-B2,"['Karthikeyan Kumaresan', 'Yuriy V. Mikhaylik']",2017-01-31,6.0,Conductivity control in electrochemical cells,2014
1414,"['RVX Therapeutics Inc', 'Zenith Epigenetics Ltd', 'ZENITH EPIGENETICS CORP', 'ZENITH EPIGENETICS LTD']",,Grant,2017.0,US-9598367-B2,"['Shuang Liu', 'Bryan Cordell Duffy', 'John Frederick Quinn', 'May Xiaowu JIANG', 'Ruifang Wang', 'Gregory Scott Martin', 'He Zhao', 'Bruce Francis Molino', 'Peter Ronald Young']",2017-03-21,9.0,Heterocyclic compounds as bromodomain inhibitors,2016
1415,"['Regeneron Pharmaceuticals Inc', 'REGENERON PHARMA']","[{'id': 'grid.418961.3', 'name': 'Regeneron (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9622459-B2,"['Lynn MacDonald', 'Cagan Gurer', 'Karolina A. MEAGHER', 'Sean Stevens', 'Andrew J. Murphy']",2017-04-18,1.0,Humanized light chain mice,2013
1416,"['Adaptive Biotechnolgies Corp', 'ADAPTIVE BIOTECHNOLOGIES CORP', 'ADAPTIVE BIOTECHNOLOGIES CORP', 'ADAPTIVE BIOTECHNOLGIES CORP']","[{'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9528160-B2,"['Francois Pepin', 'Malek Faham', 'Martin Moorhead']",2016-12-27,1.0,Rare clonotypes and uses thereof,2013
1417,"['Genentech Inc', 'GENENTECH INC']","[{'id': 'grid.418158.1', 'acronym': 'Roche', 'name': 'Roche (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9550829-B2,"['Dorothy French', 'Erik Huntzicker', 'Christian W. Siebel']",2017-01-24,6.0,Compositions and methods for diagnosis and treatment of hepatic cancers,2014
1418,"['Genentech Inc', 'GENENTECH INC']","[{'id': 'grid.418158.1', 'acronym': 'Roche', 'name': 'Roche (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-10011661-B2,"['Yvonne Chinn', 'Julie Q. Hang', 'Christian W. Siebel', 'Yan Wu']",2018-07-03,,Anti-Jagged1 antibodies and methods of use,2016
1419,"['Regeneron Pharmaceuticals Inc', 'REGENERON PHARMA']","[{'id': 'grid.418961.3', 'name': 'Regeneron (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9932408-B2,"['Lynn MacDonald', 'Sean Stevens', 'Andrew J. Murphy']",2018-04-03,1.0,ADAM6 mice,2014
1420,"['Sion Power Corp', 'WILKENING WILLIAM F', 'CAMPBELL CHRISTOPHER T S', 'BURNSIDE SAVANNAH V', 'SION POWER CORP']","[{'id': 'grid.422265.5', 'name': 'Sion Power (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9005809-B2,"['William F. Wilkening', 'Christopher T. S. Campbell', 'Savannah V. Burnside']",2015-04-14,8.0,Electrochemical cells comprising porous structures comprising sulfur,2010
1421,"['University of Texas System', 'UNIV TEXAS']","[{'id': 'grid.55460.32', 'acronym': 'UT System', 'name': 'The University of Texas System', 'country_name': 'United States'}]",Grant,2018.0,US-10082496-B2,"['Jef De Brabander', 'Jerry W. Shay', 'Wentian Wang', 'Deepak Nijhawan', 'Pano Theodoropoulos']",2018-09-25,,Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis,2016
1422,"['Sion Power Corp', 'SION POWER CORP']","[{'id': 'grid.422265.5', 'name': 'Sion Power (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9419274-B2,"['William F. Wilkening', 'Christopher T. S. Campbell', 'Savannah V. Burnside-Joubert']",2016-08-16,5.0,Electrochemical cells comprising porous structures comprising sulfur,2014
1423,"['Cornell University', 'SZETO HAZEL H', 'FELSEN DIANE', 'UNIV CORNELL']","[{'id': 'grid.5386.8', 'acronym': 'CU', 'name': 'Cornell University', 'country_name': 'United States'}]",Grant,2015.0,US-8940696-B2,"['Hazel H. Szeto', 'Diane Felsen']",2015-01-27,2.0,Methods for prevention and treatment of acute renal injury,2013
1424,"['Johns Hopkins University', 'UNIV JOHNS HOPKINS']","[{'id': 'grid.21107.35', 'acronym': 'JHU', 'name': 'Johns Hopkins University', 'country_name': 'United States'}]",Grant,2016.0,US-9505727-B2,"['Frank Bosmans', 'Dimpy Kalia']",2016-11-29,1.0,Rufinamide and derivatives and their use in modulating the gating process of human voltage-gated sodium channels,2015
1425,"['Sion Power Corp', 'SION POWER CORP']","[{'id': 'grid.422265.5', 'name': 'Sion Power (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9214678-B2,['Yuriy V. Mikhaylik'],2015-12-15,6.0,"Porous support structures, electrodes containing same, and associated methods",2013
1426,"['RVX Therapeutics Inc', 'Zenith Epigenetics Ltd', 'ZENITH EPIGENETICS LTD']",,Grant,2018.0,US-9861637-B2,"['Shuang Liu', 'Bryan Cordell Duffy', 'John Frederick Quinn', 'May Xiaowu JIANG', 'Ruifang Wang', 'Gregory Scott Martin', 'He Zhao', 'Bruce Francis Molino', 'Peter Ronald Young']",2018-01-09,10.0,Heterocyclic compounds as bromodomain inhibitors,2017
1427,"['Sion Power Corp', 'SCHMIDT RUEDIGER', 'PANCHENKO ALEXANDER', 'EWALD BASTIAN', 'HANEFELD PHILIP', 'IVANOVICI SORIN', 'MOEHWALD HELMUT', 'KOVALEV IGOR P', 'SION POWER CORP']","[{'id': 'grid.422265.5', 'name': 'Sion Power (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9577243-B2,"['Ruediger Schmidt', 'Alexander Panchenko', 'Bastian Ewald', 'Philip Hanefeld', 'Sorin Ivanovici', 'Helmut Moehwald', 'Igor P. Kovalev']",2017-02-21,5.0,Use of expanded graphite in lithium/sulphur batteries,2011
1428,"['RVX Therapeutics Inc', 'Zenith Epigenetics Ltd', 'ZENITH EPIGENETICS LTD']",,Grant,2017.0,US-9765039-B2,"['David John Fairfax', 'Gregory Scott Martin', 'John Frederick Quinn', 'Bryan Cordell Duffy', 'Gregory Steven Wagner', 'Peter Ronald Young']",2017-09-19,7.0,Biaryl derivatives as bromodomain inhibitors,2013
1429,"['ADAPTIVE BIOTECHNOLOGIES CORP', 'FAHAM MALEK', 'MOORHEAD MARTIN', 'WILLIS THOMAS', 'SEQUENTA INC']","[{'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8691510-B2,"['Malek Faham', 'Martin Moorhead', 'Thomas Willis']",2014-04-08,37.0,Sequence analysis of complex amplicons,2011
1430,"['Hutchinson Fred Cancer Research Center', 'ADAPTIVE BIOTECHNOLOGIES CORP', 'ADAPTIVE BIOTECHNOLOGIES CORP', 'HUTCHINSON FRED CANCER RES']","[{'id': 'grid.270240.3', 'acronym': 'FHCRC', 'name': 'Fred Hutchinson Cancer Research Center', 'country_name': 'United States'}, {'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9279159-B2,"['Harlan S. Robins', 'Robert J. Livingston', 'Jason H. Bielas']",2016-03-08,3.0,Quantification of adaptive immune cell genomes in a complex mixture of cells,2012
1431,"['Sion Power Corp', 'MIKHAYLIK YURIY V', 'KOVALEV IGOR P', 'AFFINITO JOHN D', 'MOEHWALD HELMUT', 'SCHMIDT RUEDIGER', 'CRISTADORO ANNA', 'HAUPT INGRID', 'PIETRUSCHKA RAIMUND', 'SION POWER CORP']","[{'id': 'grid.422265.5', 'name': 'Sion Power (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9853287-B2,"['Yuriy V. Mikhaylik', 'Igor P. Kovalev', 'John D. Affinito', 'Helmut Moehwald', 'Ruediger Schmidt', 'Anna Cristadoro', 'Ingrid Haupt', 'Raimund Pietruschka']",2017-12-26,1.0,Electrolyte materials for use in electrochemical cells,2011
1432,"['Cornell Research Foundation Inc', 'CORNELL RES FOUNDATION INC']","[{'id': 'grid.5386.8', 'acronym': 'CU', 'name': 'Cornell University', 'country_name': 'United States'}]",Grant,2018.0,US-9950026-B2,['Hazel H. Szeto'],2018-04-24,,Methods for reducing oxidative damage,2015
1433,"['Genentech Inc', 'GENENTECH INC']","[{'id': 'grid.418158.1', 'acronym': 'Roche', 'name': 'Roche (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9982058-B2,"['Dorothy French', 'Erik Huntzicker', 'Christian W. Siebel']",2018-05-29,,Anti-JAG1 antibody compositions and methods for treatment of hepatic cancers,2016
1434,"['RVX Therapeutics Inc', 'Zenith Epigenetics Ltd', 'ZENITH EPIGENETICS LTD']",,Grant,2018.0,US-9855271-B2,"['John Frederick Quinn', 'Vladimir Khlebnikov']",2018-01-02,7.0,Quinazolinones as bromodomain inhibitors,2014
1435,"['ADAPTIVE BIOTECHNOLOGIES CORP', 'FAHAM MALEK', 'WILLIS THOMAS', 'SEQUENTA INC']","[{'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8795970-B2,"['Malek Faham', 'Thomas Willis']",2014-08-05,36.0,Methods of monitoring conditions by sequence analysis,2012
1436,"['REGENERON PHARMA', 'UNIV DUKE']","[{'id': 'grid.418961.3', 'name': 'Regeneron (United States)', 'country_name': 'United States'}, {'id': 'grid.26009.3d', 'name': 'Duke University', 'country_name': 'United States'}]",Application,,WO-2014124156-A1,"['HAYNES, BARTON', 'KELSOE, GARNETT', 'LOWY, ISRAEL', 'MACDONALD, LYNN', 'BARAS, Aris, I.', 'GURER, CAGAN', 'MEAGHER, Karolina, A.', 'MCWHIRTER, JOHN', 'MURPHY, ANDREW, J.', 'YANCOPOULOS, GEORGE, D.']",2014-08-14,4.0,B CELL LINEAGE BASED IMMUNOGEN DESIGN WITH HUMANIZED ANIMALS,2014
1437,"['General Hospital Corp', 'MASSACHUSETTS GEN HOSPITAL']","[{'id': 'grid.32224.35', 'acronym': 'MGH', 'name': 'Massachusetts General Hospital', 'country_name': 'United States'}]",Grant,2016.0,US-9457057-B2,"['Ronald G. Tompkins', 'A. Aria Tzika', 'Yong-Ming Yu', 'Laurence Rahme', 'Jeevendra A. Martyn']",2016-10-04,2.0,Methods for the prevention and treatment of burn injuries and secondary complications,2013
1438,"['ADAPTIVE BIOTECHNOLOGIES CORP', 'ADAPTIVE BIOTECHNOLOGIES CORP']","[{'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9365901-B2,"['Francois Pepin', 'Victoria Carlton', 'Mark Klinger', 'Malek Faham']",2016-06-14,1.0,Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia,2013
1439,['GENICAP BEHEER B V'],,Application,,WO-2015072859-A1,"['GIELIS, Johan, Leo, Alfons', 'HERMANNS, Alexander']",2015-05-21,1.0,"METHOD AND SYSTEM FOR ANALYSING, STORING, AND REGENERATING INFORMATION",2014
1440,"['CHEMETALL GMBH', 'WIETELMANN ULRICH']","[{'id': 'grid.433078.b', 'name': 'Chemetall (Germany)', 'country_name': 'Germany'}]",Application,,WO-2012171889-A1,"['WIETELMANN, ULRICH']",2012-12-20,5.0,METHOD FOR PRODUCING A CARBON-COATED LITHIUM SULFIDE AND USE THEREOF,2012
1441,"['Hutchinson Fred Cancer Research Center', 'ADAPTIVE BIOTECHNOLOGIES CORP', 'ADAPTIVE BIOTECHNOLOGIES CORP']","[{'id': 'grid.270240.3', 'acronym': 'FHCRC', 'name': 'Fred Hutchinson Cancer Research Center', 'country_name': 'United States'}, {'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9181590-B2,"['Harlan S. Robins', 'Robert J. Livingston']",2015-11-10,3.0,Quantification of adaptive immune cell genomes in a complex mixture of cells,2014
1442,"['Oncternal Therapeutics Inc', 'GTX INC']","[{'id': 'grid.476408.9', 'name': 'GTx (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9969683-B2,"['James T. Dalton', 'Mitchell S. Steiner', 'Ramesh Narayanan', 'Sunjoo Ahn']",2018-05-15,,Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS),2013
1443,"['Regeneron Pharmaceuticals Inc', 'REGENERON PHARMA']","[{'id': 'grid.418961.3', 'name': 'Regeneron (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9930871-B2,"['John McWhirter', 'Cagan Gurer', 'Karolina A. MEAGHER', 'Lynn MacDonald', 'Andrew J. Murphy']",2018-04-03,,Non-human animals with modified immunoglobulin heavy chain sequences,2015
1444,"['Institute for Systems Biology', 'INST FOR SYSTEMS BIOLOGY']","[{'id': 'grid.64212.33', 'acronym': 'ISB', 'name': 'Institute for Systems Biology', 'country_name': 'United States'}]",Grant,2018.0,US-9856532-B2,"['Leroy Hood', 'Kai Wang', 'Inyoul Lee', 'Yong Zhou', 'Ji Hoon CHO', 'Dhimankrishna GHOSH']",2018-01-02,,Markers and methods for detecting posttraumatic stress disorder (PTSD),2013
1445,"['Regeneron Pharmaceuticals Inc', 'REGENERON PHARMA']","[{'id': 'grid.418961.3', 'name': 'Regeneron (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9944716-B2,"['Lynn MacDonald', 'Sean Stevens', 'Andrew J. Murphy']",2018-04-17,1.0,ADAM6 mice,2015
1446,"['Regeneron Pharmaceuticals Inc', 'REGENERON PHARMA']","[{'id': 'grid.418961.3', 'name': 'Regeneron (United States)', 'country_name': 'United States'}]",Grant,2018.0,US-9932398-B2,"['Lynn MacDonald', 'John McWhirter', 'Cagan Gurer', 'Karolina A. MEAGHER', 'Andrew J. Murphy']",2018-04-03,,Restricted immunoglobulin heavy chain mice,2013
1447,"['Cornell Research Foundation Inc', 'SZETO HAZEL H', 'LIU SHAOYL', 'CHO SUNGHEE', 'CORNELL RES FOUNDATION INC']","[{'id': 'grid.5386.8', 'acronym': 'CU', 'name': 'Cornell University', 'country_name': 'United States'}]",Grant,2015.0,US-9150614-B2,"['Hazel H. Szeto', 'Shaoyl Liu', 'SUNGHEE CHO']",2015-10-06,,Methods for reducing CD36 expression,2013
1448,"['Genentech Inc', 'FRENCH DOROTHY', 'SIEBEL CHRISTIAN W', 'HUNTZICKER ERIK', 'GENENTECH INC']","[{'id': 'grid.418158.1', 'acronym': 'Roche', 'name': 'Roche (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9663573-B2,"['Dorothy French', 'Christian W. Siebel', 'Erik Huntzicker']",2017-05-30,2.0,Methods of treating liver conditions using Notch2 antagonists,2012
1449,"['RVX Therapeutics Inc', 'Zenith Epigenetics Ltd', 'ZENITH EPIGENETICS LTD']",,Grant,2018.0,US-10010556-B2,"['John Frederick Quinn', 'Bryan Cordell Duffy', 'Shuang Liu', 'Ruifang Wang', 'May Xiaowu JIANG', 'Gregory Scott Martin', 'Gregory Steven Wagner', 'Peter Ronald Young']",2018-07-03,1.0,Bicyclic bromodomain inhibitors,2017
1450,"['Hutchinson Fred Cancer Research Center', 'HUTCHINSON FRED CANCER RES']","[{'id': 'grid.270240.3', 'acronym': 'FHCRC', 'name': 'Fred Hutchinson Cancer Research Center', 'country_name': 'United States'}]",Grant,2017.0,US-9809813-B2,"['Harlan S. Robins', 'Edus H. Warren, III', 'Christopher Scott Carlson']",2017-11-07,11.0,Method of measuring adaptive immunity,2016
1451,"['Sion Power Corp', 'SION POWER CORP']","[{'id': 'grid.422265.5', 'name': 'Sion Power (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9531009-B2,"['Karthikeyan Kumaresan', 'Christopher T. S. Campbell', 'Bala Sankaran']",2016-12-27,6.0,Passivation of electrodes in electrochemical cells,2014
1452,"['ADAPTIVE BIOTECHNOLOGIES CORP', 'FAHAM MALEK', 'WILLIS THOMAS', 'SEQUENTA LLC']","[{'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9217176-B2,"['Malek Faham', 'Thomas Willis']",2015-12-22,15.0,Methods of monitoring conditions by sequence analysis,2012
1453,"['ADAPTIVE BIOTECHNOLOGIES CORP', 'ROBINS HARLAN SAUL', 'CARLSON CHRISTOPHER SCOTT', 'LIVINGSTON ROBERT J', 'EMERSON RYAN O', 'SHERWOOD ANNA M', 'ADAPTIVE BIOTECHNOLOGIES CORP']","[{'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9150905-B2,"['Harlan Saul Robins', 'Christopher Scott Carlson', 'Robert J. Livingston', 'RYAN O. EMERSON', 'Anna M. Sherwood']",2015-10-06,21.0,Compositions and method for measuring and calibrating amplification bias in multiplexed PCR reactions,2013
1454,"['ADAPTIVE BIOTECHNOLOGIES CORP', 'FAHAM MALEK', 'WILLIS THOMAS', 'SEQUENTA INC']","[{'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2014.0,US-8748103-B2,"['Malek Faham', 'Thomas Willis']",2014-06-10,36.0,Monitoring health and disease status using clonotype profiles,2011
1455,"['ADAPTIVE BIOTECHNOLOGIES CORP', 'ADAPTIVE BIOTECHNOLOGIES CORP']","[{'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9371558-B2,"['Harlan Saul Robins', 'Christopher Scott Carlson', 'Robert J. Livingston', 'RYAN O. EMERSON', 'Anna M. Sherwood']",2016-06-21,8.0,Compositions and method for measuring and calibrating amplification bias in multiplexed PCR reactions,2015
1456,"['Cornell Research Foundation Inc', 'CORNELL RES FOUNDATION INC']","[{'id': 'grid.5386.8', 'acronym': 'CU', 'name': 'Cornell University', 'country_name': 'United States'}]",Grant,2017.0,US-9623069-B2,['Hazel H. Szeto'],2017-04-18,,Methods for reducing oxidative damage,2013
1457,"['SANOFI SA', 'JOSLIN DIABETES CT']","[{'id': 'grid.417924.d', 'name': 'Sanofi (France)', 'country_name': 'France'}]",Application,,WO-2014128257-A1,"['MARGERIE, DANIEL', 'LOHMANN, MATTHIAS', 'GUILLEMOT, JEAN CLAUDE', 'LOYAUX, DENIS', 'KULKARNI, ROHIT', 'EL OUAAMARI, Abdelfattah']",2014-08-28,,SERPINS: METHODS OF THERAPEUTIC BETA-CELL REGENERATION AND FUNCTION,2014
1458,"['ADAPTIVE BIOTECHNOLOGIES CORP', 'SEQUENTA INC', 'ADAPTIVE BIOTECHNOLOGIES CORP']","[{'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9416420-B2,"['Malek Faham', 'Thomas Willis']",2016-08-16,21.0,Monitoring health and disease status using clonotype profiles,2013
1459,"['Stealth BioTherapeutics Corp', 'STEALTH PEPTIDES INT INC']",,Grant,2015.0,US-9023807-B2,"['Liping Liu', 'Shibo Tang', 'Xiaoling Liang']",2015-05-05,2.0,Methods and compositions for preventing or treating ophthalmic conditions,2013
1460,"['ADAPTIVE BIOTECHNOLOGIES CORP', 'ADAPTIVE BIOTECHNOLOGIES CORP']","[{'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9506119-B2,"['Malek Faham', 'Martin Moorhead', 'Thomas Willis', 'Jianbiao Zheng']",2016-11-29,7.0,Method of sequence determination using sequence tags,2013
1461,"['ADAPTIVE BIOTECHNOLOGIES CORP', 'ADAPTIVE BIOTECHNOLOGIES CORP']","[{'id': 'grid.421940.a', 'name': 'Adaptive Biotechnologies (United States)', 'country_name': 'United States'}]",Grant,2016.0,US-9512487-B2,"['Malek Faham', 'Thomas Willis']",2016-12-06,13.0,Monitoring health and disease status using clonotype profiles,2014
1462,"['Sion Power Corp', 'SION POWER CORP']","[{'id': 'grid.422265.5', 'name': 'Sion Power (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9040197-B2,"['John D. Affinito', 'Gregory K. Lowe']",2015-05-26,18.0,Electrode structure and method for making the same,2013
1463,"['Regeneron Pharmaceuticals Inc', 'REGENERON PHARMA']","[{'id': 'grid.418961.3', 'name': 'Regeneron (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9686970-B2,"['Lynn MacDonald', 'Sean Stevens', 'Cagan Gurer', 'Karolina A. MEAGHER', 'Andrew J. Murphy']",2017-06-27,1.0,Mice that make VL binding proteins,2013
1464,"['Sion Power Corp', 'MIKHAYLIK YURIY V', 'WILKENING WILLIAM F', 'CAMPBELL CHRISTOPHER T S', 'BURNSIDE SAVANNAH V', 'SION POWER CORP']","[{'id': 'grid.422265.5', 'name': 'Sion Power (United States)', 'country_name': 'United States'}]",Grant,2015.0,US-9034421-B2,"['Yuriy V. Mikhaylik', 'William F. Wilkening', 'Christopher T. S. Campbell', 'Savannah V. Burnside']",2015-05-19,9.0,Method of forming electrodes comprising sulfur and porous material comprising carbon,2009
1465,"['MANDALMED Inc', 'Texas Tech University', 'UNIV TEXAS TECH SYSTEM', 'MANDALMED INC']","[{'id': 'grid.427431.7', 'name': 'Texas Tech University System', 'country_name': 'United States'}, {'id': 'grid.264784.b', 'acronym': 'TTU', 'name': 'Texas Tech University', 'country_name': 'United States'}, {'id': 'grid.421112.5', 'name': 'MandalMed (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9744212-B2,"['Maurizio Chiriva-Internati', 'Everardo Cobos', 'Constance John']",2017-08-29,,Galectin-3C combination therapy for human cancer,2016
1466,"['MANDALMED Inc', 'Texas Tech University', 'CHIRIVA-INTERNATI MAURIZIO', 'COBOS EVERARDO', 'JOHN CONSTANCE', 'UNIV TEXAS TECH SYSTEM', 'MANDALMED INC']","[{'id': 'grid.264784.b', 'acronym': 'TTU', 'name': 'Texas Tech University', 'country_name': 'United States'}, {'id': 'grid.421112.5', 'name': 'MandalMed (United States)', 'country_name': 'United States'}, {'id': 'grid.427431.7', 'name': 'Texas Tech University System', 'country_name': 'United States'}]",Grant,2016.0,US-9272014-B2,"['Maurizio Chiriva-Internati', 'Everardo Cobos', 'Constance John']",2016-03-01,2.0,Galectin-3C combination therapy for human cancer,2012
1467,"['Bend Research Inc', 'Endocyte Inc', 'BEND RES INC']","[{'id': 'grid.421008.f', 'acronym': 'ECYT', 'name': 'Endocyte (United States)', 'country_name': 'United States'}, {'id': 'grid.423227.2', 'name': 'Capsugel (United States)', 'country_name': 'United States'}]",Grant,2017.0,US-9568449-B2,"['Brandon J. Downey', 'Jeffery F. Breit', 'Lisa Graham', 'Adam S. Carroll']",2017-02-14,,Dielectric spectroscopy methods and apparatus,2013
1468,"['National Taiwan University of Science and Technology', 'UNIV NAT TAIWAN SCIENCE TECH']","[{'id': 'grid.45907.3f', 'acronym': 'NTUST', 'name': 'National Taiwan University of Science and Technology', 'country_name': 'Taiwan'}]",Grant,2017.0,US-9742034-B2,"['Yaw-Terng Chern', 'Jyh-Long Jeng', 'Szu-Yuan Chen', 'An-Shing Wei', 'Bing-Joe Hwang']",2017-08-22,,Cyano-benzimidazole salts for electrochemical cells and method for synthesis thereof,2013
1469,['EBERHARD KARLS UNI TUEBINGEN MEDIZINISCHE FAKULTAET'],"[{'id': 'grid.10392.39', 'name': 'University of Tübingen', 'country_name': 'Germany'}]",Application,,WO-2016120471-A1,"['BERNHARD, WOLFGANG', 'FRANZ, AXEL']",2016-08-04,,PROPHYLAXIS AND TREATMENT OF DEVELOPMENTAL DISORDERS ASSOCIATED WITH PREMATURE BIRTH,2016
1470,"['UNIV MICHIGAN STATE', 'UNIV OHIO']","[{'id': 'grid.20627.31', 'name': 'Ohio University', 'country_name': 'United States'}, {'id': 'grid.17088.36', 'acronym': 'MSU', 'name': 'Michigan State University', 'country_name': 'United States'}]",Application,,WO-2015002841-A3,"['BRANDIZZI, Federica', 'WILKERSON, CURTIS', 'KIM, SANG JIN', 'HELD, MICHAEL']",2015-03-12,,IMPROVED DIGESTIBILITY OF PLANT BIOMASS,2014
1471,['COHEN-ARMON MALKA'],,Grant,2016.0,US-9486449-B2,['Malka COHEN-ARMON'],2016-11-08,,Cancer therapy,2014
1472,"['UNIV ROCHESTER', 'BURACK RICHARD', 'SPENCE JANICE']","[{'id': 'grid.16416.34', 'acronym': 'UR', 'name': 'University of Rochester', 'country_name': 'United States'}]",Application,,WO-2011140187-A2,"['BURACK, RICHARD', 'SPENCE, JANICE']",2011-11-10,5.0,DETECTING CHROMOSOMAL REARRANGEMENT,2011
1473,"['Centre Hospitalier Univ Bordeaux', 'Centre National de la Recherche Scientifique CNRS', 'Centre Hospitalier Universitaire de Bordeaux', 'Universite de Bordeaux', 'UNIVERSITÉ DE BORDEAUX', 'CENTRE NAT DE LA RECH SCIENT -CNRS-', 'CENTRE HOSPITALIER UNIV BORDEAUX']","[{'id': 'grid.42399.35', 'acronym': 'CHU', 'name': 'Centre Hospitalier Universitaire de Bordeaux', 'country_name': 'France'}, {'id': 'grid.412041.2', 'name': 'University of Bordeaux', 'country_name': 'France'}, {'id': 'grid.4444.0', 'acronym': 'CNRS', 'name': 'French National Centre for Scientific Research', 'country_name': 'France'}]",Application,,EP-3195881-A1,"['TRUCHETET, Marie-Élise', 'CONTIN-BORDES, Cécile', 'BLANCO, PATRICK', 'SCHAEVERBEKE, Thierry', 'BARNETCHE, Thomas']",2017-07-26,,"SUBSTANCE THAT INHIBITS P2Y12 RECEPTOR, FOR USE IN THE PREVENTIVE TREATMENT OF SYSTEMIC SCLEROSIS IN PATIENTS WITH RAYNAUD'S PHENOMENON AND A DYSIMMUNITY",2016
1474,['NUTRICIA NV'],"[{'id': 'grid.423979.2', 'name': 'Danone (Netherlands)', 'country_name': 'Netherlands'}]",Application,,WO-2015178762-A1,"['VAN DER BEEK, ELINE MARLEEN', 'ABRAHAMSE-BERKEVELD, MARIEKE', 'VAN GOUDOEVER, JOHANNES BERNARD', 'TELLER, Inga Christiane']",2015-11-26,,ENTERAL FORMULATIONS FOR PRETERM INFANTS COMPRISING OPTIMISED PHENYLALANINE INTAKE LEVELS,2014
1475,"['UChicago Argonne LLC', 'UCHICAGO ARGONNE LLC']","[{'id': 'grid.170205.1', 'acronym': 'UC', 'name': 'University of Chicago', 'country_name': 'United States'}]",Grant,2018.0,US-10020538-B2,"['Chen Liao', 'Trevor L. Dzwiniel', 'Baofei PAN', 'Sang-Don HAN', 'Anthony BURRELL']",2018-07-10,,Salts for multivalent ion batteries,2015
1476,"['Keygene NV', 'KEYGENE NV']","[{'id': 'grid.425600.5', 'name': 'KeyGene (Netherlands)', 'country_name': 'Netherlands'}]",Application,,US-20160010108-A1,"['Anne DESLATTES MAYS', 'Marieke Helena Adriana VAN HULTEN', 'Shital Anilkumar DIXIT', 'Martin DE VOS', 'Jesse David MUNKVOLD', 'Matthew Vitabile DILEO']",2016-01-14,,DROUGHT RESISTANCE IN PLANTS: PECTINESTERASE,2013
1477,"['PERSICO ANTONIO M', 'LOMBARDI FEDERICA']",,Application,,WO-2011045402-A1,"['PERSICO, ANTONIO M.', 'LOMBARDI, FEDERICA']",2011-04-21,,AUTISM-ASSOCIATED FUNCTIONAL POLYMORPHISMS IN SLC25A12 GENE,2010
1478,"['University of North Carolina at Chapel Hill', 'Dartmouth College', 'DARTMOUTH COLLEGE', 'UNIV NORTH CAROLINA CHAPEL HILL']","[{'id': 'grid.254880.3', 'name': 'Dartmouth College', 'country_name': 'United States'}, {'id': 'grid.10698.36', 'acronym': 'UNC', 'name': 'University of North Carolina at Chapel Hill', 'country_name': 'United States'}]",Grant,2017.0,US-9796985-B2,"['G. Eric Schaller', 'Hyo-Jung Kim', 'Joseph Kieber']",2017-10-24,,Compositions and method for modulating the sensitivity of plants to cytokinin,2014
1479,"['GIELIS JOHAN', 'CARATELLI DIEGO']",,Application,,WO-2011161548-A2,"['GIELIS, JOHAN', 'CARATELLI, DIEGO']",2011-12-29,9.0,COMPUTER IMPLEMENTED TOOL BOX SYSTEMS AND METHODS,2011
1480,"['Semiconductor Energy Laboratory Co Ltd', 'SEMICONDUCTOR ENERGY LAB']","[{'id': 'grid.471323.0', 'acronym': 'SEL', 'name': 'Semiconductor Energy Laboratory (Japan)', 'country_name': 'Japan'}]",Grant,2016.0,US-9502666-B2,"['Tomonori Nakayama', 'Takako Takasu', 'Satoko Shitagaki', 'Harue Osaka', 'Toshiki HAMADA']",2016-11-22,,"Light-emitting element, light-emitting device, electronic device, and lighting device",2013
1481,"['MJN US Holdings LLC', 'MJN US HOLDINGS LLC']","[{'id': 'grid.467517.6', 'name': 'Mead Johnson (United States)', 'country_name': 'United States'}]",Grant,2016.0,AU-2013309437-B2,"['BERSETH, CAROL LYNN', 'MUNOZ-ESPADA, ANA CECILIA', 'SCHADE, DEBORAH', 'WALSH, KELLY']",2016-09-01,,Formula fortifier,2013
1482,"['Academia Sinica', 'CHAO YU-CHAN', 'WU YUEH-LUNG', 'WU CAROL PEI YIN', 'WANG CHIA-HUNG', 'ACADEMIA SINICA']","[{'id': 'grid.28665.3f', 'name': 'Academia Sinica', 'country_name': 'Taiwan'}]",Grant,2013.0,US-8598136-B2,"['Yu-Chan Chao', 'Yueh-Lung Wu', 'Carol Pei Yin Wu', 'Chia-Hung Wang']",2013-12-03,,Baculovirus-mediated transgene expression in both mammalian and insect cells,2011
1483,"['UNIV MICHIGAN STATE', 'UNIV OHIO']","[{'id': 'grid.20627.31', 'name': 'Ohio University', 'country_name': 'United States'}, {'id': 'grid.17088.36', 'acronym': 'MSU', 'name': 'Michigan State University', 'country_name': 'United States'}]",Application,,WO-2015002841-A2,"['BRANDIZZI, Federica', 'WILKERSON, CURTIS', 'KIM, SANG JIN', 'HELD, MICHAEL']",2015-01-08,1.0,IMPROVED DIGESTIBILITY OF PLANT BIOMASS,2014
1484,"['Dicofarm SpA', 'DICOFARM SPA']",,Application,,EP-2653040-A1,"['ACRI, MAURIZIO']",2013-10-23,1.0,Food based on donkey fortified milk for preterm infants and/or term infants with allergy or intollerance to cow's milk proteins and method of preparation thereof,2013
1485,['US HEALTH'],,Application,,WO-2015084513-A1,"['QIN, Haiying', 'FRY, Terry J.']",2015-06-11,,THYMIC STROMAL LYMPHOPOIETIN RECEPTOR-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND METHODS USING SAME,2014
1486,"['Keygene NV', 'KEYGENE NV']","[{'id': 'grid.425600.5', 'name': 'KeyGene (Netherlands)', 'country_name': 'Netherlands'}]",Grant,2018.0,US-9909138-B2,"['Anne DESLATTES MAYS', 'Marieke Helena Adriana VAN HULTEN', 'Shital Anilkumar DIXIT', 'Martin DE VOS', 'Jesse David MUNKVOLD', 'Matthew Vitabile DILEO']",2018-03-06,,Drought resistance in plants: pectinesterase,2013
1487,"['Arkema France SA', 'ARKEMA FRANCE']","[{'id': 'grid.423748.e', 'name': 'Arkema (France)', 'country_name': 'France'}]",Grant,2017.0,US-9550736-B2,['Grégory Schmidt'],2017-01-24,,Salt of bicyclic aromatic anions for Li-ion batteries,2013
1488,['GENICAP BEHEER B V'],,Application,,WO-2015072859-A1,"['GIELIS, Johan, Leo, Alfons', 'HERMANNS, Alexander']",2015-05-21,1.0,"METHOD AND SYSTEM FOR ANALYSING, STORING, AND REGENERATING INFORMATION",2014
1489,"['VIB VZW', 'UNIV GENT', 'CENTRE NAT RECH SCIENT', 'UNIVERSITÉ MONTPELLIER 2', 'CT HOSPITALIER REGIONAL UNIVERSITAIRE MONTPELLIER']","[{'id': 'grid.121334.6', 'acronym': 'UM', 'name': 'University of Montpellier', 'country_name': 'France'}, {'id': 'grid.157868.5', 'acronym': 'CHRU MTP', 'name': 'University Hospital of Montpellier', 'country_name': 'France'}, {'id': 'grid.5342.0', 'name': 'Ghent University', 'country_name': 'Belgium'}, {'id': 'grid.4444.0', 'acronym': 'CNRS', 'name': 'French National Centre for Scientific Research', 'country_name': 'France'}]",Application,,WO-2015007520-A1,"['TAVERNIER, JAN', 'ZABEAU, LENNART', 'UZÉ, Gilles', 'PAUL, Franciane', 'BORDAT, Yann', 'GARCIN, Geneviève']",2015-01-22,11.0,TARGETING OF CYTOKINE ANTAGONISTS,2014
1490,"['COHEN-ARMON MALKA PROF', 'COHEN-ARMON MALKA']",,Grant,2014.0,US-8729080-B2,['Malka COHEN-ARMON'],2014-05-20,,Cancer therapy,2010
1491,"['Mead Johnson Nutrition Co', 'BERSETH CAROL LYNN', 'WALSH KELLY', 'SCHADE DEBORAH', 'MUNOZ-ESPADA ANA CECILIA']","[{'id': 'grid.467517.6', 'name': 'Mead Johnson (United States)', 'country_name': 'United States'}]",Application,,US-20140057014-A1,"['Carol Lynn Berseth', 'Kelly Walsh', 'Deborah Schade', 'Ana Cecilia Munoz-Espada']",2014-02-27,1.0,Formula Fortifier,2012
1492,"['University of South Florida', 'UNIV SOUTH FLORIDA']","[{'id': 'grid.170693.a', 'acronym': 'USF', 'name': 'University of South Florida', 'country_name': 'United States'}]",Grant,2015.0,US-9089589-B2,"['Shyam S. Mohapatra', 'Jia-Wang Wang']",2015-07-28,1.0,Micro-RNAs modulating immunity and inflammation,2013
1493,['NEKTAR THERAPEUTICS'],"[{'id': 'grid.476522.0', 'name': 'Nektar Therapeutics (United States)', 'country_name': 'United States'}]",Application,,WO-2014194289-A1,"['HOCH, UTE', 'BREW, CHRISTINE, TAYLOR', 'HARRISON, Stephen, David', 'FRY, DENNIS, G.', 'DAVIS, DARREN, W.']",2014-12-04,1.0,METHOD FOR PREDICTING AND EVALUATING RESPONSIVENESS TO CANCER TREATMENT WITH DNA-DAMAGING CHEMOTHERAPEUTIC AGENTS,2014
1494,"['Universiteit Leiden', 'DE RIJK ROLANDUS HENDRIKUS', 'KLOK MELANIE DIANE', 'DE KLOET EDO RONALD', 'UNIV LEIDEN']","[{'id': 'grid.5132.5', 'name': 'Leiden University', 'country_name': 'Netherlands'}]",Grant,2017.0,US-9644240-B2,"['Rolandus Hendrikus de Rijk', 'Melanie Diane Klok', 'Edo Ronald de Kloet']",2017-05-09,,Disease susceptibility,2010
1495,"['UNIV LEIDEN', 'KLOK MELANIE DIANE', 'DE RIJK ROLANDUS HENDRIKUS', 'DE KLOET EDO RONALD']","[{'id': 'grid.5132.5', 'name': 'Leiden University', 'country_name': 'Netherlands'}]",Application,,WO-2011047856-A1,"['KLOK, MELANIE, DIANE', 'DE RIJK, ROLANDUS, HENDRIKUS', 'DE KLOET, EDO, RONALD']",2011-04-28,1.0,DISEASE SUSCEPTIBILITY,2010
1496,['NUTRICIA NV'],"[{'id': 'grid.423979.2', 'name': 'Danone (Netherlands)', 'country_name': 'Netherlands'}]",Application,,WO-2017069612-A1,"['DE WILDE, Martijn', 'COUNOTTE, Danielle Stefanie']",2017-04-27,,METHOD FOR IMPROVING WHITE MATTER INTEGRITY IN HYPERPHENYLALANINEMIA AND PHENYLKETONURIA PATIENTS,2015
1497,"['Idorsia Pharmaceuticals Ltd', 'ABELE STEFAN', 'FUNEL JACQUES-ALEXIS', 'ACTELION PHARMACEUTICALS LTD']","[{'id': 'grid.417650.1', 'name': 'Actelion (Switzerland)', 'country_name': 'Switzerland'}]",Grant,2014.0,US-8816118-B2,"['Stefan Abele', 'Jacques-Alexis Funel']",2014-08-26,1.0,Diastereoselective preparation of bicyclo[2.2.2]octan-2-one compounds,2011
1498,"['ACTELION PHARMACEUTICALS LTD', 'ABELE STEFAN', 'FUNEL JACQUES-ALEXIS']","[{'id': 'grid.417650.1', 'name': 'Actelion (Switzerland)', 'country_name': 'Switzerland'}]",Application,,WO-2012052943-A1,"['ABELE, STEFAN', 'FUNEL, JACQUES-ALEXIS']",2012-04-26,,DIASTEREOSELECTIVE PREPARATION OF BICYCLO[2.2.2]OCTAN-2-ONE COMPOUNDS,2011
1499,['NUTRICIA NV'],"[{'id': 'grid.423979.2', 'name': 'Danone (Netherlands)', 'country_name': 'Netherlands'}]",Application,,WO-2017069630-A1,"['SAVELKOUL, Paul Johannes Maria', 'VERKUYL, Jan Martin', 'HAGEMAN, ROBERT JOHAN JOSEPH', 'DE WILDE, Martijn', 'COUNOTTE, Danielle Stefanie', 'RAKHSHANDEHROO, Myryam']",2017-04-27,,METHOD FOR IMPROVING WHITE MATTER INTEGRITY IN HYPERPHENYLALANINEMIA AND PHENYLKETONURIA PATIENTS,2016
